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Abstract
PhD Thesis - Stefan Winzeck
Methods for Data Management in Multi-Centre MRI Studies and Applications
to Traumatic Brain Injury
Neuroimaging studies are becoming increasingly bigger, and multi-centre collaborations to
collect data under similar protocols, but different scanning sites, are now commonplace.
However, with increasing sample size the complexity of databases and the entailed data
management as well as computational burden are growing. This thesis aims to highlight
and address challenges faced by large multi-centre magnetic resonance imaging (MRI) stud-
ies. The methods implemented are then applied to traumatic brain injury (TBI) data.
Firstly, a pre-processing pipeline for both anatomical and diffusion MRI was proposed, that
allows for a high throughput of MRI scans. After describing the choices for processing tools,
the performance of the integrated quality assurance was assessed based on the results from a
large multi-centre dataset for TBI. Secondly, the applicability of the pipelines for processing
mild TBI (mTBI) data from three sites was shown in a case study. For this, volumetric and
diffusion metrics in the acute phase are analysed for their prognostic potential. Further-
more, the cohort was examined for longitudinal changes. Thirdly, independent scan-rescan
datasets are examined to gain a better understanding of the degree of reproducibility which
can be achieved in imaging studies. This involves analysing the robustness of brain parcel-
lations based on structural or diffusion imaging. The effect of using different MRI scanners
or imaging protocols was also assessed and discussed. Fourthly, sources of diffusion MRI
variability and different approaches to cope with these are reviewed. Using this foundation,
state-of-the art methods for diffusion MRI harmonisation were compared against each other
using both a benchmark dataset and mTBI cohort. Lastly, a solution to localise brain lesions
was proposed. Its implications for lesion analysis, are assessed in the light of an application
to a more severe TBI patient cohort, imaged on two different scanners. Furthermore, a
lesion matching algorithm was introduced to automatically examine lesion evolution with
time post-injury. In summary, this thesis explored different options for MRI data analysis
in the context of large multi-centre studies. Different approaches are studied and compared
using a number of different MRI datasets, including scan-rescan data across different MRI
scanners and imaging protocols. The potential of the optimised solutions was illustrated
through applications to TBI data.
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1.1 Neuroimaging: A Field Moves Towards Big Data
When the first magnetic resonance (MR) images of a live human subject were acquired
in the late 1970’s, new possibilities to study human anatomy and physiology were opened
up. Shortly after, with commercially available MRI scanners, the field of neuroimaging was
born [59]. Most studies in the first three decades have been limited to small number of
subjects, but over the years medical imaging has seen many new advances in hardware and
pulse sequence design as well as image reconstruction algorithms. With MRI scanners be-
coming cheaper, faster [248] and more accessible [76] over time, and with the new emerging
fields - such as the ultra-high field MRI [201] - more scans are collected than ever. This
trend is further enforced as studies nowadays usually acquire multi-modal images to examine
anatomy, function and connectivity of the healthy and diseased brain. Besides the number
of obtained scans, their capacity has progressively transformed to capture more detailed
information about the brain. For example, the earliest functional image time series sam-
pled total volumes at a four second rate, but with better imaging technologies this interval
was more than halved while slice resolution increased [252]. Similarly, for diffusion tensor
imaging (DTI) for which initially only six volumes, each sensitised along a different gradient
direction, were acquired [16]. To better examine white matter (WM) fibre orientation, the
angular resolution was refined by increasing the number of diffusion directions [50, 279]. For
example, diffusion spectral imaging has been introduced to resolve more than 500 diffusion
directions while keeping common volume size and spatial resolution [59, 252]. Although
useful to quantify the micro-structural integrity of WM, diffusion spectral imaging is lim-
ited to research applications and today’s clinical studies often include around 60 diffusion
volumes. In addition to the general increasing size of individual datasets through multi-
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modal image acquisition, there is a trend to collect larger numbers of subjects to improve
statistical power. Large-scale databases enable the detection of subtle effects that would
not be statistically observable in smaller groups [233]. Acknowledging this need for larger
datasets, both population and multi-centre studies have emerged throughout the past few
years. While smaller studies remain important to look at very specific cohorts in future, the
shift towards larger databases in the field of neuroimaging is clearly observable [272]. Such
big databases can be shaped by either a large number of subjects (i.e. >1,000) scanned or
the extensive data acquisition with advanced scanning protocols (e.g. Human Connectome
Project1 [HCP] Adult Diffusion sequence with several shells and high angular resolution
amasses more than three gigabytes per scan) [233]. Both have the potential to improve im-
age analysis and foster more generalisable research. Eventually, larger neuroimaging studies
will help to understand specific patient cohorts as well as disease development in a general
healthy populations, however, they also come with many challenges for data management,
processing and analysis.
1.2 Design of Big Neuroimaging Studies
Collecting big data for neuroimaging studies can be difficult, which is why different ap-
proaches have been established to increase the size of databases. They can be broadly
categorised as single-centre studies and retrospective as well as prospective multi-centre
studies. All of them come with different advantages and drawbacks.
1.2.1 Large Single-Centre Studies
In a best case scenario, subject recruitment and data collection is centralised at one imag-
ing site. With one MR protocol used ideally on one scanner consistently, the acquisition
related variability can be greatly reduced. Besides this, the administrative effort and costs
can be kept to a minimum as no coordination between sites is required. One example for
a large-scale database is the single-site Cambridge Centre for Ageing and Neuroscience2
(Cam-CAN) study that collected neuroimaging and cognitive data for several hundred of
healthy subjects across a wide age range to research healthy ageing [226]. Another ex-
ample is the HCP which accumulated multi-parametric neuroimaging data on one scanner
from 1,200 healthy volunteers over the span of five years [251]. A little more specific is
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adolescents underwent multi-modal MRI to examine cognitive development and its link to
psychiatric illness. To form a big database, inclusion criteria were kept to a minimum and
no screening for specific psychiatric or other medical disorders took place at the recruitment
stage [223]. All three studies have in common, that they mainly focus on healthy volunteers
or have relative wide inclusion criteria for subject recruitment.
1.2.2 Retrospective Multi-Centre Studies
Although acquiring imaging data at a single site poses much less challenges for data organisa-
tion and harmonisation, one big shortcoming may be the availability of patients. Multi-site
studies have the potential to amass a large dataset from a specific patient cohort, which
otherwise would not be obtainable at a single site. Besides increasing the sample size, com-
bined datasets from multiple centres, various cities and different countries bear the potential
to capture the full disease profile. Since many clinical facilities collect data from specific
patient cohorts for diagnosis and treatment, a great opportunity to increase sample size
is to aggregate such legacy datasets. For a small number of partnering sites, this usually
requires little organisational effort. However, such collaborations can be limited to datasets
that were acquired with similar imaging techniques to allow any combined analysis [249].
Projects could range from two research groups, that agree to share data, up to large-scale
collaborations incorporating multiple sites. A special case are consortia which aim to aggre-
gate data from many sites to provide a large database of certain cohorts. For instance, the
Autism Brain Imaging Data Exchange4 (ABIDE) project which gathered and openly pro-
vides resting-state functional MRI for more than 1,000 subjects (fairly even split between
autistic individuals and age-matched controls) from over 24 international brain imaging sites
[54]. Another prominent example is the Enhancing Neuroimaging Genetics through Meta-
Analysis5 (ENIGMA) consortium - a growing number of scientists across 340 institutions
in 35 countries - investigating the genetic impact on brain structure. Pooling imaging and
genetics data from global existing studies amplifies the sample sizes by many folds. This
fosters research of brain abnormalities in more than 20 major cognitive, psychiatric and
neurogenetic disorders (e.g. depression or schizophrenia) [18, 242]. Since imaging data are
acquired independently and combined retrospectively in a meta-analysis, the efforts for prior
coordination are low, however, with the caveat of a highly heterogeneous database.
4www.fcon_1000.projects.nitrc.org/indi/abide
5www.enigma.usc.edu
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1.2.3 Prospective Multi-Centre Studies
Multi-centre imaging studies require the most planning and substantial effort to coordinate
the data collection. This is reaching from equalising imaging equipment and methods across
sites to building a sufficient infrastructure to centralise and share data. Such studies are very
expensive due to planning overhead, however, with the benefit of minimising the variation in
inclusion criteria, scanner calibration and imaging protocols, which facilitates the pooling of
data for a combined analysis [82, 249]. Such large databases are particularly important if the
cohort under investigation exhibits a vast heterogeneity, such as for example TBI patients,
who suffer from injuries of different severities and experience a wide spectrum of symptoms.
A well established prospective multi-centre project to investigate TBI on a large scale is the
Transforming Research and Clinical Knowledge in Traumatic Brain Injury6 (TRACK-TBI)
study. It aimed to gather neuroimaging data, including MRI two weeks after injury, at four
sites in the USA. All centres implemented equivalent imaging protocols on MRI scanners
from three different vendors [274]. Similarly, the more extended Collaborative European
Neuro-Trauma Effectiveness Research in Traumatic Brain Injury7 (CENTER-TBI) study
has been set up as a prospective collaboration between 22 countries (ca. 80 sites) across Eu-
rope and Israel with the aim to collectively gather extensive data to improve characterisation
of TBI. This included the collection of longitudinal clinical and epidemiological information
as well as blood biomarkers. Some of the sites have been contributing to an extended data
acquisition, which included multi-contrast MRI data collected up to two years post-injury
[162]. In order to minimise acquisition related differences, site-specific MR protocols were
designed with similar parameters. To ensure the image quality and provide a baseline, scan-
ning protocols were validated on custom-built phantoms. To foster a combined analysis and
allow data harmonisation, additionally to the phantoms, healthy volunteers were scanned
at each site [28]. Less targeted towards any specific disease cohort, is the UK Biobank8
project. To date it is one of the largest, highly coordinated imaging studies planning to scan
100,000 volunteers9 to collect data from 22 centres across the UK [175, 192]. The aim is to
build a homogeneous database that, in combination with follow-up metrics (both clinical and
imaging), can serve as an analysis pool for early biomarker detection within a middle-aged10
population cohort. Although subjects appear to be healthy during the recruitment, patient
groups will be identified with follow-up clinical assessments over time. It is estimated that
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Alzheimer’s disease, 8,000 will suffer from diabetes and another 1,800 will have experienced
a stroke [4, 175].
1.3 Challenges
1.3.1 Data Management
As previously established, neuroimaging databases are growing due to increasing number
of subjects, enhanced image quality as well as multi-parametric and longitudinal image ac-
quisition. This is fostered by breakthroughs in computational science (e.g. deep learning),
clinical needs to study complex diseases in larger cohorts and improved infrastructure to
acquire and share data. While beneficial for research purposes, storage, computing memory
and computational speed become a difficulty for these large-scale databases. An essential
part of neuroimaging studies is the removal of artefacts and the extraction of structured
information relevant to the research question. Although this extraction usually condenses
the available information and in theory compresses the database size, image processing tools
often create intermediate output files that further increase the demand for (temporary) disk
space. Moreover, some image analyses, such as computing brain connectivity on a voxel
level from a functional MRI time series, can even lead to expansion of data size [233]. A
centralised database that provides the same curated data for all researchers involved can
help to minimised storage needs. This, however, requires an easily accessible infrastruc-
ture to share data, transparent quality control (QC) mechanisms and constant database
maintenance [200]. With more imaging data available and the development of data-hungry
algorithms, there is a shift towards use and optimisation of modern graphical processing
units [152]. Besides advanced hardware and improved computing architecture, data man-
agement can further be supported by streamlined image processing pipelines. Since many
software tools for neuroimaging data were not designed for large-scale analysis [252], there is
also a need for new algorithms that accelerate processing performance. The combination of
new state-of-the-art methods, integrated in optimised processing pipelines, and the design
of modern computing clusters allow a high throughput of imaging data. Although optimal
data management is the backbone to any research flow, this is only one of the challenges
faced when dealing with large and heterogeneous databases.
1.3.2 Confounding Factors
Large neuroimaging studies can often be less specific as one of the primary goals is to amass
a vast amount of data to cover the variability within a cohort. Population studies, such as for
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example the UK Biobank project, have no single disease focus and data are collected before
any subgroups are identified. Therefore, acquiring a big dataset is needed to improve the
chances to detect subtle effects that were otherwise statistically not observable. Although
large sample sizes are beneficial to highlight real effects, it also increases the sensitivity to
confounding factors. This particularly holds true for large imaging studies, as the potential
for imaging artefacts increases with sample size. Such artefacts can directly affect the imag-
ing variables of interest. For example head motion or scanner hardware changes11 are much
more likely to occur in large and longitudinal studies [233]. Thus, it is important to apply
sophisticated acquisition and processing methods to reduce the impact of these confounds
while avoiding the alteration of the true signal [233]. For instance, accelerating image acqui-
sition could help to reduce head motion artefacts. In addition, methods have been developed
to reduce the effect of motion-related confounds, however, it was recently shown that this
is non-trivial as different pre-processing steps can also influence subsequent data analysis
[191]. On the other hand, there are confounding effects driven by the imaging hardware used
and scanner software. These mostly will have the same effect on different subjects, however,
will greatly vary for different imaging sites. For example, different vendors, magnetic field
strengths and type of coils have been found to affect volumetric measurements extracted
from anatomical MR scans [49, 120, 139]. Furthermore, the MR acquisition protocol was
shown to impact image quality. For example, different magnitude [24] and number [41] of
b-values were found responsible for variation in diffusion metrics. Both the angular [279]
and spatial [194] resolution had an impact on the measured diffusion signal. Even when
choosing identical imaging systems and setups, differences are inevitable, partially, since
operator inconsistency can also alter image quality [233, 252]. Moreover, some confounding
factors are unrelated to the image acquisition, but a result of anatomical differences between
subjects. For example, cortical thinning is a natural age-related phenomenon and needs to
be considered when examining tissue atrophy in diseased brains [233]. Other subjects de-
pendent effects such as alcohol [243] and caffeine [148] consumption have been shown to
influence MRI signal. Particularly when dealing with multi-centre studies, inequalities in
databases need to be addressed to avoid any site-specific biases.
1.3.3 Data Harmonisation
Combining heterogeneous databases from multiple studies retrospectively often requires dif-
ferences in image acquisition to be rectified. As a first step this could mean removing field
inhomogeneities of individual scanners, resampling images to a common spatial resolution
and/or projecting them to the same physical space. For prospective multi-centre studies,
11or inevitable hardware difference in multi-centre studies due to the different scanning location
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with matched scanning parameters, site-specific biases are ideally less pronounced but can-
not be ruled out completely. With more neuroimaging data available through collaborative
projects there is a rising awareness of MRI inconsistencies across sites. A large empirical
study showed that MR scans from 17 different databases could easily be associated with
their origin by a standard machine learning classifier (≈72% accuracy) [258]. Similarly, it
has been shown that even after meticulous pre-processing of anatomical brain scans, MR
images from different studies could still be identified by a randomised forest (RF) classifier
with high accuracy (≈80-99% for two databases) [81]. This indicates that commonly ap-
plied processing steps may not be sufficient in reducing site-specific differences. Even after
applying harmonisation methods and successfully reducing inter-site variations, scans from
different sites could still be distinguished easily (≈40-55% for 17 databases) [36, 258]. In
fact, some techniques such as Z-scoring, were reported to also diminish the underling signal
of interest [258]. This is especially problematic for prognostic analysis of multi-site data,
where differentiation between patient cohorts could be hampered or even misled by site-
specific influences. Therefore, standardised MR protocols have been employed to minimise
differences across scanners [77, 92]. This is indeed a viable option for prospective multi-
site imaging projects, however, currently many databases exists that could be harvested
for clinical research if adequate harmonisation methods were available. Moreover, today’s
multi-centre studies may be tomorrow’s legacy data. In other words, there will always be a
trend to combine different databases to leverage the vast information from previously col-
lected MR scans. Additionally, a recent survey has shown that more guidance is needed for
medical data harmonisation [119]. In particular, the impact of current techniques on MR
scans of different disease cohorts is little understood. For those reasons, harmonisation of
neuroimage data remains an open research question that will become even more important
with the increasing number of emerging multi-centre projects.
1.4 Overview of Thesis
Some of the core challenges for large-scale multi-centre studies involve optimising workflow
for processing large-scale MRI databases, understanding the impact of different MR scan-
ners and protocols on image derived features as well as general data harmonisation. This
thesis aims to explore some of these concepts with direct application to a TBI cohort. Trau-
matic brain injuries are interesting to study, since diverse injury mechanisms and pathology
development lead to highly heterogeneous disease patterns. While some patients show very
subtle changes in WM, others experience severe head injury including lesions and brain
tissue atrophy. This heterogeneity makes TBI a particular challenging cohort and some
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concepts could also be transferred to simpler neurological diseases (e.g. tumour segmen-
tation is less challenging than TBI lesion segmentation). At first, pre-processing pipelines
will be introduced that were specifically, but not exclusively, designed for TBI data. These
entail state-of-the art methods for artefact correction and preparing the data for subsequent
analysis for clinical research questions (Chapter 2). Thereafter, the applicability of the
pipelines will be tested on a mTBI study including data from three different sites. As a
direct output from the pipelines, QC metrics will be employed to curate the dataset. Image
derived features automatically computed via the pipelines will then be used for analysis of
the mTBI cohort (Chapter 3). Furthermore, brain parcellation methods will be examined
for their reproducibility when applied to multi-scanner data. Regional diffusion metrics will
be compared for different scanners and/or MR protocols (Chapter 4). Acknowledging the
site-specific differences in diffusion MRI, different harmonisation methods will be evaluated
(Chapter 5). Finally, lesions of severe TBI patients scanned on two different scanners will
be analysed (Chapter 6).
The following paragraph briefly describes the content of each chapter:
• Chapter 2 presents two flexible pipelines that allow processing anatomical and diffusion
MRI. Besides the tailored artefact correction, the image derived features as well as the
integrated QC are described.
• Chapter 3 showcases the application of the processing pipelines for TBI analysis. Re-
gional volumetric and diffusion differences between controls and mTBI patients are
examined and linked to patient outcome.
• Chapter 4 evaluates the robustness of anatomical white and grey matter parcellation
methods with regards to different scanner hardware and investigates the influence of
different acquisition protocols on diffusion MRI metrics.
• Chapter 5 compares different diffusion MRI harmonisation techniques and examines
their application to a small mTBI study.
• Chapter 6 studies contusion and oedema in TBI patients scanned on two different
scanners and introduces algorithms for automated lesion localisation as well as for
lesion matching for longitudinal lesion analysis.




2.1 Requirements and Concept of Processing Pipelines
With data being collected for hundreds of subjects at several time points across different
sites and vendors, datasets become quickly very complex [264]. As a consequence, a lot of
time needs to be invested to curate and process a database such that it is ready to use for
analysis by a multi-disciplinary team of clinicians, machine learning researchers and statis-
ticians. Therefore, there is a demand for robust pipelines that facilitate image processing,
data curation and information extraction. To build effective pipelines that support neurosci-
entific research they need to fulfil a number of requirements. To allow a high throughput of
data, the pipelines need to be computationally efficient. This can be achieved by using fast
methods, parallelising processes and connecting modules smartly together. Furthermore,
data need to be processed in a robust way to minimise variation when rerunning the same
pipeline on the same data. In addition, it is desirable to have a modular pipeline that allows
the seamless integration of well-validated tools and new state-of-the-art methods. Since it
becomes intractable to visually inspect large databases, QC metrics will need to assess the
processed output and flag up corrupted scans and failed processing steps. Eventually, after
removing artefacts and enhancing image quality, the pipelines will need to extract meaning-
ful image features that can then be used to answer clinical questions. Ideally, input data fed
to the pipeline and any processing steps are thoroughly documented, to provide information
about what data were used and how it was handled.
Two pipelines were designed for this project, one for structural MRI, and another for dif-
fusion MRI data. Both pipelines were implemented with the python library nipype (version
9
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1.1.8) [86]. Alternatives could be FDT1 (FSL’s Diffusion Toolbox) or FreeSurfer 2, however,
these mostly focus on algorithms developed for the particular toolbox. On the other hand,
nipype is scriptable library facilitates the access to various sophisticated software packages
(e.g. FSL, ANTS, MRtrix3, Dipy) via unified semantics. Many of them have been applied
throughout multiple neuroimaging studies making results more replicable. One great ad-
vantage is, that once a processing module has been completed, it will be stored in a cache.
So, when rerunning the pipeline on the same data again, processed data can be retrieved
without any further computational effort as long as the input and the parameters for the
particular module were unchanged. This makes the pipelines not only more efficient, but
also more robust. Generally, if rerunning a processing module without any changes, the
output quality might still be influenced by statistical variance of an applied tool (for ex-
ample because of random initialisation of an algorithm). Besides the access to well known
neuroimaging tools, nipype also enables the implementation of customised interfaces. This
allows the integration of any command line tool or script, in order to link together the most
suitable methods and tailor the pipelines to one’s needs. The pipelines include modules to
compute QC metrics for different tools as well as modules to extract image derived pheno-
types (IDPs). Both QC metrics and IDPs are stored in comma-separated values (CSV) file
format for each subject individually. After prepossessing a whole database, those CSV files
can easily be concatenated within seconds to combine information for one study all together.
Another great advantage of nipype is that all parameters for any applied processing tool are
saved as text file such that the information can be retrieved and processes repeated any
time. Furthermore, a custom text file is generated and stored for each processed scan, that
exactly documents which pipeline version was run and what data were fed into it. The setup
of both pipelines will be described in detail in the following sections.
2.2 Data Acquisition
Cam-CAN Database. Images for the Cam-CAN study were collected on a three Tesla (3T)
Siemens Trio Tim scanner with a 32-channel head coil at the Medical Research Council (UK)
Cognition and Brain Sciences Unit (MRC-CBU) in Cambridge, UK. The T1-weighted (T1w)
magnetisation-prepared rapid acquisition with gradient echo (MPRAGE) scans were collected
with an echo time TE = 2.99ms, a pulse repetition time TR = 2250ms, an inversion time
TI = 900ms and a 9◦ flip angle. A 2-fold acceleration factor was applied (generalised auto-
calibrating partial parallel acquisition) to cover the field of view (FOV) (256×240×192) with
1www.fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT
2www.surfer.nmr.mgh.harvard.edu
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isotropic 1mm3 voxels. Diffusion weighted images (DWI) were acquired for two different b-
values (b = 1000, 2000 s/mm2) with each 30 non-co-linear directions and three non-diffusion
sensitised images (b = 0 s/mm2). Images with isotropic 2×2×2 mm3 voxels (axial slices;
FOV = 192×192) were all acquired with TR = 9100ms and TE = 104ms. More details
are available in the Cam-CAN repository publication [239]. Although DWI are relatively
low in angular resolution for today’s standard, this represents a state-of-the-art imaging
protocol given a limited acquisition time (approximately 10 minutes) at the time when the
MR sequence was designed (multi-band imaging was not yet established).
To create a new age-unspecific T1w template and a corresponding atlas, T1w images of 652
healthy subjects (aged 18-87) from the Cam-CAN study were iteratively registered. For this,
images were initially affinely registered to Montreal Neurologcial Institute (MNI) template
space. After merging data to create an initial template (average image), images were repeat-
edly registered and merged, whereas for each new iteration the previous generated average
image served as registration target. The iterative approach included three rigid, three affine
and six deformable registration steps. T1-weighted images were parcellated in native space
[151] (for more information see next section). Eventually, these individual parcellations were
projected to template space with the corresponding transformation for non-linear registra-
tion (last step of registration iteration) and merged. All registration steps were performed
with ANTS antsRegistration.
CENTER-TBI Database. For this multi-centre study multi-contrast MRI data were
collected on 17 3T scanners (three different vendors: General Electrics [GE], Philips and
Siemens) at 14 different sites. The various contrasts acquired during a scan session entailed
T1w, T2-weighted (T2w), fluid attenuated inversion recovery scans (FLAIR) and susceptibil-
ity weighted imaging (SWI) as well as DWI.3 Acquisition protocols were harmonised across
all participating sites as well as possible, while coping with site-specific limitations (e.g.
number of diffusion directions that can be acquired at once). Table 2.1 provides an example
of MR parameters for one site (other sites are similar). Structural scans were acquired with
1×1×1 mm3 voxel size. Diffusion images were collected with 2×2×2 mm3 voxel size and
the angular resolution varied between 30 or 32 gradient directions (site-dependent). Some
centres collected a rescan of the same diffusion directions, which can be useful for analysing
intra-scanner reproducibility. Further information can be found online.4
Scan-Rescan Database Twelve subjects (10 female, two male, age = 33.7 ± 6.8), were
3resting-state functional MRI was also acquired, but will not be specified here
4www.center-tbi.eu/project/mri-study-protocols
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scanned twice within a few months on each of two scanners (Siemens Prisma & Trio) to ac-
quire T1w MR image. In addition, six subjects underwent diffusion MR imaging during the
same session. The scanning protocols were equal for T1w images except for slight difference
in TE. A longer TE allows more time for the net magnetisation to return to its initial max-
imum value parallel directed to the main magnetic field. This results in decay of the T1w
signal, which can lead to lower contrasts between tissues (given that the TR is short, and
no T2w image is acquired, for which both TE and TR are long). A decreased contrast could
directly influence image parcellation, however, this effect is expected to be minimal for this
data due to the very small difference in TE (i.e. 0.04 ms). Besides the different TE, the total
number of channel varied for the T1w images (40 and 32 for Prisma and Trio, respectively).
Generally, a higher number of channels will result in a better signal-to-noise ratio (SNR),
however, the spatial distribution of the receiver coils will need to be considered as well.
Therefore, the impact of the different number of channels on this dataset cannot directly be
assessed. Since the number of channel is fairly similar (only 8 more on Prisma than Trio),
the differences are expected to be small. A recent study [199] has shown a high reliability
between MR images collected on Prisma and Trio scanners, but a significant higher SNR
for Prisma than Trio scans was found. This could be linked to larger (e.g hippocampus)
or smaller (thalamus) volumes derived from Prisma scans (FreeSurfer). Diffusion imaging
protocols mainly differed in the applied TR, but were otherwise mostly identically. On both
scanners single-shell data (b = 1000 s/mm2) with 64 non-collinear gradient directions were
collected. While for Trio DWI scans one non-diffusion sensitised image (b0) was acquired,
DWI scans on Prisma included five b0 volumes. For better compatibility of both scanner
protocols, the four additional baseline image were not considered. Since, these were acquired
at the very end of the scan no artificial time gap between consecutive diffusion volumes was
created. For both scanners 64 channels were employed. All scans were collected via parallel
imaging in k-space (GRAPPA) covering 100% of FOV. Protocol parameters are summarised
in Table 2.2.
2.3 Pipeline for Structural Magnetic Resonance Images
The pipeline for structural MR images takes several files as input. This consists of most
importantly a T1w image and several other MR scans, here collectively defined as additional
structural scans. Among those are T2w, FLAIR, SWI, gradient echo (GRE) and proton
density (PD) images. The most commonly acquired MRI sequences are T1w and T2w scans,
as they show excellent soft tissue contrast within the brain. While T1w images show brain
anatomy most clearly (cerebrospinal fluid [CSF] dark and brain tissue bright), T2w scans can
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Table 2.1: Example of Acquisition Parameters of CENTER-TBI Database
Contrast TR TE TI Flip Angle PxBW
T1w 2300 2.98 900 9◦ 240
T2w 3000 222 - 90◦ 751
FLAIR 6000 394 2100 90◦ 781
SWI 29 20 - 15◦ 120
DWI 9800 91 - 90◦ 1698
TR: Repetition time in ms, TE: echo time in ms, TI: Inversion time in ms, PxBW: Pixel
bandwidth in Hz/Px
Table 2.2: Acquisition Parameters of Scan-Rescan Database
Prisma Trio
T1w DWI T1w DWI
FOV Read 256 mm 192 mm 256 mm 192 mm
Slice Thickness 1 mm 2 mm 1 mm 2 mm
TR 2250 ms 8500 ms 2250 ms 8400 ms
TE 3.02 ms 90.0 ms 2.98 ms 90ms
TI 900 ms n/a 900 ms n/a
Flip Angle 9◦ 90◦ 9◦ 90◦
Pixel
Bandwidth
230 Hz/Px 1628 Hz/Px 230 Hz/Px 1628 Hz/Px
Echo Spacing n/a 0.77ms n/a 0.72 ms
EPI Factor n/a 96 n/a 96
also highlight pathology, which appears bright. Since, CSF also is bright on T2w images,
FLAIR images are acquired which allows to suppress the signal originating from normal
CSF (appears dark) while signal in abnormalities remain bright. Since all of the above
mentioned scans are three dimensional (3D) images showing complementary information of
brain anatomy, they are clearly differentiated from diffusion and functional MR images. Of
course the latter show brain anatomy as well, but due to their more complex data structure,
they will be processed in separate pipelines specifically designed for DWI. While the T1w
scan is essential to run the structural MR pipeline, all other additional scans are optional
and the pipeline would run completely without or with any subset of those scans. This is an
important feature, as scan availability varies within and across studies, which may include
different image contrasts. Usually, a T1w scan is always acquired by default and additional
scans are collected as needed to answer research questions. But even scan sessions within
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one study may be incomplete due to corrupted MR images or interrupted scanning session
(for example due to patient discomfort). The flexible data input enables to automatically
process different sets of anatomical scans more easily. Figure 2.1 provides an overview of
the different pipeline modules.
Figure 2.1: Schematic Overview of Pipeline for Structural MRI
2.3.1 Processing Modules
Neck Cropping. Although not the most pivotal step, cropping the neck reduces the num-
ber of voxels5 and will accelerate many subsequent computing steps. Any registration based
step, such as brain extraction and parcellation tools, will process images faster if less voxels
are present. Besides reducing the computational costs, it also helps to make some processing
steps more robust, as algorithms do not have to consider large areas solely including neck or
background. In an earlier development stage, for example, it was observed that multi-atlas
registration needed for the brain parcellation (see below) failed due to images showing a big
proportion of the neck. So initially, the FSL [112] tool robustfov was used for neck cropping.
However, this often led to cutting the image through the cerebellum and brainstem (Fig-
ure 2.2 B). This was mostly, but not exclusively, linked to images with tilted head position.
Therefore, a simple but more robust tool was introduced (custom nipype interface): At first,
T1w image intensities were corrected for inhomogeneity in the magnetic field, also known
as N4 bias field correction [2]. This image was then affinely registered to a template (here:
Cam-CAN template, Section 2.2) via ANTS antsRegistration [12]. Then, the transforma-
tion found was inversely applied (ANTS antsApplyTransforms) to the template’s FOV mask
5voxels are the 3D building block of image volumes, analogous to pixels in a two dimensional image
2.3. PIPELINE FOR STRUCTURAL MAGNETIC RESONANCE IMAGES 15
(practically a mask that fills out the complete template image space). Subsequently, the
most inferior point of the projected FOV mask was identified (if oriented in standard space,
this is usually the mask’s lowest z-coordinate, i.e. the lowest point along the neck) and used
as location to crop the image within the transverse plane (Figure 2.2 C).
Figure 2.2: Example of Neck Cropping. As seen on the sagittal slice, the originally acquired
T1w image included a big portion of the neck (A). Attempting to crop the image with com-
mon tool robustfov cut off parts of the cerebellum and brainstem (B). Affinely coregistering
the T1w image to a template, and backprojecting the template’s FOV mask (red area),
allowed to find a more conservative lower bound (yellow line) to crop the image (C).
Eventually, the actual neck cropping is applied to the input T1w image, rather than the N4
bias corrected one, to preserve the original intensities. Applying robustfov to an early release
of CENTER-TBI data (CENTER Core 1.0), including 1252 T1w scans, 132 scans (>10%)
were incorrectly cropped. The customised approach turned out to be more conservative and
has failed only in two cases (failed cases were identified as described later in Section 2.3.2 QC
#1). These were then manually cropped to support affine coregistration to the template,
before applying the same tool successfully again.
Brain Extraction. Generating a brain mask is often one of the first steps in brain image
processing. This allows to focus the computational effort and the analysis only on voxels that
actually show brain. Before integrating one or the other tool in the pipeline, several algo-
rithms were applied to a severe TBI database (number of subjects N>100)6, and compared
directly against each other. Brain lesions and other abnormalities can drastically affect the
quality of brain extraction, which is why the algorithms were tested on a clinical cohort. The
included T1w images showed head deformations and lesions of various sizes and at different
locations. After correcting T1w images for gradient field inhomogeneities (N4 correction),
three different brain extraction tools were applied. The output of ANTS antsBrainExtraction
[12], FSL’s brain extraction tool (BET) [231] with different parameter settings and ROBEX
[106] was blindly evaluated through visual inspection by a clinician. The total of 396 T1w
6This was part of a legacy dataset, as described in Section 6.2.1
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scans included 136 scans of healthy controls as well as 260 scans of severe TBI patients. All
three algorithms were designed for non-lesioned brains, which is why a perfect segmentation
for all scans is unlikely. Hence, the superiority of an algorithms was defined as the one
that failed on the least cases based on the visual quality control. Although BET extracted
the brain accurately on 294 or 322 scans (depending on settings), it was outperformed by
ROBEX and antsBrainExtraction with 348 and 353 successful segmentations, respectively.
Furthermore, ANTS performed better than ROBEX on 18 scans. While BET often under-
or oversegmented the brain, ROBEX and antsBrainExtraction performed almost equally well
(Figure 2.3). In failed cases antsBrainExtraction included the eyes or CSF, which could be
observed for both healthy subjects and patients. Since, antsBrainExtraction is based on a
registration framework, the oversegmentation may be caused by inadequate alignment of
T1w images to template space, however, no systematic bias was identified. Since subdural
haematomas are found on the surface of the brain, antsBrainExtraction sometimes fails to
include those lesions into the brain mask. This is patient specific and may be problematic
if lesions were only located within the brain mask as subdural haematomas would not be
detected.
Figure 2.3: Example Comparison of Brain Masking Algorithms. Both options for BET with
fractional intensity 0.4 (A) and 0.5 (default setting, B) showed over- (green arrow) and
undersegmentation (blue arrow), here illustrated on a sagittal slice of a T1w image with
frontal contusion. ROBEX (C) and antsBrainExtraction (D) performed equally well, both
including the pathology. All masks highlighted in red.
The latter slightly tended to cope better with challenging anomalies in and around the brain.
Skull stripping with ROBEX relies on brain shape priors, which cannot be changed, as they
are part of the tool. Contrary, antsBrainExtraction is based on non-linear registration of
the T1w scan to an atlas, and backprojection of a corresponding atlas mask from template
to T1w image space. The atlas and its brain mask can be chosen by the user. Although
being the slowest of all tools, antsBrainExtraction was eventually chosen for the pipeline, as
it seemed to be most robust and allows for an external atlas to be provided, that might be
best suited for challenging datasets (here: Cam-CAN template, Section 2.2).
Brain Parcellation and Cortical Thickness Estimation. One important aim in clin-
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ical neuroscience is to examine whether for example a patient cohort differs from a control
group. Usually, measuring global metrics within the entire brain, e.g. total brain volume
or amount of grey matter (GM), is too crude to capture subtle differences and provides not
enough information to draw a clinical conclusion. Therefore, a common process is to subdi-
vide the brain into different anatomical regions, which allows for changes to be observed on
a more local level. Once the brain is parcellated, information such as volume, GM content
or cortical thickness, can be retrieved from each individual region. This enables a more
detailed analysis while still summarising the images’ information in contrast to considering
all voxels as a single unit (e.g. voxel based morphometry).
Figure 2.4: Example of T1w Image and Computed Feature Maps from a Healthy Subject.
T1w bias-corrected image (T1w) and the corresponding brain parcellation (MALP-EM,
random colours for different ROIs), its GM probability map (GM, yellow indicates a higher
probability than red) and cortical thickness map (CorT, blue indicates a thicker cortex than
purple).
The multi-atlas label propagation with expectation maximisation based refinement (MALP-
EM) tool was chosen for parcellation, as it has been shown to work well for deformed brain
anatomy including TBI cases [151]. The better performance of MALP-EM can be attributed
to the multi-atlas segmentation approach and the retrospective intensity refinement based
on the segmentation posteriors. In theory, any region atlas could be used in combination
with MALP-EM’s underlying algorithms, however, this would require several pairs of T1w
images and their corresponding ROI atlases. In brief, this approach makes use of 30 atlases
from the Open Access Series of Imaging Studies (OASIS) database [167] that have been
manually subdivided into 138 regions of interests (ROIs). After non-linear registration of
the 30 atlases to the T1w image that is supposed to be segmented, the manual label maps
are projected onto the T1w image and merged to calculate probabilistic posteriors for each
ROI. With those posteriors7 the parcellation is refined via expectation maximisation. The
registration is based on T1w image intensities as well as tissue segmentation maps, so that
besides the brain parcellation MALP-EM provides also tissue probability and label maps.
7the posterior distributions are actually first relaxed to facilitate the refinement
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The tool can easily be applied via the command line, but it was integrated in the nipype
pipeline for a streamlined use. Although MALP-EM comes with an innate brain masking
algorithm, the mask previously computed with ANTS was used, as it provided more ac-
curate and more robust results. The output of probabilistic tissue maps for GM and WM
were further fed to the diffeomorphic registration-based cortical thickness (DiReCT) [46] es-
timation (via nipype’s built-in interface for the ANTS KellyKapowskialgorithm). Figure 2.4
shows an example of T1w images and the corresponding maps for MALP-EM parcellation,
GM segmentation and cortical thickness estimation.
One of the IDPs that can be computed from the brain parcellation are the ROI volumes.
Besides the 138 ROI volumes, MALP-EM further provides summarised volumes for total
brain volume, cortical as well as deep GM, WM and CSF. Furthermore, the average tissue
densities or cortical thickness (i.e. the mean value of the GM probabilities within a region)
could be computed within each ROI (IDP #1).
Processing of Additional Magnetic Resonance Sequences. The strength of multi-
parametric analysis lies in observing several MR contrasts simultaneously to derive clinically
useful information. To achieve direct correspondence between all MR scans for the same
individual, the different image contrasts were aligned to one another, commonly known as
coregistration. Usually, a high resolution (1mm3) T1w image is acquired by default, which
is why it served as reference to which all other images were registered to. Therefore, ANTS
antsRegistration was integrated to rigidly8 align all additional MR sequences to the neck
cropped T1w image. Mutual information (MI) served as similarity metric during optimisa-
tion. All sequences are treated equally and individually, so that regardless of which sequence
was present, the pipeline will align all available raw images. However, since T2w and PD
were acquired simultaneously, the pipeline was designed to keep the perfect alignment be-
tween PD an T2w images intact. So, in case both PD and T2w images were present the
transformation of the T2w to T1w scan was simply applied to the PD image (antsApply-
Transforms). Furthermore, all additional scans were also N4 bias corrected, analogous to the
T1w image. After that, the corresponding transformation for each scan was applied to the
bias corrected image. This order was chosen, to prevent any possibly failed N4-bias correc-
tion (for example because of pathology) to hamper the coregistration process. Eventually,
all raw and bias-corrected images were projected to T1w image space.
After coregistration two additional feature maps were computed, given that the particular
scans were available: One was the ratio of the aligned bias-corrected T1w and T2w image
(T1w/T2w), because this has been suggested as a surrogate for mapping myelin. It has been
8only translation and rotation of moving image
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shown that signal intensities on those myelin maps correlated well with subcortical myelin
development [74]. Measuring a surrogate of the myelin content could help to estimate WM
related brain atrophy if diffusion weighted MRI was unavailable. The other feature map was
the product of the aligned bias-corrected T2w and FLAIR image (FLAIR2), which has been
shown to provide higher grey-white matter contrast-to-nose ratio (CNR) than the standard
FLAIR image. Furthermore, it has been observed to yield an increased CNR between WM
and lesions in comparison to T2w and FLAIR images [266]. Since it has been reported to
improve automated segmentation for multiple sclerosis lesions [149], this enhanced image
contrast could also be beneficial for analysing other WM pathologies.
Spatial Normalisation. The spatial normalisation was performed with ANTS as it has
been shown to be one of the most capable algorithms [134]. The process was split into two
stages: the linear and the non-linear registration of the T1w scan to the template (antsReg-
istration). A custom template created from the Cam-CAN T1w scans (Section 2.2) was
chosen over the standard MNI atlas. The former provides better anatomical detail and is
less age biased, due to the larger number and wider demographic range of included subjects.
The linear registration entails both the rigid and affine transformations. At first, the rigid
registration phase aims to align both images via translation and rotation of the T1w image.
Thereafter, the similarity function is further optimised in the affine registration stage by
allowing shearing and scaling alongside rigid transformations. For both stages MI between
the two whole images served as cost function for optimisation. The non-linear registration
(SyN) was then initialised with the previously found affine transformation. For this stage,
cross-correlation within the brain mask was chosen as similarity measurement.
As previously mentioned, the integrated brain extraction was also based on spatial normal-
isation. To understand whether the additional spatial normalisation provided any benefit
over the deformable alignment entailed in the brain extraction (both are based on ANTS
SyN), their effect on 424 T1w scans from the severe TBI database was compared. For this,
the transformations found in both approaches were first equally applied to the same T1w
images. Then, the normalised cross-correlation (NCC, also see Equation 2.2) between all
pairs of warped images and Cam-CAN template was computed. In 98% of all cases (414
out of 424) the additional deformable registration resulted in a higher NCC than the initial
spatial normalisation during brain extraction. This can likely be attributed to a longer op-
timisation phase and uni-modal registration approach. The optimisation process focuses on
minimising the cost-function between template and T1w image only. In contrast, the spa-
tial normalisation performed during brain masking is driven by multi-modal registration,
including T1w images and tissue prior maps, which may hamper the optimal alignment.
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In addition, a more customised spatial normalisation could also be beneficial when working
with brain scans that show lesions (see below).
White and grey matter probability maps are generated as a by-product of MALP-EM ROI
parcellation. Both tissue maps and the maps for cortical thickness are projected to Cam-
CAN atlas space. By calculating the gradients at each element of the deformable trans-
formation field, a Jacobian matrix was derived (ANTS CreateJacobianDeterminantImage),
indicating the relative position of neighbouring voxels. The Jacobian determinants are often
used to modulate the intensities of the spatially normalised tissue maps, to preserve the
actual amount of tissue within each voxel (multiplication of Jacobian with tissue probability
maps after spatial normalisation). Besides that, they also have been shown to be useful
for analysing brain volume changes in moderate to severe TBI patients [38]. If satisfied
with the spatial normalisation and using a study-unspecific atlas, the user could compare
the maps for tissue density, cortical thickness and Jacobian determinants in a voxel-based
morphometry (VBM) [10] analysis right after the data have been fully processed (IDP #2).
Lesion Data Processing. Although this branch of the pipeline is not yet fully inte-
grated, it will still be described to explore ideas about how modules could be tied into the
grand scheme of the structural MRI pipeline.
A very important first step is the detection and segmentation of a lesion. For the purpose of
a fully automated pipeline, a lesion segmentation tool is needed, that does not require any
user interaction. Current state-of-the-art methods for lesion segmentation involve convolu-
tional neural networks (CNNs). For the presented pipeline, a version of DeepMedic [125] will
be integrated, as it has been shown to outperform many other approaches (including other
neural networks) for different types of lesions such as TBI [124] or stroke [123]. DeepMedic
is a supervised neural network, meaning it is trained on MR scans and their corresponding
label maps, which specify the presence of a lesion on a voxel-wise level. Besides differentiat-
ing between lesion and healthy tissue (binary case), DeepMedic can also learn to distinguish
lesion types (multi-class case). It can be trained on single image contrast, but performs
best when multiple (ideally complementary) MR contrast are used. Furthermore, this open
software tool has been developed by collaborators on the CENTER-TBI project, so that
their expertise can be directly leveraged for the pipeline. Usually, before feeding the images
to a neural network, their intensities are standardised. One approach would be to calculate
global mean (µ) and standard deviation (σ) of the voxel intensities within a brain mask
for each scan individually, and then subtract µ and divide by σ (Z-score normalisation).
To deal with gross intensity outliers, the mean and standard deviation can be computed
only for voxels within a percentile range. This process results in centred image intensities
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(µ=0) with unit variance (σ2=1) [109]. This potentially increases comparability of images
from different scanners an sites (multi-centre data), but also supports the training of CNNs.
Features of similar range help numerical optimisation during neural network training.
From the segmented lesion, it is straightforward to compute total and relative lesion volume
(IDP #3), however, it would be also important to analyse where the lesion is located within
the brain. This could be achieved by comparing the detected lesion against an atlas and
derive informative metrics. More details for brain lesion localisation can be found in Chap-
ter 6. Once a lesion is automatically detected, it could also be used to improve the spatial
normalisation, since cost function masking of lesioned areas has been shown to be necessary
for deformable registration of brains with large lesions [5, 27].
2.3.2 Quality Control Metrics
The processing tools were selected and designed to be as robust as possible, however, it is
important to check the quality of their output. Quality control metrics should help to high-
light situations where the processing steps failed or corrupted the data. Good QC metrics
are robust and provide an interpretable, quantitative measurement that can be computed
efficiently.
QC #1: Neck Cropping. First, the ROBEX mask was computed on the raw T1w im-
age. After cropping the T1w image, the cropping mask found was applied to the ROBEX
brain mask as well. Since, the aim is only to prune the neck, the brain volume estimated
by the ROBEX mask should be unaffected. This concept was tested on the CENTER-TBI
database. If there was a discrepancy between brain volumes before and after neck cropping,
the images were checked visually. Only two out of 1245 cases failed, which were manually
cropped with fslroi and then pre-processed successfully.
QC #2: Brain Masking. The earlier mentioned experiment for brain masking has shown
that antsBrainExtraction and ROBEX were both fairly robust. Ideally, they would generate
the same brain mask resulting in equal brain volumes. In practice this is rarely the case
due to the different nature of the underlying algorithms. Nonetheless, if both worked ac-
curately the ratio of the extracted brain volumes should be close to 100% and any strong
deviation might flag a sup-optimal performance of one of the two algorithms. When plot-
ting the ratio of the total brain volume as extracted from antsBrainExtraction (VANTS) and
ROBEX (VROBEX) for all CENTER-TBI T1w scans (139 control & 1252 patient scans),
the QC metrics showed a slightly different distribution for controls and patients (Figure
2.5 left). While the average ratios were fairly similar for controls (104.8%) and patients
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(103.8%), there was a large number of patient scans with brain volume ratios below 98%.
Both subject categories tended to have a larger ANTS than ROBEX brain volume, which was
cohesive with the general observation when checking brain masks visually. Inspecting both
masks for outliers revealed different causes for the diverging brain volumes. The first scan
(Figure 2.5 A1 & B1) displays the control subject with the highest volume ratio (111.7%),
which resulted from ROBEX under segmenting the cerebellum. The outlier with the highest
ratio (128.7%) showed that ANTS strongly oversegmented a patient’s brain laterally (Fig-
ure 2.5 A2 & B2). The large amount of soft tissue around the skull, might have hindered
an accurate spatial normalisation during antsBrainExtraction. At the lower end with ratios
lower than 95% it was observed that ROBEX commonly oversegmented patients’ scans as
displayed in Figure 2.5 A3 & B3 (90.0%). Furthermore, ROBEX was found to underperform
in the presence of lesions. It seemed to exclude pathological areas which consequently led
to undersegmentation (111.8%, Figure 2.5 A4 & B4)
Figure 2.5: Quality Control of Brain Extraction for CENTER-TBI Database. Left: The
distribution of the brain volume ratio shows wider spread for patients (Inter Quartile Range:
IQR=2.8%) than for controls (IQR=2.3%). Right: Top row shows the ROBEX brain mask
on four different scans with different performances: Undersegmentation of cerebellum in
controls scan (A1), adequate brain extraction for patient (A2), oversegmentation of patients
frontal brain region (A3), exclusion of lesion tissue (A4). Bottom row shows antsBrainExtrac-
tion performance on the same scans: It failed to deal with large amount of tissue surrounding
the skull (B2), but performed better than ROBEX for all other scans (B1, B3, B4).
QC #3: Spatial Normalisation. Experiments that require spatial correspondence be-
tween different subjects or alignment to a template (e.g. VBM or lesion localisation) rely an
accurate registration to a template. When correctly spatially normalised, the template and
warped image would show similar anatomical structures at certain locations. This similarity
was estimated by computing the NCC between both images images. The closer the value is
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Considering such a QC measurement before any analysis could help to spot failed spatial
normalisation and flag corrupted scans, that both, if included, could adversely influence the
final results. Extracting this information from the QC report from the structural pipeline for
all CENTER-TBI T1w scans, a clear difference between scans from controls (mean=0.804)
and patients (mean=0.778) was observed. While NCCs for controls stayed well above 0.70,
NCCs for patients were as low as 0.37.
Figure 2.6: Quality Control of Spatial Normalisation for CENTER-TBI Database. Top:
Scans for patients had much more distributed NCCs (interquartile range IQR=0.051) than
controls (IQR=0.026). Middle: Scans with low NCCs exhibited prominent image features
such as lesions (A, C), head motion artefacts of different severity (B, E) or tissue atrophy
and enlarged ventricles (D). Bottom: The mosaic, chequerboard images alternating between
atlas and registered images provide the means for a quick visual QC (F).
Figure 2.6 shows five examples of spatially normalised T1w scans from patients with some
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of the lowest NCCs. The first example shows a brain scan with large subdural haematoma
(Figure 2.6 A). Its low NCC (0.370) could be explained by the high intensities within the
lesion, skewing the measurement unfavourably. Although the spatial normalisation was not
necessarily unsuccessful, such a case probably should be excluded in a voxel-wise group
analysis and for any parcellation based extraction. To derive a NCC that is less sensitive to
pathology, the similarity metric could be computed in healthy tissue only. This, however,
would require a lesion annotation (manually or automatically generated) and in the presence
of large lesions the similarity metric would be computed on a lower number samples, which
may hamper the comparability to other scans. Another case with low NCC (0.383) displayed
a T1w scan severely corrupted by motion (Figure 2.6 B). Scans with severe blurring must
be excluded from any analysis. A low NCC could also indicate the presence of dominant
anatomical abnormalities, such as a large contusion and oedema (NCC=0.397, Figure 2.6 C)
or significantly enlarged ventricles (NCC=0.432, Figure 2.6 D). Severe pathological patterns
can impede spatial normalisation and should be excluded from analysis reliant on spatial
correspondence. Besides flagging up cases with severe deviations from the template due to
artefacts or pathology, NCC was also found to gradually change with scan quality. A mod-
erate low NCC (0.605) could highlight less dominant acquisition artefacts, such as ringing
from head motion (Figure 2.6 E). Those scans might still be used for certain experiments,
but have to be inspected to avoid potential biases in subsequent processing steps or analysis.
By design, the pipeline also provides a mosaic overview of the chequerboard image, alter-
nating between the template (here Cam-CAN in red) and the spatial normalised T1w image
(grey, excerpt shown in Figure 2.6 F). This allows a quick and easy visual quality check. The
chequerboard displayed here corresponds to the scan in Figure 2.6 C. Although the NCC
was quite low, the registration seemed successful, as boundaries of anatomical structures
(see ventricles) seamlessly continue across the mosaic tiles. The findings suggest that low
NCC could pick up on a variety of different problems for spatial normalisation, including
image artefacts and brain pathologies.
QC #4: Coregistration. Multi-parametric analysis requires the alignment of different
sequences from one scan session. For example, coregistered scans are needed for predictive
lesion segmentation, or if anatomical information such as ROI parcellation should be used
to derive features from other sequences than T1w images. Similarly to the spatial normali-
sation, the accuracy of coregistration can be estimated by computing the similarity between
aligned images. Again NCC was chosen as it is less sensitive to intensity scaling than, for
example, mean absolute error and can be applied to sequences with different contrast. The
metrics were calculated between the T1w image and a resampled image of the sequence
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(matched resolution but no change of position or orientation) as well as between the T1w
image and the coregistered scan. If successful, the metric should be closer to one after coreg-
istration than before. The quality assessment on the CENTER-TBI database was two fold.
Firstly, to flag scans that had a generally low NCC, and secondly, to inspect scans with a
lower NCC after coregistration than before.
Table 2.3: NCC for Coregistered Sequences. Values displayed as mean [IQR].
Controls Patients
resampled coregistered resampled coregistered
T2w 0.364 [0.171] 0.696 [0.094] 0.353 [0.145] 0.666 [0.116]
FLAIR 0.393 [0.499] 0.830 [0.096] 0.376 [0.186] 0.796 [0.146]
SWI 0.220 [0.201] 0.632 [0.106] 0.207 [0.179] 0.663 [0.102]
Besides T1w images, T2w, FLAIR and SWI images were available for the CENTER-TBI
database. Table 2.3 lists the average NCC results for the resampled and coregistered se-
quences for both healthy controls and patients. The improvement was quantified by the
ratio of average NCC of coregistered over resampled scans (NCCcoregistered/NCCresampled
× 100%). The NCC improved for all T2w (average NCC ratio = 191%) and FLAIR (av-
erage NCC ratio = 211%) scans of the control group through coregistration. Only three
SWI controls scans did not improve upon coregistration, however, this was due to severely
corrupted images (Figure 2.7 A), and overall the coregistration was advantageous (average
NCC ratio = 287%). For patients the NCC was higher after registration for all 1211 FLAIR
scans (average NCC ratio = 212%). Just eight out of 1251 T2w scans and 14 out of 1230
SWI scans for the patients showed a lower NCC after coregistration. Nonetheless, there
was an average overall improvement for T2w and SWI patient scans of 189% and 321%,
respectively. The best relative improvement was yielded for SWI patient and control scans,
which is likely due to the low starting point (≈ 0.2) to begin with. Furthermore, flagged
scans could be associated with poor image quality (Figure 2.7 A, B and C1). Interestingly,
the NCC for patient scans was always slightly lower than the NCC for control scans, except
for coregistered SWI scans. This may be explained by the presence of lesions that are more
prevalent on MR contrasts other than T1w images. Moreover, this could indicate a bias
in the acquisition of patient scans, possibly caused by increased head movement resulting
motion-induced blur, ultimately leading to lower image similarities.
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Figure 2.7: Quality Control of Coregistration of CENTER-TBI Database. Top: NCC
between T1w and addition sequences improved for all three contrasts through coregistra-
tion (T2wcoreg, FLAIRcoreg, SWIcoreg) in comparison to simple image resampling (T2wres,
FLAIRres, SWIres). Mostly, NCC was slightly higher for controls than for patients, however,
both groups were comparable for all three sequences before and after coregistration. Bot-
tom: Scans with low NCC could be associated with poor image quality, such as corrupted
acquisition (A) and noise artefacts (B) on SWI scans. A noisy FLAIR scan was flagged with
a low NCC (C1), however, structures between FLAIR and T1w images still aligned as seen
in the chequerboard image (C2).
2.4 Pipeline for Diffusion Magnetic Resonance Images
The pipeline for diffusion MR images also takes several files as input. Most importantly this
is the diffusion weighted images (DWI) and its corresponding text files with the information
for b-values (bvals) and b-vectors (bvecs). During DWI, different gradients of magnetisation
are applied to encode a spatial correspondence of received MR signal. While the duration
and strength of the employed gradients are defined by the b-values, the direction is indicated
by the b-vectors. Diffusion along the b-vectors direction causes signal attenuation which is
reflected in lower intensities in the diffusion sensitised scan. The diffusion pipeline takes as
further input a T1w image and its associated brain mask. The pipeline coregisters diffusion
tensor imaging (DTI) parameter maps to the T1w image (see below). Thus, for optimal
results the T1w image must be from the same subject as the diffusion images and ideally
also from the exact same scan session. Furthermore, it is advisable to use the cropped
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and bias-corrected output files from the previously described structural MRI pipeline. After
applying both pipelines, all anatomical MR sequences and the diffusion feature maps for one
scanning session are aligned all together in the T1w image space. For artefact correction the
pipeline also expects a text file with acquisition parameters (ACQP). In addition, the user
has the option to provide a previously computed or manually delineated DTI mask and an
extra b0 volume. Both options will be discussed in more details below. Figure 2.8 provides
an overview of the different components of the pipeline.
Figure 2.8: Overview of Pipeline for Diffusion MRI
2.4.1 Processing Modules
Denoising. Diffusion weighted imaging is affected by acquisition noise stemming from
signal reconstruction. Especially for images with low SNR, the noise distribution deviates
from a Normal distribution [90, 55], which makes noise reduction non-trivial. This is par-
ticularly important for advanced DWI that includes higher b-values, as this leads to images
with lower SNR, which could hamper the correct estimation of diffusion measures [197, 118].
One effective way of suppressing noise is based on local principal component analysis (PCA).
Assuming multi-directional signal redundancy within the diffusion images, PCA can be used
to find components that are associated with statistical noise rather than structured infor-
mation. By excluding components of low magnitude noise can be reduced. The initial
suggestion to eliminate components by thresholding the associated eigenvalues [166] was
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later improved through a data driven way through matrix theory (Marcenko-Pastur-PCA,
MPPCA) [255]. This technique has been found to reduce noise while preserving anatomical
structure and outperformed other approaches, such as adaptive non-local means or total
generalised variation. Denosing is the very first step for image enhancement in the diffusion
MRI pipeline, and was integrated via nipype’s MRtrix3 interface for dwidenoise. Figure 2.9
shows an example of a multi-shell DWI image before and after denoising. The difference
between both images shows that mostly random noise was eliminated.
Gibbs Ringing Removal. Magnetic resonance images are reconstructed by applying
Fourier transforms to the raw signal. In practice, only a finite number of frequencies can
be sampled, which is why the images are only approximated by a few components of the
Fourier representation. This signal truncation is unproblematic for gradual changes in sig-
nal intensity (i.e. homogeneous regions), however, results in multiple fine ripples directly
adjacent to high-contrast interfaces (e.g. the boundary of brain tissue such as at ventricles).
Also known as Gibbs ringing, this artefact can be diminished by increasing the number of
phase-encoding steps 9 or reducing the FOV, but cannot be completely avoided [44, 254]. A
variety of methods have been suggested to reduce this effect of signal truncation. For the
pipeline the MRtrix3 command mrdegibbs was integrated via a customised interface.10 This
algorithm is based on the technique proposed by Kellner et al. [130]. Here, the idea is to
sample the image not at the sinc-function’s extrema but rather close to its zero-crossings.
To achieve this for all edges across the image, a local subvoxel-shift is enforced.
Brain Extraction. Many tools for brain extraction of diffusion MR data rely on thresh-
olding the b0 volume, as this usually provides the highest SNR and highest contrast between
brain tissue and background. However, thresholding is not very robust and error-prone
for noisy data. For the pipeline a simple method based on coregistration to T1w images
was integrated. Therefore, the denoised and Gibbs artefact corrected b0 volume was rigidly
coregistered (antsRegistration) to the provided input T1w image. Subsequently, the input
mask for the T1w image was backprojected (antsApplyTransforms) to diffusion image space.
This approach underlies two assumptions: First, the brain mask for the T1w image must
be accurate. Second, both T1w and b0 volumes show the same brain shape and size, and
neglects distortions resulting from echo-planar imaging (EPI) of the diffusion images. The
user has also the choice to provide a DWI brain mask, in which case the automated brain
masking would be suspended to save computing time. The pipeline recognises which path-
9usually less samples are collected in phase-encoding direction making the artefact more noticeable
10mrdegibbs is part of nipype since version 1.2.0, thus the custom interface will be replaced in future
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Figure 2.9: Example of Multi-Shell DWI Denoising from Cam-CAN Database. The first
row shows a representative images for all three different b-values: Left to right, the diffusion
unsensitised image, the first shell with b=1000 s/mm2 and the outer shell with b=2000
s/mm2. The second and third row show the corresponding images after MPPCA denosing
and noise (difference) maps, respectively. The average absolute difference within the brain
mask of the noise was 2.9 for the b0 volume and 3.7 for both diffusion sensitised volumes.
Image contrasts were adjusted for each shell individually, noise was scaled equally for all
three difference maps for direct comparison.
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way - using the input or automatically computed mask - has been triggered and selects the
appropriate mask for the subsequent processing steps (Figure 2.8: Mask Selection). After
head-motion correction (see next paragraph) another brain mask was calculated with MR-
trix3 dwi2mask [53] mostly for subsequent QC (Section 2.4.2 QC#3).
Distortion & Head-Motion Correction. When performing spin-echo EPI, the result-
ing diffusion images can look distorted due to the acquisition’s sensitivity to non-zero off-
resonance fields. These will be induced by both the susceptibility distribution of the subject’s
head and eddy currents resulting from rapid changes of the diffusion weighted gradients. Ad-
ditionally, for DTI multiple images with different gradient directions need to be acquired,
which leads to longer scanning times and unavoidable head motion. Strong susceptibility
induced artefacts can be problematic when comparing to undistorted T1w images. Further-
more, the distortion of anatomy might introduce inaccuracies when extracting region-based
IDPs. If an extra b0 volume was collected with reversed polarity of the phase-encoding
blip relative to the diffusion weighted images, this can be used to correct for susceptibility
artefacts (b0 field map correction is not yet supported). Providing the images with oppos-
ing phase direction and the acquisition parameters, the pipeline estimates the susceptibility
induced off-resonance field via FSL’s topup [6]. This tool aims to find the deformation field
that would match the b0 volumes with opposing directions of distortions such that their
similarity (sum-of-squared differences) is maximised. Once the susceptibility induced field
was approximated, topup output can be fed to FSL’s tool eddy , which concurrently corrects
for eddy current distortions and head movements [7, 8]. In case no extra b0 volume was
acquired, the pipeline skips the correction of susceptibility distortions and moves straight to
reducing eddy current and head motion artefacts. The pipeline currently does not support
any alternative correction of susceptibility artefacts.
Bias Correction. To remove effects of the inhomogeneous magnetic field, a bias correction
approach was included in the pipeline. This followed the approach as initially suggested by
Jeurissen et al. [114]. First all non-diffusion weighted images (b=0 s/mm2) within the scan
are averaged before estimating field inhomogeneity via the N4 algorithm (analogous to T1w
images). Subsequently, the bias is removed from all diffusion images separately. Since this
approach assumes spatial correspondence between all DTI volumes, this process is applied
after the head motion correction. This method was already implemented as complete work-
flow within nipype (nipype.workflows.dmri.fsl.artifacts.remove bias), ready to be integrated
into the diffusion pipeline.
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Diffusion Feature Maps. Depending on the tissue composition in the brain, the dif-
fusion of water molecules is more or less restricted. While diffusion is equal in all direction
in cavities such as ventricles, it is more directional in structured tissue like WM fibres.
The reason for this are cell structures that form a barrier for water molecules, forcing the
diffusion to be more anisotropic in organised tissue compartments. Very briefly, diffusion
can be measured by applying gradients of magnetic fields in different directions. To de-
scribe anisotropic diffusion in a three dimensional space adequately, at least six diffusion
weighted and one non-diffusion weighted image will need to be acquired. From this the
proportion of diffusion along the principal axis (diffusion coefficients) can be estimated and
described as a symmetric 3×3 matrix called the diffusion tensor. The diffusion tensor can
also be represented as an ellipsoid, characterised by the three orthogonal eigenvectors and
their eigenvalues λ1, λ2 and λ3. These define the orientation and shape of the ellipsoid.
Therefore, diffusion can also be characterised by the eigenvalues’ relationship. To express
this as a scalar value, different options have been suggested [197]. For example, fractional
anisotropy (FA) is measuring the anisotropic portion at each position (i.e. every voxel),










The average of the eigenvalues characterises the mean diffusivity (MD), with high values




(λ1 + λ2 + λ3) (2.4)
Although MD is rotational invariant, it can be affected by the choice of b-values [194]. For
the pipeline, both were computed via least weighted squares optimisation through nipype’s
FSL interface for dtifit). In addition DWI trace maps11 were calculated, as they can provide
a good contrast for manual lesion delineation:
DWItrace = S0e
−b MD (2.5)
With b representing different b-values, so consequently, multi-shell diffusion data would have
several DWI trace maps. Furthermore, the anisotropic power (AP) map was computed. The
aim of the AP map was to introduce a noise robust measurement to characterise anisotropy.
It has been reported to have a similar contrast to a T1w image, which is why it could
facilitate coregistration of diffusion to anatomical scans [47]. This map was defined as the









11not to be confused with Trace, which is the sum of the eigenvalues
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where Cl,m is the coefficient for the SH base of order l and degree m (further explanation to
SH in Section 5.1.2). This was computed via the nipype interface (dipy.anisotropic power).
Figure 2.10: Overview of Diffusion Parameter Maps for an Individual Subject
Although standard DWI assumes a Gaussian distribution of water molecule diffusion, this
does not hold true for complex biological tissue. This deviation from a normal distribution,
becomes stronger when stronger diffusion gradient are applied (i.e. higher b-values) and can
be characterised by the kurtosis [113]. The pipeline automatically recognises if any b-values
larger than 1500 s/mm2 are present and in that case models the diffusion kurtosis imaging
(DKI) tensor to compute diffusion parameter maps such as mean kurtosis (MK, see Figure
2.10). Resolving the image of the brain into small discrete units during acquisition can result
in partial volume effects, where different tissue types are influencing the signal within one
voxel. This is particularly problematic when free water (FW) reduces the apparent diffu-
sion coefficients of tissue structures. Different approaches have been proposed to estimate
FW diffusion on DWI images. The method integrated in the pipeline does not require any
local spatial constraints and works reliably for multi-shell DWI data [100]. So if more than
one non-zero b-value exists, the pipeline automatically triggers a custom interface applying
Dipy’s (version 0.15.0) FW elimination model. This allows to estimate the FW volume
(Figure 2.10) and corrected FA and MD parameter maps accordingly (not shown).
Fibre Tract Segmentation. Analogous to the anatomical pipeline, the brain was parcel-
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lated based on the diffusion data. For this, the open source tool TractSeg12 was used as
it has been shown to rapidly and accurately segment WM tracts in healthy subjects [263].
The technique is based on a neural network that predicts the labels of 72 fibre tracts. The
network was trained on semi-automatically segmented fibre tracts for 105 selected HCP sub-
jects. For this, tracts were first automatically identified after whole brain tractography and
refined where needed. After several quality checks and manual adjustments, binary maps
for all tracts for all subjects could be generated. Those served as reference segmentations
to train a 2-dimensional encoder-decoder CNN. TractSeg has been shown to outperformed
other fibre tract segmentation methods (e.g. ReconBunlde, TRACULA or multi-atlas ap-
proaches) and is fast to apply. The available pretrained model can be applied via command
line, hence was easily integrated as a custom nipype interface.
From the automated segmentations the tract volumes, mean and standard deviation for
FA and MD of each ROI were automatically computed (IDP #1). Since the tool provides
probabilistic estimates for voxels belonging to a region, both statistical metrics were also
calculated with a weighted voxel input. All computed metrics were stored in one CSV file
for easy access. Eventually, those single files could simply be concatenated for all processed
data within one study.
Coregistration. In order to understand which modality is most beneficial for the coregis-
tration of diffusion parameter maps to T1w image, a short experiment was conducted. First
the diffusion MR images from the Scan-Rescan database were corrected for artefacts (noise,
Gibbs ringing, removal, head motion, and bias-field) and diffusion parameter maps were ex-
tracted. The T1w image was bias field corrected and masked (as described in the structural
pipeline). Then single diffusion maps (b0, FA or AP) or different combinations (FA+b0,
FA+AP, FA+AP+b0)
13 were rigidly coregistered to the masked T1w image (antsRegistra-
tion). For this MI within the brain mask was chosen as cost function. The transforms found
were then equally applied to the FA map to project it to T1w image space (WelchWin-
dowedSinc interpolation). Thus, the only variable factor was the transforms used. Then,
NCC between all projected FA maps and corresponding T1w images were calculated to es-
timate the registration quality. The impact of using different diffusion parameter maps was
very subtle, with average NCC ≈ [0.634 − 0.635]. Registration with b0 maps only led to
one out of 24 failed coregistration (NCC = 0.245), however, the overall performance was
slightly worse than all other methods (NCC = 0.614). Coregistration seemed to be slightly
hampered by inclusion of the b0 volume (b0, FA+b0, FA+AP+b0), but almost identical for
12https://github.com/MIC-DKFZ/TractSeg
13b0+AP was not tested
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all other combinations. There was a tendency of AP maps alone performing marginal better
than FA maps alone or FA+AP maps. Despite that, a coregistration based on FA+AP maps
was integrated in the pipeline to leverage the robustness of a multi-parametric approach.
The b0 volumes were not included as they seemed to have an adverse effect on registration
quality and including of more image contrasts prolongs the registration process. Besides
this, coregistration mostly benefited from T1w images to be masked and starting the align-
ment with a good initialisation. ANTS allows for an image intensity based initialisation,
which led to a robust overall performance. A statistical significant difference between all ap-
proaches could not be found (repeated measurement ANOVA: p = 0.3034, individual t-tests
for repeated samples: all p > 0.2). In the end, a multi-modal coregistration of FA and AP
maps to T1w images was integrated into the pipeline as it provided qualitatively best results.
All diffusion maps (FA, AP, MD, trace maps) were eventually projected to T1w image space.
Spatial Normalisation. Analogous to anatomical scans, spatial normalisation of diffu-
sion images would be beneficial to analyse DTI data via VBM or tract-based spatial statis-
tics (TBSS) [232]. Since, tensor-based registration [281] has been shown to outperform
intensity-driven registration of diffusion parameter maps [260], the former was favoured to
be integrated into the pipeline. However, diffusion tensor registration can be error prone and
is most successful when using a study-specific template. Which is why, artefact corrected
DWI images are converted to a tensor-format readable by the DTI-ToolKit (DTI-TK).14
This allows to conveniently compute a study-specific template right after all scans of in-
terest have been pre-processed. Such a template is usually not very generalisable and has
to be computed for each study individually, which it why it was not integrated in the pre-
processing pipeline.
2.4.2 Quality Control Metrics
QC #1: Denosing. To evaluate the noise level of the diffusion scans the SNR was com-
puted. This was defined as the ratio of the mean µ of the denoised b0 signal and the standard
deviation σ of the noise estimated by the denoising algorithm (difference between original




with X = {x1, ..., xn | x ε M} (2.7)
Examining the metric on all CENTER-TBI DWI scan, the average SNR was found to be
lower for controls (N=271, mean [IQR] = 116.4 [97.3]) than for patients (N=2355, mean
14http://dti-tk.sourceforge.net/pmwiki/pmwiki.php
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[IQR] = 153.1 [94.3]). Usually, better signal would be expected for control subjects, how-
ever, hyper-intense pathology in patients can skew SNR to higher levels. Generally, a varying
SNR was observed across different centres (Figure 2.11), which will need to be taken into
account for a multi-centre analysis. While some centres (A, I, K, N) showed an SNR well
below the overall average across all centres, some other had a much higher SNR (e.g L). An
image with one of the lowest SNR (16.3, centre I, Siemens scanner) had a high variation
in noise (σ=17.0) but low b0 signal (Figure 2.11 A). In contrast, a high SNR scan (1008.7,
centre L, Philips scanner) had a low noise variance (σ=5.9), but a twice as high b0 signal,
which was likely a consequence of hyper-intense pathology being present (Figure 2.11 B).
The discrepancy between healthy and lesioned brains will need to be taken into account
when curating a TBI database.
Figure 2.11: Distribution of SNR across Centres. Left: The SNR distribution was centre
specific. The dotted lines show the average over all controls (green) and patients (purple)
Right: Images with very low (16.3, A) and high (1008.7, B).
QC #2: Physically Implausible Signal. Diffusion leads to signal decay, which is why
for each voxel the signal should be higher in the non-diffusion weighted image than in the
diffusion sensitised image. However, because of acquisition artefacts (e.g. Gibbs ringing)
this might be violated, leading to measurements of physically implausible signal (PIS). With
PIS defined as the voxels x within brain mask M for which the signal in the first DWI
volume is higher than that in the b0 volume
PIS = {x ε M | (xDWI − xb0) > 0} (2.8)
the number of voxels with PIS were counted before (PISbefore, that is right after denosing)
and after (PISafter) Gibbs ringing removal. To combine both metrics into one, the ratio
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of both counts was computed (PISafter/PISbefore). A lower ratio would indicate a signal
improvement after Gibbs artefact correction. The PIS count ratio was below 100% for all
scans, but for the two images with excessive noise corruption (see example later in Figure
2.12 A). Excluding those two scans, the number of PIS voxels after the corrections was
slightly higher for patients (mean [IQR] = 945 [794]) than for controls (mean [IQR] = 861
[643]). The PIS ratios for controls (mean [IQR] = 43.7% [16.1%]) and patients (mean[IQR]
= 45.6% [21.6%]) were similar and indicated that on average more than half of the voxels
with PIS were eliminated by Gibbs correction.
QC #3: Brain Masking. Similar to the quality control for the T1w image brain extrac-
tion, two masks are computed for DWI scan as described earlier. The ratio of the MRtrix3
and ANTS brain mask could yield information about the quality of the brain mask. Both
controls (mean [IQR] = 98.4% [3.2%]) and patients showed a very similar average ratio
(mean [IQR] = 98.9% [3.7%]), however, patients included more outlier scans on both sides
of the spectrum. The lowest ratio for controls (75.4%) was the result of MRtrix3 strongly
undersegmenting the brain, the ANTS brain mask used for all subsequent processing steps,
however, was intact. The 2nd lowest ratio for controls (90.0%) was not noticeably corrupted.
The two control scans with the highest ratio (117.6% and 122.4%) belonged to the same
subject and showed severe noise artefacts (Figure 2.12 A). Brain masking via coregistration
to T1w images seemed to be successful, but sometimes failed when applying MRtrix3. This
discrepancy is reflected in the ratio of the brain mask volumes. Other outliers among the
controls showed an over- or undersegmentation of MRtrix3. Ratios varied more for patients,
and various causes for low QC rations were observed. These included strong brain distor-
tions (Figure 2.12 B: 50.3%), flawed mask back projection from T1w space (Figure 2.12 C:
81.7%) or deformed brains due to injury (Figure 2.12 D: 82.1%, E: 88.8%). Scans with ratio
higher than 90% seemed to have only minor discrepancies between both brain extractions.
However, scans with high ratios started to show different artefacts, such as signal fading
where MRtrix3 grossly oversegmented the brain (Figure 2.12 F: 129.2%). Besides this, a
systematic corruption of scans through failed distortion correction could be identified. Al-
though displaying susceptibility artefacts the brain mask (ANTS) could still be computed
fairly accurately before the correction (Figure 2.12 G1). However, the failed susceptibility
correction left the brain deformed (Figure 2.12 G2) and resulted in a much larger MRtrix3
brain mask. Consequently, this was reflected in a high QC ratio (125.6%). Upon closer
visual inspection, a corrupted and misaligned extra b0 volume (with opposite phase encod-
ing direction) was found. A QC mask ratio within the range 90-110% seemed to indicate
sufficiently accurate brain masking.
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Figure 2.12: Quality Controls for DWI Brain Masking. Left: Comparison of controls and
patients showed a fairly similar distribution of the QC mask ratio, although, patients showed
unsurprisingly more outliers. Right: Displayed are different examples of cases with low or
high QC ratio and the respective ANTS brain mask (red). Noticeably different ratios could
point out flawed image acquisition such as excessive noise (A, 117.6%) or distortions (B,
50.3%), failed brain extraction (C, 81.7%), deformed brains due to brain injury (D, 82.1%
and E, 88.8%) as well as scans for which correction of susceptibility distortion failed (G1
and G2, 125.6%). G2 shows the MRtrix3 brain mask (red).
QC #4: Head Motion Parameters. FSL eddy provides as output the estimated average
and maximum head motion during the DWI acquisition. This includes both the total mo-
tion, which is relative to the very first acquired volume (usually b0), and the relative motion,
which is the motion with respect to the preceding volume.
Table 2.4: Quality Metrics for Head Motion During DTI Acquisition. Quality control metrics
displayed as mean [IQR]
Total Motion Relative Motion
average max average max
controls 0.364 [0.217] 0.675 [0.361] 0.177 [0.074] 0.514 [0.281]
patients 0.476 [0.264] 0.863 [0.496] 0.193 [0.106] 0.608 [0.340]
t-test p < 0.001 p < 0.001 p = 0.084 p = 0.027
While total motion could help to identify a head drift throughout the scan, relative mo-
tion could highlight a subject’s sudden head movements. Since head motion can have an
impact on diffusion parameters, it is important to detect outlying subjects and a possi-
ble bias between control and patient groups. Table 2.4 summarises the QC results for the
CENTER-TBI database. Apart from relative average motion, patients were observed to
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have a significantly higher total and relative motion compared to controls.
When inspecting subjects with increased QC metrics, obvious head motion was observed.
For example, a patient that tilted the head mid-scan, such that all subsequent scans were
strongly rotated relative to the first volume, resulting in the highest average total motion
(5.082, Figure 2.13 A). Severe head movements also led to inter-scaling signal across slices
and striping artefacts (Figure 2.13 B, maximum total motion = 9.183). Such scans should
be excluded from analysis. Once corrupted scans are excluded, the motion parameters of
the remaining subjects would need to be checked across groups of interest to rule out any
group-effects. Eventually, motion metrics may be incorporated as covariates in the analysis.
Figure 2.13: Quality Control for DWI Head Motion for CENTER-TBI Subjects. Left:
Inspecting the patient with the highest average total motion (5.082) revealed a strong tilt
of the head mid-scan that was kept through the rest of the scan (A, left: volume #18,
right: volume #28, brain axis visualised in red). Left: Scans with high motion QC metrics
associated also showed striping artefacts, such as the ones visible on the sagittal DWI image
slice (B, maximum total motion = 9.183).
QC #5: Coregistration. For joint analysis of T1w and diffusion MRI scans (e.g. FA
metrics within MALP-EM ROIs), it is useful to align both to create a spatial correspon-
dence. To monitor the quality of coregistration of FA maps to T1w space, again the NCC
between the two scans was computed. Since two different contrast images were compared,
a generally lower NCC was expected than for the T1w images spatially normalised to the
Cam-CAN template (see Section 2.3.2 QC) #3). For the CENTER-TBI database the av-
erage NCC was slightly higher for controls (mean [IQR] = 0.613 [0.115]) than for patients
(mean [IQR] = 0.597 [0.119]). The control scans with the lowest NCC could again identify
the noise corrupted images as shown before (Figure 2.12 A). Lower NCC cases were found
for patients and some of those cases are shown in Figure 2.14. Overall, the coregistration
between T1w images and DTI scans was successful and lower NCC values mostly flagged
images with pathology. This could be useful to pre-sort scans for visual inspection, but also
to exclude those scans from analysis based on processing steps that are likely to fail due to
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the presence of lesions (for example brain parcellation). Possibly the NCC could be linked
to size and type of pathology.
Figure 2.14: Assessment of DTI Coregistration. Left: Similar distribution of QC ratio
for patients and controls, although patients displayed more outlier cases. Right: Top
column shows the T1w image (A1-D1) and bottom column shows the aligned FA maps
(in colour) overlaying on top of the corresponding T1w images (A2-D2). Cases with low
NCC included different types of pathology, such as hyper-intense subdural haemorrhage (A1,
NCC = 0.243), contusions in occipital (B1, 0.303) and frontal (C1, NCC = 0.357) lobes and
lowered intensity in pathological frontal lobe (D1, NCC = 0.446).
2.5 Discussion
2.5.1 Database Management and Quality Control
As neuroimaging studies grow in sample size, so do the challenges to process and analyse
databases adequately. In the past, suitable subjects were pre-selected, based on the clinical
questions that should be answered, before processing any of the MRI data. This, however,
easily leads to inefficient data handling, because different researchers may choose overlap-
ping subsets of subjects from a larger study. While this not only takes up unnecessary disk
space to store duplicates of the database, it is also computationally ineffective to recompute
common processes that have already been completed. Moreover, different and sometimes
sub-optimal tools would be chosen, as there is a bias towards familiar methods, rather
than potentially more complicated state-of-the-art techniques. Consequently, findings from
different researchers (even in the same lab) may be less comparable when using different pro-
cessing tools. Thus, centralising imaging databases should be strongly advocated. Instead
of processing a subset of the imaging study, the whole database should be sorted, curated
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and processed in the same way and made easily accessible for collaborating researchers.
Processing and IDP extraction could change flexibly with new requirements for analysis.
Besides centralising data processing, the emphasis lies also on methods for automated qual-
ity control. The more data are available the less feasible visual quality assessment becomes.
Imagine 1000 scans that shall be processed: Visually checking each input is already tedious,
but checking in addition the output of one single processing step already doubles the work
load. With many, inter-connected processing steps the complexity increases exponentially,
and an initially daunting task becomes intractable.
The quality control metrics introduced in this chapter have been shown to be useful to
detect corrupted imaging data or flawed results of processing steps. However, one current
limitation is that they are unspecific, as they act more as a surrogate then actually explain-
ing the source of failure. The ratio of the two different brain masks, for example, indicates
whether either of the two algorithm failed to extract the brain. However, the reason for
failed brain extraction is currently not characterised automatically. Only a visual check can
reveal whether the image is completely distorted, includes minor acquisition artefacts or
the brain anatomy is too uncommon (e.g. deformed brain due to TBI, or large amount of
tissue surrounding the head). In order to improve the pipeline, it is important to assess if
a processing tool failed because of a flawed image or an unsuitable algorithm. If an algo-
rithm’s performance is found to be systematically inadequate for a challenging dataset, it
should be replaced by a more powerful or better tailored tool. On the other hand, if images
are corrupted during data collection, they will need to be detected early on to minimise
computational costs and call the researchers attention to exclude this scan from any anal-
ysis. Therefore, after processing large databases, MR scans that have been flagged by the
current QC metrics, will need to be assessed and categorised. Once patterns of problematic
images have been identified, more specialised QC tools could be developed and integrated
into the pipeline. Different machine learning models have already been suggested for au-
tomated quality assessment [17, 160, 63, 145, 235, 87]. Future work will focus on tools
that target specific artefacts to first detect whether the images are usable for any further
processing. Eventually, each processing step within the pipeline should be assessed for qual-
ity in one or the other way. Currently the pipelines only provide QC metrics summarised
in a spreadsheet. Although already useful to support subsequent image analysis, machine
learning methods could help to flag flawed data and failed processing steps based on the full
set of QC measurements. Ultimately, a comprehensive QC report could be generated that
enables imaging researchers to confidently set up their experiments and also could be in-
cluded in publications. Furthermore, QC metrics that flag severe failure cases should evoke
the abortion of the pipeline while informing the user immediately in order to save time and
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resources.
Although other open-source toolboxes - such as DTIprep [190] - exist, the pipelines pre-
sented here were tailored to the needs of clinicians working on TBI neuroimaging data. One
of the main advantages of the in-house pipelines are their flexibility that easily allows to inte-
grate any new tools required. For example, DTIprep indeed provides similar pre-processing
modules as the diffusion pipeline, but it does not automatically segment WM tracts via
TractSeg, which is a fairly novel method. Furthermore, DTIprep seems to only allow to
process DTI data, whereas the diffusion pipeline described here also allows to estimate dif-
fusion kurtosis parameter maps. Another advantageous example is that LPCA was used
for denoising diffusion images, whereas DTIprep employs the linear minimum mean squared
error algorithm. The latter has been shown to be inferior, introducing artefacts at frontal
areas due to inaccurate noise estimation [166].
2.5.2 The Pipeline - An Ever Evolving Process
The current state of the pipelines has to be understood as one version of many towards the
perfect workflow, as it will change over time with new demands. Although the presented
pipeline has been developed for and applied to different datasets, new databases might come
with different challenges and processing requirements. These may need to be addressed with
adjusted parameters or completely new approaches. Since novel algorithms and techniques
will constantly be developed, the pipeline will need to integrate such improvements to re-
main state-of-the-art. Moreover, clinicians and neuroimaging researchers will come up with
new ideas for image derived features, which may require additional processing modules.
All this together asks for agile development of the pipeline, and only if it is considered an
ongoing process will it provide the best possible output in future. Some changes may be
only enhancements of the pipeline, such as including new IDPs, others might change the
state of the data completely (e.g. new methods for denoising [209]). Consequently, this
means that databases would co-exist in different versions, depending on the applied process-
ing pipelines. Centralised data management and processing will allow for versions of the
previously processed data to be kept, while providing the most recently updated output.
2.5.3 Future Developments
One obvious improvement will be to update nipype to the most recent version, as this will
allow to use newly developed interfaces. For example the diffusion pipeline currently inte-
grates a custom interface that accesses MRtrix3 mrdegibbs for Gibbs ringing removal. Newer
nipype versions have a readily implemented interface for that, which will be used in future
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versions of the pipeline.
Many processing tools and analyses are based on an accurate brain masking, however, this
is far from trivial for deformed brains due to lesions and other pathology. For structural
T1w images the ANTS brain extraction tool seemed to work best, but this accuracy comes
with high computational costs. These are caused by intermediate steps, such as tissue seg-
mentation, which results are not used for later processing steps. Additionally, this brain
extraction is based on spatial normalisation which is inherently slow. As previously de-
scribed (Section 2.3.1) this spatial normalisation seemed to be inferior to the subsequent
deformable registration results, hence, it will not find any application later in the pipeline.
So, ANTS brain extraction could be replaced with a tool that is much faster, but at least
as accurate. Alternatives could for example aim to segment GM, WM and CSF separately
and combine tissue segmentations retrospectively. However, this approach likely will fail for
brains with large TBI lesions, that skew the intensity profile. One possible improvement
could be obtained by integrating a predictive brain extraction model. Many new deep learn-
ing methods have been suggested to perform skull stripping [52, 105, 133] including on TBI
data [221]. Ideally models for brain extraction would be directly linked to brain tissue seg-
mentation [207]. The advantage of such approaches would be the very quick computing time
as well as the ability to incorporate lesion information. Even more challenging is the brain
extraction on diffusion MRI. Coregistering the b0 volume to T1w images and projecting
the ANTS brain mask from the T1w scans back to DWI space was fast and rather robust.
Nonetheless, by design this involves only a rigid registration, which could introduce errors
when susceptibility distortions on DTI scans are too severe. Using a learning approach could
easily consider information from T1w images, while still being tailored to the exact brain
shape (including distortions) on a DWI scan. So, future developments could be to test new
machine learning tools for brain extraction for reliability and integrate the most appropriate
one. Furthermore, uncertainty measures from the model could be leveraged to estimate the
brain mask accuracy. This could replace the repeated computation of brain masks for QC
in both pipelines (ROBEX and MRtrix3 in structural and diffusion pipeline, respectively).
On the other hand, the overlap between different brain mask could be estimated via Dice
scores, a common metric to compute congruence between segmentations maps, and serve as
QC metric.
Once an automated lesion segmentation has been integrated in the pipeline, the information
can directly be used for spatial normalisation. This has been shown to be advantageous
[5, 27] and ANTS conveniently provides an option for cost function masking during reg-
istration. Deep learning tools could also be beneficial to accelerate spatial normalisation
through deformable image registration. Promising results for neural network frameworks
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have been reported to reach accuracy levels close to state-of-the-art methods [14, 140, 185].
Moreover, neural network based spatial normalisation [14] could also help to drastically ac-
celerate registration approaches based on multi atlases, such as MALP-EM. Alternatively,
neural networks could be integrated to directly segment structural images [220]. However,
further investigation is needed to understand the impact of such approaches on lesioned
brains.
Besides that, deep learning could also help to enhance image quality such as removing mo-
tion artefacts [144, 195] or improving resolution [237]. Certainly, deep learning tools have
improved performances for many MRI processing tasks (e.g. lesion segmentation) and with
new developments the boundaries of data processing will be pushed even further. Nonethe-
less, one pitfall to avoid for future versions of the pipelines is to replace each conventional
tool by a better performing neural network. Instead, tasks should be combined to be solved
together. For example, rather than having a neural network predicting the brain mask and
another segmenting tissue compartments, it would be more beneficial to have one model that
does both simultaneously. Although more challenging, aiming for multi-task approaches will
provide more efficient and stronger solutions.
This chapter focused on the the modularity of the pipelines and the integration of efficient as
well as accurate image processing tools. However, it did not examine the effects of different
methods on clinical research questions (e.g. finding differences between patients and control
subjects). While it is generally desirable to use robust and precise algorithms, marginal
changes in accuracy may not have a strong impact in the grand picture of the clinical data
analysis. The influence of different modules on effect size between patients and controls
could be investigated in future.
2.5.4 Integrated Lesion Segmentation
One very important branch of the pipeline will be the integration of lesion analysis. Modern
machine learning methods such as CNNs have helped to make great progress in accuracy
and precision of lesion detection and segmentation. Despite the convincing performance on
controlled training and validation datasets, the applicability in a general setting of a pipeline
remains complex and poses different challenges. One of them is to achieve a high accuracy
on unseen data. Currently, the best results for lesion detection are achieved with supervised
deep learning algorithms. This means, however, that lesions of interest will always have to
be annotated first to be able to train a strong model. Multi-centre MRI data might vary
enough to break an algorithm that had performed well on a validation dataset. So annota-
tions have to be generated either for most centres, or models have to be included that can
deal with the different intensity domains [122].
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Commonly, CNNs are trained on a given set of image contrasts (e.g. T1w, T2w, FLAIR
etc.)15, which for most network designs means the model can only detect lesions when the
exact same contrasts are given (or a surrogate if one assumes two images are interchange-
able). For a scan session where one contrast is missing due to inadequate or interrupted
acquisition, lesions cannot be detected with such a model in a straightforward way. Con-
sidering for example four different MRI contrasts, this leads possibly to 15 different cases
where none, one or several scans are missing. Training a model for all scenarios is impracti-
cable and has implications for more complex analyses. That is because lesions are likely to
be detected more accurately with four sequences than when some scans are missing. One
way to deal with heterogeneous data input for segmentation could be to compute statistical
features of the image representation in the latent space of the neural network [94], but this
requires further exploration to evaluate its applicability.
2.6 Chapter Summary
Two automated MRI pre-processing pipelines were introduced. The structural pipeline
is centred around T1w images, while facilitating the inclusion of other anatomical scans,
such as for example T1w or FLAIR images, for flexible application to different databases.
The core elements are the brain parcellation via MALP-EM, coregistration of all anatomical
sequences to T1w images as well as spatial normalisation to an age-agnostic template created
from T1w image of the Cam-CAN study. The diffusion pipeline is based on two pillars:
Firstly, the minimisation of image artefacts through denoising and Gibbs ringing removal
as well as head motion and eddy current distortion correction. Secondly, the extraction of
diffusion parametric maps (e.g FA or MD) and their co-registration to T1w space as well
as WM tract parcellation (i.e. TractSeg). Both pipelines extract QC metrics for convenient
post-processing data curation. These metrics have been validated on a TBI cohort. Data
processed with the pipelines are not only prepared for further analysis, but also extract IDPs
that can directly be used for statistical analysis of patient and control cohorts to investigate
clinical question.
15CNNs can also be trained on a single image contrast if there is only one available
Chapter 3
Application to Mild TBI
3.1 Introduction
3.1.1 Brief Introduction to Traumatic Brain Injury
Risk Factors & Epidemic Character. Traumatic brain injury is defined as an alteration
in brain function, or other evidence of brain pathology, caused by an external force [173]. In-
duced by a sudden event, initial injuries generally could happen to anyone regardless of sex,
demographic or ethnic characteristics. However, with traffic accidents, falls, assaults and
sport-related concussions being the leading causes for TBI, some groups are at higher risk.
For example, men are almost three times more likely to suffer a TBI than women. Another
strong risk factor is age, as elderly (≥65) and children (age<14) may be more vulnerable to
traumatic incidents [75, 161]. It is estimated that approximately 69 million people world-
wide suffer a TBI each year [51]. Overall, more TBI incidents were found in high-income
countries which, however, may be biased by better reporting systems [51]. With increasing
median age, falls becoming proportionally the greatest cause for TBIs in western countries,
and a clear change in the epidemiological patterns of TBI has been observed [217]. In con-
trast, for developing regions - such as Africa or Southeast Asia - road traffic incidents remain
the leading cause of TBI closely linked to uprising industrialisation in these countries. The
traumatic injury is often only the start of disease progression and recovery from TBI can
possibly take years, with some individuals requiring lifelong care and support. In 2016, the
annual financial costs associated with TBI were estimated between nine to ten billion US
dollars [75]. Due to its ubiquitous character and the wide spanning consequences, TBI has
often been described as a silent epidemic which creates an immense socio-economic burden
globally [161, 217].
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Pathological Patterns. Depending on the mechanism and the strength of the initial
impact, brain injuries occur with different severities. Although these cover a wide spectrum,
patients are usually trichotomised as mild, moderate or severe TBI (approximately 80%,
10% and 10% of all cases, respectively), usually based on the Glasgow Coma Scale (GCS)
[240].1 Besides this classification, patients can be grouped according to radiological evidence
of brain damage. Primary traumatic injuries can include focal injuries such as cortical contu-
sions, intraparenchymal haemorrhage and subdural or epidural haematomas. Each of these
are a consequence of impact site and severity as well as different underlying pathological
mechanism. Cortical contusions, for example, mostly appear where the brain makes contact
with irregular, prominent bone structures on the inner surface of the skull, and commonly
occur in the inferior frontal or temporal lobes. Contusions can be observed both directly
at and opposite to the site of impact termed coupe and contre-coupe injuries, respectively.
Moreover, vascular damage can result in haemorrhage and haematoma. Besides this, impact
forces can cause skull fractures that further damage the brain and can cause for example
injury to nerves and arteries (at the base of the skull). Alongside those patterns, diffuse
vascular and diffuse axonal injury may occur. These are usually caused by rapid accelera-
tive and decelerative forces. After the trauma and the initial presentation of pathological
patterns, a complex cascade of mechanisms causes secondary injuries to the brain. Vascular
damage can lead to a formation of new haemorrhages within hours after the TBI, resulting
in increased intracranial pressure or hypoxic ischaemia [75]. Additionally, secondary injuries
are triggered on a cellular level through an immune system response [111, 229] and on a
molecular level as an unregulated flux of ions due to compromised cell membrane integrity
[196]. Furthermore, neuroinflammatory processes can take place minutes to months after
the traumatic event and the release of neurotransmitters may create a toxic environment
exacerbating the initial tissue damage [75, 141]. This heterogeneity in pathological patterns
also brings a great variation of symptoms in TBI patients.
Consequences & Outcome. While TBIs can be very different, all grades of severity
share common linkages to acute and long-term neuropathologic damage and brain dysfunc-
tion [172]. Some symptoms may resolve within days, weeks or months post-injury. However,
others such as fatigue, poor cognitive performance, depression or chronic pain may develop
and persist for years, drastically impairing life quality. A meta-analysis [224] of 39 studies
revealed that cognitive functioning (e.g. memory or attention capacity) is restored most
quickly within the first few weeks after mild injury and reaches a plateau during one to
three months post-injury. Moderate to severe TBI patients may experience continuing im-
1other metrics can be the level of consciousness or post-traumatic amnesia
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provement within the first two years after the incident, but their cognitive functions might
remain impaired beyond that time point [224, 262]. Although difficult to distinguish from
somatic symptoms, depression and social impairment have been repeatedly linked to TBI.
Both have been described as consequence after TBI since the mid 1980’s [128], and were
shown to be present at least up to 12 months post-injury [84]. Symptoms of depression
were reported by patients of any injury severity, and may even be pronounced in patients
who had suffered a mild TBI (mTBI) [204]. Further long-term consequences can be chronic
pain and closely linked sleep disorders [265], or other secondary psychiatric sequelae such
as post-traumatic stress syndrome [61, 146] or sexual dysfunctions [216]. A long term study
showed that, despite high levels of independent daily living, approximately 40% of patients
were dependent on more support than before the injury. Moreover, problems that were
present at two years after the TBI (e.g. fatigue or balance problem), often persisted un-
til the ten year mark post-injury [202]. Further down the line, TBI have been associated
with increasing the risk for neurodegenerative diseases (e.g. Alzheimer’s disease) [208, 230].
Finding early biomakers that help to characterise injury better and quantify the likelihood
of recovery or disability is crucial to improving patient management, outcome and quality
of life.
3.1.2 Role of Neuroimaging for Mild Traumatic Brain Injury
The majority of TBIs (75-85% in 2003) are considered to be mild with a GCS score of
13 to 15 [68]. However, the definition of mTBI has been challenging due to the lack of
reliable biomarkers of injury [22] and the influence of various factors (e.g. education and
training of the physician observing the patient) on the GCS score [214]. Most mTBI patients
experience a full recovery from neurological deficits, but a substantial subgroup (5–30%)
develops prolonged neurocognitive problems [45, 172]. Distinguishing those patients with
persistent symptoms from those making a full recovery in a mTBI cohort is difficult based
on clinical assessment exclusively. Therefore, radiological metrics bear a great potential to
characterise injury severity and predict outcome. Nonetheless, while skull fracture and large
lesions often mark severe cases, mTBI can be much more subtle. Sudden acceleration or
deceleration forces acting on the brain induce deformation and shearing within the brain
causing microscopic, multi-focal or diffuse tissue damage on a cellular level. Particularly
affected are axons due to their elongated cell structure. Besides cortical contusions and
hyper-intensities or micro-haemorrhages linked to shearing related WM injury, most mTBIs
appear normal on conventional MR images [188]. Since diffusion MRI is able to characterise
the state of cerebral WM integrity [3], DTI has seen a tremendous interest in the field
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of TBI research.2 Substantial evidence of the effectiveness of DTI in detecting TBI has
emerged over the last decade. This established the consensus of lowered FA in WM as a
characteristic of TBI-related abnormalities [102]. Decreased FA can reflect less isotropic
diffusion as it can be observed in traumatic axonal injuries [88], which may potentially
indicate the disruption of the integrity of WM fibre tracts. For example lower FA values
within some ROIs (i.e. internal and external capsules, or corpus callosum [CC]) were found
to correlate with worse three and six months outcome after injury [276]. A systematic review
revealed that an unfavourable outcome in TBI with diffuse axonal injury was three times
more likely compared to TBI in the absence of such axonal pathology [250]. Another meta-
analysis of mTBI studies, confirmed the decrease or increase of FA and MD, respectively,
within the CC [9]. Further examinations of mTBI using DTI have shown that frontal and
temporal WM pathways are predominantly affected. Such micro-structural changes in WM
could be linked to behavioural and cognitive performance measurements [188, 157]. In fact,
severities of traumatic axonal injury and TBI seem to correlate. Physical alterations found
in different regions such as the CC, fornix, subcortical WM, as well as the cerebellum are
believed to contribute to the extent of symptoms after mTBI [172]. Although aberrations
of DTI metrics could be associated with specific brain locations and patient outcome, the
heterogeneity of patient cohorts have hampered the generalisability of abnormal DTI findings
[102]. A recent meta-analysis summarising 42 studies reaffirmed previous discoveries of
lower FA and higher MD values in TBI subjects and reported more subtle WM changes
for mild patients in comparison to moderate and severe TBI cases. Moreover, the measured
differences in DTI parametric maps seemed widespread3, indicating global WM damage after
TBI [259]. Imaging derived diffusion characteristics were repeatedly reported to be useful
biomarkers for WM injury [211] and differentiate TBI at a group level. However, there is
still a lack of strong evidence to prognosticate patient outcome at the level of individual
patients [58, 261]. One step in this direction could be the analysis of multi-modal images,
including volumetric measurements from structural MR (i.e. T1w scans) and quantification
of abnormal diffusion within the brain [246]. Besides cross-sectional analysis, longitudinal
studies could provide further information for disease progression in TBI patients.
3.1.3 Related Work for Analysis of Mild TBI MRI Data
Although not exhaustive, this section aims to provide a broader overview of volume and
diffusion changes in the brain after mTBI.
2Number of Google Scholar results for ”DTI mTBI” (Jan. 2020): 1480 in 2001-2010; 7720 in 2011-2020
3abnormalities were observed for 35 different ROIs across the studies included for the meta-analysis
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Volumes. Structural brain volume changes in mTBI have been investigated in several
reports, and overall highlighted the influence of time after the traumatic incident on devel-
opment of tissue atrophy. A comparison of mild and moderate TBI patients three months
after injury found no differences in brain parenchyma or CSF volume when compared to
healthy controls [163]. However, global brain volume loss was detectable in mTBI patients
one year after the injury, with atrophy observed both in GM and WM [284]. Moreover, a
decrease in brain volume was found to be present in the chronic stage (approximately two
years post-injury), with regional volume losses in the forebrain, cerebral WM and cerebellum
appeared to be affected [218]. More recently, significantly reduced cortical and subcortical
volumes (in the nucleus accumbens, and caudate) were found in mTBI when comparing
one year follow-up scans to the initial image obtained one month post-TBI. [98]. These
findings may suggest that tissue loss in mTBI evolves over time. Nonetheless, a longitu-
dinal study has reported regional volume decrease (in the caudate, putamen or thalamus)
as early as two month after injury [278]. And another study found that mTBI patients
experience significant cortical volume loss and an increase in ventricle size within one month
post-injury [247]. Furthermore, mTBI patients were found to have a significantly higher at-
rophy rate than controls a few months (>3) after the injury [163]. While discrepancies have
been repeatedly found between patients and controls, differences between patient groups
with varying symptoms or outcome is less consistent. For example, there were no significant
longitudinal changes observed when comparing patients with complicated or uncomplicated
mTBI. [98]. However, volume of brain parenchyma was observed to decrease more in pa-
tients with loss of consciousness [163]. In addition, an elevated rate of tissue atrophy was
linked to the inability to return to work [218] and decreased ROI volumes were associated
with neurocognitive performance [284].
While brain volume loss in mTBI patients has been observed multiple times, increases in the
volume of brain regions has also been reported, but far less frequently. A very recent study
has found abnormally enlarged cortical GM areas in mild to moderate TBI patients when
compared to a large database of control subjects. At the same time, however, the authors
found tissue atrophy in cerebral WM [219].
General volume loss in mTBI patients has been well established, but most of the above
mentioned studies included less than 20 [163, 218, 247, 284] or up to approximately 60
[98, 219, 278] mild and moderate TBI patients. A small sample size introduces biases as-
sociated with patient selection and reduces the robustness of these studies and limit their
generalisability. In fact, a recent review [93] concluded that observations of brain tissue
atrophy after mTBI remain inconclusive, but moderate and severe TBI patients show more
distinct patterns of general and focal atrophy on a global or regional level. More specifi-
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cally, this includes widening of cortical sulci, cortex thinning, shrinking of the hippocampus
and increase in ventricle size [93]. The underlying mechanisms for brain atrophy are direct
disruption of structural cell components, but also a cascade of secondary responses on a
molecular level [93]. While the incidence of a TBI may have a direct impact on brain tissue
loss, it also seems to trigger an ongoing process of accelerated tissue atrophy months and
years after the insult [20, 39].
Diffusion. Besides volumetric changes in anatomical brain regions, mTBI has frequently
been associated with abnormal water diffusion within the brain. This reflects the disintegrity
of axons in the WM, which are particularly vulnerable to mechanical loading of brain tis-
sue during rapid head accelerations due to their elongated cell structure and anisotropic
arrangement [116]. The mechanical impact on the WM can lead to disconnection of axons
at the time of injury, however disruption is mostly induced by secondary damage caused by
axon swelling [116]. Progressive degradation of WM has been shown to extend long after
the impact, resulting in loss of brain connectivity in the entire brain [20]. White matter
alterations in mTBI can be subtle and highly dependent on the examined cohort and the
choice of analysis [103]. However, a comprehensive meta-analysis summarising 28 DTI stud-
ies showed the robust findings of significant FA reduction and increase in MD in the CC after
mTBI [9]. The splenium was mostly affected, with marginal and no significant differences
for the mid-body or genu of the CC, respectively [9]. Nonetheless, measuring differences in
WM integrity in TBI is far from trivial as diffusion metrics change dynamically with days
post-injury (DPI) [227].
Early on, DTI metrics were analysed for mTBI patients at different time points. Inglese et
al. [107] have examined two patient groups, scanned in the acute or chronic phase (approx-
imately 4 DPI or 6 years post-injury, respectively). At both time points, patients showed
significantly reduced FA and increased MD (splenium, internal capsule) compared to con-
trols. A link to neuropsychological data was not reported for this study [107]. Lowered
FA values have also been reported for the corticospinal tract (CST), sagittal stratum and
superior longitudinal fascicle (SLF) in chronic (approximately 7.5 years post-injury) mTBI
patients [138]. Kraus et al. [138] could show that the number of WM tracts in TBI patients
with lower FA than the control group had worse executive functions and memory. However,
for this they have pooled patients scans from both available time-points (approximately 7.5
and 10 post-injury), which does not allow the assessment of progression of neuropsychologi-
cal functions over time. In contrast to examining patients at a very chronic stage, mTBI has
also been investigated on hyper-acute MRI scans (on average 10 hours post-injury). This
has revealed a similar pattern of decreased FA and MD within in the splenium, internal
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capsule or cingulate gyrus (CG) in patients compared to controls [253].
Besides contrasting patients against controls, different patient groups have also been com-
pared to one and another. Patients that showed intra-cranial lesions at admission also dis-
played decreased FA at follow-up. However, patients without visible lesions, demonstrated
no abnormal diffusion in comparison with controls [276]. Despite patients deviating from
controls, diffusion was not found to be different for two separate patient groups scanned in
the acute (approximately 4.5 DPI) and chronic phase (approximately 6 years post-injury)
[107]. Patients dichotomised as achieving good or poor outcome according to their functional
status at follow-up (three months post-injury) showed different diffusion patterns on MRI
scans approximately two weeks post-trauma [174]. While those patients with good outcome
had similar DTI measures to controls, patients with poor outcome showed increased MD
compared to controls as well as patients with good outcome. Regions for which such differ-
ences were observed included the CC, the inferior fronto-occipital tracts (IFOs), the anterior
thalamic radiations (ATR), the CST as well as the superior and inferior longitudinal fasci-
cles (ILFs). Although no differences were discovered between groups when examining FA,
this provided evidence that abnormal diffusion measured on sub-acute scans could be useful
for TBI outcome prognosis [174]. No changes were detected between sub-acute and 3-months
scans [174]. Likewise no variation was found between the two patient groups scanned dur-
ing the acute or chronic phase [107]. These data suggest that DTI can detect both initial
microstructural injury and late tissue status following TBI.
Although many studies replicated the findings of lowered FA and increased MD, discordant
results have also been reported. For example, increased FA and reduced MD values were
found in smaller mTBI cohorts both during the hyper-acute (approximately 3 DPI) [270],
semi-acute (6 DPI) [267] and sub-acute stage (within 21 DPI) [156].
Longitudinal Diffusion Changes. With the growing awareness of time-dependence of
TBI, recent studies have addressed changes of diffusion in WM over time. A tract-based
comparison of hyper-acute (approximately 24 hours) and three-months scans did not reveal
any differences in DTI metrics. With initially elevated MD for the mTBI cohort, this in-
dicated the persistence of WM damage few months post-injury [184]. The comparison of
DTI data from two and 12 months after injury has shown different patterns for FA and
MD in mTBI patients. While some fibre tracts (e.g. CC, CST) showed decreasing FA and
increasing MD over time, others (e.g. internal capsule, ILF and SLF) showed decreased MD
values between the two visits [19]. Longitudinal changes both in FA and MD were more
pronounced in patients than in the control group [19]. A recent longitudinal study showed
initially lower FA (internal capsule, IFO) during the semi-acute phase (seven DPI), which
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however, seemingly recovered to baseline one month after injury. Other tracts (e.g. CC)
showed evidence of evolving injury, detected by progressive changes up to three months
after the TBI [273]. In contrast, in another report, patients with mTBI were found to show
initial regional elevations in FA during the semi-acute phase (on average six or 12 DPI),
which partially recovered to normal levels within three to five months [171] or a year [43]
after injury. Moreover, the examination of a smaller mTBI cohort on several scans within
the first eight days revealed complex changes in diffusion patterns with patient-individual
trajectories [268].
A substantial amount of research has focused on mTBI, establishing the picture of brain
atrophy after injury. Generally the CC seems to be one of the most affected locations of
abnormal diffusion in mTBI patients [103]. However, many earlier studies only included
around 20 patients [107, 138, 171, 174]. Although more recent studies increased the patient
numbers [19, 43, 184, 253, 273, 276], the largest sample size of 80 patients is still very low
given the vast heterogeneity of the mTBI patient cohort. In addition, the variation in time
points and inconsistency in the chosen analysis tools hamper comparison across studies. A
key factor that needs to be taken into consideration for an adequate interpretation of DTI
metrics seems to be the time post-injury [48]. Despite the existing efforts, more research is
needed to gain a better insight in disease progression after mTBI.
3.1.4 Aims
Although more recent studies have started to recruit larger number of patients, most previous
observations are based on small TBI cohorts. Undoubtedly, this limits the generalisation of
the findings. To date, there is seemingly only one combined analysis of TBI data from more
than one site. This, however, enrolled less than 15 patients from two out of the three centres
(104 patients in total). Moreover, this study relied on visual inspection of images, rather
than quantitative metrics [228]. Changes in regional volumes (derived from MALP-EM)
and DTI metrics (tract count) have been investigated before, but only addressed a smaller
cohort of moderate to severe TBI patients [186]. Therefore, the aim for this chapter is to
retrospectively build a multi-centre database to examine a larger cohort of mTBI patients.
The analysis entails volumetric measures obtained from the MALP-EM atlas as well as
regional FA and MD metrics derived from the relatively new TractSeg WM atlas. Besides
investigation of site-specific differences, results are presented for three individual databases
and their joint analysis. The clinical aim of the study was to assess whether features derived
from acute MRI scans are different for controls and patients with good or poor outcome.
Furthermore, the prognostic value of regional volumes and diffusion for functional outcome
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was examined. Lastly, a longitudinal analysis of all acquired scans looked at the disease
progression in patients and whether it differed for patients with good or poor outcome.
3.2 Data Acquisition, Processing & Curation
3.2.1 Databases
Data from three separate TBI studies were examined independently, as well as pooled to-
gether for a retrospective multi-centre analysis. The following section provides information
for acquisition parameters and numbers of scanned subjects in each of these studies.
Cambridge Database. Mild TBI patients were scanned on a 3T Siemens Verio Mag-
netom at the Wolfson Brain Imaging Centre in Cambridge, UK. Structural MR images,
T1w MPRAGE with FOV: 256×240×192 and isotropic 1mm3 voxels, were acquired with
TE = 2.98ms, a TR = 2300ms, and TI = 900ms and a 9◦ flip angle. Diffusion weighted
images included 63 different directions on a single shell (b = 1000 s/mm2) and five non-
diffusion sensitised images (b = 0 s/mm2) evenly distributed across the acquisition time. A
2-fold acceleration factor was applied (GRAPPA) to obtain images with isotropic 2×2×2
mm3 voxels (63 axial slices; FOV = 96×96) were all acquired with TR = 11700ms and
TE = 106ms. Additional data (e.g. b0 volumes with reversed phase encoding direction) to
correct for susceptibility artefacts were not collected. The database included 20 healthy and
22 trauma4 controls as well as 51 patients. These were scanned at different time points up to
approximately 24 months post-injury to capture the TBI progression. With those follow-up
scans of the the 51 patients, the databases encompassed a total number 183 patient scan
sessions.
Trondheim Database. Structural and diffusion MR images were also collected for 156
mild TBI patients along side 83 healthy control subjects. Subjects underwent imaging on a
3T Siemens Skyra scanner upon admission at the St. Olavs University Hospital Trondheim,
Norway, and at follow-up times of three and 12 months. This longitudinal study eventually
included 402 and 206 scan sessions for patients and controls, respectively. All those scan
sessions included a T1w and DWI scan. The T1w MPRAGE scans were acquired with
TE = 4.21ms, a TR = 2300ms, and TI = 996ms and a 9◦ flip angle. T1w images entailed
176 slices covering a FOV of 256×256 with isotropic 1mm3 voxels. Diffusion weighted scans
included four baseline volumes (b = 0 s/mm2) and 60 diffusion sensitised volumes with two
4trauma controls were patients who experienced an external trauma that has not directly affected the
head, e.g broken leg
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different b-values (b = 1000, 2000 s/mm2, same 30 directions each). Scanner parameters
were set at TR = 8800ms and TE = 95ms to image DWI images (60 axial slices; FOV =
96×96) with isotropic 2.5×2.5×2.5 mm3 voxels. Additional b0 volumes with opposite phase
encoding directions were acquired (otherwise same parameters).
Turku Database. From the TBI study at the Turku University Hospital (Tyks), Turku,
Finland, 114 mTBI patients and 30 trauma controls subjects with both T1w and DWI scans
(3T Siemens Verio) were selected based on GCS scores (GCS ≥ 13). Follow-up scans around
∼6-8 months post-injury make this a longitudinal database consisting of 204 patient and 51
control scan sessions. The T1w scanning parameters were TE = 2.98ms, TR = 2300ms,
TI = 900ms and a 9◦ flip angle. The 176 slices covered a FOV of 256×240 isotropic 1mm3
voxels. The 65 volumes of the DWI scan included one baseline volume (b = 0 s/mm2) and
64 diffusion sensitised volumes (b = 1000 s/mm2). Isotropic images (voxel size: 2×2×2
mm3; 81 axial slices; FOV = 96×96) were acquired with TR = 11700ms and TE = 106ms.
Additional scans to correct for susceptibility artefacts were no collected.
3.2.2 Specifications of MRI Processing
All images were processed with both the structural and diffusion pipelines, as described
in the previous chapter. The additional b0 volumes acquired alongside the DWI scans for
the Trondheim database were used to correct the diffusion scans for susceptibility distor-
tion. Both other databases did not include such a scan. The Trondheim databases included
multi-shell diffusion imaging with higher b-values, which would allow employing more sophis-
ticated models to calculate diffusion in WM microstructure. However, diffusion data from
Cambridge and Turku were collected using single-shell acquisition, restricting the diffusion
estimation to standard tensor modelling. With the aim in mind to compare and combine all
three databases, the same tensor fitting model was applied to all data (FSL dtifit). Since the
assumption of linearity of the logarithmic signal attenuation does not hold true for higher
b-values [176], the diffusion tensor model was only fitted to the lower (b = 1000 s/mm2)
single shell for Trondheim scans. Moreover, to consider a similar number of non-diffusion
weighted images (b = 0 s/mm2) for the tensor estimation, b0 volumes after the acquisition
of the first shell (b = 1000 s/mm2) were disregarded. So, only one b0 volumes was included
for Trondheim, despite several b0 volumes having been acquired. All b0 volumes have been
used for Cambridge data, as they were interleaved between the diffusion sensitised scans.5
Study data from Trondheim and Cambridge included mTBI subjects only. Turku patients
were defined as mild when their GCS score was larger than 12 (GCS ≥ 13). Only controls
5This was a choice based on practicability, but is acknowledged as a limitation of this study.
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and mTBI patients that had both a T1w and a DWI scan were included. The extracted
IDPs were regional volume (as provided by MALP-EM) and average diffusion metrics (FA
and MD) within TractSeg parcellations. These tools were chosen as MALP-EM has been
shown to cope well with TBI-related deformations [151] and ROI based approaches were
found to be more sensitive than voxel-wise DTI analysis [103]. Although other structural
scans were acquired and processed as part of the automated pipeline, they were not con-
sidered for this analysis. Assuming latent axonal injury, patients with visible pathology
(in particular lesions visible on T1w scans) were excluded to avoid any bias due to brain
parcellation failures.
3.2.3 Data Curation Prior to Analysis
The diffusion processing pipeline provides QC metrics as output (Section 2.4.2) that help
to identify problematic scans for which, for example, the acquisition was corrupted. Any
scan that was associated with exceeding or unexpected QC measures was visually exam-
ined. Cut-off values were empirically chosen for each QC metric individually based on the
metrics observed in the whole mTBI database. Once a scan was rejected, its QC metrics
were not considered anymore for the subsequent curation. At first, the PIS ratios were
checked. Highlighted by a low value (PIS ratio = 66%), one Cambridge scan was excluded
as it showed strong striping artefacts due to head motion. Both available scans of one Turku
control were picked up on: one showed visible ghosting artefacts outside the brain mask (PIS
ratio = 57%), the other displayed noticeable hyper-intensities (PIS ratio = 53%). As the
scan quality within the brain seemed unaffected, both scans were kept for analysis. Then,
the SNR of the non-diffusion weighted images were analysed. None of the retained scans
showed any obvious artefacts. It is noteworthy, that nine scans with the lowest SNR were all
collected in Cambridge, while most scans with the highest SNR were from the Trondheim
database. Checking the ratio of the actual and control DTI brain mask highlighted a few
subjects. Some of those with high ratio were picked out, because the control algorithm
(MRtrix3) failed and oversegmented the brains. Since the actual skull stripping algorithm
(ANTS) performed as expected, flagged scans were not excluded. Similarly, at the lower
bound of the mask ratio, the control mask (MRtrix3) severely unsegmented the brain, but
the used mask (ANTS) was acceptable. However, two Trondheim scans highlighted by a
low ratio showed strong signal drop-out in the frontal part of the brain. Both scans were
rejected to avoid inaccurate results. Two further scans demonstrated very high intensities
in the cerebellum, which seemed to have neither directly affected brain masking nor tensor
fitting. Therefore, they were kept for the analysis. The scans with the lowest NCC between
FA and T1w images after coregistration were checked. Two scans (NCC = 0.38 and 0.43)
56 CHAPTER 3. APPLICATION TO MILD TBI
were excluded from the analysis due to observable lesions on the DTI scans affecting the
WM parcellation. The corresponding follow-up scans were also inspected, and one of them
was excluded for the same reason. Remaining scans that were highlighted by greater head
motion QC values showed no apparent motion artefacts, such as striping or blurring, upon
visual inspection.
The curation process described above led to excluding a total of six scans (one Cambridge,
two Trondheim, three Turku). Quality control values were checked for significant differences
between the healthy and trauma controls from Cambridge. Since they could not be dis-
tinguished statistically (p > 0.3 for all t-tests), both categories were considered as a single
group for subsequent analysis. Table 3.1 summarises the number of available subjects and
scan sessions after the curation process.
Table 3.1: Number of Subjects and Scans of the mTBI Databases
Category Cambridge Trondheim Turku All
controls (subjects/scans) 42/47 83/206 30/51 155/304
patients (subjects/scans) 50/182 155/400 112/201 317/783
3.3 Experiment Setup
3.3.1 Data Categorisation
Brain tissue atrophy and changes in WM are a consequence of healthy ageing [67]. This
is why the age of a subject at scan time needs to be taken into account for any analysis
measuring brain volume loss and WM integrity. Dependent on study design and availabil-
ity, cohorts can vary in age and the time point of imaging after injury across different sites.
Plotting the distribution of age at scans revealed that overall Trondheim included younger
subjects than both other databases. While Trondheim and Turku showed matching distri-
butions of age for patients and controls, Cambridge patients were spread over a wider range
than control subjects (Figure 3.1 left). When combining the databases, the age distribution
was mostly driven by the large Trondheim dataset. Pathological patterns in TBI vary over
the course of the injury (Section 3.1.3). Therefore, it is important to consider the time point
of image acquisition for analysis of TBI patients. All three TBI studies were setup with a
different MR collection scheme. In Cambridge patients were scanned at five distinct time
points over the course of two years. Trondheim focused on acquiring a hyper-acute scan
(DPI≤3) as well as two follow-up scans at three and 12 months. Turku collected scans at
mostly the acute phase and six months after the injury, as well as a few follow-up scans one
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year post-injury (Figure 3.1 right). Five time frames were defined based on the scan time
point distribution and clinical relevance: Acute phase6 (DPI ≤ 42), three months (42 < DPI
≤ 150), six months (150 < DPI ≤ 300), 12 months (300 < DPI ≤ 500), and chronic phase
(DPI > 500).
Figure 3.1: Overview of Age and Scan Time Distribution. Left: The distribution of ages at
scans shows that the Trondheim cohort included younger subjects that the other two TBI
databases. Patients and controls scanned at Cambridge showed a different age distribution.
Right: All three studies collected scans at different time points. Cambridge patients were
scanned from the acute to chronic phase. Trondheim subject were scanned very early on
and at the three (3 M ) and 12 months (12 M ) mark post-injury. Turku patients were mostly
scanned during the acute and 6 months (6 M ) periods after injury (each point represents a
patient scan).
3.3.2 Region Selection for Analysis
Volumetric Analysis. Regional volumes within the brain were estimated via MALP-EM
(Section 2.3.1). As summarised previously (Section 3.1.3), mTBI has been associated with
regional volume loss at different stages post-injury. This analysis focused on similar anatom-
ical regions, as found in the MALP-EM atlas including: Nucleus accumbens (ROI #3 & #4)
[98], caudate nuclei (ROI #8 & #9) [278], cerebellar WM (ROI #12 & #13) [218], lateral
ventricles (ROI #23 & #24) [247], putamen (ROI #27 & #28) [278], thalami (ROI #29 &
#30) [278], anterior CG s(ROI #41 & #42) [284] and precuneus (ROI #101 & #102) [284].
Besides these ROIs, the cerebral WM [218], cortical GM [247] and ventricles were analysed
as a whole [278].
6including all three stages of hyper-, semi- and sub-acute
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Diffusion Analysis. Analogous to the volumetric analysis, regional diffusion was com-
pared between patient groups and the control group. As described above (Section 3.1.3),
differences in diffusion pattern were found in various regions at all phases after the injury.
The analysis examined 24 regions that were previously found to be affected by mTBI. These
were segmented by TractSeg and included: The ATRs (ROI #2 & ROI #3) [174], and in
both hemispheres the cingulum (ROI #12 & ROI #13) [253], the CSTs (ROI #14 & ROI
#15) [19, 138, 184], the IFOs (ROI #24 & ROI #25) [174, 273], both ILFs (ROI #26 &
ROI #27) [19], the SLFsI,II,III (ROI #35-40) [138] and the uncinate fascicles (UF: ROI
#43 & ROI #44) [171]. Furthermore, the CC as a whole (ROI #45) [19, 103, 174, 184]
and its sub-parts such as the rostrum (ROI #5), genu (ROI #6) [142, 171], anterior and
posterior mid-body (AMB: ROI #8 and PMB: ROI #9, respectively) [273] and the splenium
(ROI #11) [9, 107, 142, 253] were included. Although the internal and external capsules
[107, 184, 253, 273] as well as the corona radiata [171, 273] were also reported to show devi-
ating diffusion they were not included, since they are not explicitly segmented by TractSeg.
3.3.3 General Statistical Analysis
After scan selection (see below), volumes or diffusion measurements were harmonised across
sites by standardising the distributions for each ROI separately. For this, mean (µ) and
standard deviation (σ) of the control population within a centre were computed at first.
Then, Z-scores (z) for the particular cohort were derived by subtracting the mean from the
metrics (x) and dividing by the standard deviation (z = (x− µ)/σ).
Linear regression analysis was chosen to identify differences between subject groups while
considering age, sex and acquisition site as confounding factors. Since an initial test showed
that a simple linear model with least square fitting resulted in non-normally distributed
residuals, a generalised linear model (GLM) was employed (statsmodels python library) to
fit a Gamma distribution. Non-linear models were not tested to keep statistical model as
simple as possible. To respect the domain of the Gamma family of real positive values, all
Z-scores were shifted towards positive values with a global constant (i.e. subtracting the
global minimum Z-score per ROI metric and adding a vanishing small constant such that the
minimum Z-score was just above zero). These Z-scored data were used for all experiments.
To account for multiple comparisons, all results were corrected for false discovery rate (FDR)
via the Benjamini-Hochberg method (statsmodels) and reported as statistically significant
when the corrected p-values were below 0.05. False discovery rate was chosen over Bonfer-
roni, as the latter is more conservative and may produce false negatives when correction for
a large number of tests. Throughout this chapter, the terms prediction and prognosis are
used to describe the fitting of statistical models to regress imaging data (mostly collected in
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the acute phase) against the functional outcome (i.e. GOSE assessed several months after
MR acquisition). In other words, no prediction in the sense of data science was performed
(e.g. cross validation).
3.3.4 Site-Specific Biases
Since data were included from three centres, at first differences between control subjects
were analysed for regional volumes and diffusion metrics (i.e. FA and MD). For this, a GLM
was fitted to the control data (subject i) to assess the influence of the acquisition site on
the ROI metric (Yi) while accounting for age at scan and sex. These covariates were chosen
as they are know to affect volumes and diffusion in the brain and, furthermore, are widely
available.
Model #1: fγ(Y ) = β0 + β1Sitei + β2Agei + β3Sexi + εi
with fγ representing for the log link function to fit a Gamma distribution, β0,...,3 repre-
senting the parameters to be fitted by the GLM and εi is the error unexplained by the
model. A separate GLM was employed for each ROI individually.
Besides applying a GLM to all three databases pooled together, all combinations of two
different databases were examined via regression analysis as well to identify the impact of
different centres. To visualise regional differences, another GLM was fitted analogously, but
excluding Site as predictive variable. That way, the GLM residuals represented the site-
specific differences while adjusted for age and sex. Table 3.2 lists the number of controls
included.
3.3.5 Acute MRI Differences between Controls and Patient Groups
The aim was to examine databases in a joint analysis to investigate whether IDPs from the
acute phase can be associated with patient outcome. Patients were dichotomised accord-
ing to their extended Glasgow Outcome Scale (GOSE) [269] score into groups with good
(GOSE=8) and poor (GOSE<8) functional outcome. Clinically it is more of interest if
a patient will show symptoms later on (GOSE<8) or has fully recovered from the TBI
(GOSE=8), rather than identifying how bad the symptoms are (GOSE 3-7). Furthermore,
combining all patients with unfavourable outcome (GOSE<8) improves the class imbalance.
Even when pooling them together, patients with poor outcome only made up 39% of the
whole patient cohort (Table 3.2). Examining Cambridge patients with GOSE scores at both
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three and six months showed that eight out of 37 subjects had a changing outcome (good
vs. poor) between both time points. Seven of those patients changed towards a good out-
come, showing a general trend towards improved outcome from three to six months. So, the
assumption was that patients functional outcome is mostly stable after three months, but
if it was changing it seemed more likely to improve. Thus, GOSE scores from either three
and six months were used, since Trondheim and Turku only measured GOSE at three or six
months, respectively. In case GOSE scores had been recorded at both time points (i.e. in
Cambridge database) the three-months GOSE score was used as it was available more often.
In case a patient had multiple scans within the acute phase, the earliest scan was chosen.
Eighteen patients had to be excluded, because they had no GOSE score recorded. Any miss-
ing records of GCS scores were imputed for patients with the majority value (i.e. GCS=15).
Table 3.2 shows the number of subjects included. The employed model included Category as
predictive variable, indicating a subjects belonging to the control or patient group with ei-
ther good or poor outcome, while also accounting for age, sex and site as confounding factors.
Model #2: fγ(Y ) = β0 + β1Categoryi + β2Agei + β3Sexi + β4Sitei + εi
with fγ representing for the log link function to fit a Gamma distribution, β0,...,4 repre-
senting the parameters to be fitted by the GLM and εi is the error unexplained by the
model. The continuous dependent variable (Y ) was replaced with the volume or diffusion
metric of a particular ROI. An individual GLM was fitted for each ROI.
To visualise regional differences, a GLM was fitted analogously, but excluding Category as
predictive variable. That way, obtained GLM residuals represented the category-specific
differences while adjusted for age, sex and site.
3.3.6 Prognostic Value of Acute MRI for Mild TBI Outcome
To test whether regional metrics derived from acute MRI have a prognostic value to differen-
tiate patients with good or poor outcome, a GLM was fitted considering age, sex, acquisition
site as well as GCS and DPI as covariates. Control subjects were excluded.
Model #3: fη(Y ) = β0 +β1ROIi+β2Agei+β3Sexi+β4Sitei+β5GCSi+β6DPIi+εi
with fη standing for the logit link function to fit a Binomial distribution, β0,...,6 repre-
senting the parameters to be fitted by the GLM and εi is the error unexplained by the
model. The binary dependent variable (Y ) indicated the patients’ good or poor outcome.
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Table 3.2: Overview of Available Data for MRI Analysis





s # Subjects 42 83 30 155
Sex (M/F) 23/19 50/33 14/16 87/68









# Subjects 39 134 82 255
Sex (M/F) 28/11 84/50 52/30 164/91
Age 41 [17,76] 33 [16,60] 47 [18,84] 39 [16,84]
DPI 14 [0,23] 2 [0,5] 17 [1,42] 8 [0,42]
Good (%) 26 (67%) 95 (71%) 34 (41%) 155 (61%)
Poor (%) 13 (33%) 39 (29%) 48 (59%) 100 (39%)
GCS 13/14/15 2%/13%/85% 3%/15%/82% 7%/26%/67% 4%/18%/78%
GOSE 6 [5, 7] 7 [5, 7] 6 [3, 7] 7 [3, 7]
Sex displayed as male (M)/female (F). Age at scan (Age), days post injury (DPI ) sown as
mean[min, max]. Patients dichotomised in groups with good (GOSE=8) or poor (GOSE<8)
outcome, are displayed as absolute number and as percentage, indicating the portion of all
patients. GCS indicates the proportion of patients with GCS scores equal 13, 14 or 15.
GOSE shown only for poor outcome patients as median [min, max]
Models mentioned above were fitted to individual ROIs, which did not account for depen-
dencies between ROIs. Hence, a GLM was fitted to predict outcome using the information
of all ROIs from the pooled databases simultaneously.
Model #4:
fη(Y ) = β0 + β1Agei + β2Sexi + β3Sitei + β4GCSi + β5DPIi + α1−nROIi,1−n + εi
with ROIi,1−n representing the regional information and n is the number of ROIs (e.g.
24 for TractSeg). Complexity of the model was neglected for this analysis. The variables
β0,...,5 and α1−n are the parameters to be fitted.
3.3.7 Longitudinal Analysis
For the longitudinal comparison patients were only included if they had at least two MR
scans (Table 3.3). The aim was to examine whether volumes or diffusion metrics change
over time differently for patients with good or poor functional outcome. Therefore, regional
metrics were expressed as a linear function of time after injury (i.e. DPI) in interaction with
the dichotomised outcome. Since each patient was likely to have a different baseline to start
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Table 3.3: Overview of Available Data for Longitudinal Analysis





s # Subjects/Scans 42/47 83/206 30/51 155/304
Sex (M/F) 23/19 50/33 14/16 87/68






# Subjects/Scans 41/172 136/377 87/174 264/723
Sex (M/F) 29/12 87/49 56/31 172/92
Age 42[17,74] 34[16,60] 47[18,84] 39[16,84]
DPI (acute) 11[0,23] 2[0,5] 17[1,42] 8[0,42]
DPI (3 months) 94[81,123] 96[80,122] 56[43,100] 93[43,123]
DPI (6 months) 198[174,253] - 223[151,299] 215[151,299]
DPI (12 months) 381[357,431] 371[348,426] 394[336,491] 374[336,491]
DPI (chronic) 736[681,798] - - 736[681,798]
Good (%) 25(61%) 96(71%) 34(39%) 155(59%)
Poor (%) 16(39%) 40(29%) 53(61%) 109(41%)
GCS 13/14/15 2%/13%/85% 4%/15%/81% 9%/24%/69% 5%/17%/78%
GOSE 6 [5, 7] 7 [5, 7] 6 [3, 7] 7 [3, 7]
Sex displayed as male (M)/female (F). Age at scan (Age), days post injury (DPI ) sown in
mean[min, max]. Patients dichotomised in groups with good (GOSE=8) or poor (GOSE<8)
outcome, are displayed as absolute number and as percentage, indicating the portion of all
patients. GCS indicates the proportion of patients with GCS scores equal 13, 14 or 15.
GOSE shown only for poor outcome patients as median [min, max]
with, a linear mixed effect model was fitted to the data to allow a random intercept for each
patient. Age, sex, acquisitions site as well as GCS were considered as confounding factors.
Model #5:
fγ(Y ) = β0 + β1Outcomei ∗DPIi + β2Agei + β3Sexi + β4Sitei + β5GCSi +
β6Outcomei + β7DPIi + εi
where β0,...,7 are the parameters to be fitted by the GLM, fγ representing the log link
function to fit a Gamma distribution and εi is the error unexplained by the model. The
dependent variable (Y ) was replaced with continuous volume or diffusion measurement of




Volumes. Initial results of the regression analysis of Z-scored volumes have disclosed that
half of the examined ROIs (ten), demonstrated on average different volumes across cen-
tres. Among these were the whole cortical volume (pfdr = 0.0367), the right precuneus
(pfdr = 0.0496), and in both hemispheres the nucleus accumbens (left: pfdr = 0.0223,
right: pfdr = 0.0035), putamen (left: pfdr = 0.0041, right: pfdr = 0.0041), thalamus
(left: pfdr = 0.0087 right: pfdr = 0.0121) and the anterior cingulum (left: pfdr = 0.0228
right: pfdr = 0.0223). Although the total brain volume was increased for Turku subjects
(p = 0.0496), this was statistically not significant after FDR correction (pfdr = 0.0763).
The number of ROIs with deviating volumes was reduced to three by normalising the regional
volumes by the total brain volume for each subject individually before Z-scoring. Nonethe-
less, among the 19 selected ROIs (excluding total brain volume), control subjects from
Turku showed significantly higher volumes for the right nucleus accumbens (pfdr = 0.0164,
β1 = 0.2770) as well as the left and right putamen (left: pfdr = 0.0286, β1 = 0.1192, right:
pfdr = 0.0329, β1 = 0.2717). Figure 3.2 shows a shift towards higher volumes in Turku
controls compared to both other databases. Other regions with increased volumes in Turku
controls were the left nucleus accumbens (p = 0.0334) and both the left and right anterior
CG (p = 0.0365 and p = 0.0373, respectively), however, these trends were not statistically
significant.
Figure 3.2: Examples of Regional Volume Differences Across Sites. The residuals of the
GLM after correcting for age and sex differences, still showed a deviation between controls
from Turku and the other two imaging sites within the accumbens and putamen. Area
shaded in grey highlights the area under the distribution of all subjects.
Examining combinations of pairs of databases, showed no differences between Cambridge
and Turku, but significant differences between Trondheim and the other two databases were
present. Affected regions were WM and cortex overall as well as the caudate and thalamus
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in both hemispheres (pfdr < 0.05). Differences between imaging sites were most pronounced
for Trondheim and Turku.
Fractional Anisotropy. When jointly analysing all three databases together, no sig-
nificant differences were found for any of the 24 pre-selected TractSeg ROIs between the
three sites (for all ROIs: p > 0.4344). The rostrum showed a trend of higher FA values
for Turku controls compared to Cambridge controls (p = 0.0414, β1 = 0.1109), however,
this could not statistically be confirmed (pfdr = 0.7494). Comparing Cambridge controls
against Trondheim data showed no significant differences (for all ROIs: p > 0.2909). In
contrast, Turku controls were found to have divergent FA values from Cambridge controls
in the right ART (p = 0.0285, β1 = 0.0775), rostrum (p = 0.0458, β1 = 0.1433), right CST
(p = 0.0160, β1 = 0.2263) and right SLFIII (p = 0.0499, β1 = 0.0785). However, none of the
ROIs showed significant FA differences after FDR correction (for all ROIs: pfdr > 0.2200).
Similarly, the left ATR (p = 0.0463, β1 = 0.0683), rostrum (p = 0.0144, β1 = 0.1215) and
genu (p = 0.0395, β1 = 0.0819) demonstrated higher FA values for Turku than Trondheim,
but differences were not statistically significant after correction for multiple comparisons
(for all ROIs: pfdr > 0.3444).
Figure 3.3 shows the distribution of the GLM residuals (accounted for age and sex) for the
detected ROIs with FA variation across sites. While the distributions of Cambridge and
Trondheim mostly align, FA metrics seemed slightly elevated for Turku controls.
Mean Diffusivity. None of the chosen TractSeg ROIs showed significantly different MD
values across the sites in a joint analysis of all three databases (p > 0.3742). Similarly,
combining Cambridge either with Trondheim or Turku data alone revealed no noticeable
different regions (for all ROIs: p > 0.2489 and p > 0.2552, respectively). Only when leav-
ing out Cambridge data, MD in the left ATR (p = 0.03307, β1 = −0.2133) and right IFO
(p = 0.0426, β1 = −0.2115) was found to be slightly decreased in Turku with respect to
Trondheim. Both findings were not statistically significant after FDR correction (ATRleft:
pfdr = 0.4487, IFOright: pfdr = 0.4487).
3.4.2 Acute Differences between Controls and Patients
Volumes. Volumes of ventricles overall (p = 0.0298, β1 = 0.1696) and specifically the right
lateral ventricle (p = 0.0470, β1 = 0.1622) were found to be increased in patients with poor
outcome compared to controls, however, this was not statistically significant after FDR cor-
rection. Likewise, the right anterior CG showed a decreased volume for both patients with
good (p = 0.0266, β1 = −0.1087) and poor outcome (p = 0.0336, β1 = −0.1192) compared
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Figure 3.3: Regional FA Differences in Control Subjects. The residuals of the GLM after
correcting for age and sex differences, still showed a deviation between controls from Turku
and the other two imaging databases within the ATR, CST, SLFIII , rostrum and genu.
Differences were not significant after FDR correction.
to controls, but neither of the differences was statistically significant after FDR correction.
Analysis of individual data did not reveal any deviations between the three subject groups.
Fractional Anisotropy. A comparison of data from all three sites revealed 15 ROIs
with significantly lower mean FA values in patients with poor outcome relative to controls.
However, patients with good outcome did not show any significant deviation from subjects
without head injury (Table 3.4). Considering only subjects scanned in Cambridge, FA val-
ues in both the left and right IFO (pfdr = 0.04717 and pfdr = 0.0403, respectively), as well
as in the left UF (pfdr = 0.0471) were significantly lower in the patient group with poor
outcome. However, patients with good outcome did not statistically differ from controls. No
significant FA differences were found between the three subject groups within the Trond-
heim database. In contrast, Turku patients with poor outcome demonstrated reduced FA
values in 17 ROIs compared to controls (Table 3.5). Turku patients with good outcome were
statistically indistinguishable to controls.
Analysing regional FA differences in the three databases individually and together revealed
various patterns. For example, FA was reduced in IFOleft for Cambridge patients with poor
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outcome. This difference was not observed in the two other databases, but remained present
in the joint analysis. On the other hand, regions such as the ILFleft, showed no significantly
different FA values between subjects at individual sites, but revealed lowered FA values
in patients with poor outcome in the combined databases. Cambridge patients with poor
outcome had lower FA values in ILFleft, which, however, was deemed non-significant after
FDR correction. The joint analysis allowed to recover this difference. In contrast, combin-
ing databases also diminished previously found differences. While FA value in SLFI,left was
lower for Turku patients with poor outcome, this difference was not statistically present in
the pooled dataset. Besides those changes, some regions showed decreased FA values across
databases. For example the UFleft demonstrated significantly decreased FA values for pa-
tients with poor outcome in the Cambridge and Turku as well as the fused databases (Figure
3.4). From this analysis we can only infer changes when looking at different databases, but
cannot say with certainty which differences between changes are true discrepancies between
subjects.
Table 3.4: Overview of ROIs with Different FA in Acute Phase Across Sites
Cambridge & Trondheim & Turku
ROI good - β1 good - pfdr poor - β1 poor - pfdr
FA
ATRright -0.0130 0.9748 -0.0504 0.0271
Rostrum -0.0549 0.7731 -0.1142 0.0110
Genu -0.0292 0.9748 -0.0731 0.0271
PMB -0.0013 0.9748 -0.0984 0.0498
CGleft -0.0157 0.9748 -0.1366 0.0152
CGright -0.0081 0.9748 -0.1260 0.0115
IFOleft -0.0243 0.9748 -0.0921 0.0271
IFOright -0.0052 0.9748 -0.1079 0.0115
ILFleft -0.0035 0.9748 -0.0972 0.0271
ILFright -0.0025 0.9748 -0.1243 0.0123
SLFI,right -0.0300 0.9748 -0.0950 0.0271
SLFII,right -0.0091 0.9748 -0.0625 0.0311
UFleft -0.0635 0.7731 -0.1184 0.0123
UFright 0.0252 0.9748 -0.0942 0.0271
CC -0.0067 0.9748 -0.0846 0.0311
Model #2 coefficients (β1) and p-values after FDR correction (pfdr) for patients with good
and poor outcome.
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Figure 3.4: Examples of Regional FA Differences in Individual Databases and Joint Analysis
After Correction for Confounding Factors. IFOleft: FA values were lowered in Cambridge
data (red) and combined analysis (All). Trondheim (blue) and Turku (green) subject were
indistinguishable within the particular database. ILFleft: FA values, despite lowered in poor
Cambridge patients, were not significantly different when examining databases individually,
however, joint analysis recovered this difference. SLFI,left: FA was significantly reduced
in patients with poor outcome in Turku, but not in Cambridge or Trondheim. In a joint
analysis this difference was not present. UFleft: Mean FA values were decreased for patients
with poor outcome in Cambridge and Turku as well as the combined analysis. Mean values
are marked with a cross (×). Regions with significantly lowered FA are highlighted with an
asterisk (*)
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Table 3.5: Overview of ROIs with Different Diffusion Metric in Acute Phase
Cambridge
ROI good - β1 good - pfdr poor - β1 poor - pfdr
FA
IFOleft 0.0175 0.9752 -0.3066 0.0471
IFOright 0.0287 0.9752 -0.3370 0.0403
UFleft -0.0380 0.9752 -0.2717 0.0471
MD
Rostrum 0.0843 0.9143 0.5686 0.0203
CSTleft -0.0024 0.9879 0.5374 0.0186
IFOleft -0.0767 0.9143 0.5188 0.0430
ILFleft 0.0271 0.9572 0.4974 0.0296
UFleft 0.1092 0.8390 0.4080 0.0203
Turku
ROI good - β1 good - pfdr poor - β1 poor - pfdr
FA
ATRright -0.0423 0.3783 -0.0724 0.0418
Rostrum -0.0566 0.4517 -0.1391 0.0331
Genu -0.0679 0.3783 -0.1298 0.0283
AMB -0.1126 0.3783 -0.1337 0.0319
PMB -0.2540 0.3590 -0.3795 0.0145
CGleft -0.2720 0.3590 -0.3341 0.0148
CGright -0.1957 0.3590 -0.2713 0.0145
IFOright -0.1005 0.3783 -0.1712 0.0283
ILFright -0.2375 0.3590 -0.3246 0.0145
SLFI,left -0.1466 0.3783 -0.2429 0.0222
SLFI,right -0.1152 0.3783 -0.2037 0.0222
SLFII,left -0.0949 0.3783 -0.1696 0.0331
SLFII,right -0.0772 0.3783 -0.1508 0.0222
SLFIII,left -0.0747 0.3783 -0.1125 0.0319
SLFIII,right -0.0498 0.3783 -0.0880 0.0418
UFleft -0.1134 0.3783 -0.1327 0.0474
CC -0.1138 0.3783 -0.1990 0.0222
MD
ATRright 0.1922 0.5885 0.2326 0.0385
PMB 0.1367 0.5885 0.3304 0.0037
ILFright 0.0993 0.5885 0.1456 0.0496
Model #2 coefficients (β1) and p-values after FDR correction (pfdr) for patients with good
and poor outcome.
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Mean Diffusivity. None of the examined TractSeg ROIs showed different mean MD values
between controls and patients with good outcome in the pooled dataset. Patients with poor
outcome had a trend towards elevated MD values relative to controls within the rostrum
(p = 0.0222, β1 = 0.1381), the right ILF (p = 0.0391, β1 = 0.0780) and the left UF
(p = 0.0234, β1 = 0.0964). However, those results were statistically insignificant (for all three
ROIs: pfdr > 0.2805). Analysing differences between subject groups within the Cambridge
databases, uncovered increased MD values for patients with poor outcome in the rostrum
(pfdr > 0.0203, β1 = 0.5686) as well as in the CST (pfdr = 0.0186, β1 = 0.5374), IFO
(pfdr = 0.0430, β1 = 0.5188), ILF (pfdr = 0.0296, β1 = 0.4974) and UF (pfdr = 0.0203,
β1 = 0.4080) in the left brain hemisphere. No differences were found for patients with good
outcome (Table 3.5). Similarly to previous findings, MD values were statistically inseparable
for the controls and patients within the Trondheim databases. The Turku database also
demonstrated increased MD values in the ATRright (pfdr = 0.0385, β1 = 0.2326), the PMB
(pfdr = 0.0037, β1 = 0.3304) and the ILFright (pfdr = 0.0496, β1 = 0.1456) for patients
with poor outcome, but overall no MD differences for patients with good outcome (Table
3.5).
3.4.3 Prognostic Value of Acute MRI
Volumes. Although regression analysis indicated a volume difference for the right caudate
between patients with good and poor outcome (p = 0.0478), none of the 19 selected MALP-
EM ROIs were predictive of functional outcome several months post-injury. The left nucleus
accumbens (p = 0.0330) and the right cerebellar WM (p = 0.0132) showed a potential
predictive power within the Trondheim data, however, differences were not strong enough to
remain statistically significant after FDR correction. Similarly, the right nucleus accumbens
(p = 0.0376) and both caudates (left: p = 0.0050, right: p = 0.0145) in Turku data showed
differences for both patient groups but differences did not remain after FDR correction.
Regression analysis in Cambridge database alone did not allow to derive any results, as the
variables used as covariates perfectly separated the small number of patients. Hence, the
suggested regression model could not be fitted to infer differences between patients with
good or poor outcome. Only when jointly analysing of Cambridge and Turku data while
excluding Trondheim patients, volumes for the cortex (pfdr = 0.0065) and the caudates
(left: pfdr = 0.0049, right: pfdr = 0.0037) were predictive of functional outcome. Linear
regression analysis of all selected MALP-EM ROIs (Model#4 ) did not reveal any regional
volumes that were predictive of patient outcome.
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Fractional Anisotropy. Considering all three databases together, FA in the right IFO
fascicle (p = 0.0310), left ILF (p = 0.0463) and right UF (p = 0.0177) had the potential
to predict patients with good and poor outcome. However, after FDR correction none of
the regions showed a statistically significant impact on outcome prediction. Examining only
Trondheim data did also not reveal any statistical significant FA differences between patient
with different outcome. In Turku patients, the FA of the right CST (p = 0.0203) may be
predictive for poor outcome, but this was not statistically significant after FDR correction.
As before, Cambridge database included too few patients for the regression analysis. Note-
worthy, the acquisition site was a strong predictor of outcome. In fact, when leaving out
Trondheim patients, 14 ROIs showed a discriminative power (pfdr ≤ 0.05) to distinguish
both patient groups. Among the three different centres, Trondheim scanned patients with
the mildest TBI. This means it is hardest to differentiated patient groups. Including Trond-
heim patients may diminish the discrepancy between both patient groups that may be more
prevalent in Cambridge and Turku data. This discrepancy was uncovered when exclud-
ing Trondheim patients, which previously have masked the subtle differences (hence the 14
ROIs). This suggested site-/cohort-specific biases. Other combinations of two databases did
not show the same effect. Although it is difficult to say what effects are truly a characteristics
of patients with good or poor outcome, this shows the heterogeneity of TBI patients. A GLM
(Model#4 ) fitted to mean FA values from all ROIs simultaneously for the fused databases
revealed the AMB (p = 0.031) and right UF (p = 0.048) to be predictive of patient outcome.
Mean Diffusivity. Similar to FA, none of the 24 TractSeg ROIs showed a predictive
influence on patient outcome. This was observed in both the analysis of fused databases
as well as in Trondheim and Turku individually. As before, sample size for Cambridge was
too small to infer results. On the other hand, excluding Trondheim patients resulted again
in an increase of relevant ROIs. Average values for MD were predictive of outcome in 17
TractSeg ROIs (pfdr ≤ 0.05). When fitting a linear regression model to all regional MD
values for the pooled databases (Model#4 ) both ATRs (left: p = 0.002, right: p = 0.026)
as well as the left cingulum (p = 0.038) and right IFO (p = 0.010) were predictive of patient
outcome. Considering all ROIs simultaneously to predict outcome may be more sensitive to
find outlier regions than analysing individual fibre tracts. With more information provided,
the linear model seems to be fitted to the data differently to map the random variables (i.e.
here MD values) to patient outcome. From this analysis it is not clear whether this is due
to better or worse data fitting through the GLM.
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3.4.4 Longitudinal Analysis
Volumes. After accounting for age, sex, site and injury severity only volumes of the right
and left caudate demonstrated a minimal negative dependency on DPI (left: p = 0.0132,
β1 < −0.0002, right: p = 0.0132, β1 = −0.0002). In other words, both regions showed
a trend of progressing volume loss. The left cerebellar WM showed a positive association
with time after injury (p = 0.0044, β1 = 0.0005), indicating a higher volumes at a later
stage. These findings were, however, not statistically significant after correction for multiple
comparison (pfdr > 0.0831). Fitting a regression model to all three databases together did
not reveal any differences in regional volume loss over time between patients with good and
poor outcome. Similarly, analysing Cambridge and Trondheim databases individually re-
sulted in the same findings. A difference in temporal tissue atrophy between both outcome
groups was found for the overall cortex in Turku patients (p = 0.0428, β1 = 0.001), but this
difference was not significant after FDR correction (pfdr = 0.6667).
Fractional Anisotropy. A dependency of FA on time after injury was found for six
TractSeg ROIs. The CST in both hemispheres (left: pfdr = 0.0297, β1 = −0.0004,
right: pfdr = 0.0045, β1 = −0.0006) and the IFO (pfdr = 0.0014, β1 = −0.0006), ILF
(pfdr = 0.0017, β1 = −0.0006) and SLFI (pfdr = 0.0297, β1 = −0.0004) on the right side
showed a significant negative correlation with DPI. This suggested progressively lower FA
values in those regions after mTBI. On the other hand, the rostrum showed a significantly
positive association with DPI (pfdr = 0.0017, β1 = 0.0005), indicating an increase in FA
values over time. The right IFO (pfdr = 0.0490, β6 = −0.4950) and right UF (pfdr = 0.0490,
β6 = −0.4190) showed a significantly stronger decreased of FA in patients with poor than
with good outcome. Analysing the three databases individually revealed slightly negative
trends for patients with poor outcome in the rostrum for the Trondheim cohort (p = 0.0096,
β1 = −0.001) and in the PMB for the Turku cohort (p = 0.0323, β1 = −0.002). Differences
could not be statistically verified after FDR correction (pfdr > 0.2295).
Mean Diffusivity. Time post injury was found to also have an effect on regional MD. In
particular, diffusion in the splenium (pfdr = 0.0049, β1 = 0.0005), CST (left: pfdr = 0.0069,
β1 = 0.0006, right: pfdr = 0.0049, β1 = 0.0006), right IFO (pfdr = 0.0049, β1 = 0.0005),
ILF (left: pfdr = 0.0313, β1 = 0.0004, right: pfdr = 0.0158, β1 = 0.0005) and right SLFI
(pfdr = 0.0204, β1 = 0.0005) showed a significant dependency on DPI. This implied an in-
crease of MD values over time in those seven regions. In contrast, the rostrum (pfdr = 0.0234,
β1 = −0.0004) and genu (pfdr = 0.0371, β1 = −0.0004) were associated with negative slopes
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for DPI, indicating decreased MD. Although MD seemed raised at later stages, there were
no significant differences between patients with good or poor outcome. This was also the
case, when fitting an individual regression model to either Cambridge or Turku data. Trond-
heim patients with poor outcome by themselves demonstrated a negative slope for the left
and right SLFI (left: p = 0.0411,β1 = −0.001, right: p = 0.0121,β1 = −0.001), right
SLFII (p = 0.0427,β1 = −0.001) and right SLFIII (p = 0.0487,β1 = −0.001). These obser-
vations in the Trondheim database were not significant after multi-comparison correction
(pfdr > 0.2893).
3.5 Discussion
3.5.1 General Challenges in Database Comparability
Since TBI disease patterns are time-dependent [19, 43, 171, 273] the imaging time point
needs to be considered for any analysis. However, independently designed studies may offer
a different scan collection scheme that hampers pooling all data for a cross-sectional analy-
sis. Among the databases presented here, for example, Trondheim acquired scans at three,
but not six months post-injury. In contrast, Turku collected almost all of the follow-up
MR scans at the six months time-window. Thus, both time-points - three and six months
post-injury - cannot be examined in a joint analysis of all three databases. Furthermore, this
deviation was also observed for other clinical assessments such as the GOSE scores. Both
Trondheim and Turku collected GOSE scores during a patient’s follow-up visit. Hence, for
the prognostic evaluation of acute MR scans GOSE scores from three and six months had
to be combined. This followed the assumption that the functional outcome is fairly stable
between three and six months post injury (80% of the 37 Cambridge patients showed a
stable GOSE score between both time points, see also Section 3.3.5).
Even if clinical and imaging data are available for the same time points, retrospective multi-
centre studies are likely to combine databases for which images were acquired with different
scanning parameters. Some variations can be rectified fairly easily, such as for example
the selection of equal number of b0 volumes. Other parameters may be more difficult to
harmonise, and could have a more direct impact on image quality. For all three datasets
only single-shell data (b = 1000 s/mm2) was chosen to apply the same tensor fitting model.
Cambridge and Turku acquired approximately 60 directions on one shell, whereas, Trond-
heim only acquired DWI along 30 non-collinear gradient directions. While MD metrics have
been reported to be more affected by variations in the b-values, FA was found to be sensitive
to the number of diffusion gradient directions [15]. Hence, acquisition-/site-specific biases
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were expected to be more reflected in FA, due to different angular resolutions, than in MD
values. The fact that ROIs were observed to be more often significantly different between
subject groups could be an indication of site- and population-specific biases still present
despite harmonising metrics (Z-scoring) and considering site as a co-variable in the linear
regression models. Future experiments could investigate the impact of choosing the same
number of diffusion directions. For this data this would mean to artificially reduce the an-
gular resolution for Cambridge and Turku data by selected a subset of 30 directions that are
most similar to the 30 directions acquired for Trondheim data. However, the retrospectively
selected 30 directions would not have been optimised to find the best spatial distribution of
directions and might lead to suboptimal results. The effect of number of directions has been
explored for Parkinson [206] and similar experiments could provide valuable insight for the
design of future multi-centre studies in the context of TBI. Since there is no groundtruth
available for this clinical dataset, simulation of such datasets could help to understand the
impact of different number of directions (the reader is also referred to [279]).
3.5.2 Biases Across Imaging Sites
Despite Z-scoring volumes and considering acquisition site as a confounding factor in the re-
gression analysis, a site-specific bias was detected for half the MALP-EM ROIs. Differences
between Trondheim and Turku were most pronounced, which may reflect the age differences
between the cohorts despite accounting for age in the linear regression model (average age
was 33 and 51 for Trondheim and Turku, respectively).7 While this bias could be cohort-
specific (larger heads or younger age) this should be reduced by normalising to the average
volume in control subjects at each site. Alternatively, Z-scoring itself may introduce a bias.
Control subjects scanned in Turku showed the widest range of ages (i.e. 69 years, compared
to Cambridge: 60 years, and Trondheim: 43 years). This is also reflected in the highest
average absolute age difference between controls and the cohort mean age (i.e. 17 years,
compared to Cambridge: 10 years, and Trondheim: 11 years). This higher variation in
the Turku control subjects may lead to less accurate volume normalisation with respect to
age, particularly, as tissue atrophy was reported to accelerate with increasing age [67]. This
hypothesis seems supported by the drastic decrease in number of ROIs with site-specific
differences for controls after normalising regional volumes to total brain volume (including
CSF). Since both the left and right putamen persisted to have a different volume across
sites, this may indicate a potential systematic difference in segmentation.
No difference in diffusion metrics were found between Cambridge and Trondheim controls,
which suggests that differences were either not prevalent despite the difference in angular
7Future experiments could aim to statistically model non-linear age effects.
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resolution, or that Z-scoring could account for some of the acquisition-induced variation.
In contrast, Turku control subjects showed slighter elevated FA values in a few ROIs com-
pared to Cambridge controls. This again may be due to a bias introduces via Z-scoring.
Fewer deviations were observed for MD than for FA. This may be attributed to the use of
single-shell data benefiting MD, which FA is more sensitive to the different angular reso-
lutions across centres. Since none of the findings were statistically significant, subsequent
experiments are likely to show indeed differences resulting from TBI pathology rather than
acquisition-specific biases exclusively.
3.5.3 Differences between Patients in Comparison to Controls
Patients with poor outcome were found to have increased ventricle volumes compared to
control subjects. Since ventricles did not show a site-specific bias in the previous analysis,
this indicates potential TBI-related brain tissue atrophy. Patients with good outcome did
not show a similar trend, thus, enlarged ventricles in the acute phase could hint a worse
outcome a few month after the injury. Both patient groups demonstrated a volume decrease
of the right anterior CG. All findings were, however, not statistically significant after FDR
correction, which shows the subtlety of differences between controls and patients with dif-
ferent outcome.
More prominent were the differences seen for FA. Among the examined WM tracts, 15
ROIs showed decreased FA for patients with poor outcome during the acute phase. Since
this number of regions exceeded the few regions for which potential site-specific differences
between controls were found, reduced regional FA could indeed be an indication for poor
outcome, especially, as lower FA values were not observed for patients with good outcome.
The finding of FA values in the good outcome group similar to control subjects, may indicate
a lack of injury, which could explain the better functional outcomes for that patient group
three to six months post-injury. Alternatively, this could indicate a better brain plastic-
ity that allows those patients to recover from TBI more easily. When analysing individual
databases, Trondheim and Cambridge patients showed none or only a low number of ROIs
with deviating FA. In contrast, Turku patients with poor outcome had decreased FA values
compared to controls in 17 ROIs. These more prevalent FA changes may be connected to the
initial severity of injury [172]. Turku patients showed the largest proportion of patients with
lower GCS scores (i.e. GCS=13: 7%, GCS=14: 26% of all patients) and with poor outcome
(59%). In addition, some Turku patients had a worse outcome (minimum GOSE=3) than
the other two patient cohorts. The discrepancy between individual databases and the fact
that the analyses that were either based on Turku data alone, or in combined analysis with
Turku data, had a similar number of abnormal ROIs, suggests that the differences found in
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the joint analysis were strongly driven by Turku patients. Some differences observed in in-
dividual databases were both weakened or strengthened by the fusion of all three databases.
The joint analysis of all three databases showed that poor outcome patients followed a trend
towards elevated MD values in some of the regions during the acute phase. Although these
findings were not statistically significant, the higher MD values may mark a differences
between patients that will recover and ones that show persistent symptoms later on. Ex-
amination of individual databases also underlined this. Cambridge and Turku patients with
poor outcome showed significantly higher MD values. In contrast, Trondheim patients, who
had generally less severe injuries, did not demonstrate any deviating MD values, regardless
of their outcome. Overall, abnormalities in MD were less pronounced - showing differences
in a lower number of ROIs - than those for FA. Disregarding that MD benefited from better
rectification of sites-specific acquisition (i.e. number of b0 volumes, also see Section 3.5.1),
one reason for this could be the inclusion of acute scans over a wide time span post-injury.
Mean diffusivity has been shown to pseudo-normalise during the semi-acute phase [19], which
may balance out any abnormalities found in the hyper-acute phase. Subdividing the acute
phase in smaller time increments could help to identify more transient changes in FA and
MD [60].
3.5.4 Prognosis Based on Acute MRI
Although the volume of the right caudate showed some predictive influence for patient out-
come, none of the examined structural volumes showed significant values for mTBI progno-
sis. Regions such as the caudate, nucleus accumbens or cerebellar WM had slightly different
volumes between both patient groups in individual databases. However, these trends were
not statistically significant, and only achieved significance as predictors of outcome when
Trondheim data were excluded. The early time-point of acute data acquisition for Trondheim
patients and the lack in prognostic value of volume difference may indicate that progressive
volume loss, although induced by the injury, may take some time to become severe enough
to be measured on a group-wise level.
Similar observations were made for FA, where some regions showed a discrepancy between
patient groups, but were not strong enough to provide any power for outcome prediction.
Outcome in Trondheim patients could not be distinguished by FA metrics, supporting the
idea of low injury severity and FA differences on acute MR were not present or too subtle to
be observed. Excluding Trondheim patients from the analysis resulted in a higher number
of ROIs with different FA between patients. Combining Cambridge and Turku patients may
enhance differences between patients by increasing power, but not diluting the magnitude
of difference between groups. Acquisition parameters (e.g. number of diffusion directions)
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were similar for both databases, and site-specific biases were accounted for by Z-scoring and
using site as covariate. Moreover, the previous comparison of control subjects from the three
different centres has shown only potential site-specific biases in FA for four ROIs (none were
significant). Therefore, abnormal FA may indeed show patient differences related to TBI,
rather than only site-specific biases. Nonetheless, it is likely that some centre-biases persist,
and allow a statistical model to identify whether data originated from Turku or Cambridge.
Since Turku patients had worse outcome than Cambridge patients, identifying the site could
falsely seem to help to predict outcome more accurately.
Similarly, MD did not provide any significant prognostic value to differentiate patients based
on outcome, unless Trondheim patients were excluded.
3.5.5 Longitudinal Findings in Mild TBI Patients
Both the progressive volume loss [98] and unchanged volumes [278] between early and follow-
up scans have been reported for regions such as the nucleus accumbens, caudate, putamen or
thalamus. In the mTBI cohort presented here, an ongoing tissue atrophy could be observed
for GM regions such as the caudate in both hemispheres. Furthermore, WM volume in the
left part of the cerebellum seemed increased with time after injury. However, time-dependent
differences between patients with good or poor outcome were not found. One reason for the
lack of differences could be that conventional MRI is not very sensitive to mTBI pathology
[188]. Although loss of cerebral WM volume between three and 17 DPI was recently observed
for mTBI patients compared to control subjects, the study did not examine volumetric
changes between patients with different functional outcome [215]. Further investigation is
needed to understand if WM volumes derived from T1w images could provide sufficient
information to distinguish patient groups with different outcomes. Another reason could be
the complex subject-dependent pathological evolution within different regions. Although the
regression model estimated a different baseline per subject, a group-wise analysis might be
to crude to detect patient-specific volume loss. To account for different patient trajectories
of regional tissue atrophy, a model could be trained to fit a different slope and interception
for each subject. However, the available data did not allow optimal convergence of such a
model. Future experiments on a larger dataset might be more successful.
As expected, diffusion metrics were much more sensitive to capture longitudinal differences.
Some of the examined regions showed a progressive decrease of FA over time indicating
ongoing disease evolution. This is coherent with findings in previous studies (e.g. [19, 273]).
In contrast, mean FA values in the rostrum increased with time after injury, which may be
attributed to tissue recovery over time. The CC is one of the largest WM tracts allowing
the communication between the two hemispheres of the brain. As anterior part of the CC,
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the rostrum connects parts of the frontal lobes. These are often involved in TBI due to
the prevalence of impact at the front of the head. An increase in FA suggests an elevated
anisotropic diffusion, which possibly could indicate better more structured and well aligned
fibre tracts. Hence, an increase in FA in the rostrum, may be associated with a stronger
connection between the frontal lobes. One previous study reported initially decreased FA
values in the internal capsule and the IFO at seven DPI, which recovered at one month after
the injury. Increased FA values in both tracts were positively linked to better performances
in cognitive information processing [273]. So, one can cautiously hypothesise that over time
neural structures are enforced within the rostrum to strengthen the connection between
frontal lobes to account for possible deficiencies in the frontal lobes due to TBI. However,
more experiments would be needed to confirm such a hypothesis. Despite accounting for
confounding factors, the longitudinal analysis presented here might not be completely free
from site-specific factors. Comparing controls across sites, showed a trend for higher FA
values in the rostrum for Turku than for Trondheim or Cambridge patients. This could
have had an effect on the longitudinal analysis. However, patient data from later stages
(12 months or chronic phase) were predominantly acquired at Trondheim and Cambridge.
Consequently, their site-specific lower FA values from these centres would be more likely
to support a decrease in rostrum FA values over time. Hence, the rostrum increase cannot
directly be associated with site-specific effect, which may suggest a true recovery of FA
values over time.
The longitudinal analysis also showed a positive association of DPI and MD in some regions,
such as the CST, IFO or ILF. Increasingly higher MD values could indicate less structured
WM with time after injury. The IFO tract passes from the frontal lobe radiating into
the temporal and occipital lobes. The latter is the visual processing centre within the brain
[212], and the temporal lobe is involved in visual memory as well as language comprehension
[42]. Similarly, the ILF has been recognised to be involved in processing visual cues and its
disruption has been linked to neuropsychological impairments of visual cognition [99]. So,
deterioration of WM in the IFO and ILF could lead to problems in processing visual and
verbal information. Indeed, differences in FA and MD between TBI patients and controls
in IFO and ILF were observed to correlate with visual and verbal memory [23]. Again,
rostrum was the exception with seemingly lower MD values at a later stage. Despite the
sensitivity of diffusion metrics to pathophysiology in TBI, neither FA or MD demonstrated
greater temporal changes for patients with poor than with good outcome. Diffusion may
change differently for each patient following an individual trajectory [268, 273], which makes
it more difficult to find group-wise differences.
78 CHAPTER 3. APPLICATION TO MILD TBI
3.5.6 Heterogeneity of the TBI Cohort
Apart from site-specific confounding factors, the heterogeneity of subjects suffering from
mTBI makes diagnosis/prognosis difficult [75, 102] and poses a challenge for any model
to fit the data. In theory, patients could have the same GOSE score and similar clinical
characteristics, but different regions that are affected by the TBI. A model based on group-
wise analysis may not be flexible enough to fit to this complex data distribution. Including
many more patients possibly enhances the changes of two subjects show similar patterns,
which however, is uncertain due to the high variation of observed pathologies after TBI.
Nonetheless, expanding the database would enable application of more data driven machine
learning algorithms such as neural networks. However, these are not necessarily a guarantee
for better performance [89]. Moreover, inference of valuable knowledge for clinical research
from neural networks is more difficult, since it is not yet fully understood how these algo-
rithms draw their conclusion [79]. Besides this, extending the database would incorporate
data from many different sites, which comes with the drawback of an increased variation
of non-diseases related biases. Consequently, the solution to these issue may lie in build-
ing models which, rather than targeting group differences, focus on anomaly detection for
single-subjects. Such an approach based on TractSeg ROIs has been suggested for paediatric
WM analysis [34]. Future experiments could investigate its application to TBI subjects.
3.6 Chapter Summary
Traumatic brain injuries are complex and show different pathological patterns closely linked
to the time after injury. While most studies have been based on smaller single-site datasets,
this chapter presented results from a multi-centre analysis including three mTBI databases.
Experiments focused on imaging features, such as regional volumes and diffusion, derived
from acute MRI as well as longitudinal changes. Hereby, differences between acquisition
sites were accounted for via Z-scoring IDPs and including site as confounding factor for the
regression analysis. Patients with good outcome seemed to display features similar to control
subjects, whereas, patients with poor outcome showed enlarged ventricles and decreased FA.
Nonetheless, patients with different outcome could not easily be differentiated based on their
acute MR scans. Although longitudinal analysis revealed progressive tissue atrophy in the
caudate, no differences were found for patients with good or poor outcome. Diffusion metrics
displayed a stronger dependency on DPI, with more decreased FA or increased MD. However,
patients with different outcome showed no differences in diffusion changes. The individual
databases included mTBI cohorts of different severity and age, which also influenced the
joint analysis. Acquisition-specific biases may have had an impact on enhancing differences
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between subjects groups, but cannot be accounted for all observed variation.
Chapter 4
Reproducibility of MRI Metrics
4.1 Introduction
For many neuroimaging studies, features are derived from the MRI scans and compared for
different groups of interest. This could involve volumetric changes over time or divergence
between control and patient groups. Furthermore, mean intensity values of images within
anatomical regions are often calculated to quantify differences between a patient cohort and
healthy volunteers. Such findings can only be interpreted correctly if the applied methods,
used to extract image derived features, are robust. With well validated tools this assumption
usually holds true for MR images that were acquired under the same protocol on the exact
same scanner. However, tools and measurements could be biased when considering multi-
centre data. This could be especially problematic for the comparison of signal intensities
across centres, since voxel values in common MRI sequences do not reflect quantitative
absolute measurements. Different acquisition protocols or imaging equipment could lead to
inherent biases that affect the performance of neuroimaging tools and with it the imaging
derived results. To gain a better understanding of inter-scanner variability, this chapter first
summarises related work and proceeds then to examine differences in brain parcellation and
signal magnitude for datasets of various complexity.
4.1.1 Variability of Anatomical Brain Segmentation
While a number of studies have analysed the accuracy between automated brain region seg-
mentations, only few have investigated the magnitude of inter-scanner variability. Jovicich
et al. [120] examined the impact of acquisition variables on FreeSurfer’s brain parcellation.
The variability of major brain volumes (hippocampus, thalamus, caudate, putamen, lateral
ventricles and total intracranial volume) was measured to be less than 4.3% on MR im-
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ages collected on the same scanner within a few days. The reproducibility error was higher
for smaller anatomical structures such as pallidum, amygdala and inferior lateral ventricle.
Differences in bias field correction, MRI sequences, scanner updates and brain extraction
affected the region volumes only minimally. However, a bias was identified when comparing
inter-vendor data (Siemens vs. GE) and different field strengths (1.5T vs. 3T). Image qual-
ity factors (e.g. SNR) were found to have a strong influence on the segmentation outcome.
Similar results were observed when subdividing T1w images with the topology-preserving
anatomy-driven segmentation algorithm into nine cranial structures (cerebral GM and WM,
cerebellar GM and WM, brainstem, caudate, putamen, thalamus, and ventricular CSF).
Scan-rescan volume variation was less than 5% for all structures. The reproducibility of
structural scans was found to be higher than for imaging modalities aiming to measure
physiological quantities (e.g. DTI, functional MRI) [147]. A comparative study of hip-
pocampal volume change has reported more coherent findings for automated segmentation
than for manual annotations. Noteworthy is that FreeSurfer provided a higher reproducib-
lity than manual segmentation or volume estimation with FSL FIRST. This was, however,
only achieved when failed cases had been excluded after visual inspection [183]. Another
recent study also explored the consistency of automated segmentation of the hypocampus
in comparison to a manual approach. The intra-scanner variability for FreeSurfer volume
estimation was less than 2% and comparable to that of manual annotations. Automatically
derived hypocampal volumes were systematically different for Siemens and Philips scanners,
resulting in a higher inter-vendor variation (coefficient of variation [CV], CV = 4.4%) than
that observed for manual region delineations (CV = 2.6%) [49].
4.1.2 Reproducibility of Diffusion Magnetic Resonance Imaging
Diffusion tensor imaging metrics have been reported to show good scan-rescan repeatability
on the same scanner regardless of vendor and scanner models [121], however, significant dif-
ferences could be observed when comparing diffusion data across scanners. Various studies
measured the intra- and inter-scanner variability for DTI metrics for different datasets and
experiment setups. The following paragraphs aim to provide a non-exhaustive overview.
Hereby, the focus lies on human brain imaging data analysing FA and MD metrics. The
studies were roughly categorised according to whether their experimental design incorpo-
rated rescans on the same scanners, travelling volunteers or both.
Scan-Rescan Studies. To evaluate intra-scanner variation of DTI scans, Marenco et
al. [168] scanned 20 subjects twice on one scanner and compared FA and MD measurements
within 14 manually drawn regions. Variability was measured by the CV, which was defined
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as the ratio of standard deviation and mean (see Equation 4.1). While nine out of 14 ROIs
had a CV below 10%, there were noticeable regional differences, with CV scores ranging
between 2.5% and 20.5% for FA and from 2.1% to 6.2% for MD. Highest CV for FA was
found in the cerebellar cortex and frontal GM, and lowest was seen in the CC. The CV for
MD was highest in the peduncles and lowest in the insula. Overall, MD showed more precise
reproducibility (lower CV) than FA.
A later study, conducted by Lemkaddem et al. [154], compared intra- and inter-scanner vari-
ability of DTI scans on four different scanners. Two of them were located at the same site and
shared the same configurations, hence thereafter referred to as twin-scanners. Although the
intra-scanner measurements showed a lower variability than the inter-twin-scanner, overall
no significant differences were observed. Intra- and inter-twin-scanner experiments revealed
low CV for both region-based (CV ≈ 1.0%− 4.2%) and tract-based (CV < 3.0%) analysis.
Comparing images across scanners showed a substantially higher variability with CV rang-
ing between 4.0% and 8.9% for FA and from 4.2% to 10.0% for MD measurements. Some
ROIs and tracts showed significant differences across the two scanners for MD but not for
FA maps. The DTI metric deviation in ROIs and tracts was found to be larger between
the two Siemens scanner models (Trio vs. Verio) than between scanners of the same model
(both Trio), despite the unequal number of radiofrequency head coil channels for the latter.
Noteworthy, data acquired with the lower number of channels exhibited a two fold reduction
of SNR. Since, FA metrics have been shown to be sensitive to SNR [66], the characteristics
of a head coil array may be an important factor to consider for multi-centre studies.
Vollmar and colleagues [256] analysed the reproducibility of DTI metrics in nine healthy
subjects scanned twice on two different, but identical scanners. The variability of FA mea-
surements was assessed both in the whole brain and in three manually outlined ROIs (sple-
nium of CC, left frontal WM and left UF). The CV for FA within site ranged from 0.8% to
3.0%, and slightly increased across sites ranging from 1.0% to 4.1%. Highest variance was
found in the smallest regions (left UF), and lowest in the whole brain average FA. Overall
variation was lower in WM tracts (<5%) then in GM regions (10-15%). It has been men-
tioned that non-linear image coregistration improved reproducibility metrics in comparison
to affine coregistration [256].
Another large multi-centre study [283] included 27 scanners (two vendors: Siemens & GE;
six scanner models; seven software versions). Except for one scanner, MR data were collected
with a harmonised single-shell DWI protocol (64 gradient directions, b = 700 s/mm2). To
assess the variation across centres, a single and for each scanner different healthy volunteer
was scanned twice.1 The CV was computed for WM masks within single scanners and across
1one subject per centre, scanned twice: 27 subjects and 54 scans in total
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scanners of the same vendor. This revealed no statistical deviation between intra-scanner
images, however, significant differences were found for FA metrics across vendors. On aver-
age, FA and MD values were both lower on GE than on Siemens scanners. Cross-scanner
variability was observed to be higher for FA (CV = 5.7%) than for MD (CV = 2.9%) [283].
This study showed overall good repeatability of DTI metrics across different scanners, but
the results were only based on a single subject per scanner and were restricted to whole WM
analysis. This may underestimate non-linear regional variability.
Travelling Head Studies. While studies with multiple scans and rescans on one scan-
ner can confirm the reproducibility of DTI metrics at one site, they do not provide direct
comparability between centres. Therefore, some studies have focused on acquiring data for
the same subjects at different imaging sites and/or scanners. One of those [241] examined
the comparability of DTI metrics in a multi-centre setup, involving 16 different scanners at
12 different imaging sites. Apart from one scanner (GE), all scanners were manufactured
by Siemens, including various models, software versions and field strength (1.5T and 3T).
The analysis of reproducibility was based on one healthy subject only2. For all scanners
single-shell DWI data (b = 0, 1000 s/mm2) was acquired, however, with a different num-
ber of diffusion-weighting gradient directions (either 12 or 30). To measure the differences
across scanners, the CV was computed in manually placed ROIs as well as for automated
TBSS and deformation based analysis. For the latter, FA maps were affinely coregistered to
T1w images, which were then spatially normalised, such that FA maps could be warped to
template space. This revealed a variation of FA with a mean CV of 14% for TBSS and 29%
for the deformation based analysis. The variation found was similar to the one observed
between 12 healthy subjects and 26 Alzheimer’s disease patients scanned at a single imaging
site. Such a comparability shows the need to account for inter-scanner variances in clinical
multi-centre studies. The magnitude of FA variation was only decreased marginally when
choosing a subset of similar scanners and acquisition parameters. This could indicate that
harmonised scanning protocols and identical scanners only partly diminish inter-scanner
divergence. Interestingly, increased variability was observed for less organised fibre tracts,
such as the fornix and SLF (in contrast to splenium). Despite the insight into inter-scanner
DTI variability, findings are difficult to generalise as they are exclusively based on a single
travelling subject. The impact on MD measurements was not analysed.
Slightly more elaborate was a study that included two travelling volunteers. These were
scanned on five different scanners (three Siemens Trio and two GE Signa) with a harmonised
DTI protocol including 33 directions. Mean values of FA and MD were evaluated within
2and a phantom, which will not be discussed here
84 CHAPTER 4. REPRODUCIBILITY OF MRI METRICS
16 manually delineated GM and WM ROIs. The intra-scanner CV within the WM was
slightly lower (8.7%) than that across all five scanners (9.1%). Although a similar trend
was found for MD, the relative discrepancy between intra- and inter-scanner CV (2.2% and
4.8%, respectively) was stronger. Overall, MD showed less variability than FA. Comparing
regional DTI metrics across scanners revealed high concordance correlation coefficients for
both FA (0.96) and MD (0.88). This high correlation of inter-scanner data indicates a good
comparability of DTI metrics obtained with same imaging protocols, however, the low num-
ber of subjects may hamper generalisability [72].
For many studies, acquiring scans for one or several volunteers was not the main aim under
investigation, but rather the methods for assessing the variability between scanners for a
larger patient study. For example, in the case of the TRACK-TBI study, diffusion MR
images were acquired for one travelling volunteer on 13 scanners at 11 different centres.
Inter-scanner variability of DTI metrics was assessed by comparing intensities of the whole
WM skeleton obtained from the standard FSL TBSS pipeline. This revealed small regional
differences for the 14 selected fibre tracts, with CV ranging between 2.1% and 7.8% for FA
and from 2.6% to 7.0% for MD. The globally measured CV values were below 5%, with MD
exhibiting a lower variation than FA (CV = 2.4% and CV = 4.2%, respectively). Moreover,
DTI measurements were found to be more similar across imaging sites for large central fibre
tracts (e.g. CC) than in small regions at the WM periphery (e.g. UF) [193].
Multi-Centre & Multi-Scan Studies. More advanced are studies that scanned sev-
eral subjects repeatedly on all involved scanners, with the main aim to measure variability
of DTI metrics in larger multi-centre data. For example, Magnotta and colleagues [164]
scanned five healthy controls multiple times at eight imaging sites. Four DWI scans were
acquired with a protocol that complied with the standard sequence for the employed scan-
ner’s vendor (30 directions on Siemens scanners or 32 directions on Philips scanners). Two
further scans were collected with a semi-harmonised sequence with 71 directions but varying
repetition times. All scans were single-shell data (b = 1000 s/mm2). Reproducibility was
measured via CV within six selected ROIs from the Talairach3 atlas [236] (cerebrum, frontal
lobe, temporal lobe, parietal lobe, occipital lobe, and subcortical regions). Significant dif-
ferences, assessed via mixed-effects model analysis, were found for inter-vendor comparison
of DTI metrics. Mean FA values for Siemens scanners were slightly lower that for Philips
scanners. Contrary, mean MD values were lower for Philips than for Siemens scans. While
no differences were found for MD between the scanning protocols, the mean FA based on 71
directions was observed to be slightly lower than that calculated from the 30 or 32 directions.
3http://www.talairach.org
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For most sites, the intra-scanner variability was below 1.0% for all DTI metrics. Coefficients
of variation were slightly increased for inter-site comparison (CV ∼ 1.0%− 3.0%), whereas
FA showed marginally higher variability than MD. Variation was similar across regions, how-
ever, slightly elevated for all metrics within the occipital lobe. The mean CV for 30 or 32
direction images was lower (1.8%) than than for 71 direction scans (2.2%). Images were also
denoised via median filters, which resulted in decreased CV scores. Variation scores were
lower in Siemens than in Philips data for the 71 directions protocol, but the opposite was
observed for 30 or 32 DWI scans. Mixed-effect model analysis suggested a significant impact
on variability between sites through due to protocol type, vendor and median filtering [164].
In a recent study, Tong et al. [245] analysed the fibre-tract density on a voxel- and region-wise
level and structural connectome for three travelling volunteers across eight imaging centres.
The same multi-shell (b = 1000, 2000, 3000 s/mm2) diffusion MRI scanning protocol was
implemented on each of the similar scanners4 (Siemens Prisma) to create ideal conditions of
inter-scanner comparability. To form a baseline for intra-centre variability and investigate
scan reproducibility on one scanner, the same subjects were scanned thrice at each site.
Besides comparing the full DWI acquisition, all different combinations of shells and single-
shell data were examined. A fair reproducibility of fibre-track density within and across
centres (CV < 15.0%) was observed. However, for all single- and multi-shell combinations
the intra-centre variability was lower (average CV = 10.4%) than for data across centres
(average CV = 11.3%). A closer look at tissue compartments revealed lower CVs for intra-
than inter-scanner data at WM-GM boundaries (CVintra = 16.7% vs. CVinter = 19.9%) and
pure WM regions (CVintra = 6.6% vs. CVinter = 8.0%). Interestingly, regions with more
complex directional fibres (e.g. crossing fibres) showed generally higher variances than re-
gions with single-directional fibres, which is consistent with the previously mentioned finding
from Teipel et al. [241]. Reproducibility of links in the structural connectome was higher for
intra-centre data, however, was also dependent on the number of considered regions. Finer
parcellations resulted in less reproducible connections [245].
Besides considering the influence of scanners, the variability for different sequences has been
systematically assessed as well. Eight healthy subjects were scanned with three diffusion
imaging protocols (both with a different set of six gradient directions, and b-values of 1044
and 1034 s/mm2) on two different scanners (Siemens & Philips). Additionally four healthy
volunteers underwent diffusion imaging twice on the same scanner to quantify intra-scanner
variability. This was measured by CV of histogram metrics within the whole brain exclud-
ing CSF. Among the derived quantities were the mean as well as the position and relative
height of the peak of the histogram. Inter-sequence MD metrics exhibited less variation
4Here: inter-scanner and inter-centre are equivalent
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(CV = 1.7%−5.6%) than FA measurements (CV = 5.5%−7.3%). Variability for scans and
rescans were comparable to inter-sequence CV scores [31].
Longitudinal Reliability. A different approach was pursued by Hawaco et al. [95] where
four healthy subjects underwent annual DWI on five different scanners at three sites re-
peatedly over three years. Eventually, this longitudinal dataset included 27 MRI sessions
acquired with a semi-harmonised scanning protocol (60 gradient directions, b = 1000 s/mm2,
but varying TR). After spatial normalisation, mean FA values in 63 ROIs from the Johns
Hopkins University (JHU) WM atlas [181] were computed. Estimating variability with
mixed effect models highlighted a significant cross-scanner difference for FA. Furthermore,
the aim was to investigate whether DTI metrics are reliable descriptors for individual sub-
jects. Therefore, present inter-scanner effects were corrected for by regressing those from
each ROI and a hierarchical clustering method was employed to classify subjects based on
their image derived metrics. The high accuracy achieved, indicated a good reliability of FA
metrics.
4.1.3 Overview & Aims
A number of studies [49, 120, 147, 183] have found that parcellating anatomical regions
on structural MRI is fairly robust for data collected on different scanners. Automated
region segmentation (i.e. FreeSurfer) has been reported to be equal or superior to manually
outlined ROIs of inter-vendor data, but a bias between Siemens and Philips scanners has
been observed [164].
A common finding of all DTI reproducibility studies was the lower variation for MD than
for FA metrics. More specifically, a higher variability has been reported for FA in GM than
in WM tissue regions [256]. Inter-scanner variability for different but identical scanners
was low. However, statistical discrepancies for DTI metrics were observed for different
scanner models from the same vendor as well for inter-vendor data. Although most studies
report similar trends, a direct comparison is hampered, as different approaches were use to
measure variability. Often analysis was performed on basis of manually delineated regions,
which usually did not cover the full extent of WM fibre tracts. Despite offering a high
precision of ROI segmentation, results become less reproducible when using non-automated
brain parcellation. Furthermore, some studies were based on a low number subjects (1-2),
which challenges the generalisability of those observations.
The objectives of this chapter is the evaluation of inter-scanner robustness of novel brain
parcellation tools (i.e. MALP-EM [151] and TractSeg [263]) and measure the variability
in DTI metrics for datasets with various complexity. Previous studies have restricted their
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analysis on single subjects or small cohorts (n ≤ 3), which limits the generalisability of any
findings. Here the robustness of brain parcellations was measured in healthy subjects that
were scanned twice on two scanners (T1w: n = 12, DWI: n = 6). This allowed the direct
caparison of both intra- and inter-scanner variation of automated T1w and DWI parcellation
as well as the variability of FA and MD metrics. Besides scanner differences, the influence
of DTI parameter are examined in a cohort of healthy subjects (n = 16) scanned multiple
times on the same scanner, with varying DWI acquisition protocol. Eventually, FA and MD
variation was examined for a multi-centre study including nine physically different scanners.
The chapter aims to provide a better insight in variation of MR data as a result of either
different scanners, changing imaging protocols or both.
4.2 Data & Methods
4.2.1 Databases
Scan-Rescan Database As introduced previously (Section 2.2), this database included 12
subjects each scanned twice on each of two scanners. Six out of those subjects also under-
went DWI. Acquisition protocols were mostly harmonised.
Multi-Acquisition Database For 16 subjects (nine female, seven male, age = 25.8±5.4),
five DWI scans were acquired within the same scan session with identical acquisition pa-
rameters, but with different number of b-values. A total of 60 volumes with non-collinear
gradient direction, evenly distributed across one to five shells, were collected. These schemes
included a scan consisting of five shells (b = 250, 450, 700, 950 and 1200 s/mm2) with
each twelve directions (DTI 12×5), another included four b-values (b = 300, 600, 900 and
1200 s/mm2) with each 15 directions (DTI 15×4). Alongside these, a scan with three b-
factors (b = 400, 800 and 1200 s/mm2) with each 20 directions (DTI 20×3) and a scan
incorporating two b-values (b = 600 and 1200 s/mm2) with each 30 directions (DTI 30×2)
were collected. In addition to the multi-shell data a single-shell scan (b = 1200 s/mm2)
with 60 directions (DTI 60×1) was acquired. For each DWI scan 13 non-diffusion weighted
volumes (b0) were obtained, whereas one was always in the beginning and the remaining
twelve were equally distributed between volumes of different shells and the very first b0 vol-
ume (this means for single-shell data, all b0 volumes are concatenated at the very beginning
of the scan). Other parameters, such as TR = 8000ms, TE = 93ms, flip angle of 90◦ and
pixel bandwidth of 1628 Hz/Px, were shared across the different DWI schemes. In addition
one T1w images was collected (TR = 2250ms, TE = 2.9ms, flip angle= 9◦ and pixel band-
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width of 230 Hz/Px). All images were acquired on one Siemens Trio scanner.
Multi-Centre Database The general MRI parameters for the CENTER-TBI data have
been described previously (Section 2.2). To assess reproducibility healthy subjects were only
included if they underwent a rescan with the same number of directions (hence, excluding
three centres: a72b20, ac3478 & cb4e52 ). Another centre (8effee) was excluded as only four
scans from two subjects were left, which was deemed to be too low for this experiment. A
further centre (fe5dbb) was excluded as scan and rescan had been processed with and with-
out extra b0 volume, respectively, as the additional b0 scan with opposite phase encoding
direction was not always available.
4.2.2 Experiment Setup
Reproducibility of brain parcellation and tissue segmentation via MALP-EM, TractSeg and
JHU atlas projection was assessed. For this purpose, the Scan-Rescan dataset was used,
as it allowed the direct comparison of multiple scans of healthy controls (12 for T1w, and
6 for DWI) on the same and a different scanner (Prisma & Trio). The harmonised MRI
protocol and the paired scans on both scanners make this a highly controlled dataset. Mean
intensities of FA and MD within TractSeg and JHU ROIs were compared to intra- and
inter-scanner variation. The Multi-Acquisition database was used to examine the impact
of different scanning parameters on FA and MD metrics as well as WM parcellation. Same
principles were applied to the DWI data of the less well-matched multi-site CENTER-TBI
database. For this, all healthy subjects, scanned twice, were selected and curated via the
diffusion pipeline’s QC metrics. These were then compared across centres to highlight any
site-specific biases. Eventually, FA and MD variability was compared in different regions in
native as well as template space.
Images were all pre-processed with the same structural and diffusion pipelines as outlined
in the previous chapter (Chapter 2). The following sections describe the experimental setup
in more detail.
Reproducibility of T1w Brain Parcellation Since MALP-EM is driven by image regis-
tration and ROI refinement through expectation maximisation, its parcellation is dependent
on image intensities. While smaller errors of falsely deformed atlas regions might be can-
celled out by fusing information from several atlases, it is not entirely clear how much impact
differences in the image acquisition have on the region refinement. The examination of the
robustness of MALP-EM was subdivided in three experiments.
Firstly, MALP-EM was applied to the 48 T1w scans of the Scan-Rescan database (12 sub-
4.2. DATA & METHODS 89
jects, two scanners with each two sessions). For this the individual brain mask calculated
via antsBrainExtraction was used. Besides the comparison of tissue and region parcellation,
differences across scanners for relative region volumes were compared (relative volumes were
computed by dividing ROI volumes by total brain volume).
Secondly, intensities of T1w images were first matched across scanners before re-applying
MALP-EM. For this, T1w images collected on the Prisma scanner were matched to the mean
intensity profile of the Trio T1w images with the recently suggested NDFlow5 algorithm.
This was chosen as it has been shown to be superior to standard intensity scaling. In brief,
Dirichlet process Gaussian mixture models are fitted to the histograms of intensities found
in the images to be matched. This allows to adapt the number of components to fit the
histograms best, rather than being confined to a predefined, fixed number (as it would be
the case for Gaussian mixture models). After an initial affine alignment of the histograms
(similar to scaling image intensities), a non-linear transformation between histograms is es-
timated. This is done by considering the non-linear problem from the point of view of fluid
mechanics: Particles, equating the source histogram’s support points, follow individual tra-
jectories to ’flow’ to the target histogram. This forms a velocity field (the non-linear warp
between histograms) that can be solved via ordinary differential equations [30]. For all scans
the exact same brain masks as before were used, and since intensities for Trio scans were
not adjusted, the previous MALP-EM results were reused. Another attempt for intensity
harmonisation matched all scans from both Prisma and Trio scanners to the intensity space
of a study-independent database (i.e. Cam-CAN, see Section 2.2).
Thirdly, for each subject separately all four T1w scans were rigidly coregistered to a common
subject-specific template (NCC between registered images and subject-specific templates:
NCC = 0.988± 0.004). Corresponding ANTS brain masks were projected to this template
space and fused by averaging them, thresholding the output at 0.5 and finally binarising the
image to a common brain mask for all four scans. This was then used to re-apply MALP-EM
on the coregistered T1w scans.
While the first experiment provides results from using a standard prepossessing approach,
both other experiments aim to eliminate the impact factor of intensity shifts or skull strip-
ping. Brain vessels and CSF (that is all CSF that is not in ventricles) were observed to be
insufficiently segmented. Therefore, these regions (classified as ”other” by MALP-EM) were
excluded from any statistical analysis, reducing the number of ROIs for comparison from
138 to 133.
Reproducibility of DWI Parcellation & DTI Metrics Analogous to anatomical brain
5https://github.com/dccastro/NDFlow
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scan parcellation, WM parcellation was examined on the Scan-Rescan database. This in-
cluded six subjects with two DWI scans each on both scanners. For this reproducibility
analysis two different approaches were chosen. Firstly, the brain was parcellated into 72
regions by applying TractSeg [263], a model based prediction algorithm. Secondly, 20 re-
gions of the Johns Hopkins University (JHU) WM tractography atlas were projected to the
DWI scan space via non-linear image registration. Volumes and weighted mean values for
TractSeg were automatically computed by applying the diffusion pipeline to the DWI scans,
hence no further processing was required. For JHU tract projection, each individual FA
map was spatially normalised with antsRegistration to the JHU FA atlas as provided by FSL
(JHU-ICBM-FA-1mm). The 20 JHU fibre tract probability maps were then backprojected
from template to native space, thresholded at 25% and binarised to compute the volumes.
A threshold of 25% was used as such binarised maps are also provided by FSL in MNI space,
hence were considered as commonly used threshold.6 Weighted mean values of FA and MD
were computed before binarising projected tract probability maps. Incorporating proba-
bilistic values for both TractSeg and JHU atlas (weighted mean values) aimed to minimised
the effect of partial volume effects by marginalising the effect of voxel at ROI boundaries.
To compute binarised ROI volumes and weighted mean intensities from the TractSeg prob-
abilistic parcellation a threshold of 0.5 was applied. This was chosen, as it considered voxels
to be part of a region when the particular region class was predicted with a 50% certainty.
To understand the impact of different scanning protocols on the diffusion MRI derived fea-
tures, the same methods were also applied to the Multi-Acquisition database. This included
16 healthy subjects who underwent DWI imaging on the same scanner, but with five differ-
ent protocols, all varying in number and strength of b-values.
Multi-Centre Differences in DTI Acquisition The previous experiments were con-
ducted on strongly regulated databases that included the same subjects. These were either
scanned multiple times under the same protocol, but on different scanners (Scan-Rescan), or
imaged with varying acquisition parameters, but on the same scanner (Multi-Acquisition).
Moreover, MR scans were all collected at the same imaging site, minimising the bias intro-
duced by different operators or imaging policies. However, for multi-centre studies different
scanners and unharmonised MRI protocols may be involved. To examine the variability of
diffusion MRI metrics across imaging sites, the previous methods for DWI parcellations were
applied to the Multi-Centre database (a subset of the healthy controls from the CENTER-
TBI imaging database).
After pre-selection of the sites (see above), the QC metrics from the diffusion pipeline were
6A threshold of 50% eliminated some of the 20 ROIs, both in DWI and atlas space.
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analysed to identify and exclude any outliers due to image corruption. The PIS ratio ranged
between 0.24 and 0.66, and no gross outliers were found. Nonetheless, both scans with the
highest PIS QC ratio (0.66) and with the highest number of voxels with PIS (2343) were
checked visually and deemed to appear normal.7 Furthermore, both scans with the lowest
(43.0) and highest (270.2) SNR, were inspected and found without any obvious artefacts.
Brain mask QC ratio ranged between 92.5 % and 105.1%, which was accepted as sufficient.
One subject from centre B with the highest average total head motion QC metric (1.06) was
examined visually and strong noise artefacts were detected. Hence this scan and the corre-
sponding rescan were excluded. The scan with the next highest average total head motion
(0.9863) seemed unaffected. After exclusion of the abnormal scan and rescan already men-
tioned, none of the other head motion QC metrics led to noticeably different scans and no
obtrusive artefacts were found. The NCC values between FA maps and T1w images ranged
from 0.43 to 0.69. Apart from susceptibility artefacts, no aberrant deformations were found
on the scan with the lowest NCC.
An overview of the final curated dataset is provided in Table 4.1, listing the scanner ven-
dor and model, the number of diffusion sensitised volumes (#Dir.) as well as age and sex.
Furthermore, it indicates whether susceptibility distortions were corrected with an extra b0
volume of opposite phase encoding direction. Additionally, the NCC between the JHU FA
map and the subjects FA maps, spatially normalised to JHU space, is shown (NCCjhu, not
to be confused with the NCC between coregistered FA maps and T1w images).
After this curation, one scan of both a female and male subject from each scanner was cho-
sen that matched the mean age across all centres (40.6 years) the closest. This pre-selection
resulted in 18 subjects with an average age (39.8 years) similar to that of all control subjects,
but with a slightly narrower age range. Those were then used to compute a study specific
template via tensor registration using DTI-TK [280, 282]. Eventually, the final DTI-TK
average FA map was parcellated with the JHU atlas as previously described. All scans
(138 from 69 subjects including the ones used to create the template) were then spatially
normalised to this template.
Before analysing variance in DTI metrics, the curated dataset was examined for inter-centre
compatibility. Therefore, the different QC metrics from the diffusion pipeline were compared
across centres. Subsequently the local variability of FA and MD metrics were studied both
in native as well as template space. These experiments aimed to investigate the differences
present within centres, across same scanner vendor located at different sites, as well as the
overall variation in the complete dataset.
7Reminder: A high PIS ratio indicated that more voxels with PIS remained after artefact correction.
Hence, high values are undesirable.
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Table 4.1: Overview of Included Data of CENTER-TBI Controls. Age (in years) and
NCCjhu displayed as mean±std.
Centre Vendor Model #Dir. b0 Age Sex NCCjhu
A Siemens Trio 30 no 41.7±15.3 1F/5M 0.758±0.021
B Siemens Skyra 30 yes 41.8±11.5 3F/5M 0.776±0.029
C1 GE MR750w∗ 32 no 38.0±11.1 4F/4M 0.726±0.016
C2 GE MR750∗ 32 no 43.3±11.2 4F/5M 0.754±0.019
D Siemens Prisma 30 no 41.6±13.1 3F/6M 0.775±0.017
F GE MR750∗ 32 no 45.1±13.0 3F/6M 0.738±0.018
G Philips Ingenia 32 no 31.0±6.2 2F/4M 0.759±0.005
H Philips Ingenia 32 yes 39.1±15.3 3F/5M 0.777±0.015
L Philips Achieva 32 no 40.2±14.3 5F/1M 0.758±0.010
Total 40.6±12.4 28F/41M 0.758±0.025
DTI-TK Template 39.8±9.6 9F/9M 0.974
∗GE Discovery MR750 & MR750w models. F=female, M=male
4.2.3 Evaluation Metrics
A common metric to estimate the deviation across scans is the CV, which is defined as
the ratio of standard deviation σ and mean µ of a distribution. For ROI analysis there
are different approaches over which distribution the CV can be calculated [256]. Here, for
images in native space, first the mean intensities in each ROI for each scan were computed,





where X̄r is the collection of means of a specific ROI r for all images to be investigated.
Analogously, the CV for volumetric measurements was computed by dividing the standard
deviation of the volume by the mean volume of the examined cohort (denoted as CV rvols for
region r).
With spatial normalised scans, the CV maps were derived on a voxel wise level, before











with xri representing the voxel intensities at a specific location i within a ROI r with N
number of voxels.
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Besides this, the statistical difference of ROI metrics (i.e. region volumes or mean intensi-
ties of FA and MD within ROIs) was estimated with an analysis of variances for repeated
measurements (rm-ANOVA). This was chosen under the assumption of equal variances.
To account for multiple comparisons, p-values were adjusted with FDR correction and the
more stringent Bonferroni correction. For this the modules AnovaRM and multipletests from
the python library statsmodels were used. If statistical differences were detected with rm-
ANOVA, a post-hoc paired t-test was applied and likewise controlled for FDR. Corrected
p-values for post-hoc tests are marked with hoc (phocfdr) to avoid confusion with p-values from
rm-ANOVA (pfdr). T-tests were conducted with ttest rel from python library scipy.
For aligned atlases in template space, the overlap between regions was measured by cal-
culating the Dice score with f1 score from the scikit-sklearn python library. The Dice score
is generally defined as the size of the intersection of two sets A and B over the sum of sizes





4.3.1 Reproducibility of Anatomical Brain Parcellation
Comparing total brain volumes and four MALP-EM tissue compartments (i.e. ventricles,
non-cortical GM, cortical GM and WM) within and across scanners showed very similar
average volumes on both scanners. Testing volume differences with rm-ANOVA and FDR
correction, identified total brain (pfdr < 0.001) and WM (pfdr = 0.0248) volumes to be sig-
nificantly different (cortical GM volume differences were close to significance: pfdr = 0.0615).
The post-hoc paired t-tests revealed only a statistically relevant difference of total brain vol-
ume between (all: phocfdr < 0.001), but not within scanners (Prisma: p
hoc
fdr = 0.1707, Trio:
phocfdr = 0.8460). The total brain volume discrepancy across scanners was on average 10.5
cm3, which corresponds to approximately 11 voxels or a 1% volume difference, which can
be considered marginal. White matter volumes were different between the rescan group
on Prisma (Prisma #2) and both scan groups on Trio (Trio #1: phoc = 0.0262, Trio #2:
phoc = 0.0191), however, this was not statistically significant after FDR correction (for both
inter-scanner: phocfdr = 0.0785). The WM volume difference for this data corresponded to
approximately 8 voxels, or a discrepancy of 1.6%. All volumes for tissue compartments and
total brain are summarised in Table 4.2 .
In a rm-ANOVA 47 ROIs had a p-value<0.05, however, after correction for multiple com-
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Table 4.2: MALP-EM Volumes for Tissue Compartments. Volumes displayed as mean ±
std in cm3
Scan Total Brain Ventricles Non-cGM cGM WM
Prisma #1 1241.2 ± 140.7 20.2 ± 6.4 179.9 ± 14.5 564.9 ± 63.8 474.7 ± 64.5
Prisma #2 1242.8 ± 140.9 20.2 ± 6.4 178.1 ± 12.2 566.0 ± 61.5 477.1 ± 67.4
Trio #1 1231.4 ± 141.8 20.2 ± 6.4 179.0 ± 12.5 562.0 ± 58.9 468.7 ± 72.0
Trio #2 1231.6 ± 142.0 20.2 ± 6.3 178.1 ± 14.2 561.9 ± 59.8 469.9 ± 70.5
parison with FDR only 34 ROIs were significantly different. This number further decreased
to 13 with more stringent Bonferroni correction.
Volume discrepancies were found mostly across scanners, and only the brainstem was signif-
icant different between both Prisma scanners (phocfdr = 0.0132). Regions in both hemispheres
with volumetric differences across scanners included the cerebellar WM (pfdr ≤ 0.0158), the
palladium (pfdr ≤ 0.0298), the thalamus proper (pfdr ≤ 0.0025), the ventricle DC (pfdr ≤
0.0155), the superior temporal (pfdr ≤ 0.0011) and lateral orbital gyrus (pfdr ≤ 0.0213),
the central operculums (pfdr ≤ 0.0074) as well as the frontal (pfdr ≤ 0.00337) and occipital
poles (pfdr ≤ 0.0001). Apart from left and right cerebral WM compartments being the
largest ROIs (≈ 218 cm3) in the MALP-EM atlas, all other mentioned ROIs were neither
particularly large or small. Figure 4.1 shows four ROI examples for both equal and deviating
volumes across scanners. There was no systematic bias of volumes being consistently larger
on Prisma or Trio.
When comparing relative ROI segmentations, the number of ROIs with deviating volumes
on different scans could be reduced (no correction: 40) and was approximately halved when
considering multiple comparison correction (FDR: 17, Bonferroni: 8).
Instead of computing relative volumes post-parcellation, image intensities were harmonised
via NDFlow before applying MALP-EM. Matching intensities from Prisma scanners to the
Trio intensity space reduced the volume discrepancy to 17 ROIs with significantly different
volumes across scanners. After multiple comparison correction with FDR or Bonferroni this
was decreased to seven ROIs or one region, respectively. Among the seven ROIs identified
with different volumes across centres were the left and right WM of the cerebellum (ROI
#12 & #13), the left putamen (ROI #28), the left thalamus proper (ROI #28), the right
ventral DC (ROI #31), the right lateral orbital gyrus (ROI #71) and the right occipital
pole (ROI #91). All ROIs that were different after intensity matching were also different
without this pre-processing step, implying the intensity matching does not introduce any
volume deviation itself. The p-values of the post-hoc t-test after FDR correction are listed
in Table 4.3. Visual inspection of ROIs with and without intensity matching showed only
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Figure 4.1: Distribution of Volumes from MALP-EM Regions Deviating Across Scanners.
Top row: ROIs which were segmented cohesive on all four T1w scans and were found to be
statistically indifferent (ROI #11, 23, 43, 63). Bottom row: ROIs with volumes that were
statistically different across, but not within scanner (ROI #12, 13, 31, 71). Deviations be-
tween both scanners were minimal. No systematic tendencies for over- or undersegmentation
was detected on either of the scanners. ROIs: 11: Left cerebellum exterior, 23: Right lat-
eral ventricle, 43: Right anterior insula, 63: Right gyrus rectus, 12: Right cerebellum WM,
13: Left cerebellum WM, 31: Right ventral DC, 71: Right lateral orbital gyrus. Boxplots:
In each subplot from left to right: Prisma #1, Prisma #2, Trio #1, Trio #2.
minimally deviating volumes. Despite the positive effect of matching intensities to the study-
independent Cam-CAN database prior to the parcellation, regional volume differences were
still present. The number of different MALP-EM ROIs across scanners was almost identical
(no correction 46, FDR: 31, Bonferroni: 13) as when no intensity harmonisation was applied.
Lastly, the analysis of MALP-EM volumes derived from scans previously coregistered showed
a slightly reduced number of ROIs with segmentation discrepancies. Forty-one regions were
highlighted as significantly different, whereas 24 or 11 remained after FDR and Bonferroni
correction, respectively. Although the same mask was provided initially, the total brain
volume was significantly different between Trio and Prisma scanners (inter-scanner compar-
isons: phocfdr ≤ 0.0007), but not within scanner (Prisma: phocfdr = 0.0867, Trio: phocfdr = 0.8450).
Apart from the lateral orbital gyrus, same regions8 were found to have different volumes as
when computing MALP-EM in native space. Intra-scanner differences were found on only
for Prisma scans for the brainstem (phocfdr ≤ 0.0182) the right pallidum (phocfdr ≤ 0.0485) and
8cerebellar WM, palladium, the thalamus proper, the ventricle DC, the superior temporal gyrus, the
central operculums, frontal and occipital poles
96 CHAPTER 4. REPRODUCIBILITY OF MRI METRICS
Table 4.3: P-Values After FDR Correction for Comparison of MALP-EM ROI Volumes
Within and Across Scanners After Intensity Matching. P-values of post-hoc t-test phocfdr <





P1-P2 T1-T2 P1-T1 P1-T1 P2-T1 P2-T2
12 0.0190 0.5301 0.3487 0.0112 0.0372 0.0131 0.0333
13 0.0190 0.8589 0.5438 0.0114 0.0114 0.0402 0.0440
28 0.0259 0.5465 0.6011 0.0010 0.0002 0.1638 0.1061
30 0.0190 0.1599 0.7383 0.0074 0.0002 0.1599 0.1063
31 0.0190 0.2244 0.2244 0.0137 0.0197 0.0197 0.0363
71 0.0083 0.0899 0.6355 0.0112 0.0016 0.0091 0.0066
91 0.0223 0.0978 0.7358 0.0034 0.0042 0.2687 0.3924
ROIs: 12: right cerebellum WM, 13: left cerebellum WM, 28: left putamen, 30: left
thalamus proper, 31: right ventral DC, 60: left frontal pole, 71: right lateral orbital gyrus,
91: right occipital pole. Scans: P1: Prisma scan #1, P2: Prisma scan #2, T1: Trio scan
#1, T2: Trio scan #2.
the left middle frontal gyrus (phocfdr ≤ 0.0446).
Since T1w images were previously registered to one and another, the MALP-EM atlases
were also aligned, allowing computation of the overlap for each region. The Dice scores for
all regions were on average marginally higher on Prisma (Dice = 0.930 ± 0.034) than on
Trio (Dice = 0.925±0.037) scanners. Overlap of regions were overall lower when comparing
images across scanners (Prisma #1 vs Trio #1: Dice = 0.896 ± 0.043 and Prisma #2 vs
Trio #2: Dice = 0.893±0.046). This finding is in agreement with the previous observations
of more significant volume deviations for inter-scanner than for intra-scanner comparisons.
4.3.2 Variation of White Matter Region Segmentation
TractSeg. The rm-ANOVA on the TractSeg volume revealed significant differences (p <
0.05) for 23 out of 72 fibre tracts. Correcting for multiple comparisons reduced this number
to 13 (FDR) and nine (Bonferroni). The p-values for the 13 ROIs with statistical differences
between the four groups (scan and rescan on both scanners) are listed in Table 4.4. A post-
hoc t-test with FDR correction revealed only significant p-values for ROI volume differences
across scanners. Intra-scanner volume measurements were comparable to one another. Par-
ticularly important are the eight ROIs which showed inter-scanner differences for all four
scan-rescan combinations, such as for example the right SLFI (ROI #36) or the CC (ROI
#45). Volumes that were observed to be different only for one scan pair, such as the genu of
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CC (ROI #6) or the left thalamic premotor cortex (ROI #48), potentially highlight single
outliers. Noteworthy, the rostral body of CC (ROI #7) as well as the left inferior cerebel-
lar peduncle (ROI #22) were found to have different inter-scan volumes (both rm-ANOVA
and uncorrected post-hoc t-test, p-values < 0.05), however, FDR correction eliminated this
statistical difference.
Table 4.4: P-Values After FDR Correction for Comparison of TractSeg ROI Volumes Within





P1-P2 T1-T2 P1-T1 P1-T1 P2-T1 P2-T2
0 0.0023 0.3460 0.4776 0.0210 0.0210 0.0210 0.0210
6 0.0365 0.9091 0.2230 0.1042 0.0266 0.1042 0.1042
7 0.0274 0.8333 0.8333 0.0736 0.0717 0.0717 0.0717
22 0.0365 0.6104 0.9630 0.0759 0.0759 0.0759 0.1004
25 0.0005 0.1192 0.3390 0.0090 0.0107 0.0032 0.0032
30 0.0040 0.2038 0.5703 0.0339 0.0339 0.0223 0.0223
31 0.0038 0.4538 0.7709 0.0118 0.0118 0.0680 0.0611
32 0.0008 0.9094 0.6386 0.0092 0.0105 0.0092 0.0105
36 0.0040 0.2865 0.2862 0.0388 0.0388 0.0388 0.0388
45 0.0009 0.9420 0.1751 0.0058 0.0094 0.0167 0.0256
48 0.0453 0.4980 0.6083 0.1105 0.0978 0.1105 0.1105
57 0.0023 0.2598 0.5339 0.0162 0.0162 0.0099 0.0099
71 0.0040 0.7229 0.8952 0.0025 0.0205 0.0205 0.0242
ROIs: 0: left arcuate fascicle, 6: genu, 7: rostral body of corpus callosum, 22: left inferior
cerebellar peduncle, 25: right IFO, 30: right optic radiation, 31: left parieto-occipital pon-
tine, 32: right parieto-occipital pontine, 36: right SLFI , 45: CC, 48: left thalamo-premotor
tract, 57: right thalamo-occipital tract, 71: right striato-occipital tract. Scans: P1: Prisma
scan #1, P2: Prisma scan #2, T1: Trio scan #1, T2: Trio scan #2.
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Figure 4.2 shows the volume distributions of four ROIs without discrepancies (top row) and
four of the ROIs that were found statistically different (bottom row). No systematic bias
of consistently smaller volumes on one or the other scanner was found. Some ROIs had a
larger volume on Trio, such as the left arcuate fascicle (ROI #0) or the CC (ROI #45).
Other ROIs, such as the left IFO (ROI #25) or the right SLFI (ROI #36) were larger on
Prisma scans.
JHU. Parcellating the brain scans via projection of the JHU-atlas ROIs did not show any
obvious volumetric differences across the four scan session. The rm-ANOVA highlighted six
ROIs to be potentially different (p < 0.05), however, after multiple comparison correction
with either Bonferroni or FDR none of the ROIs examined showed a significantly different
volume.
Figure 4.2: Distribution of Volumes from TractSeg Regions Deviating Across Centres. Top
row: Four examples of TractSeg ROIs with highly reproducible volumes. Bottom row:
Some regions showed deviating volumes when comparing across scanners, while remaining
similar on the scanner. ROIs: 10: Isthmus, 17: Right middle longitudinal fascicle, 54: Left
thalamo-parietal tract, 68: Left striato-parietal tract, 0: left arcuate fascicle 25: right IFO
fascicle, 36: right SLFI , 45: CC. Boxplots: In each subplot from left to right: Prisma #1,
Prisma #2, Trio #1, Trio #2. Whiskers show the full range of the distribution.
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4.3.3 Inter-Scanner Differences of DTI Metrics
After assessing the volume differences, local variance in DTI parameter maps was measured
by comparing weighted means of FA and MD within TractSeg and JHU ROIs.
TractSeg FA. Out of the 72 fibre tracts, 25 ROIs were flagged as having a significantly
different FA (p < 0.05). From those, mean FA values of 14 ROIs remained statistically
different after FDR correction (pfdr < 0.05). This was further reduced to five ROIs when
correction for multiple comparison with Bonferroni. Figure 4.3 shows four selected ROIs
which were detected as different by the rm-ANOVA analysis alongside ROIs with compa-
rable inter-scanner mean FA values. Regions with significantly different FA values between
Prisma and Trio scans showed no consistent bias on one of both scanners. Lower FA mean
values were found for Prisma than for Trio in regions such as for example the right superior
thalamic radiation (ROI #41: pfdr < 0.001, Prisma vs Trio: p
hoc
fdr < 0.002). A similar trend
was observed in regions such as the left CST (ROI #14: pfdr = 0.0060, Prisma #1 vs Trio:
phocfdr < 0.0076) or the left striato-postcentral tract (ROI #66: pfdr = 0.0163, Prisma #1
vs Trio: phocfdr < 0.0274). For both regions no statistical significance between Prisma #2
and Trio scans was measured (ROI #14: phocfdr > 0.0610, ROI #66: p
hoc
fdr > 0.1190). In con-
trast, the left striato-fronto-orbital tract (ROI #58: pfdr = 0.0040) exhibited lower mean
FA values on Trio scans than Prisma scans (all post-hoc paired t-tests between Prisma and
Trio scans phocfdr < 0.05). No intra-scanner differences were detected for the four mentioned
regions. A detailed list of ROIs with deviating mean FA values and p-values is provided in
the Appendix (Table A.1).
Calculating the CV of the mean FA within ROIs revealed that the inter-scanner vari-
ances (CVmean = 3.2% ± 1.2%) was comparable to the ones found on Prisma (CVmean =
3.0%±1.2%) and Trio (CVmean = 3.1%±1.4%). On Prisma scans all CV scores for individ-
ual ROIs lay below 9%. For Trio scans only the right fornix (CV 21mean = 12.5%) was above
the 10% threshold. This was also reflected when computing the inter-scanner CV scores
(CV 21mean = 10.6%).
TractSeg MD. More ROIs with significantly different mean values were found for MD
maps (41). Almost half of the segmented fibre tracts (30) showed different mean MD val-
ues between the scanners after FDR correction (pfdr < 0.05). With Bonferroni correction
nine ROIs remained statistically different. Similar to FA, there was no consistent bias and
higher average MD values were found in ROIs both on Prisma and Trio. Four representative
ROIs with no inter-scanner and with obvious differences are presented in Figure 4.4. So
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Figure 4.3: Differences of Average FA Intensities within Selected TractSeg ROIs. Top
row: ROIs where no statistical difference was found. Intra- and inter-scanner variation was
comparable. Bottom row: ROIs for which significant differences were observed. Scanner-
specific biases are inconsistent, so that both elevated and decreased means could be found on
Trio compared to Prisma. ROIs: 3: Right anterior thalamic radiation, 13: Right cinculum,
46: Left thalamo-prefrontal tract, 63: Right striato-premotor tract, 14: Left CST, 41: Right
superior thalamic radiation 58: left striato-fronto-orbital tract, 66: Left striato-postcentral
tract. Boxplots: In each subplot from left to right: Prisma #1, Prisma #2, Trio #1, Trio
#2. Whiskers show the full range of the distribution.
for example the middle and superior cerebellar peduncles (ROI #28: pfdr = 0.0004; ROI
#33: pfdr = 0.0016) showed higher MD values on Prisma than Trio. Both, however, had
lower significance levels for the Prisma rescan (Prisma #2) in comparison to Trio scans,
than the initial Prisma scan (Prisma #1). Contrary, higher MD values were found on Trio
scans for the left thalamo- and striato-postcentral tracts (ROI #51: pfdr = 0.0103; ROI
#67: pfdr = 0.0004). Again, all four combinations of inter-scanner comparisons showed
differently pronounced deviations. All 30 ROIs had comparable MD values for scans and
rescans on both Prisma and Trio scans. An overview of p-values is provided in the Appendix
(Table A.2).
Comparing the CV of mean MD values within ROIs revealed a higher variability for Trio
scans (CVmean = 2.4%±1.2%) than for Prisma scans (CVmean = 2.0%±1.2%). This was also
propagated, but not further elevated, for inter-scanner comparison (CVmean = 2.4%±1.2%).
All CV scores fell below the 10% mark except for the MD values in the right fornix
(CV 21mean = 10.1%) on Trio scans. Overall CV was lower for MD than for FA metrics.
Six TractSeg ROIs (#14, #18, #28, #33, #41 & #45) showed significant inter-scanner
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Figure 4.4: Differences of Average MD Intensities within Selected TractSeg ROIs. Top
row: ROIs which appeared to have a comparable distribution between all 4 scans. Bottom
row: ROIs for which significant deviations were found. Means within ROIs were increased
as well as reduced for Trio scans relatively to Prisma. ROIs: 1: Right arcuate fascicle, 11:
Splenium, 17: Left middle longitudinal fascicle, 70: Left striato-occipital tract, 28: Middle
cerebellar peduncle, 33: Superior cerebellar peduncle, 51: Left thalamo-postcentral tract,
67: Left striato-postcentral tract. Boxplots: In each subplot from left to right: Prisma #1,
Prisma #2, Trio #1, Trio #2.
differences for both FA and MD. Among those only the CC (ROI #45) was previously re-
ported to show a different volume across scanners.
JHU FA. Comparing mean DTI metrics in the 20 JHU ROIs via rm-ANOVA and FDR
correction on the same dataset, revealed mean FA differences for seven ROIs (with and
without FDR correction). This was reduced to four ROIs after Bonferroni correction. Sim-
ilar to TractSeg, the FA inter-scanner variability (CVmean = 4.6% ± 2.1%) was compara-
ble to that within scanners. However, CV scores were on average slightly lower for Trio
(CVmean = 4.2% ± 2.0%) than for Prisma (CVmean = 4.7% ± 2.4%) or both datasets com-
bined. Thirteen out of 20 ROIs showed lower individual CV scores on Trio than on Prisma.
Only the left CG had a high variability above 10% for both Prisma scans and inter-scanner
comparison (CV 4mean = 11.7% and CV
4
mean = 10.1%, respectively). Average variability
scores for mean FA values calculated within JHU ROIs were higher than for TractSeg ROIs.
JHU MD. Analysis of mean MD differences (rm-ANOVA) identified ten ROIs after FDR
correction as significantly different across scanners (eleven ROIs without correction and
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seven ROIs after Bonferroni correction). Intra-scanner variation of MD mean values in JHU
ROIs was practically equal for Prisma and Trio (CVmean = 2.4% ± 0.8% and CVmean =
2.4% ± 0.7%, respectively), but slightly elevated when fusing datasets from both scanners
(CVmean = 2.8%±0.8%). Coherent with the previous TractSeg findings, the variation found
for MD was lower than for FA maps.
Six of the 20 JHU ROIs were different for both FA and MD, including the left and right
anterior thalamic radiation (ROI #0: pfdr < 0.030; ROI #1: pfdr < 0.002), the left CST
(ROI #2: pfdr < 0.001), the hippocampal cingulum bundle (ROI #6: pfdr < 0.004) and
the (temporal) left SLF (ROI #14: pfdr ≤ 0.020; ROI #18: pfdr < 0.05). For a complete
list of p-values see Appendix Table A.3.
4.3.4 Impact of Acquisition Protocol on Fibre Tract Segmentation
Analysing TractSeg volumes via rm-ANOVA identifies significant differences (pfdr < 0.05)
for all regions, but the right fornix (ROI #21), across acquisition protocols. TractSeg ROI
segmentations were found to be dependent on the number of shells and directions the DWI
image was acquired with. Out of 72 TractSeg ROIs, 69 showed volumes that were on DTI
20×3 larger than on DTI 12×5, but simultaneously smaller on DTI 60×1 (DTI 12×5 < DTI
20×3 < DTI 60×1). A strict staircase pattern (Figure 4.5), where protocols with less shells
and more directions showed larger volumes (DTI 12×5 < DTI 15×4 < DTI 20×3 < DTI
30×2 < DTI 60×1), was observed for more than 60% (i.e. 45) of the ROIs. Comparing
volumes of JHU fibre tract segmentations did not reveal any significant differences after
FDR correction of rm-ANOVA results.
4.3.5 Acquisition Protocol Specific Differences in DTI Metrics
TractSeg. Analysis of mean FA and MD values within TractSeg ROIs highlighted all re-
gions as significantly different (rm-ANOVA pfdr < 0.05). When comparing mean FA or MD
values of DTI 60×1 to any other protocol, significant differences (phocfdr < 0.05) were found
almost for all regions. Discrepancy was lowest for DTI 12×5 and DTI 15×4, with twelve
or six regions observed significantly different for FA and MD metrics, respectively. Fewer
significant regions were found for protocols that had a more similar angular resolutions (and
number of shells) than for those with more deviating acquisition parameters. For example
when comparing DTI 15×4 to DTI 30×2 37 ROIs showed significant different mean MD
values, but compared to DTI 20×3 only six regions were detected.
Comparing the variation of TractSeg ROIs for data from single protocols against each other
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Figure 4.5: Reputability of Tract Volumes for Different DWI Acquisitions. Most ROIs
showed the same staircase-pattern for volumes as found for the right cingulum (ROI #13).
Larger ROI volumes were segmented on scans acquired with more directions and less shells.
Nonetheless, there were a few ROIs which disrupted this pattern such the here displayed
ROI #31 and #59. ROIs: 13: Right cinculum, 31: Left parieto-occipital pontine tract, 59:
Right striato-fronto-orbital tract. Boxplots: In each subplot from left to right: Protocols
with different number of directions per shells [dir×shell]. DTI 12×5, DTI 15×4, DTI 20×3,
DTI 30×2, DTI 60×1.
showed similar levels of CVmean ≈ 5.0% for FA. Only a significant difference was found
between data from protocol DTI 12×5 and DTI 30×2 (phocfdr = 0.0214). The TractSeg
MD ROI variation was similar for all acquisitions (CVmean ≈ 4.1%) except for DTI 60×1,
which showed a lower regional MD variance (CVmean = 3.8%) than any other protocol
(phocfdr < 0.0310).
Comparing TractSeg’s CV for volumes (CVvols) against CVmeans for FA or MD values for
all single protocol data (intra-protocol variation showing differences between subjects) and
combinations of two protocols (inter-protocol variation showing differences between acqui-
sition parameters) revealed only a weak correlation (Spearman’s correlation: rFA=0.4318
and rMD=0.1376). When plotting CVmeans for FA against CV for TractSeg ROI volumes
(CVvols, Figure 4.6 Left) the variation of mean FA values in TractSeg ROI mostly clus-
tering together around the 5% mark. However, with increasing variation in ROI volumes
(CVvols > 30%) the variations for regional FA mean values also increased to variations of
8% to 12%. Analogous for MD (Figure 4.6 Right), the variations for different TractSeg
ROIs clustered around 4% and outliers with variations between 10% to 19% were detected
mostly for highly deviating volumes (CVvols > 30%). For both FA and MD this increased
variance was not exclusive to Inter-Protocol observations, but also to data from one single
acquisition scheme. Identifying the ROIs that showed the highest CV of volumes within
data from the same protocol flagged the anterior commissure (CV 4means = 27.1%) as well as
the left and right fornix (CV 20means = 28.0%, CV
21
means = 38.1%). All three regions have on
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Figure 4.6: Relationship Between CV of DTI Metrics and Volumes of TractSeg Parcellation.
Left: CV values for FA are clustered between 3%-8% for regions with lower volumetric
variation. TractSeg ROIs with volume deviations above 25% also displayed increased dis-
crepancy in FA values (8%-12%). Right: CV values for MD mostly score between 2%-6%.
Similarly to FA, difference in regional MD values increased (12%-19%) with elevated volume
variation. Each dot represents one ROI comparison.
average the lowest volumes (4874, 905 and 794 mm3, respectively). Indeed excluding these
three volumes also eliminates all outliers detected on Figure 4.6.
JHU. Mean values in all JHU regions were identified to be significantly different across
different acquisition protocols. On average mean FA values were found to be lower for scans
with higher angular resolution per shell (i.e. DTI 30×2 and DTI 60×1), which held true
particularly for DTI 60×1. While data with three or more shells (i.e. DTI 12×5, DTI 15×4
and DTI 20×3) showed similar mean FA distributions in JHU tracts, strong significant dif-
ferences were observed when compared to DTI 30×2 and DTI 60×1 (phocfdr < 0.001). The
same effect was observed for MD mean values.
The average CV within JHU ROIs on FA maps was highest for DTI 60×1 (CVmean = 5.5%)
and was significantly (phocfdr < 0.05) larger than any other protocol CVmean (ranging from
4.9-5.1%). Average CVmean was overall lower for MD than for FA, ranging from 3.9-4.3%.
For MD CVmean in JHU ROIs, a significant difference (p
hoc
fdr = 0.05) was only observed
between DTI 12×5 and DTI 15×4. Figure 4.7 displays the CVmean distributions of FA and
MD means in JHU ROIs for data from single protocols and any other combination. When
pooling data from any arbitrary protocol together with data acquired under the DTI 60×1
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scheme, the CVmean for both FA and MD increased. This further underlines the differences
of DTI metrics of this protocol compared to any of the other four acquisition schemes.
Figure 4.7: Distribution of Regional Coefficients of Variances Across Different Protocols.
The intra-protocol CV for all JHU volumes are represented as colour coded boxplots, all
combinations of data from different DTI protocols are displayed as grey boxplots. On
average variation was found to be lower for MD than fro FA. Overall CV values for both
FA and MD are slightly elevated for data acquired with 60 directions and one shell (DTI
60×1), however, data from single protocols showed similar variations ranging between 4-5%.
Combining datasets across protocol mostly did not elevate the regional variation, excepts
when including the single-shell dataset (DTI 60×1). The latter combined with any other
single protocol data increased the average CV for FA as well as MD. Whiskers show the full
range of the distribution.
For JHU ROIs, FA deviated most for DTI 60×1 while the MD variation was similar across
protocols. This is in contrast to TractSeg ROIs, where FA showed similar variation across
acquisition schemes, but MD variation was decreased in scans acquired on one shell (60×1).
This discrepancy might be caused by underlying algorithmic methods behind both segmenta-
tion approaches (JHU: registration based, TractSeg: model prediction based). An overview
of the average CVmean for both DTI metrics and atlases is provided in Table 4.5.
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Table 4.5: Average CV of DTI Metrics for JHU and TractSeg ROIs
Atlas Metric DTI 12x5 DTI 15x4 DTI 20x3 DTI 30x2 DTI 60x1
TractSeg
FA 5.1±1.3 5.0±1.0 5.0±1.4 4.9±1.3 5.0±1.5
MD 4.0±2.1 4.1±1.7 4.1±2.0 4.1±1.7 3.8±1.4
JHU
FA 5.1±2.2 5.0±1.9 4.9±2.2 4.9±1.8 5.5±2.4
MD 3.9±1.1 4.1±1.1 4.1±1.3 4.3±1.4 4.2±1.3
4.3.6 Comparability of Multi-Centre Data Acquisition
Figure 4.8 displays the different distributions of the QC metrics for the nine scanners in-
cluded. A high PIS ratio is undesired, as it means that a large proportion of voxels with PIS
was still present after correction. For all centres, on average at least 40% of the voxels with
PIS were corrected (PISratio < 0.6). Centres A, B and D displayed lower mean PIS ratios
than all other centres. This may be related to the vendor of the MRI scanner, as those three
centres collected data on Siemens scanners (PISratio = 0.360±0.077). Philips scanners (G,
H, L) showed on average lower PIS ratios for all three scanners (PISratio = 0.466± 0.055),
than the three GE scanners (C1, C2, F; PISratio = 0.583 ± 0.033). Distributions of PIS
ratio were highly comparable for scan and rescans within centres.
Although differences between centres were observable, the SNR on b0 volumes was overall
fairly evenly distributed for most centres with average values ranging between 126.2 and
196.1. The exception was centre A which showed a much lower average SNR (SNR =
58.1 ± 9.8) than any other centre. All centres, including A, showed a reproducible SNR
distribution on the rescans.
Different levels of NCC between T1w images and coregistered FA maps were observed across
centres. No particular pattern was recognisable, however, centre G had a much lower mean
NCC than any other centre (NCC = 0.464 ± 0.023). All coregistered FA maps for centre
G were visually inspected through the QC images provided by the diffusion pipeline and
no failed coregistration was discovered. Since FA maps seemed adequately coregistered on
visual inspection and intensities are inherently scaled between [0,1], lower NCC scores poten-
tially were a consequence of different intensity ranges of the reference T1w images. Indeed,
T1w scans scanned at centre G had much higher average intensities within the brain mask
(1518.5± 337.6) than for example T1w images from centre H (223.5± 37.7), for which high
NCC values were found (NCC = 0.651± 0.019), despite images collected on scanners from
the same vendor (Philips).
Similarly, centre G showed low brain mask volume ratios (93.6% ± 0.8%), which could in-
dicate an oversegmentation of the brain when backprojecting the T1w mask to DTI space.
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Visual inspection confirmed this small discrepancy between both brain masks (T1w mask
back projected and MRtrix3 brain mask, see Section 2.4.2 QC #3). Although the backpro-
jected T1w mask did indeed slightly oversegment the brain, the MRtrix3 brain mask tended
to cut of part of the brain. Since brain mask volume ratios on H and L showed the 2nd and
3rd lowest average values (96.4%± 1.5% and 95.0%± 1.8%, respectively), this could suggest
a systematic bias on Philips scanners.
Less scattered values were seen for all four motion QC metrics, and values were comparable
for scans repetitions on individual MRI scanners. However, one exceptions was centre C1
that particularly stood out regarding average and maximum relative head motion (bottom
row Figure 4.8). Interestingly, C1 and C2 are both GE scanners at the same imaging site.
Therefore, it was expected that operational differences (e.g. different fixation of head) were
minimal. Since control subjects were fairly matched in age and sex (Table 4.1), an increased
head motion was not expected due to vastly different cohorts. Most prominent difference
in acquisition parameter was the TR which was almost twice as long for scans at centre C1
(TR = 15555 ms) than at centre C2 (TR = 8000 ms). Since head motion and shorter TR at
centre C2 were both comparable to other imaging sites, the observed increased head motion
at centre C1 is likely a direct consequence of the prolonged scan time. The average values
for all QC metrics for each centre are summarised in Table 4.6.
4.3.7 Variation of DTI Metrics for Multi-Centre Data
TractSeg & JHU rm-ANOVA. When comparing volume distributions of TractSeg ROIs
across centres, a strong undersegmentation of fibre tracts was observed for centres that em-
ployed a Philips scanner (G, H, L). An example of two volume distributions is shown in the
Appendix (Figure A.1). Concluding that TractSeg did not provide satisfactory brain par-
cellations for Philips data, the three centres were excluded from any further TractSeg ROI
analysis. Comparing volumes of segmented fibre tracts across scanners showed significant
differences (rm-ANOVA pfdr < 0.05) for most regions (64) of the TractSeg parcellation.
This was also reflected for FA (65) and MD (59) metrics across the six scanners. Regions
that showed no significant differences for all three metrics (volumes, FA and MD) included
the left fornix (ROI #20), the right IFO fascicle (ROI #23) and the right SLFI (ROI #34).
The JHU segmentation appeared to be more robust, with significant volume differences only
for the forceps major (ROI #8) as well as the left and right ILF (ROI #12 & #13). Regional
mean FA values statistical deviated across all nine scanners for more than half of the JHU
regions. Mean MD values were significantly different for all 20 ROIs.
TractSeg CV. Furthermore, the variance within and across scanners was measured via
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Figure 4.8: Distribution of Quality Control Metrics for Control Subjects from the CENTER-
TBI Database
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Table 4.6: Quality Controls Metrics Across Scanner for CENTER-TBI Controls. Average
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CV for ROI mean values of DTI metrics (CVmean, see Equation 4.1. The distribution of
CVmean values for FA TractSeg ROIs was similar for most imaging sites, except for centre A,
which had a higher average CV (CVmean = 5.4%± 4.8%) than any other centre (CVmean ≈
3.2% − 3.7%). Images collected on GE scanners showed a slightly lower average variation
(CVmean = 4.7%±1.1%) than scans acquired on Siemens scanners (CVmean = 4.9%±3.7%).
Centre A showed higher variation alone than when combined with other centres. Variation
was highest when pooling all data together (CVmean = 5.8 ± 2.3; Figure 4.9 top left). A
similar pattern was observed for TractSeg MD variations, where centre A was again show-
ing a widely spread distribution of CV scores. Centres A (CVmean = 4.9% ± 3.7%) and F
(CVmean = 3.7%±1.6%) had a higher variation than the other centres (CVmean ≈ 2%−3%).
Although average CV values for inter-scanner datasets seemed elevated, the effect was not
as prominent as for FA metrics (Figure 4.9 top right). Overall variation was less for MD
than FA metrics.
JHU CV. Generally, a higher intra-scanner variation (CVmean ≈ 4.5%− 7%) was observed
for mean FA values within JHU ROIs than for TractSeg ROIs. Although merging datasets
from different scanners increased the variation slightly with respect to some single centre
data (CVmean ≈ 5.5%− 6%) the effect was not as prevalent as for TractSeg ROIs. Highest
variation in single scanner dataset was again detected in centre A (CVmean = 6.7%± 2.5%;
Figure 4.9 bottom left). Deviation between means of MD within JHU ROIs was similar to
that observed for TractSeg ROIs (CVmean ≈ 2.5%−4%) Variation of MD on combined data
from all GE scanners (CVmean = 3.4% ± 0.9%) was comparable to the variation on single
GE scanners (CVmean ≈ 2.5%− 3.5%), and lower than for Philips (CVmean = 4.3%± 1.8%)
or Siemens (CVmean = 4.1%± 1.1%) scanners (Figure 4.9 bottom right).
Template Space. After tensor-based spatial normalisation the voxel-wise CVs were com-
puted for intra- and inter-scanner data. Subsequently, the average of the CV maps within
JHU atlas ROIs were calculated (CVvoxel, see Equation 4.2). The mean and standard de-
viation for the 20 different mean CV values within JHU regions are presented in Table 4.7.
Most obvious was the much higher average CV for FA imaged from Philips scanners (CVvoxel
= 24.7% - 27.2%) compared to Siemens (CVvoxel = 16.1%-18.5%) and GE (CVvoxel = 14.7%
- 17.2%). This discrepancy was also observed when comparing average CV scores of inter-
scanner data for each of the three vendors. While data scanned on different Siemens or GE
scanners showed a similar level of variation (CVvoxel = 18.2± 2.9 and CVvoxel = 16.3± 2.3,
respectively), the average CV on Philips scanners was much higher (CVvoxel = 27.9± 8.1).
Pooling data together across vendors (All or Siemens & GE) showed that variation is settled
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Figure 4.9: Intra- and Inter-Scanner Distribution of CV within ROIs for CENTER-TBI
Imaging Sites. Each boxplot represents the variation of all ROIs of the particular atlas. Top
left: Most centres/scanners showed a similar variation of FA mean values within TractSeg
ROIs, averaging around ≈ 3%−4%, however, centre A showed an elevated average variation
(> 4%) compared to all other centres. Variation across sites was found to be substantial
higher, and was comparable for intra-vendor (GE or Siemens) and inter-vendor (ALL: GE &
Siemens combined). Data collected on GE scanners showed tendentially less variations than
that acquired on Siemens scanners. Top right: MD variation was observed to be highest for
the single centre A. Generally intra-scanner variation was on average lower than for pooled
data from different scanners. Variation on GE scanner was lower on GE scanners than on
Siemens scanners. Bottom left: Overall higher intra-scanner variation (≈ 4% − 7%) was
observed for mean FA values within JHU ROIs than for TractSeg ROIs. Although merged
datasets from different scanners increased the variation the effect was not as prominent as
for TractSeg ROIs. Bottom right: MD variation was overall similarly distributed for intra-
and inter-scanner variations. Whiskers show the full range of the distribution.
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in between the variation measured for data collected on single-vendor scanners. Highest FA
variation for the combined dataset from Siemens and GE scanners was found in the left
hippocampal cingulum (ROI #6, CVvoxel = 22.3%). This was coherent with the highest
variation in Siemens data for the same region (CVvoxel = 24.4%). Maximum FA for GE
data were observed within the left ILF (ROI #12, CVvoxel = 20.0%). Lowest FA vari-
ability for GE and inter-vendor data (Siemens & GE) were found in left CST (ROI #2,
CVvoxel = 12.4% and CVvoxel = 14.1%, respectively). Minimum variation for Siemens data
were measured in the right CST (ROI #2, CVvoxel = 14.0%).
Variation for MD was observed to be lower (CVvoxel = 5.9% - 12.6%) than that for FA,
which is in agreement with the previous analysis of regional variation in native space. Mean
diffusivity variability was highest for Philips data, although the difference to other centres
was not as drastic (centre A showed high CV for MD as well). For GE and inter-vendor
data, the highest MD variability was observed in the forceps major (ROI #8, Siemens:
CVvoxel = 15.3%, GE: CVvoxel = 18.6%, Siemens & GE: CVvoxel = 17.7%). The left tem-
poral SLF showed the lowest for all three inter-scanner comparisons (ROI #18, Siemens:
CVvoxel = 6.4%, GE: CVvoxel = 5.1%, Siemens & GE: CVvoxel = 6.0%).
Generally, data from A showed a higher variation for FA and MD than other Siemens scanner
data. Inspecting data from Philips scanners visually showed more inadequately deformed
fibre tracts (e.g. CC showed a more unusual shape). This seemed to indicate a less accurate
spatial normalisation for Philips scans than for data from both other scanners, which might
explained the elevated variation.
Figure 4.10 presents the CV maps of the DTI maps for the CENTER-TBI controls after
spatial normalisation. For comparison it includes two maps for the centres with the highest
(A) and the lowest (C2) variations (among Siemens and GE scanners). Philips scanners
were not included in this analysis due to potentially insufficient registration to the study-
specific template (based on visual examination). When including more subjects the maps
become inherently smoother (averaging more images reduces single voxel outliers) and vari-
ation is conjointly reduced. Nonetheless, lower levels of variation were observed for single-
than multi-scanner data. Overall variation was found to be higher in cortical GM areas
(up to 80%) than in WM fibre tracts on FA maps (top panel: FA). Lower CV scores were
detected for centre C2 than for centre A. This also translates to multi-scanner intra-vendor
data (Siemens, GE) where GE showed lower CV scores than Siemens. This is particularly
visible in cortical regions and to a certain extent in WM areas. While intra-vendor variation
is likely an effect of different DWI acquisition and hardware biases of different scanners,
the generally higher CV in cortical areas is partly also caused by more anatomical variation
across subjects, that cannot fully be eliminated by spatial normalisation. Pooling data from
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Table 4.7: Average of CV Maps within JHU ROIs. CV displayed as mean ± std in %
Centre Vendor FA MD
Intra-Scanner
Intra-Vendor
A Siemens 18.5 ± 3.3 10.2 ± 1.8
B Siemens 16.1 ± 2.3 7.4 ± 1.8
C1 GE 15.6 ± 2.3 6.8 ± 2.4
C2 GE 14.7 ± 2.3 5.9 ± 2.3
D Siemens 17.2 ± 3.5 7.8 ± 2.2
F GE 16.1 ± 2.5 8.0 ± 3.1
G Philips 24.7 ± 7.6 9.1 ± 3.7
H Philips 27.2 ± 7.8 12.6 ± 6.4
L Philips 25.8 ± 6.4 11.0 ± 7.4
Inter-Scanner
Intra-Vendor
A, B, D Siemens 18.2 ± 2.9 9.3 ± 2.0
C1, C2, F GE 16.3 ± 2.3 7.6 ± 2.8
G, H, L Philips 27.9 ± 8.1 12.8 ± 6.8
Inter-Scanner
Inter-Vendor
A, B, C1, C2, D, F Siemens & GE 17.6 ± 2.5 8.9 ± 2.4
All All 24.5 ± 6.3 12.2 ± 5.4
Siemens and GE scanners together yielded CV levels in between that of both single-vendor
CV maps. A more detailed view of the FA displays lower variation (deeper blue) in the
forceps major of the CC for C2 than for A. This tendency could also be observed for the CV
of GE data compared to that of Siemens data (middle panel: FA-CC). These observations
could also be quantified by counting the number of voxels within the brain mask that had
higher CVs for one dataset than the other. This uncovered that 64% of the voxels had higher
CVs on Siemens than on GE. Combining both datasets together (Siemens & GE) resulted in
71% or 42% of the voxels in a higher CV compared to GE or Siemens data, respectively. This
further underlined the fact that a higher degree of variation is observed in Siemens data.
Similar results were observed for CV maps of MD (bottom panel: MD). Data collected at
centre C2 showed a much lower overall variation (deeper blue) than data acquired at centre
A. Particularly noticeable in the WM, this lower variability was also visible when compar-
ing inter-scanner data from single scanner manufacturers (Siemens vs. GE). Coefficients of
variation were higher on Siemens than on GE scanners in 66% of the voxels within the brain.
Pooling together data from both vendors resulted in increased variation compared to GE
(73% voxels showed higher CV scores for Siemens & GE than for GE alone), however, in
a lower variation with respect to Siemens data (43% voxels had a higher CV in Siemens &
GE data than in Siemens alone).
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Figure 4.10: Coefficients of Variation Maps for FA and MD of CENTER-TBI Controls.
Top row: CV maps for FA show higher variability for inter-scanner than in single scanner
data. FA metrics derived from scans collected on GE had lower variation than Siemens data,
which was visible for both single scanner (A vs. C2) and multi-scanner (Siemens vs. GE)
comparisons. Middle row: Less variation was for example found on FA maps within the
forceps major of the CC (FA - CC) for GE data. Bottom row: This trend was also present
for MD maps, with lower CV scores for GE scans (C2 and GE). Colourbar is the same for
all plots.
4.4 Discussion
4.4.1 Parcellation of Structural Brain Scans
Although partly robust, regional volume estimation via MALP-EM also deviated for data
acquired on different scanners. Significant differences were found for both total brain and
WM volume. This was even the case when starting with the exact same brain mask. Brain
parcellation with MALP-EM is dependent on spatial alignment and deformable registration
of multiple atlases and intensity based refinement. Both might be influenced by head orien-
tation, SNR levels and voxel resolution, which makes the algorithm’s robustness dependent
on the image acquisition parameters. For the Scan-Rescan database, volume differences
were subtle, and a 1-2% variation for volumes of tissue compartments across scanners seems
to be a fair limitation for an automated process, as even variation between two manual
annotators cannot be avoided completely [115, 210]. Nonetheless, this might be more pro-
nounced for scans collected under different protocols or on scanners from different vendors.
While travelling heads are not always feasible for large multi-centre studies, a quality check
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of volumes derived from age and sex matched controls should be conducted prior to any
analysis. Some of the regions found to be significantly different across scanners had de-
viating volume estimates for symmetric ROIs in both hemispheres. However, the affected
ROIs were not of particularly large or small volumes, which may indicate a size independent
systematic bias. Furthermore, the findings suggest that matching intensity spaces across
scanners, could result in a positive effect diminishing volume discrepancies. However, this
effect was only observed when intensities were matched across scanners with paired T1w
scans. Since projecting all scans to the intensity space of an independent database (Cam-
CAN) did not achieve the same result, the applicability for multi-centre studies will need to
be investigated further. This holds especially true for patient cohorts with visible lesions on
T1w images, as this might skew the intensity matching leading to a disadvantageous result.
Simply computing relative region volumes with respect to the total brain volume showed
that that discrepancy can partially be eliminated. However, this was only demonstrated for
a fairly small set (12) of T1w scans of matched healthy controls. Normalising volume esti-
mates to the whole brain size may be skewed if pathological patterns affect brain extraction.
Regions of the MALP-EM atlas are directly adjacent to one and another. So, if one region
is segmented more, it almost always means that another ROI segmentation needs to shrink.
Future experiments could aim to understand the interplay between regions that were found
to have significantly different volumes.
4.4.2 Segmentation of White Matter Tracts
Despite using a harmonised diffusion protocol, significant volume differences were observed
when comparing TractSeg segmentations on different scanners, using the Scan-Rescan data-
base. One reason for that could be the model based nature of the algorithm. TractSeg
is a neural network that was trained in a supervised way to predict a voxel’s association
to a specific tract based on the peak of the fibre orientation distribution function (ODF).
Although TractSeg has been shown to outperform many other segmentation approaches
[263], its superiority was shown on test data from the same cohort acquired for the HCP.
Since machine learning models are susceptible to domain shifts as they are present for
different MRI datasets, predictive segmentation might not generalise well to unseen data.
Since TractSeg’s neural network was trained on HCP, it also learned to identify/segment
fibre tracts based on intensities as they were present in the HCP dataset. For diffusion
images that were acquired differently or on a different scanner, intensities for the same fibre
tract may deviate from that in the HCP database. This would result in a TractSeg failing
to segment WM tracts adequately. This became obvious when examining the TractSeg
region volumes on differently acquired diffusion weighted scans (Multi-Acquisition dataset).
116 CHAPTER 4. REPRODUCIBILITY OF MRI METRICS
Protocols with higher angular resolution improve the accuracy of the computed ODF [279],
which directly impacts the peaks of the ODF and with-it the segmentation performance of
TractSeg. Although the Multi-Acquisition dataset consisted of 60 diffusion weighted images
for all five different protocols, the acquisitions were distributed on a different number of
shells. It is not entirely clear how much impact the different number of shells had on
computing the ODF’s peaks, however, TractSeg seemed to be biased towards the data it was
trained on. This observation was underlined, when aiming to parcellate data for CENTER-
TBI. While decent results were obtained for data collected on Siemens and GE scanners,
parcellation was inadequate for data acquired on Philips scanners. This was consistent
for Philips scanners at different imaging sites, suggesting a vendor-specific negative bias.
Training data for TractSeg was exclusively collected on a Siemens scanner. Why TractSeg
performed better on data from GE than Philips scanners may be part of future investigations.
Volumes computed for tracts from the JHU atlas seemed to be affected less by different
protocols. This may be explained by the underlying method, based on registration, to
segment WM fibre tracts. While registration can be affected by different intensities, it
is less sensitive to variability in the data - when choosing an appropriate cost function -
than predictive models. This holds especially true for registration of FA maps, as these
are normalised metrics, normally ranging between [0, 1]. By definition there is a high
contrast between WM tracts and GM tissue on FA maps. A segmented fibre tract that also
unintentionally includes GM voxels, possibly exhibits a higher variation than more precisely
segmented tracts only including WM. The fact that FA variability was overall higher for JHU
ROIs (> 4%) than for TractSeg ROIs (≈ 3%), could be a consequence of this segmentation
inaccuracy. Comparing JHU and TractSeg against each other is difficult, as there set of
ROIs is different and same regions may not overlap entirely. Nonetheless, this observations
are coherent with TractSeg being reported to be superior to single atlas segmentation [263].
4.4.3 Variability of DTI Metrics
Variation of MD was consistently found to be lower than that for FA metrics. This ro-
bust finding was observed for both the TractSeg and JHU analysis and could be replicated
for all different datasets (Scan-Rescan, Multi-Acquisition and CENTER-TBI database). A
lower MD variability agrees with previous studies and makes this result highly generalis-
able. It has been hypothesised that individual variability in eigenvalues of the diffusion
tensor may compound when combined to calculate FA metrics [72]. The lower contrast
seen on MD maps leads to an inherent lower variation within the scan itself (and also lower
impact of miss-registrations and -segmentations). Particularly WM regions usually appear
to have mostly homogeneous MD. This became also obvious when inspecting the voxel-wise
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CV maps. These displayed mostly equal CV values throughout the brain for MD metrics,
whereas in contrast FA maps showed a strong divergence between GM and WM regions.
This is in line with the previously reported higher FA variation in GM than in WM [256],
and is likely a consequence of better congruence of anatomical WM structures. While central
fibre tracts, such as the CC, can be more easily aligned or segmented, peripheral endings of
fibres within GM vary much more in shape and orientation. Interestingly, when considering
the number of ROIs with significant differences, more were counted for MD than for FA
maps. A higher number of ROIs with inter-scanner divergence for MD than for FA has been
found beforehand [66].
Furthermore, the inter-scanner variation was similar to the highest observed intra-scanner
variation. For example, FA CV scores for combined GE data (CV = 16.4%) was of compara-
ble to the CV of GE data from centre F (CV = 16.1%), but increased with respect to centre
C1 ad C2 (CV = 15.6% and CV = 14.7%, respectively). For inter-vendor analysis the total
variation (Siemens & GE CV = 17.6%) was in between the intra-vendor variation (Siemens
CV = 18.2%, GE CV = 16.3%). Coefficients of variation are based on average values across
datasets, thus, combining datasets with different levels of variation mostly resulted in CV
scores that were settled in between (compare values Table 4.7). Additionally, including
more data can also smooth out natural differences in anatomy among subjects leading to
reduced noise and eventually lower variability. This observation is further supported by the
previously reported decrease in variability through image denoising via median filters [164].
There was an evident bias between scanners in the CENTER-TBI database, where lower
variability was found for GE than for Siemens scanners. This is cohesive with aforemen-
tioned findings [283].
Despite the total number of unique gradient directions being the same across the MRI
protocols of the Multi-Acquisition database, they were distributed on one to five shells of
different b-values. This had an effect on both FA and MD metrics. The most distinct dif-
ference was found for the single-shell data with 60 gradient directions in comparison to the
multi-shell data. One reason could be that multi-shell imaging schemes show a higher re-
producibility than single-shell data [245]. This result, however, was produced for multi-shell
data with b ≥ 1000 s/mm2, whereas the data presented here relied on inner shell b-values
(b ≤ 1000 s/mm2). Future experiments may need to consider number of shells and directions
as two separate variable factors. Possibly, splitting different acquisitions into their different
shells may help to build a more descriptive model. Furthermore, it has been shown that the
choice of parameters may impact FA and MD maps unequally [206]. Understanding each
parameter’s contribution to DTI variability will help to design more robust MRI protocols
for multi-centre studies and foster solutions for diffusion MRI harmonisation.
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Regarding multi-centre data, the findings suggest that even with quasi harmonised pro-
tocols, MR image acquisition will be affected by hardware settings (scanner model and
vendor etc.) and scanner operators (different magnitude of head motions at different cen-
tres). Nonetheless, one should aim to collect data under a harmonised protocol to minimise
chances for variation. Specifically, for CENTER-TBI data, Philips scanner data will need
to be examined closely to understand its discrepancy to Siemens and GE data.
4.4.4 The Difficulty of Measuring Variability
The experiments presented here have shown variability for brain region segmentation and
DTI metrics. Although this is expected to a certain extent, quantifying differences between
data can be challenging. Any region based analysis will only be as good as the region
segmentation. White matter parcellation via TractSeg, for example, was unsuccessful for
data collected on Philips scanners for CENTER-TBI. While the discrepancy for the given
data was obvious and the systematic error was easy to detect, this might not be the case for
more subtle differences. A bias of volume segmentation for measuring regional variability
of DTI maps might be inevitable, but should be closely monitored throughout the analysis.
For the Multi-Acquisition database no strong correlation between volume variation and
FA or MD variation was found. However, some outlier regions were detected that showed
high variation for both volumetric and DTI measurements. These regions were the ones
with smallest segmented volumes. The effect of high variation in smaller regions has been
reported before [193, 256]. This seems characteristic for low volume ROIs as small deviations,
due to scan differences or flawed segmentation, strongly impact CV scores. One way to
avoid mistakes from methodological biases is to examine the problem from different angles.
Besides the ROI analysis, a voxel-wise approach was chosen to estimate reproducibility of
diffusion data. This facilitates the identification of robust results, such as the previously
mentioned lower variability for MD than for FA, but also the detection of problematic
data (i.e. here Philips MR scans). Most previous studies for reproducibility rely on CV
scores to estimate the differences between data. However, comparing CV scores of mean
values within ROIs (CVmean) against the CV values on a voxel-wise level (CVvoxel) showed
very different magnitudes. This has been reported previously [241], strongly suggesting the
dependence of CV values on how they were measured. Therefore, it might be more important
to examine the change of variation when pooling data together, rather than accepting a
cut-off threshold for acceptable reproducibility (e.g. 10% as suggested by Morenco et al.
[168]). Overall, the experiments focused on assessing variation in different datasets. Future
investigation will need examine more closely, how these differences are caused. The findings
showed that IDPs vary for different MRI acquisition parameters or imaging hardware. These
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factors and subject-specific confounding effects (e.g. head motion) jointly influence the image
signal. Disentangling the contributions of individual factors, however, is complex. Statistical
regression models will need to incorporate QC variables and other confounding factors into
any analysis.
4.5 Chapter Summary
In this chapter different datasets were analysed to estimate the reproducibility of brain
region segmentation as well as the variability of DTI metrics. Discrepancies between ROI
segmentation were found for both the parcellation of T1w and DTI scans. The former,
based on MALP-EM, shows regional differences which can be partially reduced by using a
robust mask9 or by matching intensity domains. However, further investigation is needed
to assess the applicability of such methods to more complex multi-centre data. White
matter parcellation through TractSeg seemed less replicable for data collected on different
scanners or different MRI acquisition protocols. Tract segmentation via JHU atlas appeared
to be more robust, but also less precise. Differences for DTI metrics were region-specific and
highlighted the non-linear inter-scanner variability. A direct connection between parameters
such as number of gradient directions per shell and number of shells could be drawn, but
will need further experiments to gain a deeper insight. Variation of DTI metrics was also
dependent on the employed scanner’s vendor. Overall, a lower variability for MD than for FA
was measured consistently in all experiments on various datasets. Inter-scanner variability
may impede analysis for combined multi-centre databases, in particular if variation is high for
individual scanners. Complexity of those databases will need to be addressed with advanced
harmonisation techniques and statistical modelling. Although these techniques can mitigate
effect, they likely will not remove all biases. Generally, more data may help to regress
out confounding factors and the more similar the cohorts and acquisition parameters across
sites the better. Without doubt, databases will need to be carefully examined to understand
hidden stratification [189] to allow drawing sensible conclusions from any experiment.
9for experimental purposed the same mask for different scans was used
Chapter 5
Harmonisation of DWI for
Multi-Centre Studies
5.1 Introduction
5.1.1 Sources of Variation in Diffusion MRI
Acknowledging the benefits of larger databases, multi-centre studies have been gaining in-
creasingly more attention over the years. However, as seen in previous chapters, diffusion
weighted MRI are dependent on scanning parameters as well as imaging hardware. Diffusion
MRI signal is influenced by the number, direction, strength and duration of different gradi-
ent pulses. Regional FA differences have been reported when comparing different b-values
[24]. In particular larger b-values have been associated with reduced DTI measurements
[194]. Besides their magnitude, the number of b-values used has also been shown to affect
the diffusion signal. For example, a multi-shell acquisition was found to be beneficial to re-
duce Rician noise related biases [41]. Moreover, a higher number of diffusion directions was
shown to improve contrast between GM and WM on FA maps, but had little effect on MD
metrics [80]. A more elaborate study showed empirically that a higher angular resolution
improved SNR and recovery of the orientation density function [279]. Interestingly, different
diffusion parameter maps required more gradient directions to achieve a near-optimal SNR
than others (e.g. FA: 62-66 vs. MD: 58 directions) [279]. Furthermore, spatial resolution
(i.e. voxel size) has been reported to affect DTI metrics. A larger voxel size was linked to
increased MD values, but decreased FA measurements [194]. Moreover, scanner hardware
such as, for example, field strength of the magnet [101] also have an impact on image quality.
While some sources of variations can be avoided by a careful study design (e.g. using same
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acquisition protocol), some others are inevitable. To address this problem, harmonisation
of diffusion MRI data has become a more active research field in recent years.
5.1.2 Spherical Harmonics & Rotation Invariant Features
Some harmonisation techniques operate in the DWI space, while some others employ SHs1
[129] as an alternative representation. Generally, these are a mathematical notation to







with Yl,m(θ, φ) representing the SH basis function of order l and degree m, and Cl,m are the
corresponding SH coefficients. The energies of the SH coefficients for each order l form a set






Orders of SH are even numbers only. Hereafter, only the highest order will be mentioned
to indicate the computation of SH orders up to that maximum order (e.g. lmax=4 means
order 0, 2 and 4 were computed).
5.1.3 Related Work
Meta-Analysis. A classic approach to boost sample size is the meta-analysis that spans
across imaging centres and studies. For this, group-wise analysis is at first performed inde-
pendently for each site and findings are then statistically examined to find consistent results
across sites. Alternatively, data are analysed together by reducing variation through metric
standardisation and modelling site-specific biases as random effects [198] (also see Chapter
3). Ideally, all image processing steps should be the same to minimise variability introduced
through unequal data handling [222]. A simple approach is Z-scoring, that standardise
images by transforming the signal to a standard distribution (mean µ = 0 and standard
deviation σ = 1) for each site individually [70]. However, this is highly dependent on the
subject cohort at each site and may be too crude to account for non-linear changes across
different brain regions. More recently, new approaches have been introduced, which will be
summarised in the following paragraphs. The interested reader is further referred to the
review published by Pinto et al. [198].
1reminder: spherical harmonics
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ComBat. The combined association test (ComBat) was initially introduced for gene ex-
pression analysis [117], but was later adapted for diffusion MRI harmonisation by Fortin et
al. [70]. Hereby, differences across scans and sites are estimated by modelling the diffusion
signal as an adjustment of intensity location (additive factor) and scale (multiplicative fac-
tor). The underlying assumption is that both factors follow a parametric distribution that
can be retrieved by an empirical Bayesian model to reduce site-specific effects. A diffusion
metric y can be represented for each voxel v in scan n from site i as:
yi,n,v = αv + Xi,n βv + γi,v + δi,v εi,n,v (5.3)
where αv is the overall signal for voxel v with residual error εi,n,v. Covariates of interest
(e.g. sex, age) are represented as X with a corresponding vector of regression coefficients
βv. The terms γi,v and δi,v stand for the additive and multiplicative effects, defined as prior
Gaussian and Inverse-gamma distributions, respectively.
Once the distributions of hyper-parameters are estimated (α̂v, β̂v, γ̂i,v, δ̂i,v ), the harmonised
signal y∗i,n,v can be calculated as:
y∗i,n,v =
yi,n,v − α̂v −Xi,n β̂v − γ̂i,v
δ̂iv
+ α̂v + Xi,n β̂v (5.4)
The advantage of this method is the possible application to any diffusion parameter map
(e.g. FA, MD) and in fact has also been successfully applied to harmonise non-diffusion met-
rics such as cortical thickness [69]. Due to its voxel-wise modelling of site-specific effects,
ComBat can account for local scanner differences. It has been shown to outperform other
strategies based on voxel-wise linear regression, such as RAVEL (removal of artificial voxel
effect by linear regression [71]) or surrogate variable analysis [70].
However, ComBat assumes that location and scaling factors are represented by specific para-
metric prior distributions, which may not generalise for all diffusion measurements [126].
Furthermore, ComBat is applied to DTI parameter maps rather than the DWI signal. The
performance of pre-processing steps could be biased by the differences of the unharmonised
images. According to Karayumak et al. [126], this could lead to site-specific effects be-
ing latently propagated through the processing pipeline, and make it harder to detect and
correct for those effects. Furthermore, it has been shown, that ComBat possibly has an
adversary effect on between-group differences if data were processed slightly differently [33].
This, however, can be mitigated by applying the same processing pipelines.
Linear Scaling of Spherical Harmonics. A different approach was suggested by Mirza-
alian et al. [177], for which diffusion MRI data were first parcellated2 and converted to
2FreeSurfer parcellation of T1w images, which were projected to diffusion images.
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their SH representation (Section 5.1.2). Next, a regional linear mapping between the RISH
features was calculated to map SH images from one acquisition site to the image domain
of the reference site. After scaling the images region-wise, SH coefficients were adjusted
for each voxel within the brain. Later on, this approach was improved by sub-dividing the
regions into smaller segments and refining this finer parcellation on basis of RISH feature
intensities [178]. To circumvent the sub-optimal parcellation (i.e. registration errors for too
large ROIs) entirely, the same concept of SH scaling was embedded into a registration-based
framework [179]. For this, a study specific template was calculated via multi-modal regis-
tration of RISH feature maps. For each site and each RISH feature map the expected value









where ‖Cl(v′)‖2i,n is the value of voxel v′ in the RISH feature map of order l for the nth
subject at site i within template space. Here, v′ corresponds to the voxel v in subject native
space, such that v′ = Ψn(v), with Ψn defining the subject’s diffeomorphic deformation field




√√√√ ‖Cl(v′)‖2 + E lref (v′)− E lsrc(v′)
‖Cl(v′)‖2
(5.6)
For new DTI scans, RISH feature maps are computed and registered to the template. This
allows the backprojection of the scaling maps in order to map SH components from the
source site to the reference site domain in native space:





Sψl (v)Cl,m(v)Yl,m(θ, φ) (5.7)
with Sψl representing the backprojected scaling map Ψ
−1
n (S l).





E lsrc(v′) + ε
(5.8)
with ε representing a very small number to avoid division by zero. Being model-independent,
the calculated site-specific mapping can easily be applied to any other data from the same
cohort site. Hereby, the scaling of SH coefficients allows the harmonisation of the signal am-
plitude without altering the principal diffusion directions [177]. In addition, linear scaling
of SH coefficients has been reported to harmonise the signal more accurately within most
3spherical function term (f) is dropped for brevity
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of the WM fibre tracts than ComBat [126]. Once the diffusion signal had been harmonised,
any desired downstream analysis can be applied. However, this method also needs matched
controls across sites (ideally the same subjects scanned repeatedly) scanned with relatively
similar acquisition parameters. The voxel-wise scaling is dependent on spatial normalisa-
tion, which can be time-consuming in practice, especially for the required multi-model RISH
feature map registration.
Non-Linear RISH Feature Regression. Besides computing linear scaling maps, ma-
chine learning methods were used to learn non-linear functions in order to harmonise DTI
or RISH feature maps across databases [127]. The employed models were a RF regressor [26]
to scale either DTI (RF-DTI) or RISH feature maps (RF-RISH) and a CNN [150] trained
on RISH features (CNN-RISH). All these approaches required a direct voxel-wise correspon-
dence of images from the same subjects acquired on two scanners. Comparing diffusion
parameter maps from harmonised and reference data showed that all three non-linear re-
gression models (RF-DTI, RF-RISH and CNN-RISH) outperformed the linear RISH feature
scaling. Moreover, training a RF on RISH features seemed more beneficial than training on
DTI maps. The CNN regression showed the best performance for all evaluation metrics [127].
Spherical Harmonics Mapping with Neural Networks. With the success of deep
learning, many neural network approaches have been suggested to harmonise diffusion MR
scans. In contrast to the previous RISH feature regression, most methods operate directly
on the SH coefficient maps. Tax et al. [238] provided a benchmark dataset to challenge
researchers to submit approaches for diffusion imaging harmonisation.4 The harmonisation
task required the mapping of DWI images from one scanner (Prisma) to another (Connec-
tom), for which data of ten subjects imaged on both scanners was provided. The summary
of the submitted results revealed a clear trend towards deep learning. While the neural
network architecture and training strategies varied for different approaches, they had in
common the use of pairwise 3D patches extracted from SH images matched on a subject-
an voxel-wise level across scanners. The spherical harmonic network (SHNet) consisted of
three fully connected layers operating on SH coefficient maps to learn the mapping between
both scanners. Built up on that, the spherical harmonic residual network (SHResNet) in-
cluded different convolutional pathways for each of the SH orders (i.e. l = 0, 2, 4). While
both networks were trained on small patches (3×3×3 voxel) matched between scanners, the
SHResNet also included residual blocks (ResBlocks) that combine the in- and output of the
4this challenge was hosted as part of MICCAI 2018, the 21st International Conference on Medical Image
Computing and Computer Assisted Intervention
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different pathways. Such residual connections are a common approach for neural networks
to improve its performance [96] and in theory can be included multiple times. The authors
found an optimal performance with two ResBlocks (with only marginal improved compared
to the use of one unit) [135]. Similarly, Tanno et al. suggested a fully-convolutional shuf-
fling network (FCSNet, also see [237]) that included four convolutional layers and one skip
connection that concatenates the input to the first layer and the output of the last convolu-
tional layer. In contrast to SHResNet, FCSNet operates on a much larger receptive field size
(isotropic patches of 11 voxels) and consisted of only one single pathway for all SH orders
(lmax = 6 or 8). Furthermore, the channel-wise loss function (same as for SHResNet, i.e.
mean square error [MSE] between the raw input and harmonised output SH signal) was
enhanced with a RISH feature based loss. Besides applying convolutions in SH image space,
Koppers et al. also introduced a spherical network. This samples at first 30 equidistant
gradient directions from the input SH signals and subsequently performs spherical convo-
lutions before converting the signal back to original SH space [136]. Among the mentioned
architectures, FCSNet outperformed all other neural networks on the Multi-shell Diffusion
MRI Harmonisation and Enhancement Challenge (MUSHAC) benchmark database [238].
Scaling of DWI Data. Many previously mentioned methods operate in the SH or RISH
feature space, however, direct harmonisation of DWI signal has been suggested as well. One
approach is the method of moments (MoM) [104], which effectively is a voxel-wise linear
scaling of DWI images from source (Ssrc) to reference space (Ŝsrc), where the multiplicative
factor α and the additive factor β are derived from the first spherical moment (M1) and
second central (C2) spherical moment of the DWI data:




and β = M1,ref − αM1,src (5.9)
The first and second moments correspond to the spherical mean and variance of the DWI
signal, respectively. In practice, spherical moments are first computed for all subjects and
then projected to a common space (spatial normalisation). For each individual site the
median of the first and second moments are computed before the scaling factor maps are
derived. These are then backprojected to the native space of each subject from the source
site to eventually project the DWI signal to the reference site domain. The authors reported
that MoM harmonisation preserved both the shape and directional information of the signal
profile.
Representation Learning. A different research direction for data harmonisation aims
to find a new representation of diffusion MR images that removes undesirable variation
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across scanners, but preserving the underlying biological variability of interest. One sug-
gested approach is the learning of a sparse dictionary [165], that consists of base elements D
that can linearly be combined with weighting coefficients αn to reconstruct any sample xn
in the dataset. The dictionary acts as sparse representation only keeping features necessary
to describe a database.
xn ≈ Dαn (5.10)










‖xn −Dαn‖22 + λi ‖αn‖1
)
(5.11)
whereas the `2-norm and `1-norm promote data similarity and sparsity of the coefficients
α, respectively. St-Jean et al. [234] applied this concept to diffusion MRI harmonisation
to implicit mapping between domains of a source and reference scanner. One option is
to construct reference dictionary to encode the information in the data from the reference
scanner. This can then be applied to data from the source scanner. The idea is that the
reference dictionary reconstructs images that preserve only common scanner feature, while
filtering out source-specific properties. This implicitly maps source data to the reference
scanner domain. Alternatively, a dictionary can be jointly learned on data from multiple
scanners such that the base elements represent only the common features (i.e. diffusion
signal) and discard site-specific effects (i.e. scanner variations). Such a dictionary would
project images from different sites to one common domain, rather than projecting one dataset
to the space of another pre-selected reference scanner. For diffusion data harmonisation, St-
Jean et al. [234] extracted 3D patches of a DWI volume and spatially corresponding patches
from the angular neighbouring volumes to learn dictionary.
Similar in its core idea to learn a scanner-agnostic representation, Moyer et al. [182] has very
recently developed a variational auto-encoder (VAE) framework to harmonise diffusion MRI
data. This neural network consists of two parts: The encoder that compresses the input
information to an intermediate representation, and the decoder that tries to reconstruct the
input image data from the latent space variables. For data harmonisation the goal is to
learn an encoding for the input images such that the latent representation is independent of
the scanning site. The employed architecture consisted of two fully connected layers for each
the encoder and decoder. These were trained on voxels and their immediate six neighbours
sampled from from SH images (lmax = 8) for multi-shell data and one non-diffusion weighted
b0 volume. The network parameters were learned via the reconstruction loss for the SH
signal (all seven voxels) and two auxiliary losses. These were the reconstruction error for
the DWI signal (centre voxel only) as well as an adversary loss, which captures the potential
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to distinguish samples from different sites. This approach has been shown to outperform a
re-implementation of linear RISH feature scaling as previously suggested [179].
5.1.4 Advantages and Limitations of Existing Methods
While global scaling (Z-Scoring) is straight-forward to apply, there is little potential to re-
move region-specific biases across the brain scans. Harmonising data with ComBat provides
the important advantage of simultaneously considering also clinical variables. A covariate
matrix holding such information can individually be designed for any research questions.
This also means that images from multiple sites can easily be harmonised all together. On
the other hand, ComBat operates on diffusion parameter maps (i.e. FA and MD), meaning
DWI scans were fully pre-processed before applying the harmonisation. Site-specific differ-
ences in acquisition could already lead to biases in data processing. For example registering
data to a common template is dependent on diffusion image intensities. Data from a par-
ticular site may register less successfully to a template than others, due to different image
properties (e.g. noise level).
With the initial success of RISH feature harmonisation by Mirzaalian et al. [177], many
following approaches also used either SH or RISH features representation. One of the most
promising techniques is the SH scaling via RISH feature matching in a registration framework
[126, 179]. This has been shown to outperform ComBat [126] as well as other competitive
methods (including neural networks) [238]. Since this harmonisation method operates on
a voxel-wise level, it can account for regional differences. However, similar to ComBat5
this relies on accurate spatial normalisation which is both time consuming and error-prone.
Especially, as the suggested approach requires multi-modal registration. With increasing
number of subjects, the computational burden increases, as each scan has to be individually
spatially normalised. Moreover, in case of more than two imaging sites, one would need
to select one reference site [32] and it is not entirely clear how to chose that. Although
successful in both a ROI and registration framework, simple scaling of RISH models may
not be able to capture non-linear intra-site differences. For example, if site-specific biases
had a stronger impact on a subgroup of subjects than for others within a site, the data used
to compute scaling maps might not adequately represented this subcohort. A single scaling
map per site may not be enough to account for that, which is why non-linear regression
models for RISH feature matching might have been superior [127]. The limitation of one
scaling map per imaging site was later counted for by introducing an adaptive approach
learning different scaling maps per subject. Hereby scale maps were computed from three
subjects form the training data that were most similar (MSE between RISH features) to
5ComBat can also applied on a ROI level
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the test subject. This could further boost the harmonisation performance, showing a strong
improvement in comparison to competing algorithms [187]. Despite this, the dependency of
spatial normalisation and selection of a reference site remains.
Tax et al. presented the performance of different algorithms on a benchmark dataset [238].
This revealed the superiority of linear scaling of SH (see above [126]) over most deep learn-
ing approaches. One explanation could be that the data may not be sufficient to train a
successful mapping via neural networks, however, FSCNet showed an equivalent strong per-
formance. One distinct difference between FSCNet and other neural network architectures
presented (e.g SHResNet), is the receptive field size. While most approaches operated on
small patches (3×3×3 voxels), FSCNet used large 3D patches (11×11×11 voxels), hence,
including much more image semantic context. The benefits of a larger receptive field have
been shown multiple times in other computer vision tasks [37, 64, 91]. Therefore, different
architectures might be important, but cannot outweigh including enough information. How-
ever, the larger the patches the higher the computational burden and neural networks can
be difficult to train adequately particularly with limited number of data. In addition, the
neural networks presented also did not support direct multi-site data harmonisation.
Moyer et al. [182] addressed this shortcomings by deriving a site-unspecific representation
via a VAE. This does not require any registration to template space and further allows
model learning for multiple sites simultaneously. Imaging data from various sites can either
be projected to a common scanner-agnostic space or to one selected site. The authors could
show that this approach outperformed linear SH scaling as suggested by [179], however, it is
not clear whether it would perform better than the adaptive scaling approach (see above).
5.1.5 Aims
Firstly, the linear RISH feature scaling framework as well as a neural network baseline
(i.e. FSCNet) were re-implemented to test their harmonisation performance on a bench-
mark dataset. The aim was to understand whether multiple, individual network pathways
for SH images of different orders are beneficial for diffusion data harmonisation. This was
inspired by the SHResNet architecture described above, however, was trained under simi-
lar conditions as the FSCNet, which did not happen in the benchmark publication [238].
Secondly, two options to improve the scaling maps for linear RISH feature scaling for the
CENTER-TBI database were explored. This included the denoising of the scaling maps as
well as the subselection or weighting of images from available subjects to compute the scal-
ing maps. Concepts were then applied to harmonise CENTER-TBI data from two different
scanners and evaluated based on RISH features and DTI metrics. Finally, the impact of
data harmonisation on mTBI subject analysis was examined.
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5.2 Data & Methods
5.2.1 Databases
MUSHAC. The MUSHAC data provided by Tax et al. is a benchmark dataset for diffusion
MR image harmonisation. Diffusion and structural images were acquired for ten healthy vol-
unteers on a Siemens Prisma scanner (max. gradient 80 mT/m) and a Siemens Connectom
scanner (max. gradient 300 mT/m). The DTI protocol was the same on both scanners and
entailed 30 directions for two shells with b = 1000 and 3000 s/mm2 and seven non-diffusion
weighted images (b0). The scans were collected through parallel imaging (GRAPPA=2)
with TE = 89ms and TR = 7200ms. The acquired voxel size was isotopic of 2.4mm3.
All data were already corrected for susceptibility and eddy-current distortion, head motion
and bias fields. Further, images from different scanners were aligned to each other for each
subject individually. A brain mask, was computed on T1w images that was than inversely
projected to DWI space via rigid coregistration of b0 to T1w images. For more detail the
reader is referred to the original publication [238].
CENTER-TBI. This database has been described previously (Section 2.2) and more in-
formation can be found online.6 For this analysis the subset acquired at Cambridge was
chosen, as it was the only site that scanned the same control subjects on two different scan-
ners. All other centres either employed only one scanner or collected diffusion images of
different healthy volunteers on each of their scanners. To analyse mTBI patients, data from
the two week period post-injury were selected, as this provided the most patient scans. An
overview of the data is given in Table 5.1.
5.2.2 Benchmarking Implementations of Harmonisation.
Among the previously mentioned algorithms, the linear RISH feature scaling as well as a
deep learning approach similar to the FSCNet (Section 5.1.3) were re-implemented as these
seemed most promising at the time of experiment setup. To benchmark the implementa-
tions the algorithms were applied to the openly available diffusion images from the MUSHAC
database. For this analysis, the focus laid on the inner shell data (b = 1000 s/mm2), since
the ultimate goal was to apply these concepts to the CENTER-TBI database, which col-
lected single-shell diffusion MR images only. The DWI scans of the ten available subjects
were transformed to SH representation (MRtrix3 amp2sh). Thereby, the default settings
were used which did not normalise the data by the accompanied b0 image, as initial tests
6www.center-tbi.eu/project/mri-study-protocols
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s # Subjects/Scans 7/7 7/7 7/14
Age at Scan 45 [32, 62] 45 [32, 62] 45 [32, 62]






# Subjects 14 18 32
Age at Scan 51 [21, 62] 44 [21, 67] 47 [21, 67]
Sex (M/F) 10/4 12/6 22/10
DPI 21 [8,33] 17[11,26] 19 [8, 26]
GCS (13/14/15) 1/1/12 0/3/15 1/4/27
GOSE ≤ 8 8 8 16
GOSE = 8 6 10 16
had shown strong outlier signal introduced by normalisation. The data allowed to estimate
coefficients of SH up to order six (lmax=6). Besides FSCNet, two multi-path neural networks
were designed. These were inspired by the SHResNet (Section 5.1.3), however, were trained
under the same conditions as the FSCNet to allow a fairer comparison. First and foremost,
this meant to train the multi-path neural networks on patches of 11×11×11 voxels rather
than 3×3×3 voxels. The success of harmonisation was assessed in a 5-fold cross validation:
In five separate training cycles eight subjects were used to learn the model parameters or
compute scaling maps and performance of the algorithms was validated on the remaining
two subjects. The split into the different training and validation sets was fixed for all exper-
iments. Bootstrapping was not applied, since neural networks take very long to train and
the dataset size was very limited.
Linear RISH. After converting DWI data to SH representations in native space, RISH
features were computed as described previously (Equation 5.2). Together with b0 images
the four derived RISH feature maps (for each order l=0,2,4,6) were used to calculate a study
specific template from all ten available subjects via multi-modal non-linear registration (ants-
MultivariateTemplateConstruction2.sh as recommended by [126]). For each of the five folds
scaling maps were calculated for all image contrasts (b0 and RISH features) from the respec-
tive eight training subjects (Equation 5.8). These scaling maps were then backprojected
from template space to native image space for the two remaining subjects. Eventually, SH
coefficients were scaled accordingly (Equation 5.7).
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CNN Baseline. The baseline model aimed to follow mostly the specifications of the previ-
ously described FSCNet. It operates on three dimensional patches of 11×11×11 voxels from
all SH coefficient maps and the b0 image. For example, fitting SH up to the 6
th order results
in 28 SH coefficient maps (l=0: 1 map, l=2: 5 maps, l=4: 9 maps, l=6: 13 maps). Hence,
the input would be comprised of 29 images (b0 and SH images). Input images were all scaled
by estimating mean and standard deviation for each volume individually (e.g. b0 or first
SH coefficient map), but collectively for all training scans from one scanner (i.e. Prisma or
Connectom). Input patches were passed through four convolutional layers with 75, 150, 300
and 200 feature maps (Figure 5.1). At each layer an isotropic convolutional kernel (3×3×3
voxels) and a dropout rate of 50% was applied. The output of the last convolutional layer
was concatenated with the central part (3×3×3 voxels) of the input patch, before eventually
feeding it to a bottleneck convolutional layer to reduce the number of output feature maps
(Figure 5.1 CONCAT) to the number of b0 and SH images. The network was then trained
on the MUSHAC database sampling 50,000 random patches evenly from all eight training
subjects (6250 patches per subject) for each of the 200 epochs. The network parameters were
learned on batches of size 20 via Adam optimiser [132] with a learning rate of 10−4. The
mean absolute error between output patches (projected Prisma images) and the matching,
scaled patches of the reference scanner (Connectom images) served as cost function. Since
the CNN learned a mapping between scaled image intensities, the final prediction of the
images was generated by backscaling images to the Connectom image space (i.e multiply by
standard deviation and adding the mean as estimated from Connectom training scans),
CNN Multi-Path. This network follows the same training scheme as the baseline model,
however, instead of processing b0 and all SH images together, the input was split accord-
ing to the SH order (Figure 5.1). The b0 image and the SH coefficient map of order zero
were processed together, since they show generally similar anatomical structures. Each of
the split input was passed through a block of four convolutional layers (conv block). The
number of feature maps was chosen to overall match the ones in the baseline model to allow
the comparison of networks with similar learning capacity (for example L1: 4×20=80≈75,
L3: 4×75=300). A second version of the multi-path CNN was constructed, which averages
the output of the conv blocks for the higher order SH coefficient maps (i.e. l=4, 6) before
adding this value to the input SH coefficients. This aimed to simulate a global scaling of
the coefficients rather than learning a local mapping.
Global Scaling. Since the neural networks also included global scaling of SH intensi-
ties, this was also implemented as a stand-alone harmonisation approach. In practice, mean
and standard deviations for all training input volumes were estimated for Prisma and Con-
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Figure 5.1: Schematic Architecture of Convolutional Neural Networks. The baseline CNN
consisted of four convolutional layers that act sequentially on an input of the coefficient
images of the SH representations (here lmax=6, hence 29 input channels). The output of
the last convolutional layer (L4) was concatenated with the input, before going through a
bottleneck convolution. The multi-path CNN splits up the SH input images according to
their order (l=0,2,4,6) and processes them with four individual convolutional layers (conv
block). Eventually the different paths are concatenate all together with the input, before
feeding them again through a bottleneck convolution. A second approach for the multi-path
CNN first averages (averaging operation) the output of paths for the higher order SH maps
(l=4,6), then adds this average from the SH input images (adding operation).
nectom scans separately. Prisma images were mapped to Connectom intensity space by first
subtracting the Prisma mean and dividing by the Prisma standard deviation. Then, these
scaled images were scaled to Connectom space by multiplying with the Connectom standard
deviation and adding the Connectom mean.
Quantitative Assessment. The harmonisation performance of the different models was
measured via a global and regional root mean square error (RMSE) between the harmonised







(xi − yi)2 (5.12)
with x and y representing the images to be compared and N the number of voxels within
a given ROI. The global RMSE was computed within the whole brain mask. Regional
5.2. DATA & METHODS 133
RMSEs were calculated in selected TractSeg ROIs, such as the IFO fascicles (ROI #24 &
#25), the ILFs (ROI #26 & #27), the SLFsI (ROI #35 & #36), the UFs (ROI #43 &
#44) and the whole CC (ROI #45).7 These regions were selected as they were found to be
affected in TBI patients (Chapter 3), but also to provide a general overview, rather than
comparing all 72 TractSeg ROIs. The underlying assumption was that a lower RMSE reflects
less diverging SH coefficient between scanners, which would lead to better harmonised DTI
parameter maps. Differences between methods were statistically assessed via rm-ANOVA
and post-hoc pairwise Tukey test (GraphPad Prism 8).
5.2.3 Inter-Scanner Variation for CENTER-TBI Substudy
Seven healthy controls, who underwent DWI on both a Trio and Prisma scanner for the
CENTER-TBI study, were included. After pre-processing the DWI scans with the diffusion
pipeline introduced in section 2.4, images were converted to SH representation (lmax = 4)
and RISH features were calculated. These were used alongside b0 volumes to create a study
specific template via multi-modal registration (antsMultivariateTemplateConstruction2.sh).
Subsequently, warped RISH feature images were used to compute CV maps for both scan-
ners separately as well as both datasets combined. The mean and standard deviation was
derived on a voxel-wise level. The CV maps were then calculated by dividing the standard
deviations by the means again on a voxel-wise level (see Equation 4.2). Mean and standard
deviation maps were either computed from Trio scans or Prisma scans only (intra-scanner
CV: each seven scans, seven subjects) or from all available scans (inter-scanner CV: 14 scans,
seven subjects). For quantitative comparison, mean of CV maps were computed within the
whole brain mask and selected TractSeg ROIs (see above).
5.2.4 Denosing of RISH Feature Scaling Maps
Spatial normalisation of brain scans aims to create a voxel-wise correspondence between
multiple scans usually from different subjects. The accuracy of this generally depends on the
natural anatomical variation across subjects and the success of the deformable registration.
To relax the assumption of voxel-wise comparability, images can be smoothed to include
for each voxel information from its neighbouring voxels. This can have a denoising effect if
voxels with outlier intensities are present. Therefore, the impact of smoothing RISH feature
scaling maps for diffusion data harmonisation was examined. For this, the same seven
CENTER-TBI controls were used as above. To assess the impact of different scale maps a
leave-one-out cross validation was performed. In other words, the corresponding scans of
7bilateral ROIs were combined
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six subjects were used to compute scaling maps, to then project the RISH feature maps of
the remaining validation subject. Smoothing of scaling maps was conducted with either a
median filter (kernel size 3) or a Gaussian filter (σ = 1.5). The b0 images and RISH feature
maps were directly scaled within template space without conversion back to SH space (this
also meant not to take the square root of the computed scalemaps). The RMSE error was
computed between harmonised Prisma and Trio RISH feature maps. Differences between
methods were quantified via rm-ANOVA and post-hoc paired Tukey test.
5.2.5 Subject Selection for RISH Feature Scaling Maps
The initial (standard) approach of RISH feature scaling was later on improved by computing
expected RISH feature values only on the basis of the three most similar subjects within the
training dataset [187]. The applicability of adaptive subject selection to compute scaling
maps was explored for the CENTER-TBI database in three different ways:
1. Computing of scaling maps from the three most similar subjects. For this, the similar-
ity between a test subject’s Prisma image and all Prisma training images was estimated
via global mean square error (MSE, i.e. computing the voxel-wise square error be-
tween images and average values within brain mask). The three scans with the lowest
MSE and the corresponding Trio scans were used to compute the scaling map.
2. Calculating a weighted average of all training subjects. Scale maps were computed
from the weighed mean of the different training subjects. The weighting was defined
by the test scans similarity to the training samples (reciprocal value of the relative
MSE normalised to the maximum MSE between scans). This aimed to be more adap-
tive than the standard approach, but more inclusive than the hard selection of three
subjects.
3. Computing a weighted average of all training subjects on a voxel-wise basis. Instead
of estimating a global weight for the whole feature map, a voxel-wise weighting map
was computed. This was based on the reciprocal, relative square error between test
and train scans at each voxel. The intention of this approach was to compute more
local scaling factors than the other two options.
Scaling maps were all denoised with a median filter (kernel size 3×3×3). Analogous to
the previous experiment, the performance was assessed in a leave-one-out cross-validation
and by computing the global RMSEs between Trio and scaled Prisma RISH features and b0
images. Again, differences between approaches were quantified via rm-ANOVA and post-hoc
paired Tukey test.
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5.2.6 Evaluation of Harmonisation of CENTER-TBI SH Images
Evaluating harmonisation of RISH features in template space can give an indication of a
method’s performance, however, it is also important to understand the impact on scans in
native space. For this, control subjects images on the Prisma scanner were harmonised and
compared to the corresponding Trio scans. To allow a voxel-wise comparison between Prisma
and Trio scans for each subject, Trio scans were aligned to their corresponding Prisma scan
by affinely coregistering b0 images. This allowed to examine the harmonised Prisma scans
and the original Trio scans both in their native space. If Prisma scans were harmonised
in a coregistered state, they would need to be backprojected to be analysed in their native
subject space. This would lead to multiple interpolation steps and with it blurring images
unnecessarily.
Prisma scans were harmonised via linear RISH feature scaling, a CNN with the Multi-Path
architecture (Section 5.2.2) and global scaling of b0 and SH volumes. All three methods
were evaluated in leave-one-out cross-validation as before.
1. For linear RISH feature scaling, the spatial normalised images of six control subjects8
(Section 5.2.3) were used to calculate scaling maps for the b0 and RISH feature images
(Equation 5.8). These scaling maps were denoised with a median filter (kernel size
3×3×3) and then backwarped to the native space of the held out test subject scanned
on Prisma. Eventually, Prisma SH were scaled as described previously (5.1.3).
2. The hyper-parameters for the CNN Multi-Path were set as for previous experiments
on the MUSHAC database, with the exception of an increased number of samples
extracted per subject during each training epoch. Since only six (instead of eight)
subjects were available for training, the samples per subject per epoch were set to
8,320 to keep the total sample number per epoch close to 50,000. Furthermore, SH
coefficient could only be estimated up to the 4th order, which is why there were only
three convolutional pathways.
3. For comparison, a global scaling of Prisma scans was applied as well. Mean and
standard deviation for both scanners were estimated globally for each b0 image and
SH coefficient maps. Each Prisma b0 and SH volume was then projected to match the
mean and variance of Trio scans (see global scaling in Section 5.2.2).
After harmonising SH coefficient images, the RMSE between the RISH feature maps were
computed for each subject. Differences between methods were quantified via rm-ANOVA
and post-hoc paired Tukey test.
8Note: Since multi-modal spatial normalisation is computationally expensive the same template generated
for all seven control subjects was used.
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5.2.7 Data Harmonisation of CENTER-TBI DTI Metrics
Global and Regional RMSE. To compare the impact of different methods on DTI met-
rics, the harmonised Prisma SH data were converted back to DWI representation. In addi-
tion, the unharmonised Prisma SH data were also backprojected to DWI space to examine
the information loss through conversion between representation spaces. After this, FA and
MD maps were computed (FSL dtifit with weighted least squares) for all harmonised, back-
projected and original Prisma data as well as coregistered Trio data (b-vectors had been
rotated accordingly). RMSE was computed both in the whole brain as well as selected ROIs
(Section 5.2.2). Differences between methods for the global RMSE were quantified via rm-
ANOVA and post-hoc paired Tukey test.
ROI Mean Analysis. Eventually, mean FA and MD values were extracted from the
selected TractSeg ROIs (Section 5.2.2) for Prisma scans, native as well as coregistered Trio
scans, and harmonised Prisma scans (CNN and Linear-RISH). Besides this, regional mean
Prisma values were projected to the Trio domain through ROI-wise standard scaling (analo-
gous to global scaling before, but mean and standard deviation were estimated on a regional
level).
5.2.8 Impact of Data Harmonisation on Mild TBI
Another multi-pathway CNN was trained on all seven matched CENTER-TBI control sub-
jects (training parameters the same as for the cross-validation above). This was then applied
to b0 and SH coefficient images of the CENTER-TBI mild TBI patients scanned on Prisma
(Table 5.1). Harmonised SH images were than converted back to DWI space. A tensor model
was fitted (FSL dtifit with weighted least squares) to extract FA and MD maps for original
Prisma, harmonised Prisma and Trio scans in native space. Eventually, regional mean FA
and MD values were computed within 24 pre-selected TractSeg ROIs relevant for TBI (Sec-
tion 3.3.2). As before, Prisma mean DTI metrics were also projected to the Trio domain
via ROI-wise standard scaling (see ROI Mean Analysis above). Depending on their GOSE
at six months post-injury, patients were dichotomised into a group with good (GOSE=8)
and poor (GOSE<8) outcome. Then a linear regression analysis (analogous to Model #3




5.3.1 Comparison of Selected Harmonisation Methods
When compared to non-harmonised data, the different approaches for RISH feature harmon-
isation all led to a reduced global RMSE between matched Prisma and Trio scans (Figure
5.2, repeated measurement ANOVA: p ≤ 0.022). While linear and global scaling were con-
sistent in performance, CNN approaches produced outliers for b0 and RISH0 feature images
that had a worse global RMSE than the original inter-scanner difference. This higher varia-
tion in harmonisation results could also be observed quantitatively (see standard deviation
in Table 5.2). The lowest average global RMSE for RISH0 features were achieved with lin-
ear scaling of RISH feature maps (Linear-RISH). The multi-path CNN, however, achieved
lowest global RMSE for b0 and RISH2 features. Interestingly, the more local operating
method of linear RISH feature scaling performed worse than global scaling of higher order
of RISH features (RISH4: ptukey = 0.011; RISH6: ptukey = 0.008). Similarly, global scaling
of RISH6 feature maps reduced RMSE between scanners significantly more than the baseline
CNN model (RISH6: ptukey = 0.018). The multi-path CNN approaches could significantly
decrease the RMSE between higher order RISH features compared to the baseline CNN
(Multi-Path RISH4 & RISH6: ptukey ≤ 0.001; Multi-Path #2 RISH6: ptukey = 0.041). The
second approach of the multi-path neural network (CNN Multi-Path #2 ) aimed to emulate
globally scaling of RISH4 and RISH6 features maps. Indeed, average RMSE were similar to
that of global RISH feature map scaling, albeit not statistically significant (Table 5.2 and
Figure 5.2).
Figure 5.2: Comparison of Global RISH Feature Differences after MUSHAC Data Harmoni-
sation. All five harmonisation methods led to reduced RMSE between. The CNN approaches
seemed most successful for b0 images, however, showed also outliers with higher RMSE than
before harmonisation (Inter-Scanner). Global scaling was most beneficial for higher order
RISH features (RISH4 and RISH6). While the multi-path approach (CNN Multi-Path) could
improve RISH feature harmonisation, only the adjusted second model (CNN Multi-Path #2 )
achieved similarly low levels for higher order RISH features than global scaling.
Although differences across regions could be observed, the general magnitude of inter-scanner
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variation before and after harmonisation was similar for all selected ROIs. Harmonisation
based on CNNs showed outliers for b0 images and RISH0 feature maps with higher RMSE
within the examined ROIs than non-harmonised data. Overall, all methods showed similar
trends of reduced RMSE for b0, RISH0 and RISH2 images. Stronger differences were found
for RISH4 and RISH6 feature maps, where the linear RISH feature scaling and the baseline
CNN performed worse than the other harmonisation methods. Only the CNN Multi-Path
networks could reach similar levels for higher order RISH feature maps (l=4,6) than simple
global scaling. Although data harmonisation seemed to be slightly more beneficial for UF
(e.g RISH2 or RISH4), the performances were generally robust across all ROIs (Figure 5.3).
5.3.2 Variation in CENTER-TBI Substudy
Figure 5.4 displays the average of all 14 scans from seven subjects scanned on both scanners
and corresponding CV maps. Variation was generally higher in cortical areas where anatom-
ical differences between subjects are more likely. Higher order RISH features (RISH2 or
RISH4) also showed more variation than b0 images or zeroth order RISH features (RISH0).
While structured variation was observed in b0 CV maps, for example around ventricles,
RISH4 feature maps revealed the least structured deviation. Coefficients of variation are
similar for scans collected on Prisma or Trio, but increased when combining both datasets.
The visual observation of increased variation was also confirmed quantitatively (Table 5.3).
Measuring mean CV within the whole brain and selected ROIs, revealed higher variation in
all imaged for the pooled dataset in comparison to both individual datasets. Overall, vari-
ation in b0 and RISH0 feature maps was higher for Trio than for Prisma scans. In contrast,
RISH2 and RISH4 feature maps mostly demonstrated higher mean CV for Prisma than for
Trio scans.
5.3.3 Impact of Denoising on RISH Feature Scaling Maps
Linear scaling of images generally had a positive impact on minimising differences between
RISH features from both scanners (Figure 5.5, Table 5.4, all rm-ANOVA: p ≤ 0.023). How-
ever, the standard linear scaling (Baseline) significantly increased the RMSE between Trio
and Prisma scans for RISH4 feature maps (Inter-Scanner vs. Baseline: ptukey = 0.008).
Denoising scaling maps prior to their application could counteract that adverse effect, but
not improve RMSE beyond the original inter-scanner differences (Inter-Scanner vs. Median:
ptukey = 0.008; Inter-Scanner vs. Gaussian: ptukey = 0.008). The RMSE between b0 images
and all RISH feature maps could be reduced by denoising scaling maps with a median filter
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Table 5.2: Global RMSE for Different Harmonisation Methods. RMSE displayed in 103 as
mean (median) ± std. Lowest RMSE values for each contrasts across methods are printed
in bold.
Inter-Scanner Linear-RISH Global Scaling
b0 0.098 (0.095) ± 0.025 0.079 (0.076) ± 0.013 0.074 (0.070) ± 0.014
RISH0 36.97 (37.18) ± 9.50 22.90 (20.40) ± 8.20 24.87 (23.34) ± 7.82
RISH2 0.715 (0.741) ± 0.177 0.461 (0.456) ± 0.067 0.426 (0.428) ± 0.080
RISH4 0.084 (0.086) ± 0.019 0.058 (0.055) ± 0.013 0.042 (0.042) ± 0.009
RISH6 0.097 (0.101) ± 0.024 0.065 (0.064) ± 0.016 0.041 (0.041) ± 0.009
CNN Baseline CNN Multi-Path CNN Multi-Path #2
b0 0.072 (0.064) ± 0.028 0.068 (0.061) ± 0.031 0.070 (0.067) ± 0.032
RISH0 24.87 (20.95) ± 11.79 24.28 (21.37) ± 11.45 24.79 (23.45) ± 11.44
RISH2 0.449 (0.398) ± 0.159 0.418 (0.386) ± 0.115 0.428 (0.406) ± 0.109
RISH4 0.053 (0.047) ± 0.019 0.047 (0.043) ± 0.018 0.043 (0.045) ± 0.009
RISH6 0.062 (0.059) ± 0.021 0.055 (0.052) ± 0.020 0.043 (0.044) ± 0.009
P-Values of Post-Hoc Paired Tukey-Test
Method #1 Method #2 b0 RISH0 RISH2 RISH4 RISH6
Inter-Scanner Linear-RISH 0.271 0.116 0.012 <.001 <.001
Inter-Scanner Global Scaling 0.177 0.189 0.017 <.001 <.001
Inter-Scanner CNN Baseline 0.206 0.318 0.107 0.056 0.056
Inter-Scanner CNN Multi-Path 0.148 0.264 0.030 0.021 0.026
Inter-Scanner CNN Multi-Path #2 0.159 0.273 0.026 <.001 <.001
Linear-RISH Global Scaling 0.016 0.029 0.251 0.011 0.008
Linear-RISH CNN Baseline 0.753 0.979 1.000 0.9828 0.998
Linear-RISH CNN Multi-Path 0.564 0.993 0.578 0.668 0.840
Linear-RISH CNN Multi-Path #2 0.803 0.988 0.725 0.007 0.006
Global Scaling CNN Baseline 0.998 >0.999 0.985 0.197 0.018
Global Scaling CNN Multi-Path 0.995 >0.999 0.998 0.764 0.099
Global Scaling CNN Multi-Path #2 0.995 >0.999 >0.999 0.207 0.226
CNN Baseline CNN Multi-Path 0.633 0.947 0.693 <.001 <.001
CNN Baseline CNN Multi-Path #2 0.994 >0.999 0.906 0.395 0.041
CNN Multi-Path CNN Multi-Path #2 0.783 0.988 0.806 0.944 0.214
rm-ANOVA p-val 0.022 <.001 0.003 0.001 <.001
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Figure 5.3: Comparison of Regional RISH Feature Differences after MUSHAC Data Har-
monisation. The extend of inter-scanner differences varied for different regions and different
image contrasts (b0 and RISH features. All harmonisation approaches helped to reduced the
RMSE between scanners, however, CNN approaches resulted in outlier cases with higher
RMSE than before harmonisation (particularly for b0 and RISH0). Overall, global scaling
and the CNN multi-path approaches were more successful to harmonise RISH4 features.
The CNN baseline showed a high variation is RMSE for most higher order RISH features
(l=2,4,6). Linear RISH features scaling seemed most beneficial for RISH0 features.
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Figure 5.4: Intra- and Inter-Scanner Variation for CENTER-TBI Cambridge Subset. Top
row: Average b0 images and RISH feature maps for all 14 scans from seven subjects scanned
on Prisma and Trio. Row 2-4: Lowest variation within and across scanners was found in the
WM of b0 images. Cortical areas showed generally higher variance, particularly on RISH2
feature maps. Variation was similar within both scanners (both middle rows), but increased
when combining data from both scanners (bottom row). All CV maps are shown using the
same scale.
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Table 5.3: Global and Regional Variation within and Across Scanners for CENTER-TBI
Subset. Coefficients of variation displayed as mean ± std in %. Mean values larger than the
equivalent metric at the other single scanner data printed in bold.





Whole Brain 23.2 ± 15.2 28.1 ± 20.0 52.0 ± 25.2 48.6 ± 19.8
CC 16.3 ± 12.4 17.5 ± 8.5 45.6 ± 23.4 41.6 ± 15.4
IFO 16.2 ± 11.0 17.7 ± 8.9 47.2 ± 23.7 45.2 ± 17.5
ILF 12.9 ± 7.6 17.7 ± 9.3 44.5 ± 20.5 46.4 ± 19.0
SLFI 12.5 ± 11.5 13.6 ± 5.6 39.1 ± 19.9 37.3 ± 13.8




Whole Brain 24.0 ± 14.8 28.2 ± 17.2 50.2 ± 21.5 48.3 ± 19.6
CC 17.5 ± 12.1 19.1 ± 7.4 45.0 ± 19.7 42.2 ± 15.2
IFO 16.7 ± 10.5 19.3 ± 7.1 45.2 ± 20.1 43.8 ± 17.4
ILF 14.2 ± 7.5 20.5 ± 8.0 43.9 ± 17.9 45.4 ± 18.2
SLFI 13.8 ± 11.2 15.9 ± 5.5 42.1 ± 16.9 40.1 ± 13.2









Whole Brain 24.7 ± 13.6 32.5 ± 17.4 53.8 ± 21.8 55.1 ± 19.4
CC 18.4 ± 11.1 23.2 ± 6.6 47.0 ± 19.3 47.4 ± 15.0
IFO 18.4 ± 9.7 24.2 ± 6.9 48.4 ± 20.2 48.9 ± 16.8
ILF 15.1 ± 6.5 22.8 ± 6.7 45.5 ± 17.5 51.2 ± 18.0
SLFI 14.7 ± 10.3 20.0 ± 4.1 42.4 ± 16.1 44.1 ± 12.9
UF 14.8 ± 5.3 26.4 ± 9.1 41.0 ± 13.8 48.8 ± 14.2
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Figure 5.5: Effect of Denoising of Scaling Maps for Data Harmonisation. Linear scaling of b0
images and RISH features had a positive effect on reducing the RMSE (base) in comparison
to the inter-scanner differences (inter). The exception was RISH4 features for which an
increase in RMSE was observed. Denoising scaling maps with a median filter (med) had
overall a small but beneficial effect on further reducing the RMSE. Gaussian filtering (gauss)
was less effective and negatively impacted b0 image scaling.
(Baseline vs. Median: all ptukey ≤ 0.006). This was not observed for Gaussian filtering,
with the exception of RISH4 features maps (Baseline vs. Gaussian: ptukey ≤ 0.036).
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Table 5.4: Impact of Denoising of Scaling Maps on Harmonisation between Scanners for
CENTER-TBI Subset. RMSE displayed as mean ± std ×103. P-values<0.05 printed in
bold (no correction for multiple comparison).
Method b0 RISH0 RISH2 RISH4
Inter-Scanner 0.10 ± 0.03 103.65 ± 40.80 2.92 ± 0.77 0.48 ± 0.08
Baseline 0.08 ± 0.01 64.23 ± 20.60 2.10 ± 0.36 0.53 ± 0.08
Median 0.08 ± 0.01 61.81 ± 20.69 1.98 ± 0.35 0.48 ± 0.06
Gaussian 0.09 ± 0.01 61.89 ± 19.32 2.03 ± 0.39 0.48 ± 0.06
P-Values of Post-Hoc Paired Tukey-Test
Method #1 Method #2 b0 RISH0 RISH2 RISH4
Inter-Scanner Baseline 0.335 0.082 0.069 0.008
Inter-Scanner Median 0.231 0.073 0.043 0.994
Inter-Scanner Gaussian 0.869 0.093 0.024 0.959
Baseline Median 0.005 0.003 0.002 0.006
Baseline Gaussian 0.569 0.389 0.569 0.005
Median Gaussian 0.151 1.000 0.709 0.036
rm-ANOVA p-val 0.161 0.023 0.012 <0.001
5.3.4 Scan Selection and Weighting for Scaling Maps
Scaling Maps. Figure 5.6 shows an example of differently computed scaling maps for
one healthy CENTER-TBI subject. The baseline scaling maps, computed from all available
training subjects, showed the most spatially continuous values. Selecting only the three most
similar subjects to compute scaling maps resulted in higher variation. Weighting the subjects
according to image similarity resulted in very similar scaling maps that obtained from the
baseline approach (basically, weighting all subject equally). Computing scaling values for
each voxel independently resulted in more speckled scaling maps. For all approaches the
variation in scaling values was highest for RISH4 features. Scaling maps for b0 images showed
the most values close to one, which compounds to no change between scanner intensities.
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Figure 5.6: Example of Scaling Maps of CENTER-TBI Subject. Selecting a subset of
subjects resulted in slightly more structured scaling maps (Selected). Weighting the subjects
(Weighted) obtained very similar scaling maps compared to when no weighting was applied
(Baseline). Computing a voxel-wise weighting resulted in spatially less continuous scaling
values (Voxel-Weighted). Most variation was found for RISH4 features. The least impact of
scaling was observed for b0 images.
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Global RMSE. Overall, differences between the various calculations of scaling maps were
subtle (Figure 5.7). Voxel-wise weighting resulted in the lowest RMSE between scanners for
all RISH feature maps (Table 5.5). Voxel-wise weighting was also significantly better than
global weighting (Weighted vs. Voxel-Weighted: ptukey = 0.001). Selecting the three most
similar subjects to calculate scaling maps (Selected) led to higher RMSEs than any other
approach, which was most obvious for RISH4 feature maps (post-hoc paired Tukey test: all
ptukey ≤ 0.025). No direct impact of different computation methods for scaling maps was
observable for b0 images (post-hoc paired Tukey test: all ptukey ≥ 0.962).
Table 5.5: Impact of Subject Selection and Weighting on Harmonisation for CENTER-TBI
Subset. RMSE displayed as mean ± std ×103. P-values<0.05 printed in bold.
Method b0 RISH0 RISH2 RISH4
Inter-Scanner 0.10 ± 0.03 103.65 ± 40.80 2.92 ± 0.77 0.48 ± 0.08
Baseline 0.08 ± 0.01 61.81 ± 20.69 1.98 ± 0.35 0.48 ± 0.06
Selected 0.08 ± 0.01 62.87 ± 22.88 2.07 ± 0.38 0.52 ± 0.06
Weighted 0.08 ± 0.01 61.72 ± 20.61 1.98 ± 0.35 0.48 ± 0.06
Voxel-Weighted 0.08 ± 0.01 60.10 ± 19.20 1.94 ± 0.31 0.45 ± 0.05
P-Values of Post-Hoc Paired Tukey-Test
Method #1 Method #2 b0 RISH0 RISH2 RISH4
Inter-Scanner Baseline 0.251 0.098 0.060 1.000
Inter-Scanner Selected 0.206 0.077 0.085 0.060
Inter-Scanner Weighted 0.274 0.092 0.060 1.000
Inter-Scanner Voxel-Weighted 0.311 0.092 0.063 0.240
Baseline Selected 0.997 0.998 0.128 0.025
Baseline Weighted 0.996 0.976 0.996 1.000
Baseline Voxel-Weighted 0.998 0.757 0.933 0.002
Selected Weighted 0.994 0.995 0.154 0.018
Selected Voxel-Weighted 1.000 0.989 0.303 0.003
Weighted . Voxel-Weighted 0.962 0.919 0.904 0.001
rm-ANOVA p-val 0.061 0.015 0.012 <0.001
Median filtering was applied to all four approaches.
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Figure 5.7: Impact of Selection of Subjects on Image Harmonisation. All methods re-
duced the global RMSE for b0, RISH0 and RISH2, but differences between approaches were
marginal. Selecting a subset of subjects (sel) increased the global RMSE for RISH4. Only
voxel-wise weighting (vxl) had an observable positive effect on RISH4 feature maps. All
approaches included the same median filtering of scaling maps.
5.3.5 Harmonisation of CENTER-TBI SH Images
Figure 5.8 shows the impact of different harmonisation methods on the inter-scanner variance
(measured via RMSE) for the CENTER-TBI control subjects. Linear RISH feature scaling,
global scaling and the CNN resulted in reduced RMSEs between Prisma and Trio scans
for b0 images as well as RISH0 and RISH2 features. While the neural network could also
successfully harmonise SH coefficients of higher order (RISH4), both other methods seemed
to fail to minimise the RMSE. In fact, global scaling resulted in increased RMSE between
both scanners for RISH4 features maps. Looking at RMSE for individual subjects showed
that harmonisation was not entirely consistent for all subjects. For example, two subjects
(B & G) had a higher RMSE for RISH2 features after harmonisation with CNN than with
linear scaling (Linear-RISH or Global Scaling).
All three harmonisation methods reduced the RMSE compared to non-harmonised data
(Table 5.6). The exception was global scaling for RISH4 features which yielded significantly
higher RMSE (Inter-Scanner vs. Global-Scaling: ptukey < 0.001). Linear RISH feature
scaling was beneficial to reduce RMSE for RISH0 and RISH2 feature maps (Inter-Scanner
vs. Linear-RISH: ptukey = 0.005 and ptukey < 0.001, respectively). The lowest mean RMSE
for b0 images and all RISH feature maps were achieved by the CNN Multi-Path. The
neural network outperformed both the linear RISH feature and global scaling for b0 and
RISH4 images (All: ptukey ≤ 0.025). Global scaling performed worse on higher order RISH
features.








Figure 5.8: Comparison of Harmonisation Methods on CENTER-TBI Controls. Top: All
three methods were able to reduced the global RMSE between the data from different
scanners for b0 images, RISH0 and RISH2 feature maps. Global scaling was overall similar in
performance to linear RISH feature scaling, however, worsened the inter-scanner differences
for RISH4 feature maps. The CNN Multi-Path provided the lowest RMSE. Significantly
lower RMSE than Inter-Scanner RMSE marked with an asterisk. Bottom: RMSE for
individual subjects (A-G) sorted according to descending inter-scanner RMSE for b0 images.
Harmonisation for subjects B and G was less successful than for other subjects.
5.3.6 Evaluation of Harmonisation for CENTER-TBI DTI Metrics
Global RMSE. Figure 5.9 shows the global RMSE of FA and MD maps before and after
harmonisation. For both DTI metrics, the differences in RMSE were all highly significant
between all harmonisation methods as well as no data harmonisation. Backprojection of SH
to DWI space led only to marginal, but significant (FA: ptukey = 0.025, MD: ptukey < 0.001)
differences.9 Linear RISH feature scaling had a negative effect on both DTI metrics as
the observed RMSE was significantly increased after harmonisation (both for FA and MD
Inter-Scanner vs. Linear-RISH: ptukey < 0.001). Both global scaling and CNN Multi-Path
harmonisation could significantly reduce the deviation between DTI metrics from the two
scanners (All: ptukey < 0.001). The CNN Multi-Path harmonisation achieved overall the
lowest average of global and regional RMSE among the methods analysed (Table 5.7).
9Changes are not directly reflected in the mean RMSE, but were consistent for all subjects; RMSE was
lower for FA and higher for MD for all subjects after backprojection.
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Table 5.6: Comparison of Harmonisation Methods on Control Subjects from CENTER-TBI.
Global RMSE displayed as mean ± std ×103. Lowest mean RMSE per contrast printed in
bold.
Method b0 RISH0 RISH2 RISH4
Inter-Scanner 0.11 ± 0.03 122.93 ± 46.73 4.27 ± 0.97 0.60 ± 0.13
Linear-RISH 0.08 ± 0.02 73.87 ± 27.63 2.71 ± 0.72 0.63 ± 0.12
Global Scaling 0.08 ± 0.02 72.36 ± 26.71 2.98 ± 0.84 0.78 ± 0.18
CNN Multi-Path 0.07 ± 0.01 62.08 ± 15.27 1.93 ± 0.39 0.34 ± 0.06
P-Values of Post-Hoc Paired Tukey-Test
Method #1 Method #2 b0 RISH0 RISH2 RISH4
Inter-Scanner Linear-RISH 0.059 0.005 <0.001 0.184
Inter-Scanner Global Scaling 0.043 0.004 <0.001 <0.001 ∗
Inter-Scanner CNN Multi-Path 0.026 0.008 0.005 0.006
Linear-RISH Global Scaling 0.630 0.006+ 0.015+ 0.004+
Linear-RISH CNN Multi-Path 0.008 0.082 0.141 0.002
Global Scaling CNN Multi-Path 0.025 0.103 0.093 0.002
rm-ANOVA p-val 0.007 0.005 0.002 <0.001
∗global scaling significantly worse than Inter-Scanner RMSE, +global scaling significantly
worse than Linear-RISH RMSE
Regional RMSE. A similar observation was made for regional FA metrics (Figure 5.10).
Within the ROIs examined, the RMSE was increased after harmonisation with linear RISH
feature scaling. In contrast, both global scaling of FA maps as well as the neural network
harmonisation could reduce the RMSE between matched scans from Prisma and Trio. The
CNN approach showed the best potential to minimise differences between scans. Nonethe-
less, harmonisation performance varied for the regions investigated. For example, SLFI and
UF showed low and very high variation of RMSE, respectively (Table 5.7).
Harmonisation of the MD metric between scanners showed a different pattern. Although
both linear RISH feature and global scaling could reduce the RMSE for some regions, the
effect of data harmonisation was marginal. Globally, the RMSE was increased for MD values
after linear RISH feature scaling (Figure 5.9), however, within selected WM tracts, such as
the SLFI and UF, this harmonisation approach could decrease inter-scanner differences. The
RMSEs in both ROIs were increased after global scaling of MD metrics. Overall, harmon-
isation via global scaling worked much better for FA than MD values. The neural network
was most successful in lowering regional RMSE between images from both scanners, which
was consistent with the observation made for the global RMSE.
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Figure 5.9: Comparison of DTI Metrics Before and After Harmonisation for CENTER-TBI
Controls. Backprojecting the data from SH to DWI representation did not show any impact
on the RMSE between scans from Prisma and Trio. Linear RISH feature scaling resulted
in an increase of global RMSE for both FA and MD. While global scaling could lower the
RMSE between scanners, the CNN Multi-Path showed the best potential for harmonising
DTI metrics.
Figure 5.10: Comparison of Regional DTI Metrics Before and After Harmonisation for
CENTER-TBI Controls. The RMSE between FA from different scanners could be reduced
via global scaling and the CNN Multi-Path harmonisation, whereas the latter seemed more
successful. Linear RISH feature scaling increased the RMSE of regional FA. Both linear
RISH feature and global scaling showed no clear reduction of RMSE between MD values
across scanners. Regions such as the SLFI and the UF slightly benefited from linear RISH
feature harmonisation (reduced RMSE compared to inter-scanner differences). Only the
CNN Multi-Path approach displayed reduced RMSE for regional MD between scanners.
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Table 5.7: Global and Regional RMSE for FA and MD Within and Across Scanners for
CENTER-TBI Controls. All RMSE displayed as mean ± std. MD represented as ×10−3
ROI Inter-Scanner Linear-RISH Global Scaling CNN M.P.
F
A
Global 0.093 ± 0.005 0.105 ± 0.005 0.078 ± 0.005 0.070 ± 0.006
CC 0.099 ± 0.006 0.107 ± 0.006 0.083 ± 0.006 0.072 ± 0.006
IFO 0.095 ± 0.008 0.105 ± 0.007 0.081 ± 0.007 0.072 ± 0.006
ILF 0.104 ± 0.011 0.115 ± 0.011 0.087 ± 0.011 0.079 ± 0.009
SLFI 0.094 ± 0.006 0.098 ± 0.007 0.077 ± 0.004 0.068 ± 0.002
UF 0.109 ± 0.019 0.117 ± 0.019 0.093 ± 0.019 0.085 ± 0.018
M
D
Global 0.215 ± 0.028 0.249 ± 0.026 0.196 ± 0.027 0.151 ± 0.024
CC 0.122 ± 0.013 0.121 ± 0.013 0.119 ± 0.010 0.087 ± 0.011
IFO 0.121 ± 0.017 0.122 ± 0.017 0.118 ± 0.014 0.089 ± 0.014
ILF 0.110 ± 0.009 0.110 ± 0.009 0.111 ± 0.007 0.084 ± 0.005
SLFI 0.098 ± 0.010 0.096 ± 0.009 0.102 ± 0.007 0.069 ± 0.005
UF 0.115 ± 0.009 0.112 ± 0.009 0.121 ± 0.008 0.093 ± 0.008
P-Values of Post-Hoc Paired Tukey-Test
Method #1 Method #2 FA MD
Inter-Scanner Linear-RISH <0.001 <0.001
Inter-Scanner Global Scaling <0.001 <0.001
Inter-Scanner CNN Multi-Path <0.001 <0.001
Linear-RISH Global Scaling <0.001 <0.001
Linear-RISH CNN Multi-Path <0.001 <0.001
Global Scaling CNN Multi-Path 0.003 <0.001
rm-ANOVA p-val <0.001 <0.001
Values for Backprojection not displayed for brevity and since they were near equal to Inter-
Scanner values (FA: ptukey = 0.025; MD: ptukey < 0.001). CNN M.P. stands for CNN
Multi-Path approach.
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Regional Mean DTI Metrics. Comparing mean FA metrics within the selected ROIs
revealed only marginal differences between Prisma and Trio scans (Figure 5.11 left). Inter-
estingly, there was an obvious drop in mean FA values of coregistered Trio scans compared
to the original scans. The multi-path CNN had been trained to map Prisma scans to the
coregistered Trio scans. This was also reflected in the harmonised regional mean FA val-
ues (Prisma - CNN Multi-Path), as these match the FA values from coregistered Trio scans
(Trio Coreg) much more closely than the ones extracted from the native scans (Trio). Linear
RISH and ROI-wise scaling resulted in slightly increased FA values compared to native Trio
FA values. The differences between scanners were not as obvious for MD values (Figure 5.11
right). Linear RISH scaling and CNN harmonisation showed increased MD values in the
SLFI , despite Trio MD values being lower than unharmonised Prisma MD values. Mapping
Prisma MD values to Trio space via ROI-wise scaling also resulted in outliers (e.g. reduced
MD in the CC).
Figure 5.11: Comparison of Means DTI Metrics in Controls Before and After Harmonisa-
tion. Regional mean values were marginally different between Trio and Prisma scans. Both
Linear-RISH and ROI-wise scaling overly increased Prisma FA values (e.g. ILF). The CNN
Multi-Path harmonisation strongly decreased FA values in comparison to the original values,
but matched most closely regional mean FA values extracted from coregistered Trio scans.
Differences in MD between scanners were not as drastic as for FA. However, ROI-wise scaling
led to some outliers (i.e. UF or CC).
5.3.7 Impact of Data Harmonisation on Mild TBI
The regression analysis showed that none of the 24 selected TractSeg regions was predictive
of patient outcome. This result was consistent regardless whether the examined scans came
from one of the two scanners, both scanners, or the pooled Trio and harmonised Prisma
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data. Nonetheless, a general trend of lower FA and higher MD values was observed in TBI
patients with poor outcome. As for the control subjects from CENTER-TBI, regional DTI
metrics were very similar for both Prisma and Trio scans, and the CNN harmonisation
decreased FA metrics substantially. Furthermore, it seemed that the separation between
patients with good and poor outcome increased through CNN harmonisation. Regional MD
values seemed mostly robust to any applied harmonisation method and strong effects could
not be observed visually (Figure 5.12).
Figure 5.12: Regional Mean FA and MD Before and After Harmonisation for Mild TBI
Patients in Selected Regions. Harmonisation via CNN substantially reduced the FA mean
values. This could not be observed for MD values, which seemed mostly stable regardless
whether data harmonisation was applied or not.
5.4 Discussion
5.4.1 Potential and Limitations of Harmonisation Methods
MUSHAC Database. Although not the strongest harmonisation method, the linear RISH
feature scaling performed most consistently in lowering the RMSE between b0 and RISH
feature images of the MUSHAC benchmark database. In contrast, all three neural network
approaches showed strong RMSE outliers for b0 and RISH0 images. Generally, this could
indicate an overfitting of the model. However, upon visual inspection, the outlier RMSE
metric could be associated with a particular Prisma scan that had a higher intensity range
than the other Prisma scans even in unharmonised state. Later on, this particular subject
was also excluded from a different experiment conducted by the authors who provided the
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MUSHAC database [244]. Nonetheless, this shows how machine learning models can be
sensitive to outliers and do not necessarily generalise well. Such a sensitivity could be prob-
lematic for analysis of patient data, as a neural network trained on control subjects could
artificially enhance abnormalities found in patient scans. Global scaling of SH volumes per-
formed surprisingly well and in particular outperformed more complex methods for RISH4
and RISH6 features in the MUSHAC dataset. While b0 images and lower order SH images
display anatomical structures, higher order SH images are more noisy. Approaches that
harmonise on a local level (Linear-RISH & CNN Baseline and CNN Multi-Path) may fail
to learn to scale unstructured image intensities. Therefore, methods based on global scaling
(including CNN Multi-Path #2) were more beneficial for higher order SH harmonisation.
Previous publications on the same database [187, 238] have only assessed harmonisation
methods based on lower order RISH features (i.e. RISH0 and RISH2). The experiments
presented in this chapter have shown that a neural network that processes SH of different
orders on multiple individual pathways performs better than a neural network with one
pathway. This and the fact that global scaling for higher order SH images was more ben-
eficial, is a clear indicator, that information from SH images may need to be harmonised
differently dependent on the SH order.
CENTER-TBI Database. When comparing RISH features from the CENTER-TBI
database, the multi-path neural network performed best to reduce the RMSE between Trio
and Prisma scans. Although a high variation for the different models was observed, Cohen’s
measure showed that the harmonisation was indeed effective. All three harmonisation ap-
proaches could reduce inter-scanner differences for b0, RISH0 and RISH2 images (Cohen’s
effect size d > 0.2). The strongest effect was observed for CNN Multi-Path (Cohen’s effect
size d > 1.3), which also was more effective than Linear-RISH harmonisation (Cohen’s effect
size d > 0.5) and global image scaling (Cohen’s effect size d > 0.4) for all four images (Table
7.4 in Appendix). The Linear-RISH harmonisation failed to harmonise SH of the 4th order
(RISH4) and could not significantly reduce differences between b0 images. This could be a
reason why RMSEs between FA and MD maps were increased after Linear-RISH harmon-
isation. Nonetheless, this could also be a consequence of previous processing steps: The
RMSE computed for validation is based on averaging on voxel-wise differences between the
harmonised images and the coregistered Trio scans. The CNN was trained on the match-
ing pairs of Prisma and coregistered Trio scans, hence could learn a direct mapping to the
coregistered Trio scans, later also used for validation. In contrast, the linear RISH feature
scaling maps were computed from spatially normalised images warped directly from the na-
tive space. This means a mapping between intensities of native Prisma and Trio scans was
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learned instead of native Prisma and coregistered Trio scans. Examination of regional mean
FA confirmed this hypothesis. The neural network was able to best project Prisma scans
to coregistered Trio scans. However, coregistered Trio scans introduced a bias that lowered
the FA values. This might be caused by intensity interpolation and rotation of b-vectors
during the coregistration. The mapping learned by the neural network also adapted to that
bias. Consequently, FA values after CNN harmonisation were much lower than the target
Trio FA intensity domain. For clinical applications, researchers will have to take this and
the model complexity into consideration to choose an appropriate harmonisation method.
For the control subject of both databases, MUSHAC and CENTER-TBI, the harmoni-
sation methods are qualitatively comparable. While all methods could effectively minimise
the RMSE between scans, the CNN with multiple pathways was overall more successful in
reducing the scanner differences. This was particularly evident for RISH features of higher
order (RISH2 and RISH4). For b0 and RISH0 images the benefits of CNN Multi-Path har-
monisation was not as prominent in the MUSHAC database than in the CENTER-TBI
database. As described above, data for one outlier subject were not harmonised well, which
shows the sensitivity of neural networks to such outliers.
5.4.2 Enhancement of Scaling Maps Through Post-Processing
The standard approach of linear RISH feature scaling involves computing scaling maps for
the expected values of RISH features (i.e. the average image per scanner) in template space
and apply these to SH coefficients after backprojection to native space. Inherently, there is
a disconnection between RISH features maps, that are the sum of squared SH coefficients,
and the SH images themselves. While RISH0 feature maps are only derived from one SH
image, higher order RISH features condense information from several SH images. With less
structured signal distribution in higher order SH images, the RISH features might be less
representative of SH coefficients on a voxel-wise level. Denoising images with a median filter
generally can remove speckles. For RISH feature scaling maps this means removing voxels
that are disconnected between RISH and SH images and avoid arbitrary scaling. This was
observed to be beneficial on RISH4 images, however, merely to recover the original inter-
scanner differences. A similar observation was made for Gaussian filter, but its blurring
effect was disadvantageous for more structured images such as the b0 image. Although the
benefits of denoising scaling maps were marginal, this experiment revealed a general flaw in
the concept of SH coefficient scaling via RISH features.
The linear RISH feature scaling was later on improved by including an adaptive approach
to compute the scaling maps [187]. This idea of selecting subjects to derive the scaling
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factors was applied to CENTER-TBI data. Furthermore, this was extended by computing
weighted averages of feature maps, instead of a strict subselection of a few subjects, to derive
scaling maps. Overall, these approaches resulted in very similar performances. However, the
selection of a few subjects did not bring the previously reported boost in performance. This
may be explained by the previous observation that an optimal performance was achieved
with a minimum of 16 training subjects used to calculate expected RISH feature values
[126]. Including more subjects leads to smoother average images hence less speckled scaling
maps, which further would improve scaling of higher order RISH features. Indeed, selection
of the three most similar subjects resulted in noisier scaling maps and was a disadvantage
for RISH4 images. This is coherent with the previous observation that smoother RISH4
scaling maps led to better data harmonisation. The voxel-wise weighting to compute scaling
factors was most beneficial for RISH4 feature maps, as it is most capable to adapt to the
unstructured intensities for each individual test subject.
5.4.3 Application to Traumatic Brain Injury Data
Both differences between scanners and patient groups with good and poor outcome were too
subtle to be measured on a region-wise level. This made it difficult to estimate the impact of
mapping intensities via ROI-wise scaling. The more complex neural network resulted in the
adversary effect of reduced FA. As mentioned above this is likely due to a learned mapping
between Prisma and coregistered Trio scans, rather than the raw Trio data. Important is
also the observation that the FA difference between patients with good and poor outcome
slightly increased. The models presented in the literature and in this chapter are usually
trained on control subjects. This could particularly be problematic for TBI, as the model
learns to project diffusion metrics that appear healthy, but possibly will fail for outlier
intensities associated with subtle pathology. This could lead to an artificial enhancement of
differences between patient groups.
The examined methods are based on a one-to-one mapping between scanners. This is not
necessarily feasible for a large multi-centre study, such as CENTER-TBI, that includes
more than ten acquisition sites. Not only is it computationally expensive to compute one
model for each mapping, but there is not yet a consensus how to pick the optimal reference
site to harmonise all data to. Regarding the CENTER-TBI database, there are many other
challenges to overcome. By design only a maximum of nine healthy controls were scanned at
each site. With at least 16 subjects required for an optimal mapping between scanners [126],
the Linear-RISH harmonisation might not be suitable, in particular, as Cambridge was the
only CENTER-TBI site that collected data for the same controls on all available scanners.
Both the acquisition protocol and the scanned volunteers will differ between imaging sites.
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This and the limited number of control subjects makes it much harder - or even impossible
- to match control scans across sites, which hampers the computation of adequate scaling
maps.
5.4.4 Future Work
The experiments presented in this chapter have shown that neural networks have the capa-
bility to learn a mapping between different scanner domains. However, the models presented
here and compared previously [238] rely on matched scans of travelling volunteers, which
often are not available for multi-centre studies. The Linear-RISH harmonisation has been
successfully applied to larger databases without travelling volunteers [32, 225], but require at
least 16 well matched control subjects [126]. There have been efforts to compute mappings
between RISH feature images via deep learning models that do not rely on directly matched
control subjects [127], however, these are based on Cycle-GANs [285], which are difficult to
train. In addition, any machine learning model will perform best on its training data. To
avoid a bias, training subjects would need to be excluded from any following analysis. For
a study with limited number of healthy volunteers, such as CENTER-TBI, control subjects
could be used for data harmonisation, but not for any subsequent analysis. Future investi-
gation will need to look into harmonisation methods focusing on limited data and explore
ideas how to incorporate non-imaging patient data to avoid introducing any biases.
A further development is the simultaneous harmonisation of scans from multiple sites. The
VAE introduced by Moyer et al. [182] learns scanner independent representations between
several scanners, hence could be useful for a multi-centre study. The auto-encoder out-
performed Linear-RISH harmonisation, however, could still be improved by using a larger
receptive field (patches instead on directly adjacent neighbour voxels). Furthermore, it could
benefit from including multiple-pathways for the different SH orders. The VAE could also be
extended to use more variables than just the site/scanner identifier as covariates. This could
possibly allow to include patient data as well. A recent study has successfully shown the
joint reconstruction of diffusion metrics from multiple-sites, while simultaneously reducing
scanner biases [244]. Such a model could possibly be adapted to fit control and TBI patient
data together to minimise inter-site variation while preserving information from pathological
diffusion.
Besides the use of more data, covariates or different neural network architectures, the cost
function to train the model is also worth investigating more in the future. The FSCNet
optimised the network parameters not only by computing the loss function between SH im-
ages but also RISH feature maps, that were computed from harmonised signal throughout
the training phase. Likewise, the VAE designed by Moyer et al. [182] incorporated both
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differences between SH and DWI images.
5.5 Chapter Summary
This chapter examined different methods for diffusion MRI harmonisation. The results
showed that neural networks are best at learning a non-linear mapping between scanners
based on SH representation. Thereby, it was highlighted that different orders of SH benefit
from being processed separately on multiple neural network pathways. The experiments
also revealed potential pitfalls, such as, for example, relying the harmonisation on coregis-
tered data. Here, it was shown that coregistering data from the reference site changed the
diffusion signal. Mapping data from the source site to such modified data from the reference
site may result in a skewed data harmonisation. Further investigation is needed to make
harmonisation a reliable processing step for clinical multi-centre databases.
Chapter 6
Lesions Analysis in Severe TBI
6.1 Introduction
Examination of brain lesions is a broad research field for many different pathologies. In
contrast to other brain diseases that may show distinct patterns across patients (e.g. multiple
sclerosis or stroke), TBI lesions are very heterogeneous showing a wide range of severity [21].
Dependent on the strength and site of the external force impacting the head, traumatically
induced pathologies may include focal lesion masses, such as contusions and haematomas, or
diffuse axonal and microvascular injury. Although injuries are predominately focal or diffuse,
most lesions consist of both components [172] and vary greatly in size, shape and location. To
add to the complexity, secondary brain injuries evolve long time after the traumatic incident
[40] leading to changing lesion patterns and eventually to late-life consequences [25, 172, 257].
Understanding lesion formation and evolution throughout different stages post-injury is
crucial to gain insight into traumatic head injuries and ultimately improve patient outcome.
Therefore, many studies have been undertaken to identify and characterise TBI lesions
[73, 170, 271]. Detecting abnormalities is indeed a very challenging task in itself and the first
step to analyse lesions. Therefore, much justifiable research has been conducted to detect
brain lesions on MR images [13, 110, 159]. However, far less attention has been given to
subsequent analysis strategies to derive clinically valuable information from segmented brain
lesions. Once the lesions have been manually or automatically outlined on the brain scans,
the total lesion volumes can be quickly computed. Gaining a comprehensive understanding
of the pathology, however, requires further effort. Imagine two lesions on different scans with
the exact same total volume. While one lesion may affect one large region within the brain,
the other could be separated in smaller clusters more widely distributed. Many smaller
lesion clusters may have a different effect than one large lesion, despite in sum having the
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same volume. Nonetheless, in a simple volumetric assessment both lesions would appear to
be equal. Besides that, a lesion in one brain region could be more detrimental than a lesion
of similar size found in another. Thus, lesions may be better characterised by assessing their
volume as well as their location and distribution within the brain.
6.1.1 Motivation from a Clinical Research Perspective
The following section describes some examples of TBI research in which lesion location was
linked to clinical variables, such as patient outcome. The focus lies here on visible lesions
(e.g. contusions or oedema apparent on FLAIR scans), that could be annotated and visu-
ally located by the naked eye. Latent lesions that manifest for example as changed diffusion
metrics based on ROI analysis or voxel-wise statistics will not be considered.
Moen et al. [180] evaluated the prognostic value of visible traumatic axonal injuries by
identifying and counting lesions on several MRI contrasts. Analysing 641 severe TBI pa-
tients, revealed that the number of DWI lesions and the volume of FLAIR lesions in the
CC, brainstem and thalamus were predictive of patient outcome measured by the GOSE.
The number of cortical contusions on MRI scans were more informative for moderate TBI
patients [180]. Another study that included longitudinal data with acute and chronic scans
from 16 TBI patients found lesion volumes correlated with patient outcome. It was dis-
covered that only larger TBI lesions in the temporal lobes, as found on GRE and FLAIR
scans, were connected to brain tissue volume loss. Such lesions could be associated with
worse neuropsychological outcome.2 In contrast, tissue atrophy was not tied to frontally
located lesions and their volumes seemed to have no impact on patients outcome scores.
This study, however, was only based on 16 TBI patients, with 11 lesions detected in the
frontal lobes [169]. A comparative study used different MRI contrasts to qualitatively assess
lesion locations in 38 TBI patients. For this, the brains were subdivided into a superficial,
deep and posterior fossa brain zone. Lesions were only associated with a single zone, and in
case the lesion crossed more than one zone it was assigned to the zone containing most of
the lesion. This revealed that volumes, number and regional distribution of early T2w and
FLAIR lesions were useful to distinguish patients with good and bad outcome (dichotomised
by Glasgow outcome scale [GOS]3 score). The latter was associated with larger volumes and
higher lesion numbers. Particularly, median total volumes of lesions in the superficial zone
were most consistently disseminating between different patient outcomes. The authors hy-
1the study included a total of 128 moderate or severe TBI cases
2oral and written Symbol Digit Modalities Test
31: Death, 2: Neurodegenerative state, 3: Severe disability, 4: Moderate disability, 5: Good recovery
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pothesised that this might be because the superficial zone comprises the four major brain
lobes, hence includes most of the brain volumes. However, there was not differentiation
between subcortical WM and cortical areas. Susceptibility weighted images were found to
be beneficial to highlight intraparenchymal injury, but weakly linked to outcome scores [35].
Furthermore, neurocognitive effects4 of TBI were studied in 71 patients. Lesion location
was estimated qualitatively by associating them to different brain zones, such as for exam-
ple prefrontal cortex or temporal lobe. Large prefrontal lesions were linked to an impaired
performance in the neurocognitive tests assessed. Patients with lesions that were located in
and beyond the frontal regions had the worst test performance [155].
While head trauma is an incidental event, the brain injury is often progressing during the
first hours after impact. This is due to expansion or development of new hemorrhagic le-
sions after cerebral contusions. Since this could result in tissue with likely unrecoverable
loss of function, it is important to study lesion development to gain better understanding
of secondary brain injury [143]. Rehman et al. [213] have studied the progression of hemor-
rhagic contusions in 246 patients with TBI that underwent an initial and follow-up (within
24h) computer tomography (CT) scan. Contusion volumes on CT scans were manually esti-
mated by measuring lesion diameters and counting the affected image slices (this approach
to estimate lesion volume is also known as the ABC method). Progression was defined as
an increase of > 30% of the initial volume [213]. Furthermore, the location, laterality and
multiplicity of the lesion was assessed through visual inspection. Hemorrhagic contusion
progression could be associated to initially large contusion volumes (> 20 ml) and low score
on the GCS. A retrospective study of 491 TBI patients with admission and follow-up CT
scans within 72 hours revealed a progression of intra-parenchymal haemorrhage for three
quarters of the patients. Thereby, the lesion expanded on average by approximately 62%
(∼ 5 ml). Several factors were found to contribute to the rate of haemorrhage progression,
but lesion volume on the admission CT seemed most predictive [29].
6.1.2 General Concept for Lesion Localisation
Figure 6.1 displays an example of a MR scans showing a TBI with two different lesion clusters
that were annotated manually (Figure 6.1 B). The lesion is clearly visible on different MRI
contrast images such as FLAIR (Figure 6.1 A) and T1w (Figure 6.1 C). In order to locate
the lesion, it has to be seen in context with anatomical regions within the brain. Once the
brain is divided into meaningful areas, the overlap between the lesion annotation and each
region provides information about the lesion’s location. One way to define this overlap is to
4performance in gambling test
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calculate the relative volume of a lesion that lies within a particular brain region (e.g. 20%
of the lesion is within left middle frontal gyrus). To automatically parcellate the brain in
subregions, the multi-atlas tool MALP-EM was chosen as it has been shown to deal well with
distorted brain anatomy [151]. Nonetheless, lesion pathology often introduces an additional
challenge for parcellation algorithms. Brain parcellation via MALP-EM is based on locally
non-linear registration of multiple atlases and a subsequent refinement of the regions by
means of expectation maximisation. While this latter adjustment is highly advantageous
to improve region segmentation, it is also sensitive to abnormal intensity profiles in the
images. Therefore, in the presence of lesions the algorithm could be hindered in its ability
to parcellate the brain into anatomical plausible regions leading to corrupted segmentations
(see right top corner within the brain Figure 6.1 D). Comparing any lesion segmentation
to the erroneous region atlas would be flawed and lead to incorrect results. Alternative
brain parcellation methods, such as FreeSurfer’s recon-all, would also suffer from distorted
parcellations since these algorithms were not designed to cope with large lesions. Thus,
instead of using an accurate but lesion-sensitive algorithm, the idea is to use an estimate
for the brain parcellation that was derived by projecting the MALP-EM atlas of a healthy
subject population onto a patient’s brain. While not perfectly accurate, this parcellation will
be more robust. This idea of atlas registration to a lesioned brain is not new and has been
employed to localise stroke lesions [137], however, it has not been widely adopted for TBI
research, in which lesions are often located via visual inspection. Further methodological
details will be described later on.
Figure 6.1: Problematic of Automated Brain Parcellation via MALP-EM in Presence of
Lesions. On a FLAIR scan (A) of lesioned brain, two clusters were identified and manually
annotated (B). Since the lesion is also prevalent on the T1w scan (C), the brain region par-
cellation, driven by the T1w image intensities, are disturbed (D different regions highlighted
in different colours, see right top corner within the brain).
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6.1.3 Assessment of Lesion Progression
Lesions observed in patients suffering from TBI are vastly heterogeneous. To gain a better
understanding of pathological changes over time, lesions need to be compared across longi-
tudinal scans. The usual approach for analysis is the use of manual lesion annotations to
evaluate the lesion burden at different time points. Previous studies mostly assessed lesions
by measuring the total lesion volume [213, 277] and counting the number of lesions as seen
on different imaging contrast (FLAIR, SWI, etc.) [11, 78]. However, comparing total lesion
volumes over time may oversimplify the evolution of individual lesion clusters. For example
the tissue recovery from a small lesion could go unnoticed when a different lesion cluster on
the same scans substantially grew. Measuring the total lesion volume for comparison across
time points would show an increase in lesion burden, while failing to reflect the salvageable
tissue. Therefore, it may be important to examine individual lesion clusters independently
to capture more nuanced changes. For a direct comparison, single lesion clusters will need
to be matched between scans. In other words, for each lesion cluster found on the initial
scan the corresponding part in the follow-up scan needs to be identified. With increasing
numbers of patients in recent imaging studies, the tracking of each lesion part across longi-
tudinal scans can be a tedious task, and calls for automated approaches to measure lesion
changes. Automated lesion matching across scans, however, bears many challenges. At
first, a spatial correspondence between both scans needs to be established. Two scans of
a healthy subject could be registered rigidly, assuming the scans were acquired temporally
close, as no brain tissue atrophy is expected. However, TBI patients may display different
pathological patterns at different stages, as brain tissue swelling and deformation can take
place at different time points post-injury [108]. Thus, a deformable registration is often more
successful to bring brain tissues in alignment. Secondly, lesions in the two scans will need to
be matched depending on their spatial overlap. This is simple for one large, corresponding
lesion in both scans, and is fairly straight-forward to generalise for several lesion clusters as
long as their number remains constant across scans. However, this becomes quickly more
complicated when lesions dissolve or newly form, or one big lesion partially recovers such
that is appears to split into several smaller lesion clusters at a later stage. Algorithms to
match lesions will need to account for this variability in lesion evolution.
6.1.4 Aims
The aim of this chapter is to introduce two approaches to localise TBI lesions and estimate
longitudinal lesion changes. Both methods were designed to be fully automated, without
the need for an expert to decide via visual inspection where the lesion are located or how
164 CHAPTER 6. LESIONS ANALYSIS IN SEVERE TBI
they evolve. Applied to a cohort of severe TBI patients, the localisation algorithm was used
to examine in which brain areas TBI lesions are found predominantly. Experiments will
also investigate differences for cohorts scanned on two different scanners as a case study for
potential variability in multi-centre data. Furthermore, locations of lesions will be assessed
for three different time points after injury. Lesion characteristics, such as volume and loca-
tion, will be estimated both in template and subject-space to compare the validity of both
approaches. A registration-based algorithm for matching lesions between longitudinal scans
will be introduced. This methods will then be validated qualitatively and used to examine
lesion changes over time in a subset of TBI patients.
6.2 Data & Methods
6.2.1 Severe TBI Database
Following experiments made use of a severe TBI patient cohort scanned on a Siemens Prisma
and Verio scanner. For both scanners T1w image were acquired with the same sequence
parameters as follows: TR = 2300ms, TE = 2.98ms, TI = 900ms and FOV read = 256
mm with percent phase FOV= 93.8% and a flip angle of 9 degrees. The FLAIR scans were
acquired with TR = 27840ms, TE = 95ms, TI = 2500ms and FOV read = 224 mm with
percent phase FOV= 80.8% and a flip angle of 9 degrees. Various lesion types and artefacts
were manually annotated by clinicians. However, the focus laid on the contusion core and
oedema, seen on FLAIR images, as these have been delineated within this database most
frequently. The database included 112 patients with scans at different time points after
injury. Patient were scanned fairly evenly on both scanners (Trio: 59 patients, Verio: 53
patients). In total there were 187 scan sessions with both T1w and FLAIR images. All of
these had a manually annotated oedema lesion. Contusion cores were annotated on 183 of
those FLAIR scans. Manual segmentations were generate by a clinical expert outlining both
lesion types (contusion and oedema) on FLAIR scans by means of ImSeg, an in-house tool5 to
view and annotate medical images. The selected data were processed via the structural MRI
pipeline (Section 2.3), so that the bias field corrected and spatially normalised T1w images
as well as coregistered FLAIR sequences were available afterwards. Further processing steps
for lesion localisation and longitudinal matching will be described below.
5originally developed by Microsoft Research
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6.2.2 Localisation of Lesions
The inverse of the transformation from T1w space to the Cam-CAN template from the
structural MRI pipeline was used to backproject the template’s MALP-EM ROI atlas to
each individual T1w scan. Thereby, nearest neighbour interpolation was chosen to keep
the integer ROI labels intact. The transformation for coregistering FLAIR to T1w images
was applied to the manually created binary lesion maps of FLAIR contusion and oedema,
again using nearest neighbour interpolation. Both projections led to the alignment of an
uncorrupted ROI atlas (i.e. the healthy subjects Cam-CAN ROI atlas) and the binary lesion
maps within a subject’s T1w image space. In practice the backprojection of the ROIs could
lead to part of the lesion not being covered by the atlas. To prevent this, the ROIs in the
template atlas were fully expanded to cover the whole FOV within template space. For
this, each voxel without ROI label was assigned the one of the closest ROI (estimated via
Euclidean distance). Backprojecting this expanded template atlas ensured full coverage of
any lesion. Figure 6.2 shows two examples of the original MALP-EM atlas along side the
backprojected Cam-CAN ROI atlas.
Figure 6.2: Comparison of Original and Projected Parcellation. Each row shows axial
slices of two example subjects. The first column show the T1w MR scan that was used
for brain parcellation. The corresponding FLAIR images (second column) clearly shows
the contusion core and oedema (e.g. hyper-intense regions in the frontal brain regions).
When subdividing the lesioned brains into brain regions via MALP-EM (third column) an
erroneous parcellation could be observed (white arrows). In contrast, backprojecting the
parcellation of the Cam-CAN template shows a less lesion-affected parcellation, albeit not
as precise (fourth column)
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An in-house python implementation took the aligned atlas and lesion maps as input and
first split the binary lesion annotation into individual lesion clusters by means of connected
component analysis (measure.label algorithm from the skimage python library). Then, for
each lesion cluster the overlap with all 138 MALP-EM ROIs was computed as the ratio of
the lesion volume within the particular ROI and the total lesion volume. Besides this lesion
overlap, further characteristics were computed automatically. This included the total lesion
volume, the average lesion cluster volume, the number of lesion clusters as well as the lesion
distribution, computed as the average distance between the centres of lesion clusters to one
and another.
For an alternative group-wise comparison, lesions were also directly projected from na-
tive FLAIR space to Cam-CAN space. This was achieved by applying transformations
from coregistration and spatial normalisation simultaneously to avoid multiple interpolation
steps (one nearest neighbour interpolation). To quantify the occurrence of lesions in tem-
plate space, the projected binary lesion maps were averaged to compute a probability map,
indicating each location’s relative frequency to have been labelled as FLAIR contusion core
or oedema. The mean value of these probability maps within the ROIs of the Cam-CAN
MALP-EM atlas were used to determine a region’s group-wise lesion burden/occurrence. A
comparison of the lesion burden at different time points after the incidental brain injury
was used to estimate a lesion type’s progression within the cohort. All projections were
performed with the antsApplyTransforms tool.
6.2.3 Longitudinal Lesion Matching
Subjects from the severe TBI database were selected when they have had a FLAIR con-
tusion core and oedema manually annotated on both a hyper-acute (scan within 72 hours)
and an acute follow-up scan approximately one week post injury. These inclusion criteria
were fulfilled by 21 patients (DPI [mean±std]: 1.3±0.6 or 7.6±2.1 for the hyper-acute and
acute stage, respectively).
Figure 6.3 schematically visualises the registration-based approach for longitudinal lesion
matching. At first, FLAIR scans were rigidly registered to the corresponding T1w im-
age at each scan session (Figure 6.3: 1. Coregistration to T1w Images). This alignment
has been completed as part of the structural MRI processing pipeline as discussed earlier
(Section 2.3) Afterwards the T1w scans from the hyper-acute and acute phases were regis-
tered to one and another to create a subject-specific template (Figure 6.3: 2. T1w Image
Registration). For this, the follow-up scan was at first rigidly aligned to the early scan.
Afterwards both scans were repeatedly registered to the common template, that was the
average of the aligned images of the previous registration stage. The iterative registration
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process entailed three affine and three deformable registrations. Within the subset of 21
patients, initial and follow-up scans showed strong anatomical deviance, which is why a
deformable registration was required to ensure an optimal spatial overlap between lesions
in both scans. Eventually, the NCC was computed between the last registered images and
the particular subject-specific template, to flag any cases of failed registration. High NCC
scores (average NCC=0.953±0.028) and a visual quality check confirmed the success of the
template creation process. The final deformable transformations were then applied together
with the rigid transformation, found during FLAIR image coregistration, to the FLAIR
lesions maps. This projected the delineated lesion labels with a single interpolation step
from native FLAIR to subject-specific template space. Subsequently, projected lesions were
split into individual lesion clusters, to categorise all unconnected parts of the binary lesion
map. Thereafter, the overlap between each lesion cluster within both scans was computed
to match individual lesion parts to one another (Figure 6.3: 3. Lesion Projection & Match-
ing). All matched scan pairs were visually inspected and no obvious errors, such as wrongly
assigned labels between corresponding lesion cluster, were observed. Nine lesion clusters in
total were excluded, as their volume was 1 mm3 (which corresponded to one voxel in this
database) because the registration based matching algorithm was not expected to have a
single voxel precision. Eventually, the volume of each separate lesion cluster in native T1w
scan space could be associated with the matched clusters (Figure 6.3: 4. Derive Informa-
tion from Matched Lesions). This allowed to measure the volume change, unbiased by the
deformable registration, for individual clusters between scans. Lesion volumes were derived
from binary lesions in T1w space as lesion maps are normalised to isotropic voxel space.
6.3 Results
6.3.1 Group-Wise Lesion Burden Across Scanners
After spatial normalisation of T1w images and the projection of FLAIR lesions to Cam-
CAN template space the binary maps were averaged for both scanners separately to detect
predispositions in both patient groups (in the following referred to as Trio and Verio pa-
tients/scans depending on the MR scanner model). The results presented include 89 and
96 lesion maps from Trio scans for contusion core and oedema, respectively. From Verio
scans, 92 contusion core and 89 contusion oedema annotations were found. The probability
maps of the projected lesion maps are displayed in Figure 6.4. While patient groups on both
scanners showed contusion cores predominantly in frontal brain regions, subjects scanned
on Trio had a higher lesion burden in the right hemisphere (i.e. left hand side on the image
168 CHAPTER 6. LESIONS ANALYSIS IN SEVERE TBI
Figure 6.3: Schematic Overview of Lesion Matching Between Longitudinal Scans. At first,
the sequence images with annotate lesions (here FLAIR) were linearly coregistered to cor-
responding T1w images. Secondly, a subject-specific template was generated by iteratively
registering T1w images from two different time points. This was followed by projecting
lesion annotations (red & blue outlines) directly from native to template space. Spatial
alignment allowed to computing overlaps between all different lesion clusters from longitudi-
nal scans to match lesions (yellow & green) and identify single lesions (purple). Eventually,
this association between scans was propagated to lesion annotations on T1w images to derive
characteristics for matched lesion clusters.
with radiological orientation). In contrast, Verio patients revealed a higher lesion density in
the left hemisphere (right side of image). Contusion oedema were more evenly distributed
in both hemispheres for Trio and Verio patients, but also much wider spread than contusion
cores. Additionally, a much higher occurrence of oedema was found in the Verio patients.
For the two patient groups from both scanners, the highest occurrence of contusion cores
was detected in the anterior orbital gyrus (frontal lobe). Thereby, lesions were found slightly
more often on the right (ROI #45: 6.4%) then on the left (ROI #46 4.0%) for Trio patients,
and vice versa for Verio scans (right ROI #45: 6.7%, left ROI #46: 8.4%), Generally, a
tendency for higher lesion density within the right frontal lobe was observed for Trio scans
with comparable high mean probability value in the medial orbital (ROI #81: 2.8%), in-
ferior frontal (ROI #97: 2.8%) and posterior orbital (ROI #111: 3.0%) gyri. In contrast,
contusion cores on Verio scans were more likely to be in the left frontal lobe, in partic-
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Figure 6.4: Distribution of FLAIR Contusion Core and Oedema. All axial slices show the
Cam-CAN T1w template overlayed with the lesion probability maps displayed as jet map
ranging between 0-10%. The two images on the left hand side show the distribution of
the contusion cores for all subjects and time points separated by scanner (Trio & Verio).
The Trio patients had a higher lesion occurrence in the right frontal lobe (left image side)
compared to Verio patients, that displayed a stronger contusion core presence in the left
frontal lobe (right image side). For both patient groups lesions are dominant in the frontal
areas, but also spread across temporal lobes. The two images on the right show the contusion
oedema probability maps for both patient groups. Overall, oedema is much more widely
distributed over the whole brain and fairly evenly present in both hemispheres than core
lesions. Noticeable is the high occurrence of oedema in the frontal lobes for patients imaged
on the Verio scanner. (radiological orientation)
ular in the lateral orbital (ROI #72: 4.9%) and inferior frontal (ROI #98: 4.0%) gyri.
These findings are in coherence with the previous visual observations in Figure 6.4. Besides
this opposite laterality, contusion cores were also found in the medial-frontal cortex (ROI
#76: Trio=5.6%, Verio=10.7%) and the posterior orbital gyrus (ROI #112: Trio=5.3%,
Verio=11.1%) of the frontal lobe in either of the two patient groups. Furthermore, the left
(planum polare - ROI #114: Trio=6.5%, Verio=11.9%) and right (temporal pole - ROI
#134: Trio=5.5%, Verio=11.9%) temporal lobes were affected.
Oedema was found to be mostly present in the right frontal lobe (anterior orbital gyrus -
ROI #45: 5.3%) for Trio patients and more often in the left inferior frontal gyrus (frontal
lobe - ROI #98: 12.7%) for Verio patients. Overall, contusion oedema had occurred much
more in Verio than Trio patients (lesion burden for top five ROIs: Trio∼5%, Verio∼10%).
6.3.2 Lesion Volume Progression After TBI
All scans were subdivided into three classes according to the acquisition time point mea-
sured. These were the hyper-acute (≤72 hours post-injury), acute (∼1-2 weeks post-injury)
and subacute (∼1-3 months post-injury) stages. The selected number of scans was fairly
comparable, ranging from 44 to 71 (Table 6.1), for all three defined time windows. The
number of scans were mostly balanced between both scanners (Trio:40, Verio: 60%) across
all time points. The comparison of total lesion volumes within Cam-CAN space revealed
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that contusion cores were much smaller (≈10-15 cm3) than oedemas (≈30-55 cm3) during
all three observed stages. Both, core and oedema seemed to be on average largest during
the acute phase. However, while the contusion core volume increased by approximately 15%
from the hyper-acute to the acute stage, oedema expanded on average by 81% within the
same time frame (Table 6.1).














hyper-acute 1.8 ± 0.8 [0, 3] 59 (35/24) 12.8 ± 19.9
acute 7.1 ± 2.5 [4, 12] 71 (31/40) 14.7 ± 22.2






a hyper-acute 1.8 ± 0.8 [0, 3] 61 (37/24) 30.6 ± 39.6
acute 7.0 ± 2.4 [4, 12] 71 (32/39) 55.4 ± 54.7
sub-acute 26.2± 16.4 [13, 91] 43 (19/24) 30.9 ± 42.9
∗Total volume in Cam-CAN template space
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Figure 6.5 shows the occurrence of both lesion core and oedema throughout the different time
points on one axial slice. Both lesion types were most prevalent in the acute phase, where
they spread over frontal and temporal lobes. Although already present in the hyper-acute
stage, in particular oedemas seemed to be much more dominant during the acute phase,
indicating a delayed development. The strong presence of oedemas appeared to diminish
with more time passing after the incident of the traumatic injury. These visual observations
were in agreement with the previous quantitative analysis.
Figure 6.5: Progression of Contusion Core and Oedema after TBI. The probability maps of
contusion core and oedema at different time points are displayed as overlays of the Cam-
CAN T1w template. Both lesion types were most prominent during the acute phase. Lesions
occurred predominantly in the frontal and temporal lobes. All jet colour maps ranging
between 0-10%. (radiological orientation)
A subset of 21 subjects (11/10 Trio/Verio; 7/14 female/male; average age: 42.6 ± 17.2;
initial GCS: 6.4 ± 3.1) was selected which had an available manual annotation of contusion
core and oedema at the hyper-acute (mean ± std [min, max] DPI = 1.3 ± 0.6 [1, 3]) and
acute (DPI = 7.6 ± 2.0 [5, 11]) stages. For this subset of subjects the total core lesion
volume (measured in T1w space) was on average indistinguishable (paired t-test: p=0.5990)
between the hyper-acute (19.5 ± 25.5 cm3) and the acute (18.5 ± 24.9 cm3) phases. In
contrast the total lesion volume of oedema showed a substantial (paired t-test: p<0.001)
growth between the hyper-acute (40.1 ± 47.5) and acute (58.4 ± 55.6) stages. Thirteen
subjects had on average a 37.0% (range: [0.2%-98.5%]) smaller core lesion volume in the
acute phase than in comparison in the hyper-acute phase. Six other subjects showed a
moderate 22.9% (range: [2.1%-76.2%]) core lesion growth from the hyper-acute to the acute
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phase. Only two patients experienced substantial core volume increase (465.7% and 587.4%).
Five subjects showed a small shrinkage of oedema volume (17.4% on average, range: [0.2%-
40.2%]), while the other 17 patients experienced an oedema growth (105.9% on average,
range: [0.3%-310.4%]) from the hyper-acute to the acute phase. Not only did more patients
have an increased oedema lesion, but also the volume expansion was greater (76.5%) than
that for core tissue.6 Measured by the GOS scores, there was a tendency of better outcome
for patients with contusion core lesion shrinkage (number of patients: 13, average GOS:
3.6) in comparison to patients with core lesion volume growth (number of patients: 8,
average GOS: 2.8). However, low sample numbers and small differences did not manifest
statistically (t-test: p-value=0.1067). A similar trend was not observed for oedema volume
change, remarking again the unbalanced ratio between patients with oedema volume loss
(5) and gain (17).
6.3.3 Subject-Wise Cross-Scanner Comparison of Lesions
Location. After locating all contusion cores and oedemas for all subjects separately (Sec-
tion 6.2.2), the relative frequency of lesion occurrence was estimated within each region.
For this, a patient’s brain region was counted as affected, whenever any part of the lesion
was found within that parcellated area. This low threshold (effectively one voxel would be
enough to count the lesion as affected) was chosen as any other arbitrary threshold (e.g.
50% of the lesion must be in a region to be affected) would need to be justified empirically.
It is acknowledged here that this makes the count of affected lesions very sensitive. For both
Trio and Verio scans the most frequently affected regions were the left (ROI #16: Trio =
36.8% scans, Verio = 37.1% scans) and right cerebral WM (ROI #17: Trio=32.9% scans,
Verio=28.1% scans). This means, more than a third of the patients’ scans had at least a
part of the contusion core within WM regions. Approximately, 7-8% of the scans displayed
a contusion core within cortical regions such as the orbital, frontal and temporal gyri. On
average, approximately 30%-60% of the contusion core volume was laying in one of those
mentioned regions. This was cohesive with the group-wise analysis showing a higher lesion
load in frontal and temporal areas of the brains. Likewise, oedemas most frequently were
found in the cerebral WM for cohorts scanned on both scanners (left ROI #16: Trio =
41.4% scans, Verio = 35.4% scans; and right ROI #17: Trio = 31.0% scans, Verio = 33.8%
scans). Furthermore, the right superior frontal (ROI #121: Trio = 10.2% scans, Verio =
9.4% scans) and the left middle frontal (ROI #78: Trio & Verio = 8.8% scans) gyri were
affected by oedema.
6excluding the two patients with major core volume increase
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Volumes & Distribution. The average volumes of contusion core lesion clusters were
similar for both scanners (Trio: 1.5±2.6 cm3, Verio: 1.5±2.8 cm3; t-test: p = 0.4006). In
contrast to that, oedemas for patients scanned on Verio (6.5±6.3 cm3) were larger than for
the cohort imaged on Trio (3.9±6.3 cm3; t-test: p = 0.0009). Oedemas were generally larger
than lesion cores. The distance between individual lesion clusters on single scans averaged
between approximately 5.5-5.9 cm and were comparable for both scanners (Trio & Verio)
and lesion types (core & oedema). Unsurprisingly, the mean FLAIR intensities within the
annotated lesions were different for the two scanners, as no intensity harmonisation was
performed.7 Generally, oedema displayed higher intensities than contusion cores. However,
mean intensities were lower on Trio than on Verio for both core lesions (Trio=310.5, Ve-
rio=399.4) and oedema (Trio=411.6, Verio=500.0). Interestingly, mean intensities in Verio
cores seemed closer to Trio oedema (‖∆‖ = 12.2)8 than both the differences between mean
intensities of core (‖∆‖ = 88.9) and oedema (‖∆‖ = 88.4) across scanners.
6.3.4 Subject-Wise Lesion Characteristics on Longitudinal Scans
Location. Counting the instances where at least one part of the MALP-EM ROI was
affected by core lesion tissue (overlap between atlas ROI and annotated lesions), showed
again that the most affected regions where left and right cerebral WM throughout all three
imaging stages (hyper-acute/acute/sub-acute).
Approximately 30-40% of the scans showed an overlap with cerebral WM in at least one
brain hemisphere. For both regions the average lesion overlap was highest during the acute
phase (ROI #16: 61.0%, ROI #17: 56.6%, see Figure 6.6 left), and lower for hyper-acute
ROI #16: 53.5%, ROI #17: 45.9%) and sub-acute stages (ROI #16: 52.1%, ROI #17:
47.7%). In both brain hemispheres the superior frontal gyrus (left: ROI #121, right: ROI
#122) as well as the temporal pole (left: ROI #133, right: #134) were affected with similar
frequency in 7-11% of the scans. Both superior frontal gyrus regions displayed a higher
average overlap in the hyper-acute phase (ROI #121: 49.6%, ROI #122: 45.3%) than in
the acute (ROI #121: 32.2%, ROI #122: 35.5%) or sub-acute phases (ROI #121: 39.0%,
ROI #122: 18.8%). Although lesions overlapping with the left temporal pole (ROI #133)
were progressively larger (hyper-acute: 53.5%, acute: 61.8%, sub-acute: 67.8%) no obvious
difference was found for the right counterpart (ROI #134 ∼55-58%, see Figure 6.6 left).
Likewise 30-40% of the scans showed oedema overlapping with the cerebral WM regions.
Generally, proportional overlap of oedema lesions with particular regions tended to be lower
7Adjusting intensities across scanners in lesioned brains in non-trivial and standard approaches such as
histogram matching can have an adversary effect.
8‖∆‖ representing here the absolute intensity difference.
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than that found for contusion cores. This was a side effect of oedema being larger and
more widespread across several regions. Nonetheless, the average overlap with cerebral WM
seemed slightly larger in the acute (ROI #16: 53.5%, ROI #17: 53.3%) than in the hyper-
acute stage (ROI #16: 48.9%, ROI #17: 49.0%, see Figure 6.6 right), which could indicate a
growth in lesion volume after 72 hours post-injury. Other areas affected by oedema were the
left posterior orbital gyrus (ROI #112) and the superior frontal gyri (ROI #121 & #122).
For these regions, however, the overlap tended to decrease with more time after injury
(e.g. ROI #112 - hyper-acute: 21.0%, acute: 5.8%, sub-acute: 9.1% or ROI #122 - hyper-
acute: 35.2%, acute: 29.5%, sub-acute: 24.3%). A similar but less prominent tendency was
observed for the left middle frontal gyrus (ROI #78 - hyper-acute: 31.7%, acute: 31.2%,
sub-acute: 27.6%).
Figure 6.6: Lesion Overlap at Different Phases Post-Injury. Left: Average overlap of core
lesions with MALP-EM ROIs. Displayed are lesions that were most frequently affected. The
overlaps vary depending on the anatomical regions. While core lesion seem to overlap with
cerebral WM (16 & 17) more during the acute phase, superior frontal gyri (121 & 122) show
a decrease in overlap from hyper-acute to acute stage. An opposite effect was observed for
temporal poles (133 & 134), for which the overlap appeared to steadily increase with time
after injury. Right: On average oedema overlap was highest for WM regions (16 & 17),
which seemed larger after the hyper-acute phase. Other areas such as the middle frontal
gyrus (78), the posterior orbital (112) gyrus and the superior frontal (121 & 122) gyri were
affect less by oedema. For these the overlap seemed to diminish with more time after injury.
Whiskers show the full range of ROI overlap. X-axes show the different MALP-EM ROIs.
Volumes. For all three time windows lesion volumes strongly varied for different subjects
(Figure 6.7). Table 6.2 summarises the characteristics of the lesions found in T1w space for
all subjects. The total volume of the contusion core lesions during the hyper-acute phase
averaged to 12.9 cm3. Considering the whole cohort together, the core lesion volume seemed
to slightly increase during the acute time window (14.3 cm3) and then shrunk below the
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initial state with more time elapsed after the injury (sub-acute: 10.0 cm3). A statistical
significance of total volume difference for the three time points, however, was not detected
(ANOVA: p=0.5044).
Comparing the individual core lesion clusters showed similar average volumes during the
hyper-acute (1.2 cm3) and acute (1.3 cm3) imaging time points, however, the maximum
number of clusters increased. This could indicate that a tendency for larger total core lesion
volumes may be attributed to development of new small core lesions, rather than growth
of the initial lesions. In contrast, individual clusters seemed to have become bigger during
the sub-acute phase (1.8 cm3), but both the average and maximum number of clusters was
decreased (6 and 19, respectively). This could suggest that some core lesion tissue was
salvaged, while other core lesions expanded. The observed trend for the change in cluster
volumes was not statistically supported (ANOVA: p=0.4037).
Figure 6.7: Longitudinal Comparison of Contusion Lesion Volumes Post-Injury. Left: Total
volumes of manually annotated FLAIR contusion cores seemed to be mostly stable across
all three considered time points centring around 10-15 cm3 and not exceeding 100 cm3.
In contrast oedema volume seemed to expand (∼50 cm3) after 72 hours during the acute
phase, but residing to the initial state in the sub-acute phase (∼30 cm3). Oedema volumes
were found to be on average much lager than core volumes. Right: Volumes of individual
core clusters appeared to grow marginally with more time elapsed post injury. Comparable
to total volumes, single clusters of oedema expanded during the acute phase, but resolved
at the later sub-acute stage. Note, y-axis for cluster volumes was restricted to 2 cm3 for
visualisation purposes (90% of all found clusters had a volume below 2 cm3). Whiskers show
the full range of lesion volumes.
A growth of total contusion oedema volume from hyper-acute (30.5 cm3) to acute (54.9 cm3)
stage was much more prominent than for core tissue (ANOVA: p=0.0022, post-hoc t-test:
p=0.0025). The scans acquired during the sub-acute stage showed on average lesion volume
(30.5 cm3) that was closer to the initial state when imaged within 72 hours (ANOVA:
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hyper-acute 12.9[4.5]±19.3 1.2[0.06]±5.7 11[9, 34]
acute 14.3[4.9]±20.2 1.3[0.09]±5.3 11[9, 39]






a hyper-acute 30.5[13.9]±38.5 3.6[0.16]±14.5 8[6, 24]
acute 54.9[43.7]±50.9 6.0[0.17]±20.4 9[8, 31]
sub-acute 30.5[15.8]±39.7 4.3[0.10]±16.9 7[6, 29]
1Total lesion volume [cm3] found in T1w space; 2Average volume [cm3] of lesion clusters
found in T1w space; 3Minimum number of found cluster for all stages was 1
p=0.0022, post-hoc t-test p=0.9909). The observation (Table 6.2) of an early growth of
oedema in the acute phase and its subsidence in the sub-acute stage (ANOVA: p=0.0022,
post-hoc t-test: acute vs. sub-acute p=0.0010) is in alignment with the previous results
from the group-wise analysis in Cam-CAN space. Both the maximum number of clusters
and their average lesion volume increased during the acute phase, and followed the trend
of the total lesion volumes. However, a statistically significant volume change of individual
lesion clusters across the three time points was not found (ANOVA: p=0.0629).
A linear correlation between total lesion volume and DPI was neither found for core lesions
(Spearman correlation coefficient ρ=-0.04, p=0.61) nor for oedema (Spearman correlation
coefficient ρ=-0.02, p=0.74). This underlines the findings in Figure 6.7 and Table 6.2, where
a lesion growth was observed between hyper-acute and acute phase, but lesion volumes
seemed to shrink between acute and sub-acute stage. However, a correlation between the
volume of lesion clusters against DPI could not be rejected (Spearman correlation coefficient:
Core: ρ=0.12, p<0.001; Oedema: ρ=-0.07, p=0.01). The results from volume differences for
different time points and the correlation with DPI emphasised the non-linear development
of lesions. These did not monotonically grow or subside within the first three months post
injury.
6.3.5 Automated Lesion Matching
The same 21 subjects as before (Section 6.3.2) were used to match individual lesion clusters
between the hyper-acute and acute scans (Section 6.2.3). Three selected subjects with
lesion annotations in subject-specific template space are displayed in Figure 6.8. This shows
not only the successful alignment between subjects despite severe pathology, but also the
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association of individual lesion clusters between the two imaging time points. Despite the
change in size or vanishing contusion, large contusion clusters were easily matched across
scans (Patient B & C). For smaller lesions, the matching might be challenging when clusters
do not show an overlap. On the other hand, the algorithm was able to separate contusion
core clusters in spite of close proximity (Patient A - blue & green). The association of
oedema clusters between hyper-acute and acute scans was consistently successful, even with
many new forming clusters (Patient A - green, blue & red).
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Figure 6.8: Examples of Matched Contusions between Hyper-Acute and Acute Scans. Each
row shows a different patient’s FLAIR scans from the two different time points with outlines
of the manual lesion annotations for contusion core and oedemas. Outlines with the same
colours indicate matched lesion clusters for each individual lesion type (e.g. hyper-acute and
acute core clusters matched). Patient A: One contusion cluster was successfully matched
(red). Two other clusters were recognised as independent (blue & green) since there was
no spatial overlap. The detailed scope view highlights the spatial separation between both
clusters, nonetheless, both clusters might belong to the same pathological structure. New
oedema formed after the hyper-acute scan (red, green & blue), while the existing clusters
(orange & purple) were matched to the right clusters at a later stage. Note, the orange
cluster appears only separated on this axial slice. Patient B: Despite vanishing core lesion
(red), the 2nd cluster was matched adequate (blue). Successful matching of oedema clusters.
Patient C: Both two core lesions (red & blue) and growing oedema were associated correctly
across scans. All scans in subject-specific template space, image intensities were minimally
adjusted for better visualisation. (radiological orientation)
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Table 6.3: Volume Changes of Matched TBI Contusion Clusters. Volumes displayed mean
[min, max]






































































All: Considering all lesion cluster volumes of 21 severe TBI patients. Forming: Lesion
clusters that were not present during hyper-acute phase but were visible on the acute scans.
Growing: Matched lesion clusters with larger volumes during acute than hyper-acute phase.
Shrinking: Matched lesion clusters with smaller volumes during acute than hyper-acute
phase (negative growth). Vanishing: Lesion clusters in the hyper-acute phase, that were
not observed in the acute phase.×Number of clusters found on either of the hyper-acute and
acute scan. +Growth was defined as the volume difference between matched clusters divided
by the hyper-acute cluster volume, negative growth indicated a loss in lesion volume.
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Table 6.3 summarises the volume and the growth of the matched lesion clusters. Almost half
(∼47.0%) of the contusion core clusters vanished from the hyper-acute to the acute phase.
Noteworthy is that those were overall small lesions with average volumes of 100 mm3 (and
not exceeding 1.7 cm3). Approximately a fifth (∼20.0%) of all core clusters were not present
during the hyper-acute phase, but developed later, hence, were only visible on the acute MR
scans. Similarly to the vanishing clusters, the forming cluster volume averaged to 100 mm3,
however, with a slightly higher maximum volume (3.1 cm3). The rest of the core clusters
were either growing or shrinking, whereas slightly more clusters seemed to grow (∼18.5%)
than shrink (∼14.5%). While clusters shrunk about a third (∼32.4%) in volume, growth
was much more pronounced (∼128.8%). On average, growing clusters were initially smaller
(2.5 cm3) than shrinking clusters (5.3 cm3) during the hyper-acute stage. This difference
was almost eradicated at the acute imaging phase (3.2 cm3 and 4.0 cm3 for growing and
shrinking cluster volumes, respectively). Although core lesion clusters grew more than they
shrunk, much more clusters vanished than newly formed between the hyper-acute and acute
phases. So, although there is a measurable change for individual lesion clusters the overall
burden due to contusion lesions might be consistent over time.
Fewer clusters were found for oedemas, which is likely due to their larger volumes and less
fragmented distribution. Indeed, during both imaging stages, oedema lesions were much
larger than core cluster volumes. With a substantial growth between hyper-acute and acute
injury phases. Roughly a third (∼36.0%) of the oedema clusters formed after 72 hours post
injury and were only observed on the acute scan. Another third (∼33.5%) were present
on the hyper-acute scans, but were not observed on the acute scan anymore. Both of these
cluster types showed low average volumes, whereas newly forming clusters (mean: 400 mm3,
max: 5.4 cm3) tend to be slightly larger than vanishing clusters (mean: 200 mm3, max: 1.5
cm3). Oedema lesions were observed to grow more (137.0%) than they shrank (35.0%).
With comparable numbers and volumes of forming and vanishing clusters, oedema lesion
burden seemed to increase after 72 hours.
Table 6.4 shows the total volume changes of contusion cores and oedemas between the
hyper-acute and acute phase for the individual subjects. The majority of subjects (16)
showed a gain in oedema volume, whereas seven patients experienced an increase in total
core lesion tissue (Patients 1-7). The other nine patients (Patients 9-17) showed lower core
lesion volumes. Shrinking oedema lesions were observed only in five patients (Patients 8 &
18-21), which was accompanied by contusion core growth exclusively for one single patient
(Patient 8). This highlighted the tendency of growing oedema and shrinking core lesions
volumes between the hyper-acute and the acute stage after injury.
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Table 6.4: Patient-Wise Changes of Contusion Core and Oedema Volumes. Total volume
differences (∆) between hyper-acute and acute stage listed in cm3 except for marked (×)
values, that are shown in mm3.
Core Oedema
Patient ∆ Growth Loss Total+ ∆ Growth Loss Total+
1 2.2 5.6% 2.4% 3.3% 26.7 21.7% 0.3% 21.4%
2 4.7 15.2% 2.9% 12.3% 15.5 31.7% 8.3% 23.4%
3 12.6 17.1% 1.9% 15.2% 47.6 29.6% 1.5% 28.1%
4 0.3 13.4% 11.3% 2.1% 14.2 44.2% 0.4% 43.8%
5 9.0 470.3% 4.7% 465.6% 12.3 46.0% 0.0% 46.0%
6 4.2 619.9% 32.4% 587.4% 4.1 149.0% 67.0% 81.9%
7 0.1 144.6% 68.4% 76.2% 32.0 220.8% 0.0% 220.7%
8 6.0 29.7% 1.6% 28.1% -1.1 5.1% 7.2% -2.1%
9 -2× 3.5% 7.0% -3.5% 3× 41.6% 41.4% 0.3%
10 -1.8 3.2% 31.7% -28.4% 1.6 9.2% 4.1% 5.1%
11 -6.9 2.7% 29.2% -26.5% 41.9 64.0% 0.6% 63.4%
12 -2.9 1.4% 18.7% -17.2% 32.0 97.2% 0.0% 97.2%
13 -0.2 24.9% 46.8% -21.9% 8.5 148.5% 22.6% 125.9%
14 -5.2 0.5% 70.2% -69.7% 19.0 147.5% 6.9% 140.6%
15 -3.5 4.2% 24.3% -20.0% 36.4 227.8% 7.2% 220.6%
16 -34.9 1.0% 46.8% -45.8% 59.5 270.2% 5.2% 265.0%
17 -3.9 9.3% 33.8% -24.5% 39.4 314.1% 3.8% 310.4%
18 -1.4 1.5% 100.0% -98.5% -4.0 0.0% 40.2% -40.2%
19 -44× 0.0% 66.7% -66.7% -0.1 27.2% 61.3% -34.1%
20 -0.5 2.7% 61.1% -58.4% -0.3 29.8% 40.0% -10.2%
21 -31× 2.1% 2.3% -0.2% -0.2 0.9% 1.0% -0.2%
Sorting according to total lesion change (Total): Patients 1-7: Growth of both core and
oedema lesions. Subject 8: Contusion core growth but oedema shrinkage. Patients 9-17:
Shrinking contusion core, but growing oedema. Patients 18-21: Both lesions decreased
overall in size. +Positive and negative values represent a total gain or loss of volume, respec-
tively.
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For many patients, the total lesion volume change reflected the underlying changes of lesion
clusters. This was particularly true for patients where either lesion volume gain or loss,
was dominant compared to the other. Exemplary was the oedema lesion development of
patient 4 (dominant oedema growth): The growth of the oedema volume (44.2%) was much
more prominent as its observed volume loss (0.4%). Therefore, the total oedema volume
change (43.8%) accurately represents the overall development of oedema size. Similarly for
patient 14 (dominant core loss), for which the contusion core clusters hardly grew (0.5%),
but the core lesion volume substantially decreased (70.2%). Hence, the total measured
volume loss (-69.7%) accurately reflected the overall change in contusion core size. However,
some patients’ overall lesion volume failed to represent both the gain and loss of lesion
tissue (printed bold in Table 6.4). Total contusion core change for patient 7 was observed
as 76.2%. Although there was a great growth in lesion volume (144.6%), the substantial
decrease in contusion core lesions of 68.4% was missed when measuring only the total lesion
change (0.1 cm3). Similarly, patient 6 experienced a substantial growth in oedema lesion
volume (149.0%). Although this was accompanied by a considerable loss of oedema lesion
volume (67.0%) as well, this was not reflected in the total oedema lesion change of 4.1 cm3
(81.9%). In contrast, patient 13 showed a total loss of contusion core volume of -21.9%,
while missing a lesion growth of 24.9%. Likewise, a total decrease of oedema volume was
observed for patient 19 (-34.1%), which reflected a combination of substantial oedema lesion
growth (27.2%) and loss (61.3%). Noteworthy, apart from patient 6 the total core/oedema
lesion volume differences of the four mentioned examples are below 0.3 cm3.
6.4 Discussion
6.4.1 Summary of Findings
The analysis of group-wise lesion burden showed opposite uni-lateral dominance of contusion
cores in the two TBI patient cohorts scanned either on Trio or Verio. Oedema was found
to be more evenly distributed in both hemispheres for both patient groups, however, more
strongly present in patients scanned on Verio. While categorising the patients according
to the used MR scanner was arbitrary and their opposing lesion locations is likely due to
coincidental difference in trauma impact site, it highlights the heterogeneity of TBI patient
cohorts. This advocates for an analysis of large patient database across multiple imaging
sites to capture the heterogeneity in TBI cohorts and avoid any site-specific biases. For
example, a machine learning model for automated lesion segmentation trained on data from
one scanner could learn that lesions are predominantly in one hemisphere. But when applied
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to a different cohort with lesions in both or the opposite hemisphere (as seen in core lesions
for Verio and Trio scans, Figure 6.4), the segmentation algorithm may perform poorly due
to its site-specific bias introduced by the skewed training data. Contusion cores were mostly
found in the frontal and temporal lobes. This is in agreement with previous reports of con-
tusions appearing in brain tissue that comes in contact with irregular bony protuberances
of the skull [172].
Lesion volumes were found to be largest during the acute phase (1-2 weeks post injury).
Examining a subset of 21 subjects showed that the total lesion volume of contusion cores
either grew moderately or often also decreased in a later stage post-injury. In contrast, most
of the selected subject experienced a growth of oedema volume, which strongly expanded
between the hyper-acute and acute stage. This is in agreement with previous studies, which
also have reported a delayed appearance of oedema after a few hours post injury and the
increase to its peak volume a few days later [108, 203]. There are two types of oedema,
cytotoxic and vasogenic. The former is characterised by an increase in water content in the
intra-cellular space caused by dysfunctional ion pumps that fail to regulate cell osmolarity.
An unbalanced ion gradient results in influx of extracellular water into the cells [56]. In
contrast, vasogenic oedema is caused by water movement from the vasculature system to
extracellular compartment due to an impaired blood–brain barrier (BBB). Both types of
oedema occur in TBI in a biphasic profile. Vasogenic oedema emerges within the first few
hours after TBI. This is followed by cytotoxic oedema which develops more slowly over few
days and can persisted for up to 2 weeks [56]. The increased oedema volume during the
acute phase for the available data (time frame after injury: mean [min, max] = 7 [4, 12] DPI,
see Table 6.1), may indicate the observed oedema is of cytotoxic nature. Examination of the
BBB has shown, that its permeability is highest at 4-6 hours after TBI and the commences
to close over the week following TBI. The recovery of the integrity of the BBB is the reason
why oedema stop increasing after a few days and subside eventually during the sub-acute
phase [56].
The subject-wise analysis of lesion location showed that cerebral WM regions were most
frequently affected. One reason for this is the fact that the WM regions defined by the
MALP-EM atlas are spanning the largest area within the brain. Therefore, any fairly large
lesion will almost certainly be at least partially within one of the cerebral WM regions. The
specificity of WM lesions could be increased by incorporating a more detailed subdivision
of the WM areas. Besides WM, contusion cores were observed in frontal, temporal and
orbital gyri. Hee Kwak et al. [97] have recently reported that patients with frontal lesions
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showed higher agitation (e.g. aggressiveness, restlessness or mood swings measured by on
the Agitated Behaviour Scale) and poorer performance in executive and emotional functions
(measured by Wisconsin Card Sorting Test, for more detail the reader is referred to [83, 97]).
These metrics were not available for the cohort presented in this chapter. Future investiga-
tions will have to tie together radiological observations with behavioural data. Furthermore,
contusions in the temporal lobes may be associated with with worse functional outcome after
six months [275].
While the average lesion cluster volume of contusion cores was similar for both patient co-
horts, oedema volumes were larger for the patient group scanned on Verio. The differences in
volumes might be explained by the fact that oedema volumes were largest during the acute
phase, and proportionally more acute scans were acquired on Verio (∼45%) than on Trio
(∼36%). Since MRI intensities are not standardised, another difference was found between
FLAIR intensity distributions between both lesion types and scanners. Such potential bias
between scanners will need to be considered and prevented for predictive models built for
multi-centre image analysis. For example, lesion segmentation tools dependent on image
intensities may fail to segment lesion adequately and lesion volumes might be under- or
overestimated.
Comparing the lesions for the three time points, showed that overlap with cerebral WM
was largest during the acute phase for both lesion types examined. This could indicate
a growth in lesion volume. However, the overlap with smaller ROIs (e.g. middle frontal
gyrus) simultaneously decreased. Potentially, the lesion could shrink within smaller regions,
increasing the relative portion of lesion within the large lesion without actually increasing
the overlap. Therefore, the metric of lesion overlap with certain regions needs to be consid-
ered together with lesion volumes.
The lesion matching algorithm introduced in this chapter showed potential, however, it
might face challenges in the presence of small lesion clusters. For almost half of the anno-
tated core lesion clusters on hyper-acute scans no corresponding cluster on the follow-up
scan was found. Although this might indicate actually dissolving contusion core lesions, it
also highlights the difficulty to match lesions of small volumes. Smaller lesions are more
challenging to associate across scans, since their size lowers the chance of a spatial overlap
after spatial alignment of both scans. Furthermore, small lesions are much harder to detect
and may have been missed at the annotation stage. Small lesions, however, are less likely to
progress [1], hence may not lead to major behavioural deficits. Nonetheless, the automated
lesion matching between hyper-acute and acute scans was successful for larger lesions. Since
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contusion core lesions are naturally smaller than oedema, the former are more prone to in-
accurate matching. Therefore, analysis based on the suggested automated lesion matching
approach should take into account lesion type and size. Matching individual lesion clusters
across longitudinal scans could provide better insight of lesion volume gain and loss. This
separation, rather than a single value for total volume change, may potentially be more
suitable to differentiate between patients with good and poor outcome.
6.4.2 Limitations of Study
Localisation. The results presented showed that TBI lesions could be located automati-
cally within the brain, however, this remains a challenging problem. The current approach
is strongly dependent on the successful spatial normalisation of a patient’s brain scan to
the Cam-CAN template. For severely deformed brains this could be error prone, and re-
sults will need to be considered cautiously. Assuming the spatial normalisation has worked
sufficiently well, the backprojected template ROI atlas shows an average brain anatomy
and does not perfectly align with subjects individual structures. Since it is unlikely that
a patient underwent a MRI scan prior, but timely close to the TBI, the comparison of a
lesioned brain to its true healthy anatomy is practically impossible. The suggested approach
builds on the assumption that lesions affect tissue without any occurring deformations of
anatomical regions. For example, a lesion in one region could cause swelling, pushing other
tissue compartments aside, but leaves them otherwise unaffected. Such dislocated, but still
functional brain tissue would not be captured by projecting a healthy atlas onto the lesion
scans, but would require complex physical modelling of brain tissue properties. Nonethe-
less, for a general estimate of lesion location, particularly for larger lesions, superimposing
a healthy brain atlas has worked sufficiently for the available data.
Quantification. With the successful alignment of lesion maps and anatomical atlas, quan-
tifying lesion localisation is far from trivial. One of the metrics introduced in this chapter
is the lesion overlap with an anatomical region, which was defined as the volumetric pro-
portion of a lesion cluster associated with a particular ROI. However, this measure does
not represent the lesion burden by itself. For example two lesions could both half overlap
(50% proportion within ROI) with the same region, but the region’s lesion burden could be
drastically different depending on the lesion size. The straight-forward way to measure a
region’s lesion burden would be to compute the percentage of a region that is covered by a
lesion, but because lesions clusters often have low volumes in comparison to the anatomical
region, the measured lesion burden can be vanishing small. Thus, subtle differentiation of
small lesions would be numerically difficult. Quantifying lesion burden will need to be a
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combination of lesion location, size, shape and co-occurrence with other lesion types.
Lesion Matching. The approach suggested for lesion matching was based on image reg-
istration. This is challenging for heavily distorted brains, and will have a direct impact
on the lesion matching performance. While mostly unproblematic for large lesions, small
lesion clusters are more prone to not be paired across corresponding scans. As shown earlier,
small contusion cores that were spatially apart were classified as independent core clusters,
while they might actually belong to the same pathology (Figure 6.8 Patient A - Core). The
insufficient overlap of lesion clusters could be a result of inadequate spatial correspondence
or interpolation errors of lesion masks introduced by the registration. Findings suggested
that vanishing and newly forming lesions have all lesion sizes below 0.5 cm3. While it makes
sense, that rather smaller than larger lesion were salvageable and formed at a later stage,
this indicated strong built-in biases against matching small lesions successfully. Firstly,
small lesions are generally harder to detect and to annotate, which is why small lesions
might be missing on the initial or follow-up scan. If indeed detected on both scans, finding
an overlap of small lesions via registering is much less robust than for large volumes. So
the suggested approach of lesion matching via spatial correspondence, might only be robust
for larger lesions. Although tracking the progression of individual lesion clusters was more
informative than measuring the change in total lesion volume for a few subjects, the results
did not clearly support the need for lesion matching. Considering the results as proof of
concept, future experiments will need to focus on larger cohorts to understand the benefits
of matching individual lesion clusters for overall lesion progression.
Sample Size. The presented analysis was based on manually lesion annotations. Al-
though many scans were visually inspected to label lesions, finding patients that fulfilled
all requirements (e.g. delineated contusion core and oedema on both hyper-acute and acute
scans) quickly reduced the sample size (here: 21). While this allowed to test algorithmic
concepts and per case studies, it is challenging to draw more than simple and general con-
clusions. This holds especially true for TBI cohorts as patients are very different to one and
another. High variability of lesion characteristics (size and location), demographics (age at
injury, sex) as well as clinical observations (initial injury severity, responsiveness) hinder
correlation of lesion findings to patient outcome.
6.4.3 Future Work
As mentioned, the heterogeneity of TBI patients makes it hard to find similar patterns of
lesion development within a small cohort. Since manual lesion labelling is time-consuming,
the generation of an annotated dataset is limited. However, with an automated lesion seg-
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mentation tool [125] it will be possible create lesion maps for a larger TBI database. The
same concepts for lesion localisation and matching will then be applicable to analyse le-
sion changes in an extended patient cohort. This will also help to further find strength
and weaknesses of the algorithms here suggested to examine lesions. Besides expanding the
available data, both the lesion localisation and the lesion matching algorithms can further
be improved. One obvious choice for future enhancement will be to use a more detailed
WM atlas, that allows a more refined localisation of sub-cortical lesions. In addition, a more
advanced algorithm could be developed that builds upon MALP-EM, that allows full brain
parcellation in the presence of lesions. One option would be to build a predictive model,
that learns to remove lesions [65, 205] on a scan such that MALP-EM could be applied
to pseudo-healthy brains without corrupting the underlying multi-atlas projection by the
present lesions. However, removal of pathology via inpainting is a challenging open research
question and this approach would still rely on MALP-EM’s time consuming parcellation.
Alternatively, a model could be build that predicts ROI parcellations [153, 158] and lesion
segmentation simultaneously [57, 85].
The lesion matching algorithm associated clusters when there was any overlap, however, as
discussed previously small lesions may not overlap despite belonging to the same pathology.
One possibility to avoid missed matching could be to connect smaller lesion clusters when
they are in very close proximity and have not been associated with any other clusters. A
threshold for maximum distance would need to be found empirically. Another enhancement
could be to build a graph connecting lesion clusters within the same and across longitudinal
scans to find a better correspondence between clusters. Although it is unclear how the dif-
ferent number of lesions would affect the structure of such a graph. Matching lesion clusters
by proximity and graph metrics would need extensive visual validation. The lesion matching
algorithm could be tested on synthetic data, however, generating artificial TBI lesions that
is challenging due to heterogeneous location and appearance. Furthermore, TBI lesions may
cause brain tissue deformation, why is difficult to simulate. So, synthetic lesions possibly
do not reflect the complexity found in real TBI data.
Eventually, information from both lesion location and changes over time could be combined
to fully characterise lesions. This could further be used to predict outcome measures in a
larger cohort to distinguish patients with different outcomes. One limitation of the experi-
ments presented in the chapter is the link to outcome metrics (i.e. GOS), which might be
to crude. Future investigations should also focus on examining correlations between lesion
derived metrics and more nuanced cognitive behaviour or symptom scale. For example the
Rivermead Post Concussion Symptoms Questionnaire [62, 131] could be used. Comprised
of 16 questions concerned with physical, cognitive and behavioural symptoms it provides a
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more detailed insight in a patient’s well-being. A larger sample size in combination with
a more elaborated analysis of cognitive deficits and behavioural changes will also be more
conclusive, whether longitudinal matching of individual lesion clusters actually will have a
clinical impact.
6.5 Chapter Summary
In this chapter, two concepts for a fully automated lesion analysis were examined: Firstly,
atlas registration-based lesion localisation (which has previously applied to other disorders,
such as stroke [137]), and secondly, lesion cluster matching between longitudinal MR scans.
Their potential was explored for manually annotated contusion cores and oedema found on
FLAIR scans of TBI patients. Lesions were located based on their overlap with regions of
the MALP-EM atlas. Visual inspection has shown the superiority of the backprojection of
a healthy atlas over a using the MALP-EM parcellation calculated for individual patients.
Although less detailed, the former showed better robustness in the presence of lesions visible
on T1w scans. Contusion cores and oedema were found to be predominantly in frontal and
temporal regions. Lesion volumes were generally larger for oedema, and seemed to expand
after the hyper-acute phase, but may grow or resolved later on. The overlap of lesions
with specific atlas ROIs showed a strong bias towards region size (e.g. large cerebral WM
regions were most frequently affected) and more precise metrics may need to be derived to
gain a better insight. The lesion matching between hyper-acute to acute MR scans showed
promising results for larger lesions. However, small lesions were found to be more prone to
failed matching. Despite the difficulty of accurate segmentation, lesions of lower volumes
naturally have smaller chance of overlap between with corresponding lesions, which may
limit the application of these methods. Enhancing the association of lesions between scans
through more sophisticated methods could help to improve the matching of smaller lesions.
Chapter 7
Summary
With the recognition of the potential of large sample sizes and the previously unseen avail-
ability of data, the field of neuroimaging is experiencing a shift towards big data science.
To answer more complex clinical research questions, new collaborations are formed to built
multi-centre studies that acquire thousands of MRI scans. This goes hand in hand with new
innovative analysis tools, such as deep learning, that both demand and foster the collection
of large datasets. While they need many samples to fit adequately to a data distribution,
they also allow to learn complex relations in data that could not easily be explored before.
Although big databases open up new opportunities for clinical research and data science,
they also come with challenges. These include efficient data management as well as identifi-
cation of biases and heterogeneity within the databases. This thesis aimed to address some
of the challenges in the light of TBI analysis.
7.1 Summary of Findings
Data Analysis Pipelines. At first, two complementary pipelines were introduced for
pre-processing structural or diffusion MRI scans. Both were designed with efficiency and
flexibility in mind. The pipelines run independently for each subject, which allowed to
process multiple scan sessions on a high performance computing cluster in parallel. The
goal was a balance between accurate processing steps and minimised computation time.
The structural pipeline first and foremost processes T1w images, however, also incorporates
processing of other structural scans if available (e.g. FLAIR, T2w, SWI). For example,
any provided complementary scan is coregistered to the T1w images, and additional feature
maps are calculated (e.g. FLAIR2). The diffusion pipeline allows to process DWI data with
and without an extra b0 image to apply EPI distortion correction. Furthermore, diffusion
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parameter maps are coregistered to T1w space to make use of the T1w brain mask and
allow multi-parametric data analysis that may require voxel-wise correspondence between
T1w and diffusion images. Additionally, the pipeline automatically recognises multi-shell
acquisitions and then applies free water elimination and kurtosis fitting. Besides extract-
ing image derived features useful for clinical neuroscience, both pipelines provide several
quality metrics which can be used to ensure the image usability and assess the accuracy of
pre-processing steps. Quality control metrics were shown to pick up on scans with artefacts
such as excessive head motion or noise corrupted images.
Application to Mild TBI. Both pipelines were employed to analyse mTBI data in a
retrospective multi-centre study including three imaging sites. The heterogeneity of the
data posed both possibilities and challenges. Scanning patients with varying severity of
mTBI internationally bears the potential for the pooled database to reflect the spectrum
of mTBI more accurately. However, differences in data collection scheme (e.g. scan time
point after injury) and acquisition parameters hampered a straight-forward analysis. Despite
rectifying data differences (e.g. using single-shell data exclusively) and applying the same
processing pipeline, site-specific biases remained. To account for this, data were Z-scored
and the acquisition site was used as covariate in the regression analysis. The focus laid on
regional loss of brain tissue and changes in diffusion patterns. A comparison of control sub-
jects and patients with different outcome revealed that patients with good outcome showed
similar IDPs as control subjects. In contrast, patients with poor outcome experienced tissue
atrophy, demonstrated as enlarged ventricles, and decreased FA indicating impaired WM
integrity. Mean diffusivity was less sensitive to differences between controls and patient
groups. Neither anatomical brain volumes nor diffusion parameters were found to be pre-
dictive of patient outcome. This suggested that injuries may not deviate strongly enough to
separate between patient cohorts during the acute phase. The longitudinal analysis showed
progressive tissue atrophy and changes of diffusion, suggesting IDPs may vary more between
patient groups at a more chronic stage. However, there was no clear indicator that patients
with poor outcome had stronger tissue atrophy or quicker deterioration of WM integrity.
Predicting the outcome of mTBI patients remains a difficult problem, and it might be easier
to assess how control-like the imaging features of a patient are.
Reproducibility of MRI Metrics. Combining different databases appropriately is chal-
lenging. To foster multi-centre studies it is important to understand the MR image repro-
ducibility and its dependency on factors such as different acquisition parameters or scanners
employed. For adequate analysis, the processing tools chosen to extract image features need
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to be as robust to site-specific biases as possible. The analysis of whole brain parcellation
(MALP-EM) revealed regional volume differences for the same subjects imaged on differ-
ent scanners. The deviations could me minimised by standardising volumes to total brain
volumes or partly by normalising image intensity prior to the ROI parcellation. Generally,
smaller regions were more challenging to segment and showed higher variation when scans
were acquired on different scanners or with different MR parameters. A registration based
parcellation of WM (JHU) was found to be more robust to different MRI parameters than
a model based ROI segmentation (TractSeg). However, registration was observed to be
less precise in defining region boundaries. Besides ROI volumes, diffusion metrics were also
found to be dependent on the acquisition scheme. Applying a different number of gradi-
ents of different strength and duration (single or multiple b-values) had an impact on both
FA and MD. In particular, single-shell acquisition showed more variation in diffusion pa-
rameters than scans acquired on several shells. Overall, findings suggest that more similar
parameters lead to less variation. Nonetheless, even with closely matched protocols image
quality remains dependent on hardware settings. Pooling data from multiple different sites
and scanners showed that variation did not exceed the highest variation found in individual
databases.
Harmonisation of DWI for Multi-Centre Studies. With improved data available and
the development of data-hungry algorithms, studies aim to increase sample sizes. Despite
the effort of designing large prospective multi-centre studies, there is a demand to harmonise
data across acquisition sites. Some promising methods were examined in depth to better un-
derstand their potential under a fair comparison. The previously reported success of linear
scaling of SH coefficients via RISH feature mapping could only partly be reproduced in the
experiments presented here. In particular higher order SH coefficients could not easily be
mapped between scanners. Enhancements of scaling maps had only minor positive impact.
In contrast, neural networks were shown to be more beneficial to learn non-local mappings
between diffusion data to reduce site-specific biases. However, model based approaches were
less robust to outliers than, for example, linear RISH feature scaling. The experiments also
showed that neural networks could indeed profit from learning different feature maps on
the various SH images of different orders. A caveat was that the designed neural networks
were trained to learn a mapping between coregistered scans. Coregistering images resulted
in decreased FA values for the data used for the experiments presented here. Consequently,
the neural network learned to shift data to the wrong image domain (i.e. the coregistered
images rather than the images in native space), which is why neural networks underper-
formed. Despite showing some potential to minimise site-specific variations, a benefit for
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application to TBI patient data could not be observed.
Lesions Analysis in Severe TBI. Besides the analysis of mTBI, patients with more
severe injuries were examined as well. One important factor in TBI is the presence and
location of lesions visible on MR images. In the available dataset, FLAIR contusion cores
and oedema were mostly found in the frontal and temporal lobes. Comparing two cohorts
imaged on different scanners showed that contusions were predominately in opposite brain
hemispheres. Although this is unrelated to the scanners employed, it highlighted potential
variations in different cohorts across centres. The longitudinal data revealed that volumes
for contusion cores initially grew in the acute phase, but seemed to shrink or vanish later on.
In contrast, oedema volumes consistently increased with time post-injury. The algorithm
introduced to match lesions between initial and follow up scans was successful for larger
lesions. Therefore, measuring the lesion development of individual clusters has the potential
to be more informative than simply assessing the total lesion volume.
7.2 Limitations & Future Directions
Data Analysis Pipelines. An obvious change for the pipeline will be to exchange tools
for newer methods to keep the processing pipeline state of the art. This will involve the
integration of improved methods such as, for example, reducing noise in diffusion weighted
images. To streamline the pipelines even more, some modules will need to be replaced to
accelerate processing steps. For example, instead of relying on registration (MALP-EM),
the brain parcellation could be predicted by machine learning models. With respect to TBI,
an important new extension of the pipeline will be the automated lesion segmentation and
derivation of clinically relevant information such as the lesion location. Another extension
will be the use of machine learning models trained on QC metrics to identify corrupted scans
and processing steps. This will be more beneficial than relying on finding empirical thresh-
olds for each particular QC metric to flag suspicious scans. Apart from that, the usability
could be improved. The current state of the pipeline is easily applicable via command line,
however, this might be challenging for the less trained clinical researcher. A better interface
could strongly improve usability. A challenge will be to anticipate as many different scenar-
ios as possible. The more flexible the pipeline will be, the higher the chance data will be
processed inadequately.
Application to Mild TBI. Appropriate study design and processing becomes even more
important if data from different databases are used. The pipelines were flexible enough to
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allow their application to three different mTBI databases. Processing steps were mostly
equally, but site-specific biases remained. Although these were also accounted for via Z-
scoring and linear regression modelling, it is not entirely clear whether biases could be fully
eliminated. For example, the higher shell diffusion data from Trondheim were disregarded
which likely had a positive effect on the comparability of MD across centres. However, an-
gular resolution - that rather influences FA than MD - was different across sites. This may
have left FA more vulnerable to site-specific biases. These could be helpful in differentiating
subjects based on their origin of acquisition, since the cohorts from the sites examined had
different severities of injury (Trondheim patients had experienced milder TBI than Turku
patients). Indeed, FA showed a higher sensitivity to differentiate controls and patient groups
than MD. Future investigations will need to focus on better harmonisation strategies as well
as being more patient-specific to combat the heterogeneity in imaging data and TBI cohorts.
Furthermore, the data could be enhanced in two folds. Either increasing the sample size,
by for example including CENTER-TBI data, or by exploiting multi-shell acquisition for
better diffusion modelling (i.e. DKI and free-water elimination). The latter would need to
rely on Trondheim data only.
Reproducibility of MRI Metrics. Experiments have shown the influence of MRI acquisi-
tion on image derived features (volumes and diffusion). Any study that pools data acquired
on different scanners and/or with different parameters will be affected by site-specific bi-
ases, and analysis will need to account for that. Various datasets with different sources of
variation were examined to understand their impact on image derived features. However,
influences of various parameters were still very much entangled, and more experiments are
needed to better understand the effect of single parameters. Although different acquisition
schemes affected WM parcellation, a bigger challenge was the segmentation of WM tracts
on Philips scanners. Since TractSeg is a predictive model, it drastically under-performed on
unseen data, such as the Philips scans from CENTER-TBI. Tract segmentation via regis-
tration (JHU) tract segmentation was more robust but less precise. Therefore, future work
will need to focus on multi-centre WM parcellation to allow a reliable analysis of the whole
CENTER-TBI database. This could involve either data harmonisation prior to the parcel-
lation or designing models that learn to adapt to different domains.
Harmonisation of DWI for Multi-Centre Studies. Diffusion MRI harmonisation
remains an open research question. One of the limitations in the experiments presented
here was the low sample size. Both the linear RISH feature scaling and neural networks
would benefit from including more data. However, acquiring data for travelling healthy
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controls is expensive and highly unpractical for large multi-centre studies. Even collecting
MRI data for enough matched (e.g. age, sex) control subjects is challenging. With respect
to CENTER-TBI, only a maximum nine healthy volunteers were scanned per site. Since
most of these volunteers are different for each scanner, matching controls will be difficult.
Furthermore, a small number of control subjects may not reflect the full data distribution,
which could skew any analysis following the harmonisation. Therefore, new methods will
need to be developed that can be applied to small datasets of possibly unmatched controls.
Furthermore, the methods investigated here all aim to project one database to another.
This is infeasible for multi-centre studies as one mapping for each individual database would
need to be learned which makes data harmonisation less robust. A key development will be
simultaneous representation learning of diffusion MRI, such that the information of all data
can be leveraged at once. Possibly this would also allow the inclusion of patient data in the
learning process. Instead of learning a mapping between control subjects to harmonise pa-
tient data before analysis, a strong model could learn to reduce site-specific variation while
simultaneously finding disease related differences. This could especially be advantageous for
studies such as CENTER-TBI where control subjects are limited. In addition, non-imaging
characteristics could be directly incorporated during the learning phase. One challenge, how-
ever, will be the interpretability of the neural network’s decisions to infer clinically relevant
information. Another research direction could focus on disentangling the different effects
that lead to site-related biases. If the influences of different acquisition parameters could be
differentiated from hardware induced effects, control subjects from another study, imaged
with different MRI protocol but on the same scanner, could help to learn site-specific biases.
Disentanglement learning is, however, a fairly new research field.
Lesions Analysis in Severe TBI. Lesion analysis is an important factor to examine
severe TBI cohorts. Two algorithms were introduced to foster automated examination of
FLAIR lesions. The region-based localisation of lesion is highly dependent on the atlas em-
ployed. If the atlas is too crude, it is difficult to actually locate lesions. For example, the
MALP-EM atlas does not parcellate WM regions. With WM as the largest region, almost
any lesion was located within WM, which makes differentiation of lesions by location more
difficult. On the other hand if the parcellation is too fine, a lesion will be present in many
small regions, which may hamper the identification of a distinct lesion location. Future
experiments will need to investigate the use of different atlases and the automated extrac-
tion of addition quantifiable measures (for example sphericity or surface area of a lesion).
If lesions are more prone to grow than others, therapy could focus on those. Therefore,
besides assessing the momentary characteristics of a lesion on one scan, it is important to
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understand the lesion evolution over time. The lesion matching algorithm was designed to
connect individual lesion clusters between initial and follow-up scan. Since this algorithm
is based on registration and overlap of lesion annotations, it is prone to fail to match small
lesions. This can lead to spurious results as small lesions may appear to be salvageable or
appear at a later stage. More experiments on a larger database are needed to understand
the full potential. Once lesions will be segmented automatically for the full CENTER-TBI
database, these algorithms will be applicable to investigate the connection between extracted
lesion characteristics and clinical variables (e.g. outcome or mortality) on a larger scale.
7.3 Conclusion
Neuroimaging studies are increasing in size. While this can beneficial for data analysis to
boost statistical power and examine bigger patient cohorts, this comes also with challenges.
Databases need to be managed and processed in an efficient and transparent way that fos-
ters reproducible data analysis. Flexible processing pipeline that robustly remove artefact
and extract image derived features, while being adaptive to the needs of different databases,
support answering clinical neuroscience questions. These are particularly complex for het-
erogeneous databases such as TBI patient cohorts. Depending on the severity of the injury,
patients show diffuse axonal injury best observed on diffusion MRI, or clearly visible lesions.
This high variability in pathology requires different analysis strategies. While the challenge
for mTBI cases lies in detecting very subtle differences between patients, severe TBI cases
may benefit from extraction of lesion characteristics. Generally, collecting big neuroimaging
data is challenging which is why there is demand to merge databases across sites. This
can happen retrospectively for independent studies, or as part of a prospectively designed
multi-centre study. Either way, pooling data from different centres comes with increased
variation. Acquisition dependent biases are inherently introduced and need to be accounted
for. Especially for diffusion MRI for which angular resolution and the strength and duration
of the applied gradients strongly influence the measured diffusion signal. Newest develop-
ments in MRI data harmonisation showed the great success of deep learning neural networks
to minimise site-specific biases, however, more experiments are needed to fully understand
the potential for clinical analysis of TBI data. Big databases, such as CENTER-TBI, and
advanced algorithms make TBI research an exiting field that still holds many challenges.
The hope is that larger datasets, more consistent pre-processing tools and improved data
harmonisation methods will help to analyse TBI cohorts to ultimately lead to revelations
that improve patient care.
Appendix A
Table A.1: P-Values After FDR Correction for Comparison of TractSeg ROI Mean FA





P1-P2 T1-T2 P1-T1 P1-T1 P2-T1 P2-T2
FA
14 0.0060 0.4021 0.9177 0.0049 0.0076 0.0613 0.0720
17 0.0157 0.0419 0.3799 0.0419 0.0640 0.0776 0.2369
18 0.0094 0.1580 0.9113 0.0058 0.0248 0.0341 0.1157
28 0.0157 0.0077 0.8507 0.0521 0.0236 0.1255 0.0671
31 0.0405 0.2440 0.9996 0.0132 0.0148 0.2440 0.2440
32 0.0116 0.0133 0.9658 0.0156 0.0156 0.1395 0.2797
33 0.0001 0.0941 0.9065 0.0000 0.0006 0.0182 0.0286
41 0.0000 0.1965 0.2454 0.0033 0.0007 0.0078 0.0016
45 0.0157 0.0405 0.9467 0.0828 0.1073 0.0405 0.0562
50 0.0157 0.2874 0.2874 0.0536 0.0536 0.1488 0.1003
52 0.0129 0.3720 0.8004 0.0197 0.0189 0.0829 0.0829
58 0.0040 0.1873 0.8554 0.0414 0.0128 0.0251 0.0128
64 0.0321 0.2533 0.2533 0.0588 0.0588 0.2303 0.1578
66 0.0163 0.4278 0.5731 0.0274 0.0155 0.1443 0.1198
ROIs: 0: left arcuate fascicle, 6: genu, 7: rostral body of CC, 22: left inferior cerebellar
peduncle, 25: right IFO, 30: right optic radiation, 31: left parieto-occipital pontine, 32:
right parieto-occipital pontine, 36: right SLFI , 45: CC, 48: left thalamo-premotor tract, 57:
right thalamo-occipital tract, 71: right striato-occipital tract. Scans: P1: Prisma scan #1,
P2: Prisma scan #2, T1: Trio scan #1, T2: Trio scan #2.
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Table A.2: P-Values After FDR Correction for Comparison of TractSeg ROI Mean MD





P1-P2 T1-T2 P1-T1 P1-T1 P2-T1 P2-T2
MD
5 0.0333 0.2757 0.5226 0.0998 0.1502 0.0998 0.0998
6 0.0149 0.4974 0.1078 0.0733 0.0733 0.0768 0.0768
9 0.0395 0.4232 0.4232 0.1560 0.1560 0.1560 0.1560
10 0.0164 0.3067 0.4024 0.0783 0.1968 0.0537 0.1289
14 0.0131 0.3854 0.7387 0.0057 0.0218 0.1268 0.1268
18 0.0164 0.3438 0.8842 0.0081 0.0081 0.2077 0.2077
20 0.0186 0.2993 0.0279 0.7648 0.1002 0.1284 0.0279
21 0.0163 0.6538 0.2363 0.1361 0.0660 0.0707 0.0583
22 0.0117 0.6179 0.4133 0.0190 0.0190 0.1356 0.0190
23 0.0027 0.4060 0.4060 0.0211 0.0131 0.0131 0.0131
24 0.0161 0.5126 0.2198 0.0825 0.1338 0.0519 0.0825
26 0.0159 0.5372 0.1369 0.0713 0.0454 0.1063 0.0282
27 0.0285 0.3001 0.1370 0.1370 0.1370 0.1370 0.1370
28 0.0004 0.6087 0.6087 0.0057 0.0040 0.0205 0.0057
30 0.0200 0.1145 0.1472 0.1159 0.1145 0.1159 0.1145
33 0.0016 0.4546 0.7146 0.0020 0.0021 0.0446 0.0261
34 0.0004 0.2149 0.7085 0.0044 0.0048 0.0054 0.0248
36 0.0094 0.7743 0.2857 0.0438 0.1112 0.0300 0.0678
41 0.0006 0.1460 0.4354 0.0016 0.0062 0.0323 0.0323
45 0.0015 0.3929 0.1415 0.0196 0.0394 0.0196 0.0394
51 0.0103 0.1159 0.4680 0.0378 0.1159 0.0127 0.0378
53 0.0004 0.1016 0.5783 0.0013 0.0194 0.0008 0.0167
54 0.0347 0.4286 0.4705 0.0611 0.2813 0.0611 0.1962
55 0.0175 0.3381 0.4923 0.0988 0.1888 0.0609 0.1198
57 0.0163 0.5059 0.1373 0.1249 0.1040 0.1363 0.1040
65 0.0044 0.1344 0.3487 0.0297 0.1200 0.0074 0.0297
67 0.0004 0.1711 0.4556 0.0007 0.0157 0.0001 0.0131
68 0.0175 0.3594 0.3594 0.0564 0.1880 0.0564 0.1419
69 0.0164 0.2132 0.4434 0.1025 0.1856 0.0552 0.1025
71 0.0175 0.1426 0.4318 0.0738 0.0738 0.0738 0.0738
ROIs: 0: left arcuate fascicle, 6: genu of corpus callosum, 7: rostral body of corpus callosum,
22: left inferior cerebellar peduncle, 25: right IFO fascicle, 30: right optic radiation, 31: left
parieto-occipital pontine, 32: right parieto-occipital pontine, 36: right superior longitudinal
fasicle I, 45: full corpus callosum, 48: left thalamo-premotor, 57: right thalamo-occipital,
71: right striato-occipital. Scans: P1: Prisma scan #1, P2: Prisma scan #2, T1: Trio scan
#1, T2: Trio scan #2.
198 APPENDIX A.
Table A.3: P-Values After FDR Correction for Comparison of JHU ROI Mean DTI Metrics





P1-P2 T1-T2 P1-T1 P1-T1 P2-T1 P2-T2
FA
0 0.0327 0.1230 0.7117 0.0944 0.1148 0.1837 0.2866
1 0.0002 0.0413 0.7112 0.0042 0.0042 0.0413 0.0065
2 0.0001 0.2382 0.2382 0.0017 0.0021 0.0017 0.0132
6 0.0032 0.9136 0.0662 0.0085 0.0662 0.0085 0.1444
9 0.0151 0.7641 0.9010 0.0889 0.0550 0.0550 0.0051
14 0.0026 0.2890 0.8990 0.0043 0.0098 0.0858 0.0679
18 0.0471 0.3484 0.3484 0.0352 0.2030 0.2482 0.2616
MD
0 0.0011 0.1790 0.8637 0.0202 0.0202 0.0202 0.0299
1 0.0021 0.2882 0.8223 0.0207 0.0209 0.0207 0.0455
2 0.0007 0.5181 0.7019 0.0048 0.0048 0.0048 0.0128
4 0.0255 0.4138 0.5224 0.1033 0.1033 0.1182 0.1381
6 0.0031 0.5208 0.7153 0.0389 0.0094 0.0971 0.0161
7 0.0226 0.9535 0.0050 0.2173 0.0728 0.2156 0.0728
12 0.0022 0.1880 0.4423 0.0270 0.0270 0.0270 0.0270
13 0.0031 0.5581 0.3812 0.0763 0.0344 0.0763 0.0344
14 0.0200 0.4770 0.4992 0.0031 0.0405 0.2046 0.2046
18 0.0022 0.4397 0.3083 0.0007 0.0048 0.0806 0.0698
ROIs: 0: left anterior thalamic radiation, 1: right anterior thalamic radiation, 2: left CST,
4: left CG, 6: left hypocampal cingulate, 7: right hypocampal cingulate, 9: forceps minor,12:
left ILF, 13: right ILF, 14: left SLF, 18: left SLF. Scans: P1: Prisma scan #1, P2: Prisma
scan #2, T1: Trio scan #1, T2: Trio scan #2.
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Figure A.1: TractSeg Volume Distribution for CENTER-TBI. Volume distributions in dif-
ferent CENTER-TBI imaging sites. Left: The corpus callosum (ROI #45) as largest seg-
mented region in the TractSeg atlas was segmented for in all centres, however, much lower
volumes on Philips scanners (G, H, L) were observed. Right: Volumes of the left striato-
occipital tract (ROI #69), measured on Philips scans, were strongly undersegmented in
comparison to all other centres that employed a different vendor (i.e. GE or Siemens). This
region is representative for many other undersegmented ROIs on Philips data.
Table 7.4: Effect Size of Harmonisation Methods on Control Subjects from CENTER-TBI.
Cohen’s effect size d was computed between global RMSE values. Effect sizes can be small
(d = ±0.2), medium (d = ±0.5) or large (d = ±0.8).
Method #1 Method #2 b0 RISH0 RISH2 RISH4
Inter-Scanner Linear-RISH 0.97 1.14 1.40 -0.31
Inter-Scanner Global Scaling 0.89 1.17 1.22 -1.08
Inter-Scanner CNN Multi-Path 1.38 1.37 1.73 1.61
Linear-RISH Global Scaling 0.10 0.06 -0.37 -0.95
Linear-RISH CNN Multi-Path 1.03 0.55 1.18 1.72
Global Scaling CNN Multi-Path 1.03 0.49 1.31 1.75
Cohen’s effect size measure: d = (x − y)/σ, with x and y representing the mean of the
RMSE (between the corresponding images from both scanners) for method #1 and method
#2, respectively. σ represents the pooled standard deviation of the RMSE of both methods.
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[198] Máıra Siqueira Pinto, Roberto Paolella, Thibo Billiet, Pieter Van Dyck, Pieter-Jan Guns,
Ben Jeurissen, Annemie Ribbens, Arnold J den Dekker, and Jan Sijbers. Harmonization of
brain diffusion mri: Concepts and methods. Frontiers in Neuroscience, 14, 2020.
[199] Eric Plitman, Aurelie Bussy, Vanessa Valiquette, Alyssa Salaciak, Raihaan Patel, Marie-Lise
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